data_2n40_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n40 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.98 161.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.617 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -154.81 154.23 32.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.77 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -96.99 149.03 22.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.646 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.477 HH12 ' CG2' ' A' ' 22' ' ' VAL . 14.6 ptp180 -136.66 149.02 47.73 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.427 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -144.61 159.18 43.23 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.86 140.43 36.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -83.31 -43.27 16.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 t -96.43 25.96 4.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.76 -126.92 0.95 Allowed Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.697 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -150.24 -90.13 0.07 Allowed 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 120.997 0.427 . . . . 0.0 110.334 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.75 80.64 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.16 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -130.31 32.57 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -116.63 121.1 40.72 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.249 0.547 . . . . 0.0 110.657 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 p -100.28 169.11 9.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.384 0.611 . . . . 0.0 110.502 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -56.79 -49.86 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.415 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.91 73.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.91 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -67.32 -49.98 61.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.422 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -33.54 52.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 7.0 tptm -71.48 -33.22 69.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.399 0.619 . . . . 0.0 110.748 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.43 27.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.805 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.477 ' CG2' HH12 ' A' ' 5' ' ' ARG . 7.2 p -60.11 -36.63 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' C ' ' H ' ' A' ' 25' ' ' PHE . 1.3 m -103.34 178.06 4.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.4 -14.48 0.33 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.656 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' H ' ' C ' ' A' ' 23' ' ' CYS . 92.5 t80 -61.42 -47.99 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.685 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -89.64 20.35 4.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.91 79.75 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -72.01 -168.77 10.87 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 79.9 m80 -155.49 144.58 20.78 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.605 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.6 mm? -67.01 135.91 54.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -60.72 140.85 57.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.248 0.547 . . . . 0.0 110.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 p -122.1 178.29 4.98 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.924 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.21 -53.34 59.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.684 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -54.13 -49.28 69.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 110.472 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -66.88 -38.44 86.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.942 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.22 -43.77 98.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.364 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -55.26 -49.36 72.26 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.26 -29.63 10.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.836 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -37.13 36.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.511 ' NH2' ' C ' ' A' ' 61' ' ' ILE . 46.7 mmm-85 -55.82 -32.36 63.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.326 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -71.07 -4.22 23.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.739 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 84.1 mt -108.41 9.18 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.392 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.61 17.91 53.39 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -72.44 123.23 22.66 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.81 0.338 . . . . 0.0 110.173 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.555 ' HD1' ' H ' ' A' ' 62' ' ' VAL . 84.9 t60 -139.86 113.05 8.27 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.526 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -140.32 114.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.735 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -92.89 87.26 5.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.935 0.397 . . . . 0.0 110.242 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.85 138.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.604 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.02 132.53 39.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.637 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.48 148.99 21.08 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.903 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.69 152.24 39.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 75.6 mtm -153.08 -179.13 7.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.156 0.503 . . . . 0.0 110.319 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.8 143.61 0.34 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp 55.25 39.41 31.34 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.327 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.04 10.37 1.75 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.595 HH22 ' CG ' ' A' ' 77' ' ' ASP . 47.6 ttt-85 -65.98 142.23 57.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.424 0.63 . . . . 0.0 110.172 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -143.98 144.81 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.797 0.808 . . . . 0.0 110.818 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.82 167.59 40.64 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.523 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 25.2 p90 -133.3 78.47 63.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.512 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.16 139.61 71.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.095 1.864 . . . . 0.0 112.76 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' ' NH2' ' A' ' 40' ' ' ARG . 20.0 pt -150.83 134.39 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.858 0.837 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.555 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 61.2 t -62.8 -45.87 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.38 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -158.41 -62.3 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.78 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.49 143.17 87.4 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.866 1.711 . . . . 0.0 112.494 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.88 54.47 0.1 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.15 -49.59 0.49 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.645 2.23 . . . . 0.0 111.956 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -66.46 -39.09 88.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.81 132.68 36.77 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.246 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.14 50.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -159.88 103.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.435 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.31 -140.61 35.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 tttm 55.77 169.77 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.845 0.355 . . . . 0.0 110.469 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -136.31 157.25 47.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.52 151.3 6.37 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -40.3 144.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.689 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.16 45.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.535 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.595 ' CG ' HH22 ' A' ' 56' ' ' ARG . 1.9 p30 -68.71 145.77 53.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 110.472 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -90.24 -3.77 57.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.313 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 66.13 94.14 0.03 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 79' ' ' GLY . 63.5 mt 50.77 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -97.26 152.3 19.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.332 0.587 . . . . 0.0 110.173 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -85.45 -2.83 58.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.384 0.611 . . . . 0.0 110.277 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 85' ' ' SER . 97.7 m-20 -77.83 22.12 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.985 0.898 . . . . 0.0 110.561 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.2 mtt180 -51.68 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.125 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 83' ' ' ASN . 32.7 t -95.85 -25.62 15.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.638 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.04 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.458 0.646 . . . . 0.0 110.512 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 25.7 mtp180 -94.56 136.01 35.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 81.1 m95 -154.39 175.91 12.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -71.93 -164.44 0.13 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.545 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -162.41 149.74 13.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.465 0.65 . . . . 0.0 110.933 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -121.14 161.03 22.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.612 0.72 . . . . 0.0 110.451 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.91 -170.36 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.556 0.693 . . . . 0.0 110.182 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -161.23 151.48 17.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.368 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -145.11 146.33 30.33 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.288 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.496 1.656 0 C-N-CA 122.118 1.879 . . . . 0.0 112.084 179.326 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 144.01 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.276 0.56 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.89 161.3 26.88 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.72 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.61 140.19 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.75 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.504 HH21 ' ND2' ' A' ' 94' ' ' ASN . 38.3 mmt180 -103.59 161.9 13.5 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.454 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -142.37 134.2 27.03 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.379 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.69 166.74 15.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.716 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -68.38 -38.03 80.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.193 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -72.35 -18.3 61.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.34 0.591 . . . . 0.0 110.597 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 -154.7 16.78 Favored Glycine 0 N--CA 1.478 1.444 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 13' ' ' LYS . 68.8 mttm -115.33 -177.47 3.15 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.416 0.627 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 47.62 16.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.759 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' N ' ' C ' ' A' ' 11' ' ' LYS . 51.2 mtmt -128.52 26.35 5.65 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.777 0.322 . . . . 0.0 110.72 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 88' ' ' TRP . 48.4 mt -123.38 132.14 53.87 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.9 p -97.48 168.51 10.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.508 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 47.8 p90 -51.26 -54.21 28.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.973 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.78 -41.38 64.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.24 -51.45 37.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.755 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.27 13.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.07 -34.93 77.36 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.354 0.597 . . . . 0.0 110.663 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -53.03 59.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.886 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.4 -25.87 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.442 . . . . 0.0 110.506 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' PHE . 30.7 m -103.83 179.87 4.15 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.693 0.759 . . . . 0.0 109.247 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 67.17 -3.31 1.01 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.962 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' CYS . 89.7 t80 -61.82 -45.39 94.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.981 0.419 . . . . 0.0 110.869 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.4 pm0 -94.68 5.87 50.58 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.005 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.7 -22.52 39.36 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.5 143.1 38.25 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -98.72 153.38 18.77 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.742 0.305 . . . . 0.0 110.238 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -56.52 143.02 36.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.395 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -52.05 139.19 23.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.117 0.484 . . . . 0.0 110.735 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 ' CG2' ' H ' ' A' ' 33' ' ' TYR . 43.0 m -121.93 171.64 8.78 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.838 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.448 ' H ' ' CG2' ' A' ' 32' ' ' THR . 11.3 t80 -53.76 -53.42 52.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -58.76 -48.01 82.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.64 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.49 -36.62 81.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.243 0.544 . . . . 0.0 110.795 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 32' ' ' THR . 17.9 mt -62.12 -42.86 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.162 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.09 -31.15 40.38 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.04 79.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.815 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.31 -25.34 42.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -58.8 -35.98 73.73 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -72.66 -10.59 59.98 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.13 4.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.451 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 33.21 16.69 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -66.04 129.23 39.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.83 0.348 . . . . 0.0 110.508 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.612 ' HD1' ' H ' ' A' ' 62' ' ' VAL . 82.0 t60 -147.9 102.42 3.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.39 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.61 107.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.891 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -90.08 92.62 9.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.153 0.502 . . . . 0.0 110.106 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.71 109.84 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.08 138.92 56.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.92 163.84 34.44 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.25 160.42 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.277 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 77.3 mtm -156.12 -179.14 7.86 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.299 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.53 145.31 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.254 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 56' ' ' ARG . 55.5 tttm 56.95 42.51 26.16 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.99 10.94 0.5 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.79 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 54' ' ' LYS . 10.4 tpt180 -64.97 140.23 58.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.259 0.552 . . . . 0.0 110.47 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.11 161.98 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.106 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.4 177.44 37.77 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.854 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -145.37 81.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.329 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.41 135.5 60.91 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.185 1.923 . . . . 0.0 112.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -151.26 134.37 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.495 0.664 . . . . 0.0 110.833 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.612 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 62.1 t -65.21 -44.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.176 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -167.5 -61.46 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.064 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.61 156.5 65.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.771 1.648 . . . . 0.0 112.051 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' CA ' ' SG ' ' A' ' 68' ' ' CYS . . . -172.44 65.5 0.13 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.902 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.88 -44.97 35.69 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.268 1.979 . . . . 0.0 112.403 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.47 -24.76 45.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.719 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.421 ' SG ' ' CA ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -95.72 166.85 11.62 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.448 0.642 . . . . 0.0 110.031 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 71' ' ' GLY . . . -61.8 150.39 45.61 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.384 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 71' ' ' GLY . 45.3 p90 -76.29 29.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 110.581 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 69' ' ' GLY . . . -50.71 -105.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -141.9 -165.2 1.95 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.149 0.499 . . . . 0.0 110.322 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 p -94.67 160.84 14.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.467 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.55 168.69 0.44 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 54.0 mt -52.53 145.72 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.701 0.286 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.8 pt -149.85 -39.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -87.17 120.71 28.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.967 0.413 . . . . 0.0 110.613 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -145.05 -171.13 3.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.892 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.72 -179.69 48.99 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.3 mt -103.06 116.4 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -74.4 152.86 39.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.96 0.409 . . . . 0.0 110.051 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 84' ' ' ARG . 39.9 tp -84.45 -8.04 59.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.609 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 85' ' ' SER . 45.6 p-10 -74.66 23.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 110.64 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 82' ' ' LEU . 77.9 mtp180 -51.48 -5.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.594 -0.691 . . . . 0.0 111.448 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 83' ' ' ASN . 95.0 p -98.35 4.41 48.61 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -96.93 -140.0 0.28 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -158.23 147.04 19.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.494 0.664 . . . . 0.0 110.98 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.42 ' O ' ' O ' ' A' ' 14' ' ' LEU . 91.4 m95 -154.13 176.44 12.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.295 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.91 -165.21 0.2 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.889 0.852 . . . . 0.0 110.777 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -161.26 154.17 20.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.118 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 12.1 m-85 -148.24 156.21 42.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.467 0.651 . . . . 0.0 110.352 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 81.6 m -123.46 -166.69 1.5 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.778 0.799 . . . . 0.0 110.155 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -146.87 125.5 12.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.504 ' ND2' HH21 ' A' ' 5' ' ' ARG . 1.1 m-80 -103.31 154.03 38.03 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.874 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo . . . . . 0 N--CA 1.5 1.911 0 C-N-CA 121.75 1.633 . . . . 0.0 112.659 179.287 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.7 m -85.39 154.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.008 0.433 . . . . 0.0 110.806 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.486 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 34.2 p90 -138.58 169.2 18.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.873 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -73.64 132.85 43.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.227 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.486 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 61.8 ttm-85 -135.16 131.26 36.58 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.274 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -165.0 159.18 17.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.232 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.83 137.52 56.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.929 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.18 -39.65 75.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.03 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.0 m -113.08 -32.92 6.19 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.793 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 -134.29 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.626 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 12' ' ' TYR . 24.6 pttm -173.28 -35.7 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.044 0.45 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.441 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 82.7 m-85 -159.53 80.78 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -147.19 42.52 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 0.0 110.353 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -117.25 126.44 52.74 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.315 0.579 . . . . 0.0 110.788 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.452 ' HG1' ' NH1' ' A' ' 87' ' ' ARG . 91.6 m -103.68 164.66 11.53 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.855 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 15' ' ' THR . 59.5 t80 -54.31 -48.17 71.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.486 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.2 -45.76 75.89 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.898 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 8.3 mp0 -64.49 -45.41 87.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.49 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.28 -31.16 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.827 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.88 -51.32 41.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.598 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -59.72 -23.19 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.978 0.418 . . . . 0.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.493 ' C ' ' H ' ' A' ' 25' ' ' PHE . 57.4 m -104.89 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 109.59 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 73.99 -26.12 0.19 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.873 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.0 t80 -59.78 -49.05 79.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.947 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.96 17.47 12.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.13 5.61 82.81 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -79.47 -175.53 47.67 Favored Glycine 0 C--O 1.219 -0.822 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 89.4 m-70 -154.96 158.52 39.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 136.93 57.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.044 0.449 . . . . 0.0 110.368 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 85.61 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.431 ' CG2' ' H ' ' A' ' 33' ' ' TYR . 40.9 m -71.05 170.36 13.02 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.431 ' H ' ' CG2' ' A' ' 32' ' ' THR . 26.1 t80 -55.37 -53.19 59.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.724 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.1 -49.14 77.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.577 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -66.34 -36.25 82.42 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.82 -43.75 98.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.541 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -49.72 -44.59 48.42 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.84 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.697 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.65 44.54 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.046 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.567 HH22 ' H ' ' A' ' 46' ' ' VAL . 12.1 mmm180 -56.93 -30.82 64.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.61 -6.6 57.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.452 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 5.6 mm -103.02 4.98 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 5.28 53.75 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -68.79 119.41 13.12 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.44 0.62 . . . . 0.0 109.978 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -134.85 103.43 5.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.567 ' H ' HH22 ' A' ' 40' ' ' ARG . 39.7 t -141.27 132.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.728 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -114.36 92.69 4.05 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.69 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.39 127.29 4.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.22 104.78 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.405 0.621 . . . . 0.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -122.66 157.24 17.25 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.024 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.413 ' CE3' ' CG2' ' A' ' 57' ' ' VAL . 88.9 m95 -78.68 145.7 34.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.313 0.578 . . . . 0.0 110.143 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 2.1 mpp? -142.99 171.84 13.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.324 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -38.71 149.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.665 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.7 mttt 57.27 34.81 25.3 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.194 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.83 6.85 1.36 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.796 -0.565 . . . . 0.0 111.888 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 54' ' ' LYS . 59.8 ttt85 -62.32 131.21 48.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 110.065 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.413 ' CG2' ' CE3' ' A' ' 51' ' ' TRP . 2.3 t -127.88 126.59 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.985 0.898 . . . . 0.0 110.728 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.06 -172.31 25.06 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.289 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 78' ' ' TYR . 7.8 p90 -152.5 84.83 4.62 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 114.934 -0.633 . . . . 0.0 110.344 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.15 145.04 67.2 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.36 2.04 . . . . 0.0 112.49 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -136.78 103.51 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.45 -53.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.266 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -95.09 145.9 30.35 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.327 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -39.89 140.54 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.067 1.844 . . . . 0.0 112.322 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.56 99.91 0.19 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.991 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -16.09 19.23 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.19 1.927 . . . . 0.0 112.108 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -70.83 -34.73 71.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.109 0.48 . . . . 0.0 110.687 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.7 137.25 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.236 0.541 . . . . 0.0 110.384 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.46 79.31 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 49.54 79.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.719 0.295 . . . . 0.0 110.714 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.05 -123.14 32.05 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 55.76 163.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 74' ' ' GLY . 89.1 m -138.99 164.31 30.09 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.676 0.75 . . . . 0.0 110.666 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 73' ' ' THR . . . 73.96 153.71 3.02 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.4 mt -53.32 126.17 9.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-O 120.974 0.416 . . . . 0.0 110.367 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.472 ' O ' ' CE2' ' A' ' 78' ' ' TYR . 37.2 mm -107.84 118.37 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.191 0.52 . . . . 0.0 110.424 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.58 149.73 43.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.384 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 98.5 m-85 -131.36 -16.51 3.08 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -170.0 34.63 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.1 mt -103.83 123.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.688 0.756 . . . . 0.0 110.504 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 81' ' ' ARG . 0.5 OUTLIER -98.37 130.13 45.02 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.39 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 84' ' ' ARG . 27.6 mt -83.0 8.58 12.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 85' ' ' SER . 47.7 p-10 -71.86 22.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.672 1.225 . . . . 0.0 110.981 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.545 ' H ' ' C ' ' A' ' 82' ' ' LEU . 72.0 ttt180 -48.06 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.597 -0.689 . . . . 0.0 110.986 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 83' ' ' ASN . 57.3 m -68.22 -37.66 81.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.656 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.18 -169.17 1.94 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 110.645 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.452 ' NH1' ' HG1' ' A' ' 15' ' ' THR . 92.0 mtt-85 -134.03 144.93 48.98 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.552 0.691 . . . . 0.0 110.721 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.448 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 60.3 m95 -150.32 175.42 11.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.971 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 42.5 t0 -59.86 -179.7 0.1 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 111.085 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -165.65 159.73 16.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.344 0.593 . . . . 0.0 110.884 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.11 160.54 38.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.637 0.732 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.8 t -141.95 148.54 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.159 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -115.42 141.93 47.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.124 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -147.26 148.52 32.04 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.196 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.496 1.627 0 C-N-CA 122.463 2.109 . . . . 0.0 111.897 179.145 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 t -82.96 157.15 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.665 0.269 . . . . 0.0 110.718 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.565 ' HH ' HD22 ' A' ' 94' ' ' ASN . 48.7 p90 -162.68 155.52 19.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.769 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -75.61 135.1 40.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.616 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -141.97 139.74 32.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.224 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -140.8 152.38 45.13 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.13 159.12 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.079 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -49.14 9.99 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.0 m -114.0 19.0 16.86 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.606 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.12 -176.25 14.38 Favored Glycine 0 C--O 1.215 -1.082 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' H ' ' HZ3' ' A' ' 13' ' ' LYS . 99.6 mttt -147.0 106.23 3.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.193 -0.504 . . . . 0.0 110.49 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 56.53 17.25 2.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.537 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HZ3' ' H ' ' A' ' 11' ' ' LYS . 65.5 mttp -80.48 38.64 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.44 117.12 30.85 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.264 0.554 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.9 m -101.58 163.62 12.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -53.85 -49.75 67.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.335 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.93 78.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.891 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.07 -49.28 70.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.713 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.6 -30.16 41.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' CYS . 44.1 tptt -60.93 -37.37 82.1 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.303 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.45 -54.2 13.3 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.449 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.49 -42.78 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.999 0.428 . . . . 0.0 110.788 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.563 ' C ' ' H ' ' A' ' 25' ' ' PHE . 62.1 m -100.51 173.42 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.454 ' OE1' ' NZ ' ' A' ' 20' ' ' LYS . 70.9 tt0 63.04 -7.98 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.93 -47.1 86.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.774 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -87.98 21.29 2.76 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.24 -1.2 84.33 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.81 -152.15 1.27 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 53.4 t-80 -168.67 152.74 5.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.642 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.465 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 44.0 mt -62.43 139.52 58.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.956 0.408 . . . . 0.0 110.438 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 103.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.998 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 36' ' ' LEU . 1.8 t -77.45 179.02 6.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.045 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.461 ' N ' ' OG1' ' A' ' 32' ' ' THR . 50.7 t80 -54.81 -53.65 52.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.1 -44.75 91.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.734 0.302 . . . . 0.0 110.71 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.475 ' H ' HG23 ' A' ' 32' ' ' THR . 78.8 mt-30 -71.38 -30.85 66.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 111.066 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.8 mt -63.48 -41.91 98.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -30.64 67.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.216 0.531 . . . . 0.0 110.674 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.89 65.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.828 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.74 -42.18 42.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.531 HH22 ' CA ' ' A' ' 61' ' ' ILE . 17.2 mmm180 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.161 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.36 -11.53 60.07 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.456 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 99.1 mt -96.71 4.13 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.21 9.6 55.44 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -66.85 125.36 25.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.949 0.374 . . . . 0.0 110.392 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -143.64 103.06 4.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.485 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.0 132.75 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.699 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.18 91.31 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.3 149.73 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.99 136.91 52.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.466 0.65 . . . . 0.0 110.884 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.89 -178.58 21.47 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.547 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -84.32 156.13 22.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.39 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.5 ptt? -158.16 -175.28 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.551 0.691 . . . . 0.0 110.101 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -30.71 144.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.574 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 55.35 15.46 1.39 Allowed 'General case' 0 C--O 1.2 -1.505 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.776 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 65.8 16.26 63.45 Favored Glycine 0 C--N 1.315 -0.623 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -66.59 154.5 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 0.0 110.007 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.9 118.12 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.862 0.839 . . . . 0.0 110.942 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 59' ' ' TYR . . . -113.73 -175.86 19.14 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 6.1 m-85 -141.66 69.72 25.34 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 115.065 -0.568 . . . . 0.0 110.291 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -52.62 115.32 2.15 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.72 1.614 . . . . 0.0 112.559 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.531 ' CA ' HH22 ' A' ' 40' ' ' ARG . 97.8 mt -145.58 118.23 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.607 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 66.8 t -74.73 -22.33 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 0.0 110.083 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -165.65 148.24 6.59 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.312 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -39.63 143.87 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.878 1.719 . . . . 0.0 112.926 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.91 167.79 25.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.457 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.97 -43.29 0.8 Allowed 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.164 1.91 . . . . 0.0 112.317 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -64.88 -35.21 80.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.46 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.17 113.47 25.74 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.216 0.531 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 145.65 29.03 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 45.5 -97.32 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.46 104.5 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.81 -161.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 110.148 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.2 p -94.59 150.62 20.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.429 0.633 . . . . 0.0 110.423 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 167.48 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.91 131.7 28.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 110.17 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.6 mt -86.64 126.0 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -66.66 133.68 50.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.486 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -143.81 156.45 44.49 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.754 0.787 . . . . 0.0 110.227 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.38 -161.0 34.67 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 85.6 mt -97.77 96.88 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.44 0.638 . . . . 0.0 110.193 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -71.52 141.94 50.12 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.262 0.553 . . . . 0.0 110.423 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 84' ' ' ARG . 24.1 tp -82.11 3.8 25.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.14 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 85' ' ' SER . 38.7 p-10 -76.06 20.44 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.916 0.865 . . . . 0.0 110.574 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 82' ' ' LEU . 80.9 mtp180 -54.94 -1.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.782 -0.574 . . . . 0.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 83' ' ' ASN . 96.7 p -94.94 -4.6 46.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.428 ' CD ' ' HE1' ' A' ' 88' ' ' TRP . 80.7 tt0 -94.98 154.08 17.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 83.4 mtm180 -86.17 136.81 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 110.651 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.1 m95 -153.2 176.84 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.328 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 30.9 t0 -73.55 -169.29 0.66 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.565 0.698 . . . . 0.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.47 153.88 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.499 0.666 . . . . 0.0 110.873 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.28 157.36 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.757 0.789 . . . . 0.0 110.371 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.53 -173.62 3.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.496 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -160.04 113.56 2.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.181 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.565 HD22 ' HH ' ' A' ' 3' ' ' TYR . 2.9 p30 -153.81 150.95 23.95 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.032 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.306 -1.688 0 C-N-CA 121.902 1.735 . . . . 0.0 111.581 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -147.47 130.14 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.89 0.376 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -105.35 129.55 53.66 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.831 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -79.36 149.34 31.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.759 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -128.43 154.52 45.97 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -160.94 133.14 5.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.394 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.88 31.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -75.7 -42.35 51.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.532 0.682 . . . . 0.0 110.997 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 p -109.58 25.75 11.43 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.624 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.68 -142.95 3.54 Favored Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.743 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -162.38 87.09 0.61 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.111 0.481 . . . . 0.0 110.526 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 2.3 m-85 72.39 21.71 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -74.1 48.04 0.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.408 -0.183 . . . . 0.0 110.758 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.99 130.12 52.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.543 0.687 . . . . 0.0 110.904 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.0 p -101.38 170.23 8.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -56.26 -50.19 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.91 86.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.041 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -51.74 39.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.71 -30.34 13.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' CYS . 28.8 ttpt -67.92 -33.6 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.514 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -51.91 63.32 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 111.56 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.24 -38.72 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.207 0.527 . . . . 0.0 110.71 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' C ' ' H ' ' A' ' 25' ' ' PHE . 56.8 m -101.17 178.8 4.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.871 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' GLY . 36.1 tt0 72.68 -27.28 0.18 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.7 t80 -61.27 -46.62 89.58 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 110.799 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.1 pm0 -86.49 11.74 11.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -23.1 33.79 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -78.51 134.27 13.91 Favored Glycine 0 C--O 1.22 -0.738 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.44 173.34 6.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.83 137.61 56.73 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.244 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.97 139.54 46.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.429 0.633 . . . . 0.0 110.819 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 36' ' ' LEU . 2.4 p -122.27 174.35 7.04 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.921 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -59.71 -52.83 63.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.91 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.87 -45.25 95.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.927 0.394 . . . . 0.0 110.485 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.11 -34.73 75.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.639 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.7 mt -62.53 -41.14 98.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.467 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -53.89 -40.82 66.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.755 0.312 . . . . 0.0 110.884 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.83 97.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.081 0.467 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.56 -25.47 26.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 61' ' ' ILE . 1.1 tpt85 -56.41 -25.74 51.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.593 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -81.49 -1.35 45.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.508 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 tt -91.65 6.31 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.13 26.24 34.62 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -70.55 131.23 43.67 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.83 0.315 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.65 101.77 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -143.43 133.07 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.14 78.74 6.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.862 0.363 . . . . 0.0 110.027 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.38 92.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.472 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.07 39.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.628 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.05 165.59 20.97 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.814 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -72.14 104.97 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.385 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.47 ' O ' ' N ' ' A' ' 55' ' ' GLY . 71.4 mtm -97.31 -178.33 4.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.25 0.548 . . . . 0.0 110.418 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -32.07 144.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.769 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 mttp 54.4 9.27 0.24 Allowed 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.224 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 81.86 20.87 62.49 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.045 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.438 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 69.2 ttt180 -70.38 130.01 40.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.428 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.2 p -116.57 133.09 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.806 0.812 . . . . 0.0 110.745 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.46 157.18 28.81 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -113.11 106.07 55.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.448 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 87.8 Cg_endo -79.05 126.93 7.36 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.101 1.201 . . . . 0.0 112.234 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 17.1 pt -145.97 137.95 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.831 0.824 . . . . 0.0 110.875 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.77 -45.36 98.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.285 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.574 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -168.5 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.574 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 31.8 Cg_exo -60.64 147.95 93.04 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.231 1.954 . . . . 0.0 112.164 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.461 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -156.73 50.53 0.44 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.371 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.3 Cg_endo -66.55 -53.41 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.321 2.014 . . . . 0.0 111.943 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.77 -23.19 31.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.56 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 12.1 p -151.03 124.94 9.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.56 110.5 0.25 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -144.09 -53.1 0.33 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.14 -72.7 0.58 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -172.36 -157.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 0.0 110.669 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 p -114.89 166.37 11.85 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 68.41 68.32 1.69 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' GLY . 71.9 mt 56.44 128.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.587 -0.307 . . . . 0.0 110.899 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.46 118.15 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 120.992 0.425 . . . . 0.0 110.379 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 91.9 m-20 -92.54 108.1 19.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.496 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.488 ' CE1' ' OH ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -95.93 -11.55 26.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.1 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.98 -174.51 44.16 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.5 mp -96.61 116.87 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.212 0.53 . . . . 0.0 110.556 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.503 ' CZ ' HD22 ' A' ' 83' ' ' ASN . 79.8 mtp180 -92.91 133.85 35.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.112 0.482 . . . . 0.0 110.162 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 tp -83.35 4.65 26.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 110.308 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.503 HD22 ' CZ ' ' A' ' 81' ' ' ARG . 51.4 p30 -85.66 23.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.487 0.661 . . . . 0.0 110.537 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -44.31 -32.08 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.566 -0.709 . . . . 0.0 111.261 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.1 p -49.08 -21.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.009 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -70.51 -169.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.12 0.486 . . . . 0.0 110.743 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 84.1 mtt85 -130.2 129.81 43.87 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.373 0.606 . . . . 0.0 110.776 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.428 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.4 m95 -150.1 175.71 11.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.908 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD2' ' CD1' ' A' ' 12' ' ' TYR . 1.3 m-20 -55.69 -174.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.86 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.47 143.07 18.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.425 0.631 . . . . 0.0 110.935 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -115.43 160.08 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.008 0.909 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.88 179.71 6.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -133.36 116.7 16.4 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.183 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -149.41 88.47 5.0 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.045 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.307 -1.607 0 C-N-CA 121.398 1.399 . . . . 0.0 111.559 -179.68 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.98 136.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 110.742 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.6 162.41 37.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.972 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -74.91 129.06 37.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -135.03 133.3 39.25 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.216 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -157.05 156.03 32.17 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.65 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.16 -37.02 34.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.094 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.3 m -84.71 -5.21 59.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.63 -118.65 0.81 Allowed Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.159 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -167.53 -39.94 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.36 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -146.76 67.16 1.16 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.978 0.418 . . . . 0.0 110.517 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.09 32.92 3.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.3 118.72 32.0 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.649 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -90.32 168.31 11.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.656 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 38.5 p90 -51.64 -60.23 3.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -53.16 -40.24 64.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -66.24 -47.96 72.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.64 -35.87 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.795 0.331 . . . . 0.0 110.849 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' CYS . 56.6 mtpt -68.9 -31.31 70.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.86 45.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.884 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.82 -33.87 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.709 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.462 ' C ' ' H ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -104.71 -178.45 3.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 109.586 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 96.4 mt-10 69.77 -10.28 0.62 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.923 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' H ' ' C ' ' A' ' 23' ' ' CYS . 90.5 t80 -60.48 -47.25 86.95 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 18.0 pt-20 -87.39 21.37 2.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.46 76.26 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.11 -171.28 40.45 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.467 ' HE2' ' NE2' ' A' ' 35' ' ' GLN . 47.3 p-80 -163.45 121.07 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.679 0.276 . . . . 0.0 110.451 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -42.15 136.98 2.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.701 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -66.12 144.66 56.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -123.21 177.3 5.63 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.075 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -51.6 -26.74 9.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.474 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -70.66 -56.33 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.467 ' NE2' ' HE2' ' A' ' 29' ' ' HIS . 84.1 mt-30 -69.76 -35.29 74.82 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.859 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.7 mt -61.07 -40.85 95.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.419 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.72 -34.14 71.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.541 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.2 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 110.785 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.97 66.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -56.59 -43.47 80.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.402 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.77 -11.4 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.2 mt -98.54 7.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.49 22.08 52.05 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.47 132.78 46.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.751 0.31 . . . . 0.0 110.585 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -154.23 105.38 2.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -141.71 127.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.879 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.38 82.56 1.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.82 118.21 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.721 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.99 151.04 21.19 Favored Glycine 0 N--CA 1.476 1.336 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.12 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -73.13 147.5 44.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.166 0.508 . . . . 0.0 110.258 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 48.9 mtm -150.0 179.96 7.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.018 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.8 141.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.835 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 55.39 12.37 0.72 Allowed 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.179 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 75.62 21.59 76.75 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.808 -0.558 . . . . 0.0 112.158 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -74.36 135.89 42.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.209 0.528 . . . . 0.0 110.579 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -143.41 156.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.667 0.746 . . . . 0.0 110.783 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.69 -178.47 44.6 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.271 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -116.46 67.04 3.51 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.879 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.29 118.78 5.68 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.762 1.642 . . . . 0.0 112.419 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.2 pt -145.02 147.98 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.682 0.753 . . . . 0.0 110.88 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.71 -66.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.338 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.686 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 17.7 mttt -144.76 -43.07 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.303 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.686 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 28.0 Cg_exo -63.32 150.14 89.36 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.211 1.941 . . . . 0.0 112.371 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -168.88 49.32 0.22 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.493 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.8 Cg_endo -66.73 -53.19 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.428 2.085 . . . . 0.0 112.118 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -74.4 -17.05 60.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.24 132.1 1.02 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.95 41.4 0.03 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.64 -41.82 98.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 110.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.47 -84.67 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -170.93 -156.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.213 . . . . 0.0 110.472 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.3 p -95.3 162.22 13.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.328 0.585 . . . . 0.0 110.597 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.22 19.97 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.2 mt -102.67 123.34 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.097 0.475 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.9 mt -93.88 131.21 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.351 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.51 97.33 9.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.373 0.606 . . . . 0.0 110.067 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.1 41.79 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.301 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 80' ' ' ILE . . . -91.06 -147.34 19.26 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 79' ' ' GLY . 11.5 mt 15.72 58.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.435 0.636 . . . . 0.0 111.238 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.572 ' CZ ' HD22 ' A' ' 83' ' ' ASN . 82.3 mtp180 -71.08 150.78 45.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.24 -16.6 58.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.14 0.495 . . . . 0.0 109.958 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.669 ' C ' ' H ' ' A' ' 85' ' ' SER . 9.1 p30 -91.52 25.18 2.73 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.381 0.61 . . . . 0.0 110.616 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -52.88 5.04 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.719 -0.613 . . . . 0.0 111.712 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.669 ' H ' ' C ' ' A' ' 83' ' ' ASN . 47.7 t -92.61 -8.47 44.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.413 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -85.97 -165.27 1.2 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.005 0.431 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -131.27 141.25 49.95 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.005 0.907 . . . . 0.0 110.849 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 61.7 m95 -153.07 177.26 10.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.862 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 12.4 t70 -60.71 -163.67 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.448 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -170.35 149.35 3.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.22 0.533 . . . . 0.0 110.759 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -118.21 135.32 54.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.458 0.647 . . . . 0.0 110.253 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.9 m -114.08 177.33 4.68 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.023 0.916 . . . . 0.0 109.637 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -150.43 151.41 32.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.441 ' ND2' ' OE2' ' A' ' 26' ' ' GLU . 29.8 t-20 -143.11 132.77 11.87 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.362 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.505 2.168 0 C-N-CA 122.05 1.834 . . . . 0.0 112.275 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.1 155.51 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.637 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -117.79 129.24 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.576 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -74.09 127.53 33.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 90' ' ' ALA . 24.0 ttm180 -146.06 128.78 16.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.037 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.9 pm0 -146.41 -176.82 5.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.468 0.48 . . . . 0.0 110.392 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.67 127.1 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -78.39 -33.96 48.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.846 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.82 -4.09 41.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.531 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.47 -95.16 0.1 Allowed Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.873 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -171.34 -81.5 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.917 0.389 . . . . 0.0 110.311 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.02 80.15 3.28 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.001 0.429 . . . . 0.0 110.622 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -137.61 34.62 2.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.153 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.519 0.676 . . . . 0.0 110.258 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 p -99.03 168.27 10.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.245 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.543 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 31.9 p90 -53.68 -53.56 50.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.543 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -55.12 -45.97 75.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.47 69.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.5 mttt -71.87 -40.27 69.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 0.0 110.715 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -46.64 84.53 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.33 -42.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.529 0.68 . . . . 0.0 110.94 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 20' ' ' LYS . 17.6 m -101.47 178.79 4.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.736 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 70.04 -45.78 0.59 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' CYS . 70.4 t80 -62.71 -48.02 81.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.41 21.82 3.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.022 0.439 . . . . 0.0 110.871 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.15 1.48 84.33 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.23 -171.38 9.54 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -168.41 137.03 2.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.557 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.94 141.27 47.82 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 110.25 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.3 93.96 0.35 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.291 0.567 . . . . 0.0 110.726 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.457 ' CG2' ' H ' ' A' ' 33' ' ' TYR . 34.0 m -86.01 171.66 11.24 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.898 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.457 ' H ' ' CG2' ' A' ' 32' ' ' THR . 66.7 t80 -55.53 -53.98 49.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.22 -45.05 84.21 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.542 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -70.05 -34.93 73.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 110.858 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.15 -40.87 98.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.15 -37.31 82.41 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.5 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.09 -39.77 93.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.71 -27.62 31.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.365 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -56.96 -25.0 57.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.268 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.56 -6.24 59.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -94.36 4.52 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.521 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.29 25.09 24.86 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -66.31 128.66 37.02 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.701 0.251 . . . . 0.0 110.59 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -150.03 103.19 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.278 0.561 . . . . 0.0 110.468 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.65 117.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.023 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.87 89.73 6.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.11 112.5 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.118 0.485 . . . . 0.0 110.618 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.45 137.21 52.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.905 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.98 -172.83 19.13 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.689 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.73 150.81 19.82 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.1 mtm -143.73 168.86 18.9 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.35 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.19 156.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.17 40.77 31.85 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.273 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.26 6.61 0.16 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.008 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 56.5 ttt180 -68.81 144.72 54.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.61 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.29 130.19 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.771 0.795 . . . . 0.0 110.786 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.76 175.59 45.08 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.433 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -167.55 143.19 3.33 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.724 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.11 146.68 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.184 1.922 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.2 mt -141.8 93.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.556 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.24 -36.76 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.031 0.443 . . . . 0.0 110.278 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -137.7 154.39 74.79 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.33 144.77 59.2 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.362 2.041 . . . . 0.0 112.0 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.75 179.72 20.76 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.37 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.8 -47.63 26.14 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 122.174 1.916 . . . . 0.0 112.598 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -138.41 28.69 2.47 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.3 p -151.34 150.5 30.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.381 0.61 . . . . 0.0 110.273 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.0 93.77 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.43 -44.7 96.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 110.597 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.21 -8.96 0.05 OUTLIER Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.16 155.78 38.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.708 0.289 . . . . 0.0 110.287 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -140.5 130.31 24.47 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.794 0.807 . . . . 0.0 110.598 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 75' ' ' ILE . . . 144.77 -47.02 0.78 Allowed Glycine 0 N--CA 1.465 0.625 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.195 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.438 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER 159.26 131.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 120.868 0.366 . . . . 0.0 110.607 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mm -111.24 62.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.58 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 44.5 p-10 -99.67 103.61 15.3 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.95 0.405 . . . . 0.0 110.296 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -71.17 -61.62 1.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.45 -147.44 13.09 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.515 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.0 mt -97.63 117.39 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.368 . . . . 0.0 110.074 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 50.8 mtp85 -94.24 133.5 37.7 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.54 3.34 28.96 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.592 0.71 . . . . 0.0 109.831 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 52.2 p-10 -81.66 26.2 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.846 0.832 . . . . 0.0 110.479 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -45.38 -36.35 4.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.543 -0.723 . . . . 0.0 111.262 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -45.57 -26.99 0.67 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.563 0.221 . . . . 0.0 110.99 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 8.7 mp0 -74.13 -173.08 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.932 0.872 . . . . 0.0 109.988 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -128.49 145.7 51.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.917 0.865 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -155.05 175.91 13.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.343 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 28.0 t0 -79.82 -168.36 1.57 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.72 0.771 . . . . 0.0 110.604 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -167.98 164.58 13.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.455 0.645 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.93 151.52 49.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.534 0.683 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.53 142.45 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.227 0.537 . . . . 0.0 110.308 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 94' ' ' ASN . 10.9 t80 -134.34 149.91 50.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.274 0.559 . . . . 0.0 110.312 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.482 ' N ' ' CD1' ' A' ' 93' ' ' TYR . 11.8 m120 -117.71 89.97 34.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.505 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo . . . . . 0 N--CA 1.501 1.932 0 C-N-CA 122.272 1.982 . . . . 0.0 112.537 -179.864 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.66 163.32 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -146.71 127.89 14.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.804 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -73.79 138.44 44.53 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -145.62 160.96 40.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.496 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.4 pm0 -160.92 -177.48 6.16 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.81 124.66 17.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -66.24 -39.62 89.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.018 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m -109.72 33.08 4.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.507 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.36 -134.1 1.63 Allowed Glycine 0 C--O 1.216 -1.002 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.798 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -154.87 -83.16 0.07 Allowed 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.325 -0.438 . . . . 0.0 110.424 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.61 28.78 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -94.81 33.74 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.903 0.382 . . . . 0.0 110.604 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.47 124.54 49.03 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.534 0.683 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.3 m -87.97 161.3 17.5 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.5 -43.74 96.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.388 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.24 62.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.957 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.46 -51.15 62.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -31.77 18.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 23' ' ' CYS . 10.5 mtpm? -70.59 -33.8 71.46 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 120.576 0.227 . . . . 0.0 110.567 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.54 74.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.133 0.492 . . . . 0.0 111.765 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.68 -44.31 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.251 0.548 . . . . 0.0 111.173 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' O ' ' O ' ' A' ' 20' ' ' LYS . 7.4 m -102.26 178.25 4.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.085 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 67.45 -39.32 0.37 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.9 t80 -60.0 -47.03 87.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.658 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.67 19.76 5.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.676 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.95 77.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.57 -165.75 22.11 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -167.95 137.89 2.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.201 . . . . 0.0 110.523 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.7 mp -70.54 137.4 50.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.917 0.389 . . . . 0.0 110.144 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.42 138.64 55.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 36' ' ' LEU . 11.1 p -100.31 163.71 12.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 22.9 p90 -54.4 -53.37 54.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.943 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.57 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 39.0 ttmt -62.28 -44.38 96.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.986 0.422 . . . . 0.0 110.334 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -67.06 -30.05 70.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.4 mt -62.41 -29.9 70.83 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.346 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.77 -39.36 58.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.407 . . . . 0.0 110.909 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.29 -38.03 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.83 28.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 42' ' ' ILE . 3.8 tpt85 -56.77 -37.47 71.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -63.48 -2.09 1.45 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.509 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.43 ' H ' ' C ' ' A' ' 40' ' ' ARG . 24.5 mm -106.39 13.46 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.347 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 18.93 66.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.77 127.49 33.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.885 0.343 . . . . 0.0 110.181 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -140.93 104.43 4.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.506 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.53 125.4 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.023 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -93.84 91.51 6.98 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.887 0.375 . . . . 0.0 110.303 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.28 93.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.11 121.37 19.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.479 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.59 162.6 25.82 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.961 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -80.29 109.34 14.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.39 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 40.1 mtm -97.87 -172.61 2.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.248 0.547 . . . . 0.0 110.251 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.02 152.93 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.583 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 56' ' ' ARG . 68.6 mttm 47.19 41.03 11.13 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.96 5.68 0.1 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.892 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 54' ' ' LYS . 54.8 mtp180 -68.37 128.91 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.3 122.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.806 0.812 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.81 150.74 12.16 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.516 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -160.53 140.36 8.26 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.607 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 143.37 31.59 Favored 'Trans proline' 0 N--CA 1.505 2.198 0 C-N-CA 121.632 1.555 . . . . 0.0 112.784 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.5 pt -149.49 96.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.435 0.636 . . . . 0.0 111.08 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -139.18 80.34 23.69 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.64 131.22 32.57 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 121.851 1.701 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.41 169.13 28.71 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.048 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.79 -18.4 47.43 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.504 2.136 . . . . 0.0 112.056 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -102.84 30.77 4.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.019 0.438 . . . . 0.0 110.537 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.42 -174.02 3.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.2 0.524 . . . . 0.0 110.502 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.21 135.87 34.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -73.19 134.0 44.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 72' ' ' LYS . . . 65.01 -154.93 49.37 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 71' ' ' GLY . 56.7 mtpt 54.15 109.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.197 . . . . 0.0 110.875 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -139.12 170.75 15.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.285 0.564 . . . . 0.0 110.824 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.04 68.66 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.7 mt 59.98 145.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.776 0.322 . . . . 0.0 110.39 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.43 136.28 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.11 0.481 . . . . 0.0 110.626 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -133.36 137.74 46.01 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.539 ' CZ ' ' NH2' ' A' ' 81' ' ' ARG . 9.2 t80 -143.21 -179.0 6.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.638 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.48 -69.06 1.17 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER 173.79 135.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.3 0.571 . . . . 0.0 109.98 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.539 ' NH2' ' CZ ' ' A' ' 78' ' ' TYR . 86.9 mtt-85 -111.4 133.49 53.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.232 0.539 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 mt -82.39 2.35 32.87 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.481 0.658 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -83.42 21.66 1.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.837 0.827 . . . . 0.0 110.656 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -48.91 -36.07 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.572 -0.705 . . . . 0.0 111.182 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -47.56 -30.8 3.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.564 0.221 . . . . 0.0 110.869 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.93 147.62 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.777 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 81.8 mtt85 -92.61 133.15 36.26 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.261 0.553 . . . . 0.0 110.569 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 66.6 m95 -151.53 175.62 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.17 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -63.64 -169.0 0.03 OUTLIER 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.726 0.641 . . . . 0.0 111.007 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.34 159.75 8.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.414 0.626 . . . . 0.0 111.106 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.55 156.95 40.01 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.592 0.711 . . . . 0.0 110.576 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.1 m -147.5 142.28 26.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.631 0.729 . . . . 0.0 110.002 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.32 114.67 13.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.833 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -102.96 105.96 48.14 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 118.079 -0.963 . . . . 0.0 111.163 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--N 1.308 -1.603 0 C-N-CA 121.063 1.176 . . . . 0.0 112.081 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.01 150.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -158.84 154.19 25.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -83.17 142.3 31.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -145.87 134.57 22.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 79.2 tt0 -134.48 161.03 36.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.11 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.11 133.69 38.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.525 0.678 . . . . 0.0 110.977 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 6' ' ' GLU . 86.2 mmt-85 -75.66 -39.37 57.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.834 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -113.53 -30.34 6.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.86 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.59 -170.22 43.71 Favored Glycine 0 C--O 1.216 -0.975 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -167.23 99.45 0.52 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 55.12 60.76 3.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.936 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -142.48 42.97 1.63 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.719 0.295 . . . . 0.0 110.683 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.15 137.91 53.62 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.405 0.622 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.4 p -101.65 166.62 10.6 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.766 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.583 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 33.0 p90 -51.89 -60.52 3.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -56.29 -36.36 68.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.918 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.81 -48.85 65.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.83 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.22 -30.64 7.36 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.025 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.5 mtpt -65.03 -26.37 68.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 -53.69 30.79 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.555 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.98 -33.7 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.994 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.633 ' C ' ' H ' ' A' ' 25' ' ' PHE . 56.1 m -102.88 176.11 5.26 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 64.7 -26.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.633 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.6 t80 -61.14 -47.83 84.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.854 0.359 . . . . 0.0 110.728 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.21 23.67 4.26 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.6 -5.15 84.48 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.56 -158.96 3.52 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -173.28 161.29 4.18 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.51 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.22 145.87 55.27 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.602 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.03 81.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.433 0.635 . . . . 0.0 111.145 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -62.45 152.24 34.95 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -57.93 -52.62 64.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.757 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -50.72 -49.69 57.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.587 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.17 -40.44 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.714 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.21 -40.65 96.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.3 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -63.89 -33.38 75.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.485 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.0 63.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.25 -32.32 19.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.262 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -52.47 -19.91 2.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.428 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -3.4 37.19 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.809 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tt -101.84 13.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.625 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 18.84 70.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.84 145.23 20.31 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.239 0.519 . . . . 0.0 110.326 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -140.85 132.56 27.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.708 0.766 . . . . 0.0 110.352 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.97 159.48 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.784 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.24 41.48 0.37 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.523 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.17 144.01 30.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.23 0.538 . . . . 0.0 110.595 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.46 34.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.618 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.32 -171.34 12.66 Favored Glycine 0 N--CA 1.48 1.598 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.05 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -99.12 150.04 22.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 110.054 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 42.2 ttm -134.44 161.19 35.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.117 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.8 136.93 1.84 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.2 mttp 56.77 38.03 29.21 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.598 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.84 15.47 2.29 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.836 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -75.12 50.94 0.5 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.69 0.281 . . . . 0.0 110.651 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 p -54.81 132.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.086 0.946 . . . . 0.0 110.765 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.27 71.71 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -71.23 142.99 87.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 121.161 -0.215 . . . . 0.0 111.546 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 156.47 53.75 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.511 1.474 . . . . 0.0 112.501 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.6 mt -144.13 94.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.64 -72.92 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -71.82 155.37 92.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -61.76 145.56 97.22 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.381 2.054 . . . . 0.0 111.899 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.61 83.97 0.24 Allowed Glycine 0 N--CA 1.472 1.058 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.91 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.36 -42.14 56.02 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.237 1.958 . . . . 0.0 112.322 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -98.13 23.75 7.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.701 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 4.2 p -177.7 111.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.393 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 72.21 16.61 77.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 50.85 -88.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.438 0.637 . . . . 0.0 110.803 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -158.74 18.99 0.29 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.74 126.77 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 110.164 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -94.18 172.36 8.27 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.07 -170.9 54.2 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.82 123.35 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.97 0.414 . . . . 0.0 110.714 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.9 mm -95.97 74.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.615 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -75.84 109.59 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.332 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -75.04 -4.3 37.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 50.22 69.53 1.05 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 79' ' ' GLY . 75.8 mt 56.04 120.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.071 0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -104.64 152.76 22.08 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.108 0.48 . . . . 0.0 110.388 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 84' ' ' ARG . 48.5 tp -85.93 -11.03 54.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 110.491 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 85' ' ' SER . 51.4 p30 -73.48 23.61 0.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.856 0.836 . . . . 0.0 110.508 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.3 mtt180 -47.95 -13.61 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.587 -0.696 . . . . 0.0 111.114 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.24 -32.23 26.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.717 0.294 . . . . 0.0 110.669 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.61 149.06 44.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.609 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -85.79 158.25 20.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.431 0.634 . . . . 0.0 110.507 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -155.43 179.81 8.82 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.249 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 43.6 t0 -75.31 -177.08 3.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.645 0.736 . . . . 0.0 110.765 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.502 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.82 158.19 30.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.32 159.0 44.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.672 0.749 . . . . 0.0 110.504 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.5 m -125.59 148.09 49.07 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.083 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -138.45 126.8 23.06 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 56.9 m-80 -68.41 148.83 98.18 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.709 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo . . . . . 0 C--N 1.307 -1.623 0 C-N-CA 121.993 1.795 . . . . 0.0 111.466 179.207 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.448 ' H1 ' ' H ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.448 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 35.0 m -83.14 155.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.802 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -146.99 148.67 31.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 110.794 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.74 136.8 34.62 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.754 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -102.63 158.78 16.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -141.1 113.79 8.28 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.448 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 173.75 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.61 86.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.074 0.464 . . . . 0.0 111.157 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.0 p -75.92 -7.18 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.445 0.641 . . . . 0.0 110.759 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 40.44 45.21 3.32 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 12' ' ' TYR . 53.3 tttp -152.8 46.56 0.71 Allowed 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 121.011 0.434 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.405 ' O ' ' O ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER 44.95 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -141.4 36.85 1.68 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.758 0.313 . . . . 0.0 110.486 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' TRP . 50.6 mt -123.88 137.94 54.56 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 16' ' ' TYR . 87.2 m -100.47 164.77 11.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.417 ' N ' ' CG2' ' A' ' 15' ' ' THR . 32.2 t80 -52.01 -58.5 6.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.51 84.83 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.957 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.06 -46.54 89.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.989 0.423 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.77 -29.68 60.02 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.796 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 23' ' ' CYS . 5.1 ttpm? -70.31 -31.32 68.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.975 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.19 70.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.482 . . . . 0.0 111.598 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 m -68.16 -33.84 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.462 0.648 . . . . 0.0 111.284 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.507 ' C ' ' H ' ' A' ' 25' ' ' PHE . 12.3 t -103.85 176.89 5.0 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.012 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 62.59 -3.64 0.28 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.714 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 23' ' ' CYS . 82.5 t80 -58.88 -46.2 88.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.067 0.46 . . . . 0.0 110.485 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.0 pm0 -83.38 -16.94 44.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.53 -16.37 5.65 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.477 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -60.52 -162.5 0.13 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 99.5 m-70 -156.87 148.99 22.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.567 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.5 mt -51.29 137.04 23.74 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.471 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.14 103.63 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.201 0.524 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.2 t -80.61 169.82 17.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -54.94 -52.2 63.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.076 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -57.64 -42.46 83.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 32' ' ' THR . 7.1 tp-100 -69.48 -40.39 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.96 -44.91 94.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.235 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.76 -38.35 69.75 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.803 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.21 74.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.109 0.48 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -43.77 36.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.155 0.502 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.593 HH12 ' H ' ' A' ' 46' ' ' VAL . 18.3 mmm180 -55.48 -29.27 58.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -70.73 -10.2 58.93 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.432 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.1 mm -104.98 13.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.36 11.1 78.76 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -59.12 104.22 0.23 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.023 0.412 . . . . 0.0 110.252 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -88.72 129.16 35.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.421 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.593 ' H ' HH12 ' A' ' 40' ' ' ARG . 39.2 t -136.65 157.36 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.953 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -158.49 46.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.14 146.1 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 110.65 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.87 115.16 29.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.602 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.35 160.02 20.71 Favored Glycine 0 N--CA 1.475 1.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.889 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -78.14 107.47 10.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.324 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.0 mtp -98.04 177.06 5.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.211 0.529 . . . . 0.0 110.134 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.79 144.54 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.721 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.6 tttt 59.88 12.47 3.08 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.202 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.21 78.65 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.914 -0.491 . . . . 0.0 111.929 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 58.8 ttt180 -73.33 135.94 44.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.713 0.292 . . . . 0.0 110.53 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.97 154.51 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.252 0.549 . . . . 0.0 110.672 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.05 139.5 5.81 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.664 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 24.4 p90 -148.03 70.44 11.08 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-N 115.635 -0.282 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.4 141.55 95.9 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.23 1.953 . . . . 0.0 112.449 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -133.42 129.0 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.544 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.0 t -64.52 -43.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 21.8 ttpt -177.37 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 60.9 Cg_endo -65.38 145.28 82.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.505 1.47 . . . . 0.0 112.305 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -165.14 51.98 0.28 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 59.6 Cg_endo -67.4 -49.63 1.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.476 2.117 . . . . 0.0 112.032 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.435 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -87.95 -27.12 22.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.984 0.421 . . . . 0.0 110.812 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.435 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -139.17 144.05 38.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.266 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' PHE . . . 79.01 156.46 10.01 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.431 ' CG ' ' O ' ' A' ' 69' ' ' GLY . 97.0 m-85 -157.1 105.4 2.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.858 -0.171 . . . . 0.0 110.673 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.52 -42.1 1.94 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 70' ' ' PHE . 74.2 mmtt -69.7 142.05 53.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.6 p -144.54 168.91 19.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.847 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 61.6 153.16 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 74' ' ' GLY . 82.7 mt -31.55 125.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 120.724 0.297 . . . . 0.0 111.26 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.96 126.2 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.228 0.537 . . . . 0.0 110.601 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 56.1 t0 -94.82 107.02 19.03 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.77 -15.7 23.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.04 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.51 -91.07 1.64 Allowed Glycine 0 N--CA 1.466 0.676 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.7 mt -154.61 140.53 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.614 0.721 . . . . 0.0 110.046 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.554 ' HE ' HD22 ' A' ' 83' ' ' ASN . 18.5 mmm180 -102.85 117.74 35.28 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.765 0.793 . . . . 0.0 110.456 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.5 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -80.79 -6.76 58.95 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.845 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.554 HD22 ' HE ' ' A' ' 81' ' ' ARG . 51.2 p30 -75.61 22.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.659 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 82' ' ' LEU . 8.1 ptm180 -48.08 -12.02 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.662 -0.649 . . . . 0.0 111.266 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 83' ' ' ASN . 99.7 p -80.92 -7.78 59.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 87' ' ' ARG . 7.3 tp10 -98.82 -151.78 0.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.416 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.42 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 82.4 mtt85 -144.85 147.71 33.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.312 0.577 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' LEU . 82.3 m95 -153.88 178.96 9.34 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.427 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -59.81 -170.24 0.01 OUTLIER 'General case' 0 C--O 1.235 0.328 0 O-C-N 123.77 0.669 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.511 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.0 151.07 5.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.05 0.452 . . . . 0.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.97 158.61 37.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.558 0.694 . . . . 0.0 110.594 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 t -152.75 149.43 28.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.871 0.843 . . . . 0.0 110.49 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -141.06 149.96 42.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.598 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -151.43 149.72 25.06 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 N--CA 1.503 2.076 0 C-N-CA 122.388 2.059 . . . . 0.0 112.013 179.605 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 t -82.62 148.01 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.789 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -136.07 134.92 38.92 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.699 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.96 138.29 42.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.5 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -118.15 131.27 56.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.252 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -139.3 146.04 39.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.44 124.65 23.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.916 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.28 -33.87 67.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -110.03 32.57 5.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.3 -136.22 2.07 Favored Glycine 0 C--O 1.218 -0.882 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.641 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -171.75 -30.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 120.949 0.404 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -153.86 61.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.17 32.76 3.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.042 0.449 . . . . 0.0 110.578 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' TRP . 41.8 mt -115.64 111.62 20.9 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.681 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.432 ' OG1' ' OE1' ' A' ' 18' ' ' GLU . 54.2 p -100.03 174.33 6.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 11.5 p90 -51.02 -52.62 41.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.891 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -55.09 -49.28 72.08 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.128 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 21.0 mp0 -66.58 -33.13 74.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.65 83.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.975 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.9 mttt -71.48 -31.67 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.679 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.7 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.512 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -77.84 -24.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.931 0.395 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.574 ' C ' ' H ' ' A' ' 25' ' ' PHE . 64.6 m -104.41 177.11 4.94 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 109.809 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' GLY . 78.9 tt0 67.53 -29.15 0.15 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.216 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.8 t80 -60.79 -48.49 81.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 110.734 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 3.4 pm0 -78.68 11.69 2.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.111 0.482 . . . . 0.0 110.916 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.18 -24.67 23.93 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -86.29 133.79 12.06 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -98.31 176.78 5.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.4 148.59 48.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.34 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.92 141.06 40.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -123.52 158.38 31.46 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.022 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -55.16 -28.78 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.439 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -68.66 -52.7 28.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.045 0.45 . . . . 0.0 110.85 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.5 -37.35 74.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.998 0.428 . . . . 0.0 110.606 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.6 mt -62.73 -39.77 95.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.92 -40.09 72.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.01 -23.96 48.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.7 -19.99 60.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.945 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.542 HH12 ' CB ' ' A' ' 60' ' ' PRO . 10.2 mmm180 -60.79 -41.86 96.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.663 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.36 -5.0 39.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 mm -95.78 0.15 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.519 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.37 19.3 46.03 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.619 -0.593 . . . . 0.0 111.619 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -61.49 121.24 12.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.558 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -155.79 103.3 2.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.302 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.95 126.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.745 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.86 76.21 2.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.895 0.378 . . . . 0.0 110.417 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.03 94.04 2.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 106.27 0.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.351 0.596 . . . . 0.0 110.645 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.36 151.98 20.28 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.943 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -64.01 153.46 37.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.535 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.9 ptp -155.34 -173.8 4.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -34.57 125.1 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.542 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttp 57.35 31.86 20.84 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.529 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 55.43 21.42 27.14 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.713 -0.617 . . . . 0.0 111.708 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' O ' ' SD ' ' A' ' 52' ' ' MET . 29.9 ttp85 -73.31 59.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.115 0.458 . . . . 0.0 110.888 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.47 151.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.253 0.549 . . . . 0.0 111.312 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.59 169.69 41.81 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.534 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.6 p90 -158.16 76.88 3.56 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.45 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.542 ' CB ' HH12 ' A' ' 40' ' ' ARG . 50.3 Cg_exo -56.38 143.61 85.98 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.476 2.117 . . . . 0.0 112.541 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.6 mt -137.66 96.61 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.516 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 m -64.79 -28.54 45.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 110.292 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -150.93 146.72 19.58 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -41.68 151.73 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.895 1.73 . . . . 0.0 112.656 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.05 27.94 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.552 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.27 -38.96 3.23 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.992 1.795 . . . . 0.0 112.323 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.43 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.5 p30 -66.7 -21.63 66.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.643 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.43 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 9.7 p -162.62 133.71 4.97 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.436 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.75 177.72 1.34 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 40.1 p90 -58.5 -52.63 64.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.569 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . 43.22 74.09 0.21 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt 53.23 -175.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.936 0.398 . . . . 0.0 110.668 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.2 p -148.83 172.93 13.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 73.99 77.08 0.66 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 74' ' ' GLY . 76.8 mt 50.34 103.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.755 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.3 mm -104.84 123.63 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -136.38 142.97 43.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.679 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.6 9.66 8.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.924 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.71 -92.52 1.8 Allowed Glycine 0 C--O 1.224 -0.47 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.0 mt -156.95 124.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 110.005 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -102.76 126.84 50.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.974 0.416 . . . . 0.0 110.382 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -87.57 2.65 50.22 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.445 0.641 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.33 26.02 6.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.805 0.812 . . . . 0.0 110.708 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -43.9 -26.07 0.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.656 -0.652 . . . . 0.0 111.142 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -56.2 -14.32 2.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.768 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.08 166.37 23.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 82.1 mtt85 -96.72 127.8 43.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.711 0.767 . . . . 0.0 110.413 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 82.8 m95 -155.09 178.61 10.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.07 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 22.6 t70 -75.54 -170.49 1.27 Allowed 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.866 0.729 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.514 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -166.04 159.54 15.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 0.0 111.002 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.98 160.78 17.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 110.265 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.7 t -145.13 177.26 8.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.495 0.664 . . . . 0.0 110.212 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -146.59 130.43 17.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.149 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.62 157.55 41.16 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.336 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.501 1.927 0 C-N-CA 121.929 1.752 . . . . 0.0 112.238 178.743 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.421 ' N ' ' CE1' ' A' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.28 141.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 110.749 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -148.94 154.97 40.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -79.03 133.98 36.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.504 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -120.29 124.54 45.87 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -113.24 135.44 53.82 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.459 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 145.45 55.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.403 0.62 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -81.43 -50.12 9.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.5 p -113.14 34.56 4.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.487 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.18 -146.1 4.59 Favored Glycine 0 C--O 1.217 -0.928 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.709 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -175.9 -54.59 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -134.35 12.97 3.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -94.15 38.11 1.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.093 0.473 . . . . 0.0 110.442 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.94 131.88 55.34 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.501 0.667 . . . . 0.0 110.584 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.1 p -95.29 168.22 10.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.691 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -60.34 -41.14 93.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.37 66.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.1 -49.4 77.8 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.778 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.81 -30.29 63.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.018 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.3 tttp -69.85 -38.18 76.38 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 120.792 0.33 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.09 75.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.56 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.39 -41.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.631 0.729 . . . . 0.0 110.983 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.602 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.0 m -100.35 177.79 4.94 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.968 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 64.31 -15.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' H ' ' C ' ' A' ' 23' ' ' CYS . 67.7 t80 -62.92 -50.18 71.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.985 0.421 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.52 26.29 0.69 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.755 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.07 3.92 90.6 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.9 -151.81 2.83 Favored Glycine 0 C--O 1.219 -0.824 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -168.93 147.07 3.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.424 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.11 149.72 27.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.386 0.612 . . . . 0.0 110.252 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 146.47 53.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -124.63 178.17 5.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -58.27 -52.27 66.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.638 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -49.02 -47.23 44.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.17 -43.86 73.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.293 0.568 . . . . 0.0 110.737 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.58 -42.32 99.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.666 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -60.33 -30.42 69.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.558 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.01 -27.22 54.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.19 56.33 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.819 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -55.37 -30.99 61.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.376 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.63 -3.26 55.93 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.6 mm -105.81 6.2 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.519 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 17.99 52.98 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.19 126.57 26.72 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 110.546 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.446 ' HD1' ' N ' ' A' ' 46' ' ' VAL . 1.4 t60 -131.18 128.79 40.74 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.361 0.6 . . . . 0.0 110.577 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.446 ' N ' ' HD1' ' A' ' 45' ' ' HIS . 84.1 t -139.58 160.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.776 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 11.4 t -158.75 33.84 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.702 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.29 128.78 17.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.136 0.493 . . . . 0.0 110.533 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.26 131.68 44.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.01 144.05 10.08 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.739 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -65.68 158.11 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.585 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.8 mtm -151.22 -177.69 6.19 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.229 0.538 . . . . 0.0 110.195 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.38 128.54 3.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.576 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' A' ' 56' ' ' ARG . 72.4 tttt 66.11 37.56 5.12 Favored 'General case' 0 C--O 1.201 -1.481 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.047 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.89 5.87 0.1 Allowed Glycine 0 CA--C 1.54 1.614 0 O-C-N 121.764 -0.585 . . . . 0.0 112.39 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.536 ' H ' ' C ' ' A' ' 54' ' ' LYS . 67.7 ttt-85 -66.38 89.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.257 0.551 . . . . 0.0 110.445 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.1 134.48 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.76 0.79 . . . . 0.0 110.337 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.28 26.28 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.577 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.1 p90 -162.52 81.44 1.71 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.343 -0.429 . . . . 0.0 110.677 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 133.36 57.6 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.22 1.947 . . . . 0.0 112.57 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -118.3 109.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.369 0.604 . . . . 0.0 110.689 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 m -84.63 -15.32 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.167 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.87 142.6 2.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.133 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.32 149.75 2.48 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 121.067 1.178 . . . . 0.0 112.709 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -122.17 157.51 16.88 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.526 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.28 -43.21 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.351 1.367 . . . . 0.0 112.178 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.419 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -75.6 -21.3 57.92 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.347 0.594 . . . . 0.0 111.082 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.419 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.7 OUTLIER -124.86 144.0 50.54 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.062 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.44 -172.77 4.93 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.471 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.05 169.42 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.111 0.481 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.49 -25.14 0.07 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.24 -177.92 5.24 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 110.419 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 p -138.52 156.67 47.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.775 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 66.54 164.28 1.72 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' GLY . 76.6 mt -34.25 139.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 115.641 -0.28 . . . . 0.0 111.269 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.43 17.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.648 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 56' ' ' ARG . 2.4 p30 -61.34 126.83 28.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.967 0.413 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -68.73 -43.35 76.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.529 0.681 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.9 -128.4 3.58 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.21 108.46 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 122.243 1.021 . . . . 0.0 110.019 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.656 ' H ' ' NE ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.766 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 84' ' ' ARG . 69.2 mt -90.26 -2.78 58.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.842 0.354 . . . . 0.0 110.593 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -77.64 28.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.732 0.777 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.538 ' HE ' ' NH2' ' A' ' 81' ' ' ARG . 99.4 mtt180 -51.12 -1.22 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.733 -0.605 . . . . 0.0 111.73 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.623 ' H ' ' C ' ' A' ' 83' ' ' ASN . 9.2 m -96.9 2.26 51.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -87.02 -158.84 0.46 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.936 0.398 . . . . 0.0 110.564 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 33.4 ptt-85 -155.83 134.19 11.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.608 0.718 . . . . 0.0 110.802 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.2 m0 -147.46 -172.99 4.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.274 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 20.5 t0 -57.89 -148.28 0.0 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.967 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.56 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.77 130.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.641 0.734 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -122.9 157.96 31.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.471 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.9 t -140.86 -173.8 3.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.746 0.784 . . . . 0.0 110.296 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.421 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 63.7 t80 -155.93 121.55 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.279 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -152.33 147.53 19.72 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.042 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 N--CA 1.5 1.906 0 C-N-CA 122.415 2.077 . . . . 0.0 111.886 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.25 154.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.128 0.49 . . . . 0.0 110.639 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 4' ' ' HIS . 75.1 t80 -118.98 139.16 52.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.477 ' O ' ' CE2' ' A' ' 3' ' ' TYR . 43.8 p-80 -74.77 130.63 39.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -141.23 136.43 31.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.078 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.13 177.49 6.19 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 126.61 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -70.28 -39.47 74.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -112.67 28.55 8.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.95 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.67 -139.05 2.61 Favored Glycine 0 C--O 1.216 -1.028 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.555 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -175.69 -66.98 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.272 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.5 47.61 0.87 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -132.29 31.05 4.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 120.937 0.399 . . . . 0.0 110.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp -118.32 126.09 51.42 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.54 0.686 . . . . 0.0 110.662 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.4 m -99.5 160.4 14.31 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.517 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 17' ' ' ALA . 41.2 p90 -53.38 -42.71 67.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' A' ' 16' ' ' TYR . . . -55.39 -42.91 74.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.868 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.18 -49.76 47.12 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.662 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.57 -37.84 58.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.037 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.9 tttm -71.34 -32.42 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 110.817 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.33 -54.39 17.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.569 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.21 -36.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.21 0.529 . . . . 0.0 111.029 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.596 ' C ' ' H ' ' A' ' 25' ' ' PHE . 2.0 t -103.31 176.23 5.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 20' ' ' LYS . 74.4 tt0 65.29 -15.83 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.035 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.596 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.3 t80 -61.57 -48.14 82.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 14.4 pt-20 -81.63 20.87 0.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.26 86.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.64 -155.16 1.09 Allowed Glycine 0 C--O 1.219 -0.796 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -170.54 145.26 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.449 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 mt -52.98 141.03 23.26 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.118 0.485 . . . . 0.0 110.564 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.28 106.55 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.9 m -69.92 146.99 50.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 5.4 p90 -53.55 -51.65 62.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.981 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.578 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 64.8 tttp -60.82 -45.47 94.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 110.558 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -68.46 -27.21 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -28.26 66.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -51.45 -31.06 21.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.1 73.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.18 -41.64 49.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.767 0.318 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.564 ' NH2' ' N ' ' A' ' 62' ' ' VAL . 37.2 mmm-85 -56.66 -31.86 64.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.83 -10.67 59.73 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.644 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 94.6 mt -101.75 4.95 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.558 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.7 14.14 47.92 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.37 128.31 35.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.905 0.383 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.701 ' HD1' ' H ' ' A' ' 62' ' ' VAL . 75.7 t60 -149.39 104.72 3.4 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.456 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.83 129.49 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.912 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -93.78 96.21 9.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.516 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.46 95.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.7 131.74 44.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.29 159.44 27.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.88 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -70.82 104.56 2.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 66.8 mtm -96.75 -175.56 3.33 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.219 0.533 . . . . 0.0 110.236 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.06 158.92 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.524 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' A' ' 56' ' ' ARG . 63.0 mttp 50.63 38.02 17.89 Favored 'General case' 0 C--O 1.2 -1.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.72 0.46 0.03 OUTLIER Glycine 0 CA--C 1.54 1.603 0 O-C-N 121.878 -0.514 . . . . 0.0 112.062 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.618 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.5 mtt180 -69.55 149.06 48.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.141 0.496 . . . . 0.0 110.475 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.63 141.63 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.441 1.115 . . . . 0.0 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.73 166.66 30.34 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.415 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -128.7 107.19 18.65 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.46 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.51 119.47 4.51 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.544 1.496 . . . . 0.0 112.486 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.482 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 4.4 pt -148.83 93.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.722 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.701 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 56.3 t -49.28 -21.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.282 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -142.92 146.28 36.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.12 154.51 0.79 Allowed 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.579 1.519 . . . . 0.0 112.622 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.25 154.5 26.0 Favored Glycine 0 CA--C 1.543 1.834 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.735 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.79 -41.47 1.07 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.079 1.852 . . . . 0.0 112.353 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.62 -40.68 92.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.64 145.05 25.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.665 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.23 176.92 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.619 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -70.79 139.74 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.471 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.4 135.41 1.88 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.615 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.09 -47.36 84.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.851 0.358 . . . . 0.0 110.177 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.404 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 62.6 p -132.66 165.17 25.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.284 0.564 . . . . 0.0 110.904 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 76' ' ' ILE . . . -84.28 -155.49 22.21 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 77' ' ' ASP . 40.5 mt 68.88 -7.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 74' ' ' GLY . 38.6 mt -63.55 67.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.623 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' ILE . 2.4 p30 -85.71 151.2 24.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.446 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -89.48 -139.38 0.13 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.628 0.727 . . . . 0.0 110.184 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.68 95.56 0.18 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.8 mt 45.27 96.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.62 0.248 . . . . 0.0 110.674 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.433 ' O ' ' NH1' ' A' ' 84' ' ' ARG . 78.9 mtp180 -94.78 141.29 28.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.033 0.444 . . . . 0.0 110.081 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.58 3.98 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.604 0.716 . . . . 0.0 110.6 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 85' ' ' SER . 31.9 t30 -80.19 15.22 1.61 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.801 0.81 . . . . 0.0 110.304 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH1' ' O ' ' A' ' 81' ' ' ARG . 88.8 mtm-85 -58.72 -5.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.593 -0.692 . . . . 0.0 110.868 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 83' ' ' ASN . 78.3 p -73.27 -35.58 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.646 0.26 . . . . 0.0 110.916 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -81.18 158.3 24.96 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.277 0.561 . . . . 0.0 110.617 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -86.84 149.11 25.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.734 0.778 . . . . 0.0 110.619 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -154.41 177.43 11.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.0 -172.56 2.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.647 0.737 . . . . 0.0 110.755 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -167.04 166.67 15.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.338 0.589 . . . . 0.0 111.053 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.88 156.86 46.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.953 0.882 . . . . 0.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.0 t -124.41 -167.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -159.21 145.96 16.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.999 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 26' ' ' GLU . 12.1 m120 -149.75 143.88 17.18 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.287 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 C--N 1.308 -1.593 0 C-N-CA 121.901 1.734 . . . . 0.0 111.93 179.217 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 t -84.49 136.52 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.656 0.265 . . . . 0.0 110.798 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.509 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 22.2 p90 -146.94 159.39 43.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.811 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -74.9 148.82 39.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.381 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.509 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 25.5 mmt180 -123.55 157.34 33.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.228 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -157.93 120.68 3.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.191 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 166.57 12.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.907 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.51 -36.62 81.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -64.81 -32.92 74.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.367 0.604 . . . . 0.0 110.632 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.71 177.73 23.19 Favored Glycine 0 C--O 1.216 -0.994 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.661 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.07 -105.14 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.328 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -68.8 69.92 0.18 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.665 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -144.41 29.08 1.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.787 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' TRP . 23.5 mt -123.36 143.36 50.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.8 p -95.69 168.51 10.62 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.753 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.579 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 26.5 p90 -46.9 -56.15 6.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -53.07 -42.29 65.69 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.969 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.54 -26.73 68.02 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.947 0.404 . . . . 0.0 110.555 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.95 -36.97 67.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -71.05 -30.63 66.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.222 0.534 . . . . 0.0 110.555 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.01 -49.3 75.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.614 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.56 -28.9 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.352 0.596 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.613 ' C ' ' H ' ' A' ' 25' ' ' PHE . 82.2 m -105.28 179.16 4.35 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.029 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 15.3 mp0 64.6 -28.29 0.1 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.887 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' H ' ' C ' ' A' ' 23' ' ' CYS . 59.4 t80 -62.18 -45.26 94.18 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.803 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -95.71 9.18 41.26 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.97 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.42 -4.06 66.55 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.32 -175.16 44.75 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -154.33 162.41 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.831 -0.185 . . . . 0.0 110.705 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 9.4 mp -71.09 147.23 48.68 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.087 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.71 151.31 38.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.075 0.464 . . . . 0.0 110.806 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 m -125.02 156.66 37.79 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.155 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -54.05 -21.31 8.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.397 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -76.01 -57.24 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.117 0.484 . . . . 0.0 110.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.73 -33.13 73.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.47 -42.46 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.59 -34.76 77.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.555 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.4 -33.9 73.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 110.957 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -23.62 28.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.599 ' HE ' ' HB2' ' A' ' 60' ' ' PRO . 3.8 tpt85 -60.85 -42.55 98.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.567 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -60.87 -2.45 0.57 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 40' ' ' ARG . 18.5 mm -101.23 17.19 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.33 19.99 79.79 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.37 105.03 0.3 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.156 0.478 . . . . 0.0 110.39 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -95.48 133.65 39.22 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.389 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.3 t -137.39 159.37 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 68' ' ' CYS . 2.9 t -156.11 42.03 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.752 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.68 125.18 3.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 110.723 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.38 138.74 45.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.38 152.79 24.81 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.924 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -68.07 101.96 1.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.062 0.458 . . . . 0.0 109.954 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 58' ' ' GLY . 1.4 mtp -91.38 166.29 12.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.649 0.738 . . . . 0.0 109.852 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' MET . . . -39.48 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.59 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt 58.68 7.52 0.76 Allowed 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.373 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 53' ' ' ALA . . . 77.68 8.89 87.17 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.814 -0.554 . . . . 0.0 112.106 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' MET . 62.2 ttt180 -76.29 131.93 39.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.005 0.403 . . . . 0.0 110.632 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.81 112.5 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.855 0.836 . . . . 0.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -166.53 177.85 41.22 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.541 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -167.84 142.28 2.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.745 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.599 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 72.8 Cg_endo -72.35 147.17 46.58 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.001 1.801 . . . . 0.0 112.651 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mt -139.68 93.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.842 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.61 -41.85 86.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.346 0.593 . . . . 0.0 110.542 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -136.95 101.42 9.46 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.73 130.04 14.91 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.815 1.677 . . . . 0.0 112.474 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.91 22.04 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.397 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.99 -51.75 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.335 2.023 . . . . 0.0 112.241 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -67.54 -37.24 82.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 1.5 p -152.24 123.05 7.45 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.361 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 178.69 -26.63 0.05 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 90.1 t80 52.9 -85.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 110.763 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -172.98 -172.99 39.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 54.08 -171.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 0.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 74' ' ' GLY . 35.6 m -144.86 167.24 23.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.207 0.527 . . . . 0.0 110.63 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' N ' ' CG2' ' A' ' 73' ' ' THR . . . 93.64 -151.7 20.45 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.1 mt -100.97 128.61 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.392 . . . . 0.0 110.39 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.7 mt -132.03 71.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.415 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.23 135.03 34.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.842 0.353 . . . . 0.0 110.579 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.39 110.67 22.67 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.059 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.92 95.95 0.01 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.5 mt 49.39 100.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.756 0.312 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.776 ' CZ ' HD22 ' A' ' 83' ' ' ASN . 70.6 mtp180 -68.81 148.07 50.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 84' ' ' ARG . 10.9 mp -74.95 -28.78 60.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.885 0.85 . . . . 0.0 110.555 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.776 HD22 ' CZ ' ' A' ' 81' ' ' ARG . 18.0 p30 -73.18 32.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.028 0.918 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 82' ' ' LEU . 66.0 mtp180 -48.65 -6.99 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.632 -0.667 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 83' ' ' ASN . 32.5 t -87.19 -8.2 57.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.987 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -91.39 147.57 22.94 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -83.31 152.36 25.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.266 0.555 . . . . 0.0 110.51 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.562 ' NE1' ' NH1' ' A' ' 81' ' ' ARG . 73.5 m95 -156.02 179.12 9.52 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.326 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 11.8 t70 -76.05 -161.54 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.826 0.822 . . . . 0.0 110.471 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.454 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.08 152.7 6.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.783 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.15 158.75 38.85 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.726 . . . . 0.0 110.408 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -133.11 -173.28 3.16 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.613 0.721 . . . . 0.0 110.138 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -155.29 113.4 3.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -117.41 85.81 20.95 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 N--CA 1.499 1.845 0 C-N-CA 122.48 2.12 . . . . 0.0 112.355 -179.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 t -84.89 145.87 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.63 0.252 . . . . 0.0 111.094 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -161.23 156.54 24.31 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.032 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.69 116.23 25.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.486 0.66 . . . . 0.0 110.752 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -103.85 121.5 43.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -103.85 130.7 51.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.545 0.528 . . . . 0.0 110.362 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.23 172.5 13.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -60.32 -34.7 74.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.967 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.548 ' O ' ' C ' ' A' ' 10' ' ' GLY . 73.9 m -82.14 -20.21 38.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.513 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 16.57 81.79 0.01 OUTLIER Glycine 0 N--CA 1.494 2.541 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.267 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -172.52 37.67 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 120.923 0.392 . . . . 0.0 110.398 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 52.25 62.01 2.91 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -132.08 31.83 4.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.698 0.285 . . . . 0.0 110.694 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -122.09 128.24 51.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -98.16 170.55 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.642 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 30.3 p90 -51.45 -60.14 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.584 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.39 -37.28 56.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.883 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -67.97 -49.61 60.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -34.92 58.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.645 0.26 . . . . 0.0 110.861 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 23' ' ' CYS . 71.0 mmtt -61.84 -41.88 98.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.551 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.55 -49.43 77.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.63 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -58.1 -37.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.498 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.527 ' C ' ' H ' ' A' ' 25' ' ' PHE . 3.4 m -101.76 -179.27 3.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 94.4 mt-10 71.04 -18.79 0.26 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.5 t80 -60.39 -45.94 91.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.213 0.53 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -86.57 15.87 5.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.528 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 7.69 87.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.505 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -86.5 -158.55 31.77 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -162.96 156.51 19.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.735 -0.233 . . . . 0.0 110.409 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.16 136.66 52.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.116 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.45 122.52 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -103.83 178.72 4.48 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -52.49 -52.48 54.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -57.76 -44.94 86.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.568 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -70.37 -37.7 74.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.88 -43.01 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.414 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -55.69 -47.43 76.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.82 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -32.23 71.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.077 0.465 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.24 -29.14 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.516 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.447 ' C ' ' H ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -60.91 -40.52 93.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.502 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -60.49 -4.03 0.8 Allowed 'General case' 0 N--CA 1.458 -0.05 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 40' ' ' ARG . 16.8 mm -99.18 22.9 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.385 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.51 28.93 71.83 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -70.29 126.09 28.64 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.663 -0.316 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.465 ' CD2' ' CG2' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -149.98 103.69 3.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.175 0.512 . . . . 0.0 110.37 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -140.16 129.94 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 14.8 t -90.72 69.34 6.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.331 0.586 . . . . 0.0 110.279 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.63 95.26 2.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.653 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.97 153.2 36.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.75 171.76 36.94 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.889 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -85.37 105.0 15.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.528 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -93.27 176.52 6.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.145 0.497 . . . . 0.0 110.302 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -35.49 153.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 54.8 8.91 0.25 Allowed 'General case' 0 C--O 1.199 -1.562 0 CA-C-O 121.089 0.471 . . . . 0.0 110.12 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 53' ' ' ALA . . . 74.75 20.68 79.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.941 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.535 ' HE ' ' CG ' ' A' ' 77' ' ' ASP . 63.0 ttt180 -77.09 140.05 40.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.646 0.26 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.14 134.95 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.677 0.751 . . . . 0.0 110.972 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.36 113.95 0.7 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -109.27 156.27 39.64 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-O 120.415 0.15 . . . . 0.0 110.755 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.32 133.13 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.446 1.431 . . . . 0.0 112.044 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 73' ' ' THR . 3.4 mt -144.33 95.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.588 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' A' ' 45' ' ' HIS . 0.2 OUTLIER -47.11 -38.55 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.67 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -149.02 147.73 24.85 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.824 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -52.87 139.28 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.986 1.124 . . . . 0.0 112.456 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.46 177.9 22.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.862 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.63 -51.0 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.628 1.552 . . . . 0.0 112.153 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -66.92 -27.71 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.682 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.08 151.39 21.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.193 0.521 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.37 -5.56 0.04 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -68.33 -1.88 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.3 0.571 . . . . 0.0 110.315 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.3 -165.82 26.34 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.576 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.15 79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.614 0.245 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER 176.81 173.79 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.459 0.647 . . . . 0.0 110.319 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -46.7 -95.39 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.5 mt -99.34 108.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.477 0.656 . . . . 0.0 110.208 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 pt -105.87 45.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.834 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.535 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 34.7 t0 -89.0 118.98 29.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.025 0.441 . . . . 0.0 110.721 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -67.15 -64.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.553 0.692 . . . . 0.0 110.33 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 130.04 95.12 0.73 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 111.844 -0.503 . . . . 0.0 111.844 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 79' ' ' GLY . 70.1 mt 56.76 129.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.762 0.792 . . . . 0.0 110.993 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -111.61 143.04 43.13 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.512 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 82' ' ' LEU . 3.0 mm? -86.73 -8.5 57.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.377 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -108.55 23.79 14.0 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.49 0.716 . . . . 0.0 111.072 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 86' ' ' GLU . 80.4 mtm180 -44.37 -27.47 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.672 -0.643 . . . . 0.0 111.432 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -47.07 -17.09 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.004 0.19 . . . . 0.0 110.956 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -60.89 -176.64 0.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 179.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 68.5 mtp85 -125.19 136.63 53.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.026 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.2 m95 -153.01 -176.64 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.141 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -73.07 -167.58 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -153.23 146.97 25.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.141 0.496 . . . . 0.0 111.108 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 17.6 m-85 -140.61 160.74 39.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.775 0.798 . . . . 0.0 110.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.5 m -136.44 -165.8 1.78 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.108 0.956 . . . . 0.0 110.06 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -141.04 151.13 43.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.271 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.34 149.21 70.58 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.856 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 C--N 1.306 -1.693 0 C-N-CA 121.564 1.509 . . . . 0.0 111.644 179.771 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.421 ' H3 ' ' H ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.421 ' H ' ' H3 ' ' A' ' 1' ' ' GLY . 32.8 m -125.38 132.75 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' OH ' ' CZ ' ' A' ' 5' ' ' ARG . 31.4 p90 -103.03 155.24 18.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -73.02 126.12 29.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.498 0.666 . . . . 0.0 110.548 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' CZ ' ' OH ' ' A' ' 3' ' ' TYR . 89.5 mtt-85 -101.91 167.29 10.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.384 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -163.56 120.42 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.24 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.89 169.53 17.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.33 -40.64 81.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.597 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 t -70.85 -24.36 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.402 0.62 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.62 -170.82 22.9 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 13' ' ' LYS . 26.1 pttm -108.37 -173.39 2.27 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.559 ' HH ' ' H ' ' A' ' 49' ' ' ALA . 7.5 m-85 42.23 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.628 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' LYS . 64.9 mttm -133.28 28.86 4.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.66 0.384 . . . . 0.0 110.696 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 88' ' ' TRP . 33.1 mt -124.82 135.37 52.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.233 0.539 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -89.84 161.1 16.15 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.589 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -49.89 -59.52 3.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.22 75.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.22 -49.15 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.584 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.37 32.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 16.2 tptp -58.62 -40.19 82.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.116 0.484 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -48.25 78.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.316 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.58 -22.09 17.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.426 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 25' ' ' PHE . 53.3 m -103.94 179.48 4.26 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.567 0.698 . . . . 0.0 109.518 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.465 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 70.8 mt-10 70.6 -19.08 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.16 -46.29 91.13 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 110.837 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.2 5.46 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.9 51.42 2.64 Favored Glycine 0 N--CA 1.472 1.097 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.05 -152.87 5.73 Favored Glycine 0 N--CA 1.47 0.901 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.611 ' HE2' HE22 ' A' ' 35' ' ' GLN . 24.4 p-80 -163.02 179.02 7.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.92 142.49 51.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.29 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.93 148.04 48.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.24 0.543 . . . . 0.0 110.811 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -123.54 149.41 45.27 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.259 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CD1' ' NH2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -61.09 -20.89 63.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.215 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -75.87 -57.12 4.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.095 0.474 . . . . 0.0 110.739 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.611 HE22 ' HE2' ' A' ' 29' ' ' HIS . 11.3 pt20 -68.82 -31.86 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 111.015 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.5 -36.11 79.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.368 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -49.9 -29.41 8.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.002 0.429 . . . . 0.0 110.661 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.39 -25.57 33.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.413 0.625 . . . . 0.0 111.025 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.69 -42.53 17.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -56.04 -34.7 66.13 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.29 -23.57 56.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 mm -82.5 24.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.92 24.19 74.35 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.66 128.73 37.08 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.464 ' CE1' ' H ' ' A' ' 63' ' ' LYS . 58.4 t60 -135.74 110.25 8.54 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.445 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.21 112.3 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.738 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -93.72 73.75 4.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.09 118.99 8.7 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.228 0.537 . . . . 0.0 110.778 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.559 ' H ' ' HH ' ' A' ' 12' ' ' TYR . . . -80.25 134.19 36.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.814 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.54 -143.7 4.21 Favored Glycine 0 N--CA 1.476 1.3 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -130.8 105.93 8.11 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 15.1 mmt -91.54 156.13 17.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.267 0.556 . . . . 0.0 109.647 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.03 169.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.53 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.64 38.53 30.28 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.84 6.36 0.32 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' NH2' ' CD1' ' A' ' 33' ' ' TYR . 25.3 mtp180 -84.31 162.99 19.88 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.424 0.631 . . . . 0.0 110.598 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 p -142.2 135.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.723 0.773 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.01 157.15 26.78 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 26.9 p90 -165.89 80.82 1.11 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.795 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.95 143.82 59.14 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.026 1.817 . . . . 0.0 112.677 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -132.02 91.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.414 0.626 . . . . 0.0 110.707 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.434 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 40.8 t -80.41 -20.23 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.526 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.464 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 60.0 mttp -140.94 86.33 11.72 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.95 136.8 52.65 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.02 1.813 . . . . 0.0 112.218 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.26 173.91 15.2 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.405 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.46 -47.15 3.26 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.06 1.84 . . . . 0.0 112.284 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 68' ' ' CYS . 39.2 p-10 -66.71 -36.62 82.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.704 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 23.0 p -153.55 119.39 5.33 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.049 0.452 . . . . 0.0 110.477 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 88.54 0.09 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -64.97 161.23 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.946 0.403 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.55 99.71 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -70.62 166.65 20.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.871 0.367 . . . . 0.0 110.563 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.4 p -139.64 159.83 41.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.17 -140.66 15.17 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.9 mt -89.24 119.17 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.925 0.393 . . . . 0.0 110.556 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.73 98.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.407 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 59.3 t0 -98.39 141.79 30.83 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 110.322 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 25.3 m-85 -129.99 147.51 51.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.669 0.747 . . . . 0.0 110.05 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.79 -78.73 0.46 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.8 mt -157.81 108.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.547 ' CZ ' HD22 ' A' ' 83' ' ' ASN . 52.0 mtp180 -69.08 140.95 54.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.329 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.2 mt -85.49 -10.23 56.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.335 0.588 . . . . 0.0 110.777 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.547 HD22 ' CZ ' ' A' ' 81' ' ' ARG . 13.1 p30 -83.27 22.6 0.98 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.474 0.654 . . . . 0.0 110.379 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -52.0 -5.84 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.644 -0.66 . . . . 0.0 111.361 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 83' ' ' ASN . 62.8 m -91.89 -5.13 53.81 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.838 0.351 . . . . 0.0 110.856 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 87' ' ' ARG . 6.4 tp10 -85.29 -152.8 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.399 0.619 . . . . 0.0 110.422 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 83.3 mtt85 -142.94 151.2 40.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.817 0.818 . . . . 0.0 110.564 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 86.2 m95 -154.9 177.37 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.267 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.591 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 36.2 t0 -60.45 -156.06 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.816 0.698 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.591 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.68 141.95 2.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.168 0.509 . . . . 0.0 110.947 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.408 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 16.3 m-85 -140.34 142.25 35.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.52 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . 0.437 ' SG ' ' NE ' ' A' ' 5' ' ' ARG . 49.8 m -115.56 -167.33 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.827 0.822 . . . . 0.0 110.077 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -156.42 143.68 19.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.455 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.11 148.95 22.18 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo . . . . . 0 N--CA 1.505 2.165 0 C-N-CA 122.345 2.03 . . . . 0.0 112.985 179.488 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.06 148.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 110.815 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.62 162.51 35.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -73.51 132.63 43.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.637 HH21 ' N ' ' A' ' 91' ' ' TYR . 73.5 mtm180 -117.99 149.22 41.31 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.502 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -154.78 125.02 6.78 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.594 0.559 . . . . 0.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.08 179.11 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.461 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -61.07 -48.62 80.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.504 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -87.39 -2.8 58.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.205 0.526 . . . . 0.0 110.513 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.23 66.59 0.68 Allowed Glycine 0 N--CA 1.472 1.068 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -143.99 41.82 1.42 Allowed 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.747 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 45.78 28.98 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.678 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.48 39.87 0.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.283 0.563 . . . . 0.0 110.825 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' TRP . 6.1 tp -120.31 127.74 52.64 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.781 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.8 p -90.94 167.75 12.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.529 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -61.23 -48.01 83.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.337 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.92 71.47 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.05 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.7 -50.16 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.736 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.55 -31.6 24.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' CYS . 26.1 mtpp -64.6 -34.92 79.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.428 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.16 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.65 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.04 -40.87 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.323 0.582 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.62 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.2 t -100.53 175.69 5.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.907 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 63.22 -15.84 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.62 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.7 t80 -61.87 -49.1 77.61 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.92 22.52 0.38 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.765 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 25' ' ' PHE . . . 81.04 0.91 89.58 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.31 -148.8 4.7 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -164.66 152.97 12.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.666 0.27 . . . . 0.0 110.631 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.15 145.18 54.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.051 0.453 . . . . 0.0 110.224 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -64.03 107.33 1.23 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.903 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 p -88.01 167.14 13.95 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CB ' ' HE ' ' A' ' 56' ' ' ARG . 69.6 t80 -54.66 -53.61 52.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.983 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -55.75 -43.86 77.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.993 0.425 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.26 -32.23 68.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -40.58 95.29 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -51.56 -49.38 62.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.25 64.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.431 . . . . 0.0 110.649 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.78 -37.02 31.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.2 -27.83 62.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -78.2 -4.55 48.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.67 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 76.9 mt -96.0 8.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.478 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.52 21.45 44.08 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -69.38 131.78 45.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 122.741 -0.27 . . . . 0.0 110.354 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -149.89 105.28 3.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.076 0.465 . . . . 0.0 110.469 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.19 118.02 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.83 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.4 t -91.88 84.05 5.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.191 0.52 . . . . 0.0 110.293 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.25 94.73 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.635 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.2 46.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.82 -172.42 13.92 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.931 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.7 156.74 17.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.527 0.679 . . . . 0.0 110.47 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 56' ' ' ARG . 67.4 mtm -148.09 175.02 11.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.99 147.74 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.299 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 56' ' ' ARG . 9.0 mtmp? 57.69 40.43 26.49 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.659 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.2 7.72 0.58 Allowed Glycine 0 CA--C 1.532 1.13 0 O-C-N 121.794 -0.566 . . . . 0.0 111.8 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HE ' ' CB ' ' A' ' 33' ' ' TYR . 32.2 ttt85 -68.14 146.42 53.45 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.321 0.581 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.15 162.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.668 0.747 . . . . 0.0 110.807 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.02 169.25 39.57 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.492 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 76' ' ' ILE . 3.8 p90 -154.95 79.89 4.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.386 -0.407 . . . . 0.0 110.322 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.44 128.97 32.67 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.21 1.94 . . . . 0.0 112.682 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.38 103.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.61 -24.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.304 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -161.76 143.81 8.72 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.567 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -41.23 166.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.717 1.612 . . . . 0.0 112.85 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.9 166.8 39.75 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.68 -41.89 13.53 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.403 2.068 . . . . 0.0 112.212 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -66.11 -36.06 82.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.43 . . . . 0.0 110.327 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.9 p -156.53 146.41 21.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.491 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -159.85 44.02 0.44 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -73.66 142.74 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.55 -104.69 0.89 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -162.95 -63.49 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.888 0.375 . . . . 0.0 110.469 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -145.72 171.1 15.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.387 0.613 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -153.33 20.46 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.6 mt -99.57 -60.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.755 0.312 . . . . 0.0 110.827 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.482 ' O ' ' CZ ' ' A' ' 59' ' ' TYR . 52.3 mt 56.88 105.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.317 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.467 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 4.8 p30 -136.37 148.98 48.11 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.03 0.443 . . . . 0.0 110.946 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -72.82 -72.4 0.25 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.619 0.723 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.05 -135.17 5.14 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -88.69 107.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.399 0.619 . . . . 0.0 110.151 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -94.16 129.79 40.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.44 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.17 0.14 54.35 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.424 0.631 . . . . 0.0 110.85 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.434 HD21 ' C ' ' A' ' 83' ' ' ASN . 0.4 OUTLIER -87.73 23.6 1.95 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.328 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -45.1 -24.32 0.23 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.617 -0.677 . . . . 0.0 111.662 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 m -50.54 -23.03 2.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.751 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.24 -168.26 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 0.0 110.813 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.25 139.22 44.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.391 0.615 . . . . 0.0 110.946 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' LEU . 86.8 m95 -154.18 176.2 12.54 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.451 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.0 t70 -71.23 -169.65 0.41 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.361 0.601 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.537 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.9 161.05 10.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.158 0.504 . . . . 0.0 111.002 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.637 ' N ' HH21 ' A' ' 5' ' ' ARG . 96.7 m-85 -138.57 152.81 48.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.636 0.732 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.2 t -129.99 144.48 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -119.48 122.0 40.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.359 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.467 ' N ' ' ND2' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -109.13 169.83 6.04 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.063 -179.049 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.503 2.037 0 C-N-CA 121.942 1.761 . . . . 0.0 112.146 179.062 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -83.8 151.92 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -126.75 126.94 44.29 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.559 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -76.02 148.48 38.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.48 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -133.18 143.19 49.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.07 146.64 30.05 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.263 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.93 132.4 46.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.95 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -81.04 -49.13 11.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.1 m -112.41 -33.85 6.06 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.61 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.57 177.75 53.98 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -134.69 95.82 3.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.453 0.644 . . . . 0.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 53.13 70.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.72 40.54 1.85 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.774 0.321 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 88' ' ' TRP . 46.3 mt -117.61 122.49 43.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -100.68 166.1 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.17 0.51 . . . . 0.0 110.723 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -49.11 -58.86 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -42.48 59.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.021 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.9 -26.56 66.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.526 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.46 76.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.038 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' CYS . 51.4 mtmt -67.17 -24.29 65.86 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.567 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.12 -55.46 9.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.634 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.77 -44.7 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' LYS . 3.7 m -114.31 162.09 17.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.308 0.575 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 23' ' ' CYS . 48.8 tt0 84.33 -46.11 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.813 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -62.73 -46.37 88.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.048 0.451 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.23 16.8 0.71 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.946 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.6 60.72 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -153.18 0.02 OUTLIER Glycine 0 C--O 1.218 -0.883 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.586 ' CD2' HE22 ' A' ' 35' ' ' GLN . 66.8 t60 -173.25 143.5 1.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.473 ' O ' ' CD2' ' A' ' 29' ' ' HIS . 73.6 mt -78.18 136.23 37.78 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.158 0.286 . . . . 0.0 110.541 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.32 132.38 48.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.252 0.549 . . . . 0.0 111.082 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.42 ' HG1' ' H ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -124.38 167.1 14.85 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.121 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -50.49 -22.21 1.83 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.693 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' H ' ' HG1' ' A' ' 32' ' ' THR . 37.6 ttmt -75.25 -57.96 3.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.172 0.51 . . . . 0.0 110.684 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.586 HE22 ' CD2' ' A' ' 29' ' ' HIS . 78.6 mt-30 -70.78 -34.87 72.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.7 mt -61.1 -39.76 91.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.441 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -57.78 -31.05 66.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.673 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 -24.33 48.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.338 0.589 . . . . 0.0 110.956 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.3 -45.31 33.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.414 HH21 HG11 ' A' ' 62' ' ' VAL . 20.2 mmm-85 -52.98 -31.55 41.41 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -69.46 -4.32 18.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.571 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 74.3 mt -108.86 15.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.443 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.16 16.75 71.12 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.29 143.06 58.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.904 0.352 . . . . 0.0 110.343 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -155.35 107.91 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.356 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.6 m -139.0 111.56 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.817 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.26 75.06 6.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.238 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.52 135.29 11.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.32 139.38 31.72 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.47 -174.26 21.41 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.804 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -94.12 143.27 26.52 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -145.3 173.41 12.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.142 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.78 142.86 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.685 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 62.17 14.95 7.05 Favored 'General case' 0 C--O 1.201 -1.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.48 16.98 68.15 Favored Glycine 0 CA--C 1.527 0.822 0 O-C-N 121.831 -0.543 . . . . 0.0 111.964 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.776 HH22 ' H ' ' A' ' 78' ' ' TYR . 51.6 ttt-85 -70.84 161.41 31.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.977 0.418 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.18 148.57 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 122.269 1.033 . . . . 0.0 110.458 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.77 168.28 40.57 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.405 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -154.64 76.79 5.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.334 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.77 133.1 49.02 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.474 2.116 . . . . 0.0 112.692 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -147.19 145.11 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.124 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG11 HH21 ' A' ' 40' ' ' ARG . 29.4 m -82.12 -30.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -152.68 152.15 28.11 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.427 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.3 151.32 2.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.026 1.818 . . . . 0.0 112.324 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.96 166.88 27.38 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.793 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.17 -48.44 19.45 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.833 1.689 . . . . 0.0 112.737 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -64.94 -27.34 68.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.5 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.43 144.93 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.94 -12.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -55.64 -36.42 66.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.408 . . . . 0.0 110.775 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.88 -166.39 6.64 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -73.43 -162.18 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.534 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 166.69 22.19 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.268 0.556 . . . . 0.0 110.819 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 67.76 67.03 2.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' O ' ' A' ' 74' ' ' GLY . 4.5 mt 53.23 125.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.572 -0.314 . . . . 0.0 111.071 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -119.91 91.03 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.569 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -66.89 143.39 56.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.924 0.392 . . . . 0.0 110.583 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.776 ' H ' HH22 ' A' ' 56' ' ' ARG . 59.2 m-85 -132.66 -96.59 0.31 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.523 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.42 -155.38 17.61 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.394 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.85 123.27 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.723 0.773 . . . . 0.0 110.079 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.48 141.92 34.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.186 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.47 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -82.65 -2.57 54.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.583 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -77.83 25.69 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.84 0.828 . . . . 0.0 110.649 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 82' ' ' LEU . 33.4 mtp-105 -49.4 -4.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.599 -0.688 . . . . 0.0 111.783 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.583 ' H ' ' C ' ' A' ' 83' ' ' ASN . 72.2 p -83.1 -32.12 26.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -76.91 -163.65 0.37 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 110.692 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.432 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 60.9 mtt85 -139.27 154.24 47.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.52 0.676 . . . . 0.0 110.62 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' LEU . 81.1 m95 -154.13 174.99 13.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 23.9 t0 -61.06 -175.99 0.05 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.727 0.775 . . . . 0.0 110.972 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.516 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -157.23 150.85 24.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 111.069 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -118.94 159.58 23.55 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.525 0.679 . . . . 0.0 110.641 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -134.8 175.18 9.79 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.774 0.797 . . . . 0.0 110.216 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 4.6 t80 -159.9 134.48 7.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.825 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -145.35 148.59 38.11 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.101 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 C-N-CA 122.432 2.088 . . . . 0.0 111.753 179.234 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.467 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.6 m -154.19 137.73 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.779 0.324 . . . . 0.0 110.698 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -123.12 123.68 41.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.401 ' O ' ' ND1' ' A' ' 4' ' ' HIS . 5.1 p80 -86.86 149.32 24.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.507 HH22 HD22 ' A' ' 94' ' ' ASN . 75.4 mtt85 -143.77 147.62 34.43 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.228 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -146.43 158.33 43.88 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.26 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.41 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.06 -35.82 72.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.453 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 p -111.01 19.89 18.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.628 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.01 -137.6 2.92 Favored Glycine 0 C--O 1.216 -1.03 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.657 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -171.93 -42.67 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.301 -0.449 . . . . 0.0 110.468 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -143.3 67.34 1.3 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -137.02 37.59 2.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.254 0.221 . . . . 0.0 110.533 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -120.98 123.92 43.62 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.451 0.643 . . . . 0.0 110.384 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.4 m -100.37 163.19 12.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.581 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -51.45 -52.33 47.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.517 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.8 -42.03 83.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.88 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.64 -51.5 59.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.775 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.82 -30.71 15.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.014 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -70.51 -33.22 70.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.46 21.5 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.849 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.29 -26.61 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.084 0.469 . . . . 0.0 110.365 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.509 ' C ' ' H ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -104.75 177.28 4.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.593 0.711 . . . . 0.0 109.385 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 28' ' ' GLY . 96.5 mt-10 67.67 -10.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.705 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.8 t80 -62.57 -47.75 82.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 0.0 110.789 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.9 pm0 -92.16 9.45 33.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.772 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.77 -17.16 56.84 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -82.69 127.28 7.89 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -100.1 173.17 6.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.639 0.257 . . . . 0.0 110.538 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.39 135.8 55.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.23 0.77 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.056 0.455 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 33' ' ' TYR . 1.5 t -72.43 179.85 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.778 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.471 ' N ' ' OG1' ' A' ' 32' ' ' THR . 64.4 t80 -56.0 -54.58 43.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.936 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -53.4 -50.47 65.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.845 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.556 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -66.18 -38.91 89.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.372 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 mt -61.67 -42.52 99.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.474 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.62 -50.46 73.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.717 0.294 . . . . 0.0 110.789 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.81 -33.13 55.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.33 -39.67 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.109 0.48 . . . . 0.0 111.226 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -30.16 21.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.286 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.16 -2.78 11.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.523 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 tp -92.45 9.46 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.112 0.258 . . . . 0.0 110.475 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.6 26.65 34.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -75.96 136.32 40.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.019 0.409 . . . . 0.0 110.449 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -154.02 103.04 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.55 129.05 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.757 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 t -93.96 83.46 4.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.494 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.54 95.79 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 134.91 54.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 0.0 110.779 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -140.85 170.64 24.43 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -81.51 156.75 25.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 4.8 mpp? -151.44 176.87 10.86 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 110.292 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.79 142.85 0.41 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.53 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 59.63 41.21 19.09 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.341 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.13 12.82 0.86 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.737 -0.602 . . . . 0.0 111.689 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' MET . 57.8 ttt180 -68.06 143.23 55.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 110.502 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.28 142.08 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.994 0.902 . . . . 0.0 110.928 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.01 -178.52 39.98 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.684 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 28.8 p90 -148.18 103.12 3.56 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.083 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.15 129.72 8.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.87 1.047 . . . . 0.0 112.308 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 pt -146.79 136.3 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.456 0.646 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.1 t -83.45 -26.49 7.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -156.03 150.5 20.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -42.24 130.64 4.75 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.508 1.472 . . . . 0.0 112.723 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.26 167.79 15.16 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.094 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.01 -34.54 16.85 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.937 1.758 . . . . 0.0 112.145 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -88.28 -10.16 50.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.435 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.2 p -170.54 141.35 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.612 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.18 9.36 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 54.5 p90 -62.63 -45.47 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 110.663 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . -60.58 -103.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -164.97 -151.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.78 0.324 . . . . 0.0 110.255 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.7 p -95.17 170.03 9.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.571 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.22 145.83 0.09 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -46.48 130.32 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -119.23 54.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 44.5 t0 -63.79 140.67 58.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 110.485 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.463 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 49.4 m-85 -92.31 4.51 53.19 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 58.66 84.48 0.04 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 79' ' ' GLY . 68.5 mt 50.32 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.079 0.466 . . . . 0.0 111.038 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -88.54 157.93 18.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.551 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 84' ' ' ARG . 9.9 mp -84.68 -6.67 59.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.216 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 85' ' ' SER . 49.8 p-10 -74.68 21.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.618 0.723 . . . . 0.0 110.606 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 82' ' ' LEU . 96.1 mtt180 -49.42 -10.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.6 -0.688 . . . . 0.0 111.052 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 83' ' ' ASN . 22.8 t -83.42 -36.22 24.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.624 0.249 . . . . 0.0 110.591 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -75.24 152.58 38.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.291 0.567 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -86.97 153.81 21.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.786 0.803 . . . . 0.0 110.566 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -153.86 174.92 13.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.125 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.58 -161.96 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.536 0.684 . . . . 0.0 110.996 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.06 141.98 12.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.284 0.564 . . . . 0.0 111.039 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -114.79 150.53 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.899 0.856 . . . . 0.0 110.261 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.5 m -142.26 -173.34 3.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.354 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 3.6 t80 -160.28 118.23 2.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.062 0.458 . . . . 0.0 109.993 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.507 HD22 HH22 ' A' ' 5' ' ' ARG . 3.0 m120 -103.61 150.69 38.36 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.992 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 N--CA 1.501 1.938 0 C-N-CA 121.285 1.323 . . . . 0.0 112.285 178.537 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.32 149.25 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.718 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -111.25 130.43 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -74.51 129.3 37.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.547 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.42 148.2 34.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.132 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.45 171.99 18.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.321 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.36 160.71 16.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.06 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.43 -27.73 46.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.301 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.6 p -72.6 -31.77 65.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.267 0.556 . . . . 0.0 110.966 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.09 160.19 12.21 Favored Glycine 0 C--O 1.216 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.633 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -68.06 -48.37 65.78 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.806 0.336 . . . . 0.0 110.673 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -98.52 49.35 0.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -136.44 24.23 3.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.944 0.402 . . . . 0.0 110.456 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 tp -120.68 129.96 53.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.807 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -85.14 161.33 19.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.66 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 50.0 p90 -60.16 -46.5 89.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.773 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -57.01 -40.71 77.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -66.08 -52.6 47.37 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.807 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.48 -31.62 56.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.231 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -68.15 -43.02 79.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 110.932 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.35 76.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.356 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 -26.27 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.396 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -105.35 174.79 5.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.401 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 39.2 mt-10 77.02 5.04 3.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.592 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -73.19 -37.74 66.37 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.157 0.503 . . . . 0.0 111.1 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -91.92 12.75 20.65 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.561 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 8.21 80.4 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.468 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -93.84 -157.25 33.0 Favored Glycine 0 C--O 1.218 -0.851 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -162.58 157.27 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.62 0.247 . . . . 0.0 110.721 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.69 147.76 3.41 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.498 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.65 91.9 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.029 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 t -74.48 179.16 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.961 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -58.36 -53.41 58.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -56.17 -47.57 78.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' ' CG ' ' A' ' 93' ' ' TYR . 54.3 tt0 -69.38 -37.56 77.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.957 0.408 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.49 -42.56 99.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.411 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -41.74 99.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 110.653 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.12 -36.98 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.797 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.52 -24.44 34.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.46 -30.64 65.21 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -79.17 -6.6 56.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.1 mt -94.04 1.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.525 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.41 9.52 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.31 135.29 47.32 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.662 0.268 . . . . 0.0 110.502 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.635 ' HD1' ' H ' ' A' ' 62' ' ' VAL . 79.0 t60 -155.87 102.67 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.88 117.89 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.927 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.86 94.88 9.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.75 115.15 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.559 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.05 142.2 52.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.457 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -157.28 170.81 34.51 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.803 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . 0.417 ' C ' ' SD ' ' A' ' 52' ' ' MET . 79.5 m95 -83.71 157.82 22.03 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.307 0.575 . . . . 0.0 110.185 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -152.8 177.45 10.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.281 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.0 145.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.372 0.606 . . . . 0.0 111.194 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 56' ' ' ARG . 68.7 mttm 56.6 42.74 26.71 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.167 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.29 10.98 0.38 Allowed Glycine 0 C--N 1.314 -0.672 0 O-C-N 121.746 -0.596 . . . . 0.0 112.085 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.594 HH22 ' CB ' ' A' ' 77' ' ' ASP . 64.2 ttt-85 -65.05 143.56 57.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.333 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.8 148.44 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.447 1.118 . . . . 0.0 110.781 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.1 -172.98 39.82 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.313 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 40.7 p90 -155.36 102.72 2.22 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.8 132.16 11.72 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.759 1.639 . . . . 0.0 112.4 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt -145.92 147.33 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.826 . . . . 0.0 110.909 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.635 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 14.8 t -116.06 -12.34 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.3 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -144.21 157.22 57.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.063 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -37.84 147.08 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.258 1.972 . . . . 0.0 112.548 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.64 79.82 0.35 Allowed Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.412 -0.66 . . . . 0.0 111.545 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 68' ' ' CYS . 73.1 Cg_exo -52.76 -48.12 23.73 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.439 2.093 . . . . 0.0 112.325 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -81.84 30.19 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.131 0.491 . . . . 0.0 110.472 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 70' ' ' PHE . 7.1 p -178.45 -165.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.56 86.23 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 68' ' ' CYS . 51.6 p90 -83.29 23.64 0.88 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.134 0.492 . . . . 0.0 110.494 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -131.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -79.14 -143.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 0.0 110.36 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 p -128.35 171.71 11.77 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.582 0.706 . . . . 0.0 110.39 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.6 155.25 0.76 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.1 mt -41.53 145.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.617 0.245 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mt -141.7 51.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.594 ' CB ' HH22 ' A' ' 56' ' ' ARG . 7.1 p-10 -60.62 151.77 28.08 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.643 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.73 -80.35 0.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.23 71.01 0.02 OUTLIER Glycine 0 N--CA 1.474 1.196 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.124 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.6 mt 53.99 91.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.333 0.587 . . . . 0.0 110.905 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 -87.8 155.93 19.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.506 0.669 . . . . 0.0 110.664 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 84' ' ' ARG . 53.5 mt -84.17 3.06 36.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.294 0.568 . . . . 0.0 110.281 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -72.99 18.57 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.214 1.006 . . . . 0.0 110.476 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 82' ' ' LEU . 93.7 mtt-85 -49.74 -11.69 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.591 -0.693 . . . . 0.0 111.199 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 83' ' ' ASN . 64.7 m -87.09 -42.32 13.14 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -66.48 155.59 37.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.159 0.505 . . . . 0.0 110.403 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -90.72 148.96 22.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.215 0.531 . . . . 0.0 110.483 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -154.13 175.59 13.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.249 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 8.4 t70 -79.57 -169.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.713 . . . . 0.0 110.713 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.484 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.33 168.92 9.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.359 0.6 . . . . 0.0 110.928 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -135.68 141.57 44.98 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.536 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.57 143.53 45.49 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.737 0.78 . . . . 0.0 109.763 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CG ' ' NE2' ' A' ' 35' ' ' GLN . 74.4 t80 -115.63 150.63 36.39 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -139.36 153.02 70.5 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.502 2.02 0 C-N-CA 122.826 2.35 . . . . 0.0 112.253 179.426 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.98 161.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.617 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -154.81 154.23 32.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.77 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -96.99 149.03 22.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.646 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.477 HH12 ' CG2' ' A' ' 22' ' ' VAL . 14.6 ptp180 -136.66 149.02 47.73 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.427 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -144.61 159.18 43.23 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.86 140.43 36.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -83.31 -43.27 16.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 t -96.43 25.96 4.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.76 -126.92 0.95 Allowed Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.697 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -150.24 -90.13 0.07 Allowed 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 120.997 0.427 . . . . 0.0 110.334 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.75 80.64 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.16 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -130.31 32.57 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -116.63 121.1 40.72 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.249 0.547 . . . . 0.0 110.657 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 p -100.28 169.11 9.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.384 0.611 . . . . 0.0 110.502 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -56.79 -49.86 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.415 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.91 73.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.91 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -67.32 -49.98 61.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.422 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -33.54 52.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 7.0 tptm -71.48 -33.22 69.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.399 0.619 . . . . 0.0 110.748 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.43 27.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.805 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.477 ' CG2' HH12 ' A' ' 5' ' ' ARG . 7.2 p -60.11 -36.63 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' C ' ' H ' ' A' ' 25' ' ' PHE . 1.3 m -103.34 178.06 4.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.4 -14.48 0.33 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.656 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' H ' ' C ' ' A' ' 23' ' ' CYS . 92.5 t80 -61.42 -47.99 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.685 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -89.64 20.35 4.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.91 79.75 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -72.01 -168.77 10.87 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 79.9 m80 -155.49 144.58 20.78 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.605 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.6 mm? -67.01 135.91 54.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -60.72 140.85 57.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.248 0.547 . . . . 0.0 110.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 p -122.1 178.29 4.98 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.924 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.21 -53.34 59.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.684 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -54.13 -49.28 69.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 110.472 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -66.88 -38.44 86.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.942 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.22 -43.77 98.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.364 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -55.26 -49.36 72.26 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.26 -29.63 10.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.836 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -37.13 36.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.511 ' NH2' ' C ' ' A' ' 61' ' ' ILE . 46.7 mmm-85 -55.82 -32.36 63.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.326 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -71.07 -4.22 23.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.739 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 84.1 mt -108.41 9.18 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.392 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.61 17.91 53.39 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -72.44 123.23 22.66 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.81 0.338 . . . . 0.0 110.173 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.555 ' HD1' ' H ' ' A' ' 62' ' ' VAL . 84.9 t60 -139.86 113.05 8.27 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.526 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -140.32 114.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.735 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -92.89 87.26 5.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.935 0.397 . . . . 0.0 110.242 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.85 138.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.604 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.02 132.53 39.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.637 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.48 148.99 21.08 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.903 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.69 152.24 39.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 75.6 mtm -153.08 -179.13 7.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.156 0.503 . . . . 0.0 110.319 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.8 143.61 0.34 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp 55.25 39.41 31.34 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.327 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.04 10.37 1.75 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.595 HH22 ' CG ' ' A' ' 77' ' ' ASP . 47.6 ttt-85 -65.98 142.23 57.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.424 0.63 . . . . 0.0 110.172 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -143.98 144.81 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.797 0.808 . . . . 0.0 110.818 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.82 167.59 40.64 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.523 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 25.2 p90 -133.3 78.47 63.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.512 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.16 139.61 71.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.095 1.864 . . . . 0.0 112.76 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' ' NH2' ' A' ' 40' ' ' ARG . 20.0 pt -150.83 134.39 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.858 0.837 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.555 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 61.2 t -62.8 -45.87 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.38 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -158.41 -62.3 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.78 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.49 143.17 87.4 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.866 1.711 . . . . 0.0 112.494 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.88 54.47 0.1 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.15 -49.59 0.49 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.645 2.23 . . . . 0.0 111.956 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -66.46 -39.09 88.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.81 132.68 36.77 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.246 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.14 50.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -159.88 103.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.435 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.31 -140.61 35.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 tttm 55.77 169.77 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.845 0.355 . . . . 0.0 110.469 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -136.31 157.25 47.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.52 151.3 6.37 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -40.3 144.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.689 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.16 45.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.535 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.595 ' CG ' HH22 ' A' ' 56' ' ' ARG . 1.9 p30 -68.71 145.77 53.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 110.472 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -90.24 -3.77 57.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.313 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 66.13 94.14 0.03 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 79' ' ' GLY . 63.5 mt 50.77 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -97.26 152.3 19.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.332 0.587 . . . . 0.0 110.173 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -85.45 -2.83 58.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.384 0.611 . . . . 0.0 110.277 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 85' ' ' SER . 97.7 m-20 -77.83 22.12 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.985 0.898 . . . . 0.0 110.561 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.442 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.2 mtt180 -51.68 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.125 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 83' ' ' ASN . 32.7 t -95.85 -25.62 15.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.638 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.04 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.458 0.646 . . . . 0.0 110.512 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 25.7 mtp180 -94.56 136.01 35.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 81.1 m95 -154.39 175.91 12.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -71.93 -164.44 0.13 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -162.41 149.74 13.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.465 0.65 . . . . 0.0 110.933 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -121.14 161.03 22.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.612 0.72 . . . . 0.0 110.451 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.91 -170.36 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.556 0.693 . . . . 0.0 110.182 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -161.23 151.48 17.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.368 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.475 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 6.9 m120 -145.11 146.33 30.33 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.288 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.63 7.6 2.64 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.118 1.879 . . . . 0.0 112.084 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.483 ' HD1' ' H ' ' A' ' 96' ' ' HIS . 6.5 p-80 -53.96 -41.93 68.35 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.582 0.706 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' A' ' 96' ' ' HIS . . . -150.92 147.42 27.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.933 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 C--N 1.29 -1.982 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.97 177.01 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 144.01 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.276 0.56 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.89 161.3 26.88 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.72 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.61 140.19 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.75 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.504 HH21 ' ND2' ' A' ' 94' ' ' ASN . 38.3 mmt180 -103.59 161.9 13.5 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.454 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -142.37 134.2 27.03 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.379 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.69 166.74 15.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.716 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -68.38 -38.03 80.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.193 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -72.35 -18.3 61.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.34 0.591 . . . . 0.0 110.597 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 -154.7 16.78 Favored Glycine 0 N--CA 1.478 1.444 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 13' ' ' LYS . 68.8 mttm -115.33 -177.47 3.15 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.416 0.627 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 47.62 16.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.759 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' N ' ' C ' ' A' ' 11' ' ' LYS . 51.2 mtmt -128.52 26.35 5.65 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.777 0.322 . . . . 0.0 110.72 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 88' ' ' TRP . 48.4 mt -123.38 132.14 53.87 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.9 p -97.48 168.51 10.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.508 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 47.8 p90 -51.26 -54.21 28.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.973 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.78 -41.38 64.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.24 -51.45 37.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.755 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.27 13.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.07 -34.93 77.36 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.354 0.597 . . . . 0.0 110.663 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -53.03 59.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.886 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.4 -25.87 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.442 . . . . 0.0 110.506 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.438 ' C ' ' H ' ' A' ' 25' ' ' PHE . 30.7 m -103.83 179.87 4.15 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.693 0.759 . . . . 0.0 109.247 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 67.17 -3.31 1.01 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.962 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 23' ' ' CYS . 89.7 t80 -61.82 -45.39 94.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.981 0.419 . . . . 0.0 110.869 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.4 pm0 -94.68 5.87 50.58 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.005 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.7 -22.52 39.36 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.5 143.1 38.25 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -98.72 153.38 18.77 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.742 0.305 . . . . 0.0 110.238 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -56.52 143.02 36.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.395 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -52.05 139.19 23.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.117 0.484 . . . . 0.0 110.735 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 ' CG2' ' H ' ' A' ' 33' ' ' TYR . 43.0 m -121.93 171.64 8.78 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.838 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.448 ' H ' ' CG2' ' A' ' 32' ' ' THR . 11.3 t80 -53.76 -53.42 52.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -58.76 -48.01 82.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.64 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.49 -36.62 81.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.243 0.544 . . . . 0.0 110.795 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 32' ' ' THR . 17.9 mt -62.12 -42.86 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.162 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.09 -31.15 40.38 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.04 79.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.815 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.31 -25.34 42.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -58.8 -35.98 73.73 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -72.66 -10.59 59.98 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.13 4.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.451 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 33.21 16.69 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -66.04 129.23 39.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.83 0.348 . . . . 0.0 110.508 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.612 ' HD1' ' H ' ' A' ' 62' ' ' VAL . 82.0 t60 -147.9 102.42 3.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.39 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.61 107.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.891 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -90.08 92.62 9.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.153 0.502 . . . . 0.0 110.106 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.71 109.84 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.08 138.92 56.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.92 163.84 34.44 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.25 160.42 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.277 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 77.3 mtm -156.12 -179.14 7.86 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.299 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.53 145.31 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.254 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 56' ' ' ARG . 55.5 tttm 56.95 42.51 26.16 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.99 10.94 0.5 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.79 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 54' ' ' LYS . 10.4 tpt180 -64.97 140.23 58.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.259 0.552 . . . . 0.0 110.47 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.11 161.98 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.106 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.4 177.44 37.77 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.854 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -145.37 81.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.329 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.41 135.5 60.91 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.185 1.923 . . . . 0.0 112.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -151.26 134.37 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.495 0.664 . . . . 0.0 110.833 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.612 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 62.1 t -65.21 -44.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.176 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -167.5 -61.46 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.064 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.61 156.5 65.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.771 1.648 . . . . 0.0 112.051 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' CA ' ' SG ' ' A' ' 68' ' ' CYS . . . -172.44 65.5 0.13 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.902 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.88 -44.97 35.69 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.268 1.979 . . . . 0.0 112.403 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.47 -24.76 45.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.719 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.421 ' SG ' ' CA ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -95.72 166.85 11.62 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.448 0.642 . . . . 0.0 110.031 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 71' ' ' GLY . . . -61.8 150.39 45.61 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.384 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 71' ' ' GLY . 45.3 p90 -76.29 29.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 110.581 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 69' ' ' GLY . . . -50.71 -105.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -141.9 -165.2 1.95 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.149 0.499 . . . . 0.0 110.322 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 p -94.67 160.84 14.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.467 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.55 168.69 0.44 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 54.0 mt -52.53 145.72 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.701 0.286 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.8 pt -149.85 -39.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -87.17 120.71 28.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.967 0.413 . . . . 0.0 110.613 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -145.05 -171.13 3.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.892 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.72 -179.69 48.99 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.3 mt -103.06 116.4 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -74.4 152.86 39.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.96 0.409 . . . . 0.0 110.051 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.47 ' C ' ' H ' ' A' ' 84' ' ' ARG . 39.9 tp -84.45 -8.04 59.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.609 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 85' ' ' SER . 45.6 p-10 -74.66 23.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 110.64 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 82' ' ' LEU . 77.9 mtp180 -51.48 -5.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.594 -0.691 . . . . 0.0 111.448 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 83' ' ' ASN . 95.0 p -98.35 4.41 48.61 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -96.93 -140.0 0.28 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -158.23 147.04 19.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.494 0.664 . . . . 0.0 110.98 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.42 ' O ' ' O ' ' A' ' 14' ' ' LEU . 91.4 m95 -154.13 176.44 12.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.295 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.91 -165.21 0.2 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.889 0.852 . . . . 0.0 110.777 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -161.26 154.17 20.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.118 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 12.1 m-85 -148.24 156.21 42.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.467 0.651 . . . . 0.0 110.352 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 81.6 m -123.46 -166.69 1.5 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.778 0.799 . . . . 0.0 110.155 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -146.87 125.5 12.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.504 ' ND2' HH21 ' A' ' 5' ' ' ARG . 1.1 m-80 -103.31 154.03 38.03 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.874 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -41.89 -47.31 6.52 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.75 1.633 . . . . 0.0 112.659 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.661 ' CG ' ' H ' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -149.94 -105.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.48 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.661 ' H ' ' CG ' ' A' ' 96' ' ' HIS . . . -151.62 150.04 29.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.152 0.501 . . . . 0.0 110.096 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 C--N 1.288 -2.075 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.215 176.842 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.7 m -85.39 154.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.008 0.433 . . . . 0.0 110.806 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.486 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 34.2 p90 -138.58 169.2 18.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.873 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -73.64 132.85 43.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.227 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.486 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 61.8 ttm-85 -135.16 131.26 36.58 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.274 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -165.0 159.18 17.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.232 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.83 137.52 56.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.929 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.18 -39.65 75.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.03 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.0 m -113.08 -32.92 6.19 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.793 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 -134.29 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.626 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 12' ' ' TYR . 24.6 pttm -173.28 -35.7 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.044 0.45 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.441 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 82.7 m-85 -159.53 80.78 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -147.19 42.52 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 0.0 110.353 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -117.25 126.44 52.74 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.315 0.579 . . . . 0.0 110.788 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.452 ' HG1' ' NH1' ' A' ' 87' ' ' ARG . 91.6 m -103.68 164.66 11.53 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.855 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.432 ' N ' ' CG2' ' A' ' 15' ' ' THR . 59.5 t80 -54.31 -48.17 71.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.486 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.2 -45.76 75.89 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.898 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 8.3 mp0 -64.49 -45.41 87.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.49 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.28 -31.16 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.827 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.88 -51.32 41.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.598 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -59.72 -23.19 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.978 0.418 . . . . 0.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.493 ' C ' ' H ' ' A' ' 25' ' ' PHE . 57.4 m -104.89 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 109.59 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 73.99 -26.12 0.19 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.873 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.493 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.0 t80 -59.78 -49.05 79.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.947 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.96 17.47 12.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.13 5.61 82.81 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -79.47 -175.53 47.67 Favored Glycine 0 C--O 1.219 -0.822 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 89.4 m-70 -154.96 158.52 39.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 136.93 57.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.044 0.449 . . . . 0.0 110.368 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 85.61 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.431 ' CG2' ' H ' ' A' ' 33' ' ' TYR . 40.9 m -71.05 170.36 13.02 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.431 ' H ' ' CG2' ' A' ' 32' ' ' THR . 26.1 t80 -55.37 -53.19 59.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.724 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.1 -49.14 77.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.577 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -66.34 -36.25 82.42 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.82 -43.75 98.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.541 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -49.72 -44.59 48.42 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.84 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.697 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.65 44.54 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.046 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.567 HH22 ' H ' ' A' ' 46' ' ' VAL . 12.1 mmm180 -56.93 -30.82 64.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.61 -6.6 57.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.452 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 5.6 mm -103.02 4.98 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 5.28 53.75 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -68.79 119.41 13.12 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.44 0.62 . . . . 0.0 109.978 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -134.85 103.43 5.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.567 ' H ' HH22 ' A' ' 40' ' ' ARG . 39.7 t -141.27 132.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.728 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -114.36 92.69 4.05 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.69 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.39 127.29 4.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.22 104.78 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.405 0.621 . . . . 0.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -122.66 157.24 17.25 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.024 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.413 ' CE3' ' CG2' ' A' ' 57' ' ' VAL . 88.9 m95 -78.68 145.7 34.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.313 0.578 . . . . 0.0 110.143 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 2.1 mpp? -142.99 171.84 13.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.324 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -38.71 149.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.665 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.7 mttt 57.27 34.81 25.3 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.194 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.83 6.85 1.36 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.796 -0.565 . . . . 0.0 111.888 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 54' ' ' LYS . 59.8 ttt85 -62.32 131.21 48.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 110.065 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.413 ' CG2' ' CE3' ' A' ' 51' ' ' TRP . 2.3 t -127.88 126.59 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.985 0.898 . . . . 0.0 110.728 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.06 -172.31 25.06 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.289 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 78' ' ' TYR . 7.8 p90 -152.5 84.83 4.62 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 114.934 -0.633 . . . . 0.0 110.344 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.15 145.04 67.2 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.36 2.04 . . . . 0.0 112.49 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -136.78 103.51 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.45 -53.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.266 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -95.09 145.9 30.35 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.327 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -39.89 140.54 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.067 1.844 . . . . 0.0 112.322 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.56 99.91 0.19 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.991 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -16.09 19.23 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.19 1.927 . . . . 0.0 112.108 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -70.83 -34.73 71.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.109 0.48 . . . . 0.0 110.687 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.7 137.25 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.236 0.541 . . . . 0.0 110.384 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.46 79.31 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 49.54 79.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.719 0.295 . . . . 0.0 110.714 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.05 -123.14 32.05 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 55.76 163.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 74' ' ' GLY . 89.1 m -138.99 164.31 30.09 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.676 0.75 . . . . 0.0 110.666 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 73' ' ' THR . . . 73.96 153.71 3.02 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.4 mt -53.32 126.17 9.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-O 120.974 0.416 . . . . 0.0 110.367 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.472 ' O ' ' CE2' ' A' ' 78' ' ' TYR . 37.2 mm -107.84 118.37 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.191 0.52 . . . . 0.0 110.424 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.58 149.73 43.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.384 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 98.5 m-85 -131.36 -16.51 3.08 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -170.0 34.63 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.1 mt -103.83 123.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.688 0.756 . . . . 0.0 110.504 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 81' ' ' ARG . 0.5 OUTLIER -98.37 130.13 45.02 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.39 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 84' ' ' ARG . 27.6 mt -83.0 8.58 12.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 85' ' ' SER . 47.7 p-10 -71.86 22.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.672 1.225 . . . . 0.0 110.981 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.545 ' H ' ' C ' ' A' ' 82' ' ' LEU . 72.0 ttt180 -48.06 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.597 -0.689 . . . . 0.0 110.986 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 83' ' ' ASN . 57.3 m -68.22 -37.66 81.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.656 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.18 -169.17 1.94 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 110.645 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.452 ' NH1' ' HG1' ' A' ' 15' ' ' THR . 92.0 mtt-85 -134.03 144.93 48.98 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.552 0.691 . . . . 0.0 110.721 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.448 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 60.3 m95 -150.32 175.42 11.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.971 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 42.5 t0 -59.86 -179.7 0.1 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 111.085 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -165.65 159.73 16.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.344 0.593 . . . . 0.0 110.884 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.11 160.54 38.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.637 0.732 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.8 t -141.95 148.54 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.159 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -115.42 141.93 47.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.124 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -147.26 148.52 32.04 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.196 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.68 154.83 59.4 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.463 2.109 . . . . 0.0 111.897 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 m80 52.46 20.54 1.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.427 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.07 -68.98 0.26 Allowed 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.359 1.076 . . . . 0.0 108.594 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 C--N 1.291 -1.974 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 174.472 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 t -82.96 157.15 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.665 0.269 . . . . 0.0 110.718 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.565 ' HH ' HD22 ' A' ' 94' ' ' ASN . 48.7 p90 -162.68 155.52 19.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.769 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -75.61 135.1 40.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.616 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -141.97 139.74 32.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.224 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -140.8 152.38 45.13 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.13 159.12 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.079 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -49.14 9.99 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.0 m -114.0 19.0 16.86 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.606 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.12 -176.25 14.38 Favored Glycine 0 C--O 1.215 -1.082 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' H ' ' HZ3' ' A' ' 13' ' ' LYS . 99.6 mttt -147.0 106.23 3.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.193 -0.504 . . . . 0.0 110.49 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 56.53 17.25 2.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.537 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HZ3' ' H ' ' A' ' 11' ' ' LYS . 65.5 mttp -80.48 38.64 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.44 117.12 30.85 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.264 0.554 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.9 m -101.58 163.62 12.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -53.85 -49.75 67.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.335 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.93 78.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.891 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.07 -49.28 70.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.713 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.6 -30.16 41.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' CYS . 44.1 tptt -60.93 -37.37 82.1 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.303 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.45 -54.2 13.3 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.449 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.49 -42.78 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.999 0.428 . . . . 0.0 110.788 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.563 ' C ' ' H ' ' A' ' 25' ' ' PHE . 62.1 m -100.51 173.42 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.454 ' OE1' ' NZ ' ' A' ' 20' ' ' LYS . 70.9 tt0 63.04 -7.98 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.93 -47.1 86.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.774 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -87.98 21.29 2.76 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.24 -1.2 84.33 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.81 -152.15 1.27 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 53.4 t-80 -168.67 152.74 5.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.642 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.465 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 44.0 mt -62.43 139.52 58.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.956 0.408 . . . . 0.0 110.438 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 103.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.998 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 36' ' ' LEU . 1.8 t -77.45 179.02 6.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.045 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.461 ' N ' ' OG1' ' A' ' 32' ' ' THR . 50.7 t80 -54.81 -53.65 52.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.1 -44.75 91.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.734 0.302 . . . . 0.0 110.71 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.475 ' H ' HG23 ' A' ' 32' ' ' THR . 78.8 mt-30 -71.38 -30.85 66.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 111.066 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.8 mt -63.48 -41.91 98.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -30.64 67.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.216 0.531 . . . . 0.0 110.674 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.89 65.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.828 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.74 -42.18 42.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.531 HH22 ' CA ' ' A' ' 61' ' ' ILE . 17.2 mmm180 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.161 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.36 -11.53 60.07 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.456 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 99.1 mt -96.71 4.13 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.21 9.6 55.44 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -66.85 125.36 25.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.949 0.374 . . . . 0.0 110.392 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -143.64 103.06 4.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.485 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.0 132.75 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.699 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.18 91.31 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.3 149.73 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.99 136.91 52.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.466 0.65 . . . . 0.0 110.884 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.89 -178.58 21.47 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.547 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -84.32 156.13 22.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.39 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.5 ptt? -158.16 -175.28 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.551 0.691 . . . . 0.0 110.101 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -30.71 144.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.574 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 55.35 15.46 1.39 Allowed 'General case' 0 C--O 1.2 -1.505 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.776 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 65.8 16.26 63.45 Favored Glycine 0 C--N 1.315 -0.623 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -66.59 154.5 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 0.0 110.007 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.5 p -129.9 118.12 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.862 0.839 . . . . 0.0 110.942 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 59' ' ' TYR . . . -113.73 -175.86 19.14 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 6.1 m-85 -141.66 69.72 25.34 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 115.065 -0.568 . . . . 0.0 110.291 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -52.62 115.32 2.15 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.72 1.614 . . . . 0.0 112.559 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.531 ' CA ' HH22 ' A' ' 40' ' ' ARG . 97.8 mt -145.58 118.23 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.607 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 66.8 t -74.73 -22.33 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 0.0 110.083 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -165.65 148.24 6.59 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.312 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -39.63 143.87 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.878 1.719 . . . . 0.0 112.926 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.91 167.79 25.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.457 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.97 -43.29 0.8 Allowed 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.164 1.91 . . . . 0.0 112.317 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -64.88 -35.21 80.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.46 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.17 113.47 25.74 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.216 0.531 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 145.65 29.03 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 45.5 -97.32 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.46 104.5 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.81 -161.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 110.148 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.2 p -94.59 150.62 20.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.429 0.633 . . . . 0.0 110.423 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 167.48 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.91 131.7 28.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 110.17 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.6 mt -86.64 126.0 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -66.66 133.68 50.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.486 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -143.81 156.45 44.49 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.754 0.787 . . . . 0.0 110.227 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.38 -161.0 34.67 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 85.6 mt -97.77 96.88 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.44 0.638 . . . . 0.0 110.193 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -71.52 141.94 50.12 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.262 0.553 . . . . 0.0 110.423 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 84' ' ' ARG . 24.1 tp -82.11 3.8 25.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.14 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 85' ' ' SER . 38.7 p-10 -76.06 20.44 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.916 0.865 . . . . 0.0 110.574 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 82' ' ' LEU . 80.9 mtp180 -54.94 -1.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.782 -0.574 . . . . 0.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 83' ' ' ASN . 96.7 p -94.94 -4.6 46.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' CD ' ' HE1' ' A' ' 88' ' ' TRP . 80.7 tt0 -94.98 154.08 17.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 83.4 mtm180 -86.17 136.81 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 110.651 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.1 m95 -153.2 176.84 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.328 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 30.9 t0 -73.55 -169.29 0.66 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.565 0.698 . . . . 0.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.47 153.88 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.499 0.666 . . . . 0.0 110.873 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.28 157.36 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.757 0.789 . . . . 0.0 110.371 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.53 -173.62 3.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.496 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -160.04 113.56 2.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.181 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.565 HD22 ' HH ' ' A' ' 3' ' ' TYR . 2.9 p30 -153.81 150.95 23.95 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.032 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.16 2.58 4.18 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 121.902 1.735 . . . . 0.0 111.581 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -86.95 -174.0 4.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.974 0.416 . . . . 0.0 110.377 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 58.3 -151.87 0.41 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.98 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.9 tttt . . . . . 0 C--N 1.29 -1.985 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.559 176.765 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -147.47 130.14 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.89 0.376 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -105.35 129.55 53.66 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.831 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -79.36 149.34 31.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.759 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -128.43 154.52 45.97 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -160.94 133.14 5.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.394 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.88 31.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -75.7 -42.35 51.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.532 0.682 . . . . 0.0 110.997 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 p -109.58 25.75 11.43 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.624 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.68 -142.95 3.54 Favored Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.743 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -162.38 87.09 0.61 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.111 0.481 . . . . 0.0 110.526 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 2.3 m-85 72.39 21.71 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -74.1 48.04 0.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.408 -0.183 . . . . 0.0 110.758 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.99 130.12 52.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.543 0.687 . . . . 0.0 110.904 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.0 p -101.38 170.23 8.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -56.26 -50.19 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.91 86.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.041 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -51.74 39.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.71 -30.34 13.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' CYS . 28.8 ttpt -67.92 -33.6 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.514 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -51.91 63.32 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 111.56 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.24 -38.72 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.207 0.527 . . . . 0.0 110.71 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' C ' ' H ' ' A' ' 25' ' ' PHE . 56.8 m -101.17 178.8 4.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.871 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' GLY . 36.1 tt0 72.68 -27.28 0.18 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.7 t80 -61.27 -46.62 89.58 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 110.799 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.1 pm0 -86.49 11.74 11.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -23.1 33.79 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -78.51 134.27 13.91 Favored Glycine 0 C--O 1.22 -0.738 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.44 173.34 6.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.83 137.61 56.73 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.244 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.97 139.54 46.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.429 0.633 . . . . 0.0 110.819 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 36' ' ' LEU . 2.4 p -122.27 174.35 7.04 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.921 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -59.71 -52.83 63.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.91 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.87 -45.25 95.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.927 0.394 . . . . 0.0 110.485 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.11 -34.73 75.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.639 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.7 mt -62.53 -41.14 98.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.467 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -53.89 -40.82 66.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.755 0.312 . . . . 0.0 110.884 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.83 97.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.081 0.467 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.56 -25.47 26.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 61' ' ' ILE . 1.1 tpt85 -56.41 -25.74 51.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.593 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -81.49 -1.35 45.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.508 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 tt -91.65 6.31 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.13 26.24 34.62 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -70.55 131.23 43.67 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.83 0.315 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.65 101.77 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -143.43 133.07 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.14 78.74 6.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.862 0.363 . . . . 0.0 110.027 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.38 92.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.472 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.07 39.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.628 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.05 165.59 20.97 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.814 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -72.14 104.97 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.385 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.47 ' O ' ' N ' ' A' ' 55' ' ' GLY . 71.4 mtm -97.31 -178.33 4.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.25 0.548 . . . . 0.0 110.418 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -32.07 144.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.769 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 mttp 54.4 9.27 0.24 Allowed 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.224 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 81.86 20.87 62.49 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.045 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 69.2 ttt180 -70.38 130.01 40.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.428 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.2 p -116.57 133.09 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.806 0.812 . . . . 0.0 110.745 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.46 157.18 28.81 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -113.11 106.07 55.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.448 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 87.8 Cg_endo -79.05 126.93 7.36 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.101 1.201 . . . . 0.0 112.234 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 17.1 pt -145.97 137.95 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.831 0.824 . . . . 0.0 110.875 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.77 -45.36 98.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.285 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.574 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -168.5 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.574 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 31.8 Cg_exo -60.64 147.95 93.04 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.231 1.954 . . . . 0.0 112.164 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.461 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -156.73 50.53 0.44 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.371 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.3 Cg_endo -66.55 -53.41 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.321 2.014 . . . . 0.0 111.943 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.77 -23.19 31.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.56 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 12.1 p -151.03 124.94 9.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.56 110.5 0.25 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -144.09 -53.1 0.33 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.14 -72.7 0.58 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -172.36 -157.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 0.0 110.669 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 p -114.89 166.37 11.85 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 68.41 68.32 1.69 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' GLY . 71.9 mt 56.44 128.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.587 -0.307 . . . . 0.0 110.899 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.46 118.15 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 120.992 0.425 . . . . 0.0 110.379 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 91.9 m-20 -92.54 108.1 19.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.496 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.488 ' CE1' ' OH ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -95.93 -11.55 26.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.1 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.98 -174.51 44.16 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.5 mp -96.61 116.87 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.212 0.53 . . . . 0.0 110.556 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.503 ' CZ ' HD22 ' A' ' 83' ' ' ASN . 79.8 mtp180 -92.91 133.85 35.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.112 0.482 . . . . 0.0 110.162 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 tp -83.35 4.65 26.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 110.308 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.503 HD22 ' CZ ' ' A' ' 81' ' ' ARG . 51.4 p30 -85.66 23.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.487 0.661 . . . . 0.0 110.537 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -44.31 -32.08 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.566 -0.709 . . . . 0.0 111.261 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.1 p -49.08 -21.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.009 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -70.51 -169.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.12 0.486 . . . . 0.0 110.743 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 84.1 mtt85 -130.2 129.81 43.87 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.373 0.606 . . . . 0.0 110.776 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.428 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.4 m95 -150.1 175.71 11.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.908 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD2' ' CD1' ' A' ' 12' ' ' TYR . 1.3 m-20 -55.69 -174.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.86 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.47 143.07 18.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.425 0.631 . . . . 0.0 110.935 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -115.43 160.08 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.008 0.909 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.88 179.71 6.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -133.36 116.7 16.4 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.183 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -149.41 88.47 5.0 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.045 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.89 85.49 1.7 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.398 1.399 . . . . 0.0 111.559 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -133.75 -42.88 0.83 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.19 -73.02 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.83 0.824 . . . . 0.0 108.849 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt . . . . . 0 C--N 1.291 -1.95 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.007 176.186 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.98 136.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 110.742 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.6 162.41 37.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.972 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -74.91 129.06 37.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -135.03 133.3 39.25 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.216 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -157.05 156.03 32.17 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.65 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.16 -37.02 34.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.094 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.3 m -84.71 -5.21 59.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.63 -118.65 0.81 Allowed Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.159 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -167.53 -39.94 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.36 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -146.76 67.16 1.16 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.978 0.418 . . . . 0.0 110.517 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.09 32.92 3.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.3 118.72 32.0 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.649 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -90.32 168.31 11.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.656 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 38.5 p90 -51.64 -60.23 3.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -53.16 -40.24 64.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -66.24 -47.96 72.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.64 -35.87 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.795 0.331 . . . . 0.0 110.849 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' CYS . 56.6 mtpt -68.9 -31.31 70.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.86 45.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.884 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.82 -33.87 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.709 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.462 ' C ' ' H ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -104.71 -178.45 3.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 109.586 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 96.4 mt-10 69.77 -10.28 0.62 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.923 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' H ' ' C ' ' A' ' 23' ' ' CYS . 90.5 t80 -60.48 -47.25 86.95 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 18.0 pt-20 -87.39 21.37 2.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.46 76.26 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.11 -171.28 40.45 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.467 ' HE2' ' NE2' ' A' ' 35' ' ' GLN . 47.3 p-80 -163.45 121.07 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.679 0.276 . . . . 0.0 110.451 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -42.15 136.98 2.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.701 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -66.12 144.66 56.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -123.21 177.3 5.63 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.075 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -51.6 -26.74 9.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.474 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -70.66 -56.33 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.467 ' NE2' ' HE2' ' A' ' 29' ' ' HIS . 84.1 mt-30 -69.76 -35.29 74.82 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.859 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.7 mt -61.07 -40.85 95.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.419 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.72 -34.14 71.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.541 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.2 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 110.785 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.97 66.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -56.59 -43.47 80.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.402 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.77 -11.4 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.2 mt -98.54 7.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.49 22.08 52.05 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.47 132.78 46.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.751 0.31 . . . . 0.0 110.585 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -154.23 105.38 2.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 p -141.71 127.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.879 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.38 82.56 1.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.82 118.21 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.721 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.99 151.04 21.19 Favored Glycine 0 N--CA 1.476 1.336 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.12 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -73.13 147.5 44.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.166 0.508 . . . . 0.0 110.258 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 48.9 mtm -150.0 179.96 7.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.018 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.8 141.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.835 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 55.39 12.37 0.72 Allowed 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.179 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 75.62 21.59 76.75 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.808 -0.558 . . . . 0.0 112.158 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -74.36 135.89 42.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.209 0.528 . . . . 0.0 110.579 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -143.41 156.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.667 0.746 . . . . 0.0 110.783 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.69 -178.47 44.6 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.271 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -116.46 67.04 3.51 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.879 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.29 118.78 5.68 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.762 1.642 . . . . 0.0 112.419 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.2 pt -145.02 147.98 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.682 0.753 . . . . 0.0 110.88 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.71 -66.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.338 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.686 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 17.7 mttt -144.76 -43.07 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.303 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.686 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 28.0 Cg_exo -63.32 150.14 89.36 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.211 1.941 . . . . 0.0 112.371 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -168.88 49.32 0.22 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.493 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.8 Cg_endo -66.73 -53.19 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.428 2.085 . . . . 0.0 112.118 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -74.4 -17.05 60.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.24 132.1 1.02 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.95 41.4 0.03 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.64 -41.82 98.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 110.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.47 -84.67 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -170.93 -156.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.213 . . . . 0.0 110.472 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.3 p -95.3 162.22 13.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.328 0.585 . . . . 0.0 110.597 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.22 19.97 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.2 mt -102.67 123.34 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.097 0.475 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.9 mt -93.88 131.21 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.351 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.51 97.33 9.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.373 0.606 . . . . 0.0 110.067 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.1 41.79 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.301 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 80' ' ' ILE . . . -91.06 -147.34 19.26 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 79' ' ' GLY . 11.5 mt 15.72 58.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.435 0.636 . . . . 0.0 111.238 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.572 ' CZ ' HD22 ' A' ' 83' ' ' ASN . 82.3 mtp180 -71.08 150.78 45.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.2 mp -77.24 -16.6 58.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.14 0.495 . . . . 0.0 109.958 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.669 ' C ' ' H ' ' A' ' 85' ' ' SER . 9.1 p30 -91.52 25.18 2.73 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.381 0.61 . . . . 0.0 110.616 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -52.88 5.04 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.719 -0.613 . . . . 0.0 111.712 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.669 ' H ' ' C ' ' A' ' 83' ' ' ASN . 47.7 t -92.61 -8.47 44.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.413 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -85.97 -165.27 1.2 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.005 0.431 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.47 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -131.27 141.25 49.95 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.005 0.907 . . . . 0.0 110.849 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 61.7 m95 -153.07 177.26 10.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.862 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 12.4 t70 -60.71 -163.67 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.448 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -170.35 149.35 3.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.22 0.533 . . . . 0.0 110.759 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -118.21 135.32 54.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.458 0.647 . . . . 0.0 110.253 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.9 m -114.08 177.33 4.68 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.023 0.916 . . . . 0.0 109.637 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -150.43 151.41 32.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 96' ' ' HIS . 29.8 t-20 -143.11 132.77 11.87 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.362 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.8 11.66 1.62 Allowed 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 122.05 1.834 . . . . 0.0 112.275 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.479 ' N ' ' OD1' ' A' ' 94' ' ' ASN . 71.3 t60 -160.11 77.99 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.04 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.5 155.8 28.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.972 0.415 . . . . 0.0 110.25 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.945 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.056 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.2 t -85.1 155.51 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.637 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -117.79 129.24 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.576 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -74.09 127.53 33.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 90' ' ' ALA . 24.0 ttm180 -146.06 128.78 16.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.037 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.9 pm0 -146.41 -176.82 5.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.468 0.48 . . . . 0.0 110.392 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.67 127.1 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -78.39 -33.96 48.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.846 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.82 -4.09 41.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.531 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.47 -95.16 0.1 Allowed Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.873 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -171.34 -81.5 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.917 0.389 . . . . 0.0 110.311 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.02 80.15 3.28 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.001 0.429 . . . . 0.0 110.622 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -137.61 34.62 2.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.153 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.519 0.676 . . . . 0.0 110.258 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 p -99.03 168.27 10.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.245 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.543 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 31.9 p90 -53.68 -53.56 50.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.543 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -55.12 -45.97 75.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.47 69.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.5 mttt -71.87 -40.27 69.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 0.0 110.715 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -46.64 84.53 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.33 -42.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.529 0.68 . . . . 0.0 110.94 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 20' ' ' LYS . 17.6 m -101.47 178.79 4.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.736 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 70.04 -45.78 0.59 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' H ' ' C ' ' A' ' 23' ' ' CYS . 70.4 t80 -62.71 -48.02 81.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.41 21.82 3.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.022 0.439 . . . . 0.0 110.871 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.15 1.48 84.33 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.23 -171.38 9.54 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -168.41 137.03 2.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.557 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.94 141.27 47.82 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 110.25 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.3 93.96 0.35 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.291 0.567 . . . . 0.0 110.726 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.457 ' CG2' ' H ' ' A' ' 33' ' ' TYR . 34.0 m -86.01 171.66 11.24 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.898 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.457 ' H ' ' CG2' ' A' ' 32' ' ' THR . 66.7 t80 -55.53 -53.98 49.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.22 -45.05 84.21 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.542 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -70.05 -34.93 73.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 110.858 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.15 -40.87 98.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.15 -37.31 82.41 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.5 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.09 -39.77 93.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.71 -27.62 31.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.365 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -56.96 -25.0 57.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.268 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.56 -6.24 59.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.1 mt -94.36 4.52 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.521 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.29 25.09 24.86 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -66.31 128.66 37.02 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.701 0.251 . . . . 0.0 110.59 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -150.03 103.19 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.278 0.561 . . . . 0.0 110.468 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.65 117.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.023 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.87 89.73 6.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.11 112.5 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.118 0.485 . . . . 0.0 110.618 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.45 137.21 52.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.905 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.98 -172.83 19.13 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.689 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.73 150.81 19.82 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.1 mtm -143.73 168.86 18.9 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.35 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.19 156.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.17 40.77 31.85 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.273 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.26 6.61 0.16 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.008 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 56.5 ttt180 -68.81 144.72 54.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.61 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.29 130.19 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.771 0.795 . . . . 0.0 110.786 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.76 175.59 45.08 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.433 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -167.55 143.19 3.33 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.724 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.11 146.68 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.184 1.922 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.2 mt -141.8 93.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.556 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.24 -36.76 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.031 0.443 . . . . 0.0 110.278 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -137.7 154.39 74.79 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.33 144.77 59.2 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.362 2.041 . . . . 0.0 112.0 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.75 179.72 20.76 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.37 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.8 -47.63 26.14 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 122.174 1.916 . . . . 0.0 112.598 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -138.41 28.69 2.47 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.3 p -151.34 150.5 30.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.381 0.61 . . . . 0.0 110.273 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.0 93.77 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.43 -44.7 96.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 110.597 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.21 -8.96 0.05 OUTLIER Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.16 155.78 38.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.708 0.289 . . . . 0.0 110.287 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -140.5 130.31 24.47 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.794 0.807 . . . . 0.0 110.598 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 75' ' ' ILE . . . 144.77 -47.02 0.78 Allowed Glycine 0 N--CA 1.465 0.625 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.195 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.438 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER 159.26 131.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 120.868 0.366 . . . . 0.0 110.607 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mm -111.24 62.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.58 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 44.5 p-10 -99.67 103.61 15.3 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.95 0.405 . . . . 0.0 110.296 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -71.17 -61.62 1.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.45 -147.44 13.09 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.515 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.0 mt -97.63 117.39 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.368 . . . . 0.0 110.074 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 50.8 mtp85 -94.24 133.5 37.7 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mp -82.54 3.34 28.96 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.592 0.71 . . . . 0.0 109.831 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 52.2 p-10 -81.66 26.2 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.846 0.832 . . . . 0.0 110.479 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -45.38 -36.35 4.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.543 -0.723 . . . . 0.0 111.262 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -45.57 -26.99 0.67 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.563 0.221 . . . . 0.0 110.99 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 8.7 mp0 -74.13 -173.08 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.932 0.872 . . . . 0.0 109.988 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -128.49 145.7 51.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.917 0.865 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -155.05 175.91 13.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.343 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 28.0 t0 -79.82 -168.36 1.57 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.72 0.771 . . . . 0.0 110.604 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -167.98 164.58 13.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.455 0.645 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.93 151.52 49.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.534 0.683 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.53 142.45 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.227 0.537 . . . . 0.0 110.308 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 94' ' ' ASN . 10.9 t80 -134.34 149.91 50.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.274 0.559 . . . . 0.0 110.312 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.482 ' N ' ' CD1' ' A' ' 93' ' ' TYR . 11.8 m120 -117.71 89.97 34.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.505 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.54 132.02 34.35 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.272 1.982 . . . . 0.0 112.537 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 96' ' ' HIS . 16.3 t-80 39.63 42.7 0.98 Allowed 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 122.387 0.275 . . . . 0.0 110.287 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 56.27 -135.2 1.27 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 122.171 0.986 . . . . 0.0 109.047 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.0 tttm . . . . . 0 C--N 1.29 -1.98 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 176.024 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.66 163.32 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -146.71 127.89 14.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.804 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -73.79 138.44 44.53 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -145.62 160.96 40.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.496 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.4 pm0 -160.92 -177.48 6.16 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.81 124.66 17.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -66.24 -39.62 89.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.018 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m -109.72 33.08 4.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.507 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.36 -134.1 1.63 Allowed Glycine 0 C--O 1.216 -1.002 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.798 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -154.87 -83.16 0.07 Allowed 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.325 -0.438 . . . . 0.0 110.424 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.61 28.78 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -94.81 33.74 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.903 0.382 . . . . 0.0 110.604 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.47 124.54 49.03 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.534 0.683 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.3 m -87.97 161.3 17.5 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.5 -43.74 96.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.388 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.24 62.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.957 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.46 -51.15 62.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -31.77 18.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 23' ' ' CYS . 10.5 mtpm? -70.59 -33.8 71.46 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 120.576 0.227 . . . . 0.0 110.567 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.54 74.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.133 0.492 . . . . 0.0 111.765 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.68 -44.31 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.251 0.548 . . . . 0.0 111.173 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.578 ' O ' ' O ' ' A' ' 20' ' ' LYS . 7.4 m -102.26 178.25 4.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.085 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 67.45 -39.32 0.37 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.9 t80 -60.0 -47.03 87.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.658 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.67 19.76 5.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.676 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.95 77.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.57 -165.75 22.11 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -167.95 137.89 2.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.201 . . . . 0.0 110.523 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.7 mp -70.54 137.4 50.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.917 0.389 . . . . 0.0 110.144 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.42 138.64 55.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 36' ' ' LEU . 11.1 p -100.31 163.71 12.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 22.9 p90 -54.4 -53.37 54.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.943 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 39.0 ttmt -62.28 -44.38 96.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.986 0.422 . . . . 0.0 110.334 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -67.06 -30.05 70.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.4 mt -62.41 -29.9 70.83 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.346 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.77 -39.36 58.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.407 . . . . 0.0 110.909 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.29 -38.03 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.83 28.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 42' ' ' ILE . 3.8 tpt85 -56.77 -37.47 71.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -63.48 -2.09 1.45 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.509 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.43 ' H ' ' C ' ' A' ' 40' ' ' ARG . 24.5 mm -106.39 13.46 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.347 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 18.93 66.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.77 127.49 33.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.885 0.343 . . . . 0.0 110.181 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -140.93 104.43 4.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.506 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.53 125.4 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.023 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -93.84 91.51 6.98 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.887 0.375 . . . . 0.0 110.303 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.28 93.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.11 121.37 19.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.479 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.59 162.6 25.82 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.961 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -80.29 109.34 14.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.39 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 40.1 mtm -97.87 -172.61 2.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.248 0.547 . . . . 0.0 110.251 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.02 152.93 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.583 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 56' ' ' ARG . 68.6 mttm 47.19 41.03 11.13 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.96 5.68 0.1 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.892 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 54' ' ' LYS . 54.8 mtp180 -68.37 128.91 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.3 122.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.806 0.812 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.81 150.74 12.16 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.516 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -160.53 140.36 8.26 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.607 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 143.37 31.59 Favored 'Trans proline' 0 N--CA 1.505 2.198 0 C-N-CA 121.632 1.555 . . . . 0.0 112.784 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.5 pt -149.49 96.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.435 0.636 . . . . 0.0 111.08 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -139.18 80.34 23.69 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.64 131.22 32.57 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 121.851 1.701 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.41 169.13 28.71 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.048 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.79 -18.4 47.43 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.504 2.136 . . . . 0.0 112.056 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -102.84 30.77 4.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.019 0.438 . . . . 0.0 110.537 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.42 -174.02 3.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.2 0.524 . . . . 0.0 110.502 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.21 135.87 34.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -73.19 134.0 44.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 72' ' ' LYS . . . 65.01 -154.93 49.37 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 71' ' ' GLY . 56.7 mtpt 54.15 109.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.197 . . . . 0.0 110.875 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -139.12 170.75 15.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.285 0.564 . . . . 0.0 110.824 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.04 68.66 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.7 mt 59.98 145.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.776 0.322 . . . . 0.0 110.39 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.43 136.28 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.11 0.481 . . . . 0.0 110.626 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -133.36 137.74 46.01 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.539 ' CZ ' ' NH2' ' A' ' 81' ' ' ARG . 9.2 t80 -143.21 -179.0 6.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.638 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.48 -69.06 1.17 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER 173.79 135.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.3 0.571 . . . . 0.0 109.98 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.539 ' NH2' ' CZ ' ' A' ' 78' ' ' TYR . 86.9 mtt-85 -111.4 133.49 53.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.232 0.539 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 mt -82.39 2.35 32.87 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.481 0.658 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -83.42 21.66 1.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.837 0.827 . . . . 0.0 110.656 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -48.91 -36.07 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.572 -0.705 . . . . 0.0 111.182 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -47.56 -30.8 3.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.564 0.221 . . . . 0.0 110.869 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.93 147.62 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.777 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 81.8 mtt85 -92.61 133.15 36.26 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.261 0.553 . . . . 0.0 110.569 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 66.6 m95 -151.53 175.62 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.17 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -63.64 -169.0 0.03 OUTLIER 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.726 0.641 . . . . 0.0 111.007 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.34 159.75 8.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.414 0.626 . . . . 0.0 111.106 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.55 156.95 40.01 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.592 0.711 . . . . 0.0 110.576 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.1 m -147.5 142.28 26.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.631 0.729 . . . . 0.0 110.002 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.32 114.67 13.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.833 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -102.96 105.96 48.14 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 118.079 -0.963 . . . . 0.0 111.163 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.32 -11.49 17.45 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.063 1.176 . . . . 0.0 112.081 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.486 ' O ' ' CG ' ' A' ' 96' ' ' HIS . 84.8 t60 -94.79 42.46 1.09 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.516 0.674 . . . . 0.0 111.008 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.3 -61.18 0.06 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 C--N 1.289 -2.041 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.518 176.402 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.01 150.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -158.84 154.19 25.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -83.17 142.3 31.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -145.87 134.57 22.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 79.2 tt0 -134.48 161.03 36.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.11 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.11 133.69 38.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.525 0.678 . . . . 0.0 110.977 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 6' ' ' GLU . 86.2 mmt-85 -75.66 -39.37 57.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.834 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -113.53 -30.34 6.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.86 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.59 -170.22 43.71 Favored Glycine 0 C--O 1.216 -0.975 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -167.23 99.45 0.52 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 55.12 60.76 3.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.936 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -142.48 42.97 1.63 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.719 0.295 . . . . 0.0 110.683 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.15 137.91 53.62 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.405 0.622 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.4 p -101.65 166.62 10.6 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.766 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.583 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 33.0 p90 -51.89 -60.52 3.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -56.29 -36.36 68.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.918 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.81 -48.85 65.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.83 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.22 -30.64 7.36 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.025 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.5 mtpt -65.03 -26.37 68.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 -53.69 30.79 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.555 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.98 -33.7 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.994 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.633 ' C ' ' H ' ' A' ' 25' ' ' PHE . 56.1 m -102.88 176.11 5.26 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 64.7 -26.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.633 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.6 t80 -61.14 -47.83 84.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.854 0.359 . . . . 0.0 110.728 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.21 23.67 4.26 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.6 -5.15 84.48 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.56 -158.96 3.52 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -173.28 161.29 4.18 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.51 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.22 145.87 55.27 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.602 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.03 81.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.433 0.635 . . . . 0.0 111.145 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -62.45 152.24 34.95 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -57.93 -52.62 64.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.757 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -50.72 -49.69 57.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.587 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.17 -40.44 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.714 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.21 -40.65 96.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.3 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -63.89 -33.38 75.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.485 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.0 63.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.25 -32.32 19.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.262 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -52.47 -19.91 2.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.428 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -3.4 37.19 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.809 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.8 tt -101.84 13.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.625 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 18.84 70.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.84 145.23 20.31 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.239 0.519 . . . . 0.0 110.326 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -140.85 132.56 27.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.708 0.766 . . . . 0.0 110.352 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.97 159.48 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.784 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -156.24 41.48 0.37 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.523 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.17 144.01 30.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.23 0.538 . . . . 0.0 110.595 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.46 34.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.618 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.32 -171.34 12.66 Favored Glycine 0 N--CA 1.48 1.598 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.05 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -99.12 150.04 22.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 110.054 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 42.2 ttm -134.44 161.19 35.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.117 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.8 136.93 1.84 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.2 mttp 56.77 38.03 29.21 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.598 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.84 15.47 2.29 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.836 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -75.12 50.94 0.5 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.69 0.281 . . . . 0.0 110.651 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 p -54.81 132.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.086 0.946 . . . . 0.0 110.765 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.27 71.71 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -71.23 142.99 87.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 121.161 -0.215 . . . . 0.0 111.546 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 156.47 53.75 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.511 1.474 . . . . 0.0 112.501 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.6 mt -144.13 94.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.64 -72.92 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -71.82 155.37 92.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -61.76 145.56 97.22 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.381 2.054 . . . . 0.0 111.899 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.61 83.97 0.24 Allowed Glycine 0 N--CA 1.472 1.058 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.91 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.36 -42.14 56.02 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.237 1.958 . . . . 0.0 112.322 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -98.13 23.75 7.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.701 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 4.2 p -177.7 111.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.393 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 72.21 16.61 77.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 50.85 -88.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.438 0.637 . . . . 0.0 110.803 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -158.74 18.99 0.29 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.74 126.77 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 110.164 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -94.18 172.36 8.27 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.07 -170.9 54.2 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.82 123.35 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.97 0.414 . . . . 0.0 110.714 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.9 mm -95.97 74.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.615 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -75.84 109.59 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.332 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -75.04 -4.3 37.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 50.22 69.53 1.05 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 79' ' ' GLY . 75.8 mt 56.04 120.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.071 0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -104.64 152.76 22.08 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.108 0.48 . . . . 0.0 110.388 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 84' ' ' ARG . 48.5 tp -85.93 -11.03 54.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 110.491 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 85' ' ' SER . 51.4 p30 -73.48 23.61 0.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.856 0.836 . . . . 0.0 110.508 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.3 mtt180 -47.95 -13.61 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.587 -0.696 . . . . 0.0 111.114 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.24 -32.23 26.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.717 0.294 . . . . 0.0 110.669 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.61 149.06 44.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.609 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -85.79 158.25 20.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.431 0.634 . . . . 0.0 110.507 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -155.43 179.81 8.82 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.249 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 43.6 t0 -75.31 -177.08 3.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.645 0.736 . . . . 0.0 110.765 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.502 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.82 158.19 30.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -151.32 159.0 44.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.672 0.749 . . . . 0.0 110.504 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.5 m -125.59 148.09 49.07 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.083 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -138.45 126.8 23.06 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 56.9 m-80 -68.41 148.83 98.18 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.709 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.49 -18.14 38.41 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.993 1.795 . . . . 0.0 111.466 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -52.84 -89.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 50.62 -168.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.165 0.507 . . . . 0.0 110.172 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.225 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' H1 ' ' H ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.448 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 35.0 m -83.14 155.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.802 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -146.99 148.67 31.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 110.794 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.74 136.8 34.62 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.754 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -102.63 158.78 16.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -141.1 113.79 8.28 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.448 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 173.75 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.61 86.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.074 0.464 . . . . 0.0 111.157 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.0 p -75.92 -7.18 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.445 0.641 . . . . 0.0 110.759 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 40.44 45.21 3.32 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 12' ' ' TYR . 53.3 tttp -152.8 46.56 0.71 Allowed 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 121.011 0.434 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.405 ' O ' ' O ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER 44.95 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -141.4 36.85 1.68 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.758 0.313 . . . . 0.0 110.486 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' TRP . 50.6 mt -123.88 137.94 54.56 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 16' ' ' TYR . 87.2 m -100.47 164.77 11.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.417 ' N ' ' CG2' ' A' ' 15' ' ' THR . 32.2 t80 -52.01 -58.5 6.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.51 84.83 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.957 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.06 -46.54 89.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.989 0.423 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.77 -29.68 60.02 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.796 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 23' ' ' CYS . 5.1 ttpm? -70.31 -31.32 68.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.975 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.19 70.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.482 . . . . 0.0 111.598 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 m -68.16 -33.84 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.462 0.648 . . . . 0.0 111.284 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.507 ' C ' ' H ' ' A' ' 25' ' ' PHE . 12.3 t -103.85 176.89 5.0 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.012 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 62.59 -3.64 0.28 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.714 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 23' ' ' CYS . 82.5 t80 -58.88 -46.2 88.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.067 0.46 . . . . 0.0 110.485 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.0 pm0 -83.38 -16.94 44.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.53 -16.37 5.65 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.477 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -60.52 -162.5 0.13 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 99.5 m-70 -156.87 148.99 22.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.567 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.5 mt -51.29 137.04 23.74 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.471 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.14 103.63 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.201 0.524 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.2 t -80.61 169.82 17.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -54.94 -52.2 63.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.076 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -57.64 -42.46 83.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 32' ' ' THR . 7.1 tp-100 -69.48 -40.39 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.96 -44.91 94.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.235 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.76 -38.35 69.75 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.803 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.21 74.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.109 0.48 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -43.77 36.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.155 0.502 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.593 HH12 ' H ' ' A' ' 46' ' ' VAL . 18.3 mmm180 -55.48 -29.27 58.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -70.73 -10.2 58.93 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.432 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.1 mm -104.98 13.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.36 11.1 78.76 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -59.12 104.22 0.23 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.023 0.412 . . . . 0.0 110.252 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -88.72 129.16 35.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.421 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.593 ' H ' HH12 ' A' ' 40' ' ' ARG . 39.2 t -136.65 157.36 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.953 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -158.49 46.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.14 146.1 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 110.65 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.87 115.16 29.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.602 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.35 160.02 20.71 Favored Glycine 0 N--CA 1.475 1.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.889 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -78.14 107.47 10.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.324 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.0 mtp -98.04 177.06 5.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.211 0.529 . . . . 0.0 110.134 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.79 144.54 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.721 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.6 tttt 59.88 12.47 3.08 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.202 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.21 78.65 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.914 -0.491 . . . . 0.0 111.929 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 58.8 ttt180 -73.33 135.94 44.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.713 0.292 . . . . 0.0 110.53 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.97 154.51 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.252 0.549 . . . . 0.0 110.672 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.05 139.5 5.81 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.664 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 24.4 p90 -148.03 70.44 11.08 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-N 115.635 -0.282 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.4 141.55 95.9 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.23 1.953 . . . . 0.0 112.449 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -133.42 129.0 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.544 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.0 t -64.52 -43.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 21.8 ttpt -177.37 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 60.9 Cg_endo -65.38 145.28 82.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.505 1.47 . . . . 0.0 112.305 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -165.14 51.98 0.28 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 59.6 Cg_endo -67.4 -49.63 1.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.476 2.117 . . . . 0.0 112.032 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.435 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -87.95 -27.12 22.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.984 0.421 . . . . 0.0 110.812 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.435 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -139.17 144.05 38.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.266 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' PHE . . . 79.01 156.46 10.01 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.431 ' CG ' ' O ' ' A' ' 69' ' ' GLY . 97.0 m-85 -157.1 105.4 2.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.858 -0.171 . . . . 0.0 110.673 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.52 -42.1 1.94 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 70' ' ' PHE . 74.2 mmtt -69.7 142.05 53.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.6 p -144.54 168.91 19.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.847 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 61.6 153.16 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 74' ' ' GLY . 82.7 mt -31.55 125.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 120.724 0.297 . . . . 0.0 111.26 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.96 126.2 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.228 0.537 . . . . 0.0 110.601 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 56.1 t0 -94.82 107.02 19.03 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.77 -15.7 23.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.04 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.51 -91.07 1.64 Allowed Glycine 0 N--CA 1.466 0.676 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.7 mt -154.61 140.53 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.614 0.721 . . . . 0.0 110.046 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.554 ' HE ' HD22 ' A' ' 83' ' ' ASN . 18.5 mmm180 -102.85 117.74 35.28 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.765 0.793 . . . . 0.0 110.456 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.5 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -80.79 -6.76 58.95 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.845 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.554 HD22 ' HE ' ' A' ' 81' ' ' ARG . 51.2 p30 -75.61 22.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.659 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 82' ' ' LEU . 8.1 ptm180 -48.08 -12.02 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.662 -0.649 . . . . 0.0 111.266 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 83' ' ' ASN . 99.7 p -80.92 -7.78 59.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 87' ' ' ARG . 7.3 tp10 -98.82 -151.78 0.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.416 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.42 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 82.4 mtt85 -144.85 147.71 33.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.312 0.577 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' LEU . 82.3 m95 -153.88 178.96 9.34 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.427 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -59.81 -170.24 0.01 OUTLIER 'General case' 0 C--O 1.235 0.328 0 O-C-N 123.77 0.669 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.511 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.0 151.07 5.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.05 0.452 . . . . 0.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.97 158.61 37.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.558 0.694 . . . . 0.0 110.594 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 t -152.75 149.43 28.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.871 0.843 . . . . 0.0 110.49 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -141.06 149.96 42.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.598 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -151.43 149.72 25.06 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.3 -10.14 26.6 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.388 2.059 . . . . 0.0 112.013 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -152.14 165.37 34.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.53 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 53.59 -175.5 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp . . . . . 0 C--N 1.291 -1.965 0 CA-C-O 117.806 -1.092 . . . . 0.0 110.012 177.339 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 t -82.62 148.01 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.789 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -136.07 134.92 38.92 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.699 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.96 138.29 42.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.5 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -118.15 131.27 56.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.252 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -139.3 146.04 39.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.44 124.65 23.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.916 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.28 -33.87 67.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -110.03 32.57 5.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.3 -136.22 2.07 Favored Glycine 0 C--O 1.218 -0.882 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.641 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -171.75 -30.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 120.949 0.404 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -153.86 61.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.17 32.76 3.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.042 0.449 . . . . 0.0 110.578 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' TRP . 41.8 mt -115.64 111.62 20.9 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.681 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.432 ' OG1' ' OE1' ' A' ' 18' ' ' GLU . 54.2 p -100.03 174.33 6.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 11.5 p90 -51.02 -52.62 41.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.891 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -55.09 -49.28 72.08 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.128 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 21.0 mp0 -66.58 -33.13 74.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.65 83.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.975 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.9 mttt -71.48 -31.67 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.679 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.7 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.512 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -77.84 -24.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.931 0.395 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.574 ' C ' ' H ' ' A' ' 25' ' ' PHE . 64.6 m -104.41 177.11 4.94 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 109.809 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' GLY . 78.9 tt0 67.53 -29.15 0.15 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.216 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.8 t80 -60.79 -48.49 81.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 110.734 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 3.4 pm0 -78.68 11.69 2.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.111 0.482 . . . . 0.0 110.916 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.18 -24.67 23.93 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -86.29 133.79 12.06 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -98.31 176.78 5.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.4 148.59 48.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.34 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.92 141.06 40.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -123.52 158.38 31.46 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.022 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -55.16 -28.78 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.439 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -68.66 -52.7 28.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.045 0.45 . . . . 0.0 110.85 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.5 -37.35 74.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.998 0.428 . . . . 0.0 110.606 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.6 mt -62.73 -39.77 95.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.92 -40.09 72.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.01 -23.96 48.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.7 -19.99 60.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.945 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.542 HH12 ' CB ' ' A' ' 60' ' ' PRO . 10.2 mmm180 -60.79 -41.86 96.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.663 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.36 -5.0 39.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 mm -95.78 0.15 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.519 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.37 19.3 46.03 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.619 -0.593 . . . . 0.0 111.619 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -61.49 121.24 12.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.558 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -155.79 103.3 2.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.302 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.95 126.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.745 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.86 76.21 2.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.895 0.378 . . . . 0.0 110.417 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.03 94.04 2.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 106.27 0.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.351 0.596 . . . . 0.0 110.645 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.36 151.98 20.28 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.943 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -64.01 153.46 37.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.535 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.9 ptp -155.34 -173.8 4.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -34.57 125.1 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.542 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttp 57.35 31.86 20.84 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.529 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 55.43 21.42 27.14 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.713 -0.617 . . . . 0.0 111.708 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' O ' ' SD ' ' A' ' 52' ' ' MET . 29.9 ttp85 -73.31 59.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.115 0.458 . . . . 0.0 110.888 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.47 151.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.253 0.549 . . . . 0.0 111.312 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.59 169.69 41.81 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.534 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.6 p90 -158.16 76.88 3.56 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.45 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.542 ' CB ' HH12 ' A' ' 40' ' ' ARG . 50.3 Cg_exo -56.38 143.61 85.98 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.476 2.117 . . . . 0.0 112.541 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.6 mt -137.66 96.61 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.516 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 m -64.79 -28.54 45.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 110.292 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -150.93 146.72 19.58 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -41.68 151.73 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.895 1.73 . . . . 0.0 112.656 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.05 27.94 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.552 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.27 -38.96 3.23 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.992 1.795 . . . . 0.0 112.323 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.43 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.5 p30 -66.7 -21.63 66.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.643 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.43 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 9.7 p -162.62 133.71 4.97 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.436 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.75 177.72 1.34 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 40.1 p90 -58.5 -52.63 64.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.569 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . 43.22 74.09 0.21 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt 53.23 -175.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.936 0.398 . . . . 0.0 110.668 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.2 p -148.83 172.93 13.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 73.99 77.08 0.66 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 74' ' ' GLY . 76.8 mt 50.34 103.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.755 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.3 mm -104.84 123.63 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -136.38 142.97 43.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.679 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.6 9.66 8.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.924 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.71 -92.52 1.8 Allowed Glycine 0 C--O 1.224 -0.47 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.0 mt -156.95 124.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 110.005 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -102.76 126.84 50.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.974 0.416 . . . . 0.0 110.382 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -87.57 2.65 50.22 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.445 0.641 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.33 26.02 6.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.805 0.812 . . . . 0.0 110.708 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -43.9 -26.07 0.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.656 -0.652 . . . . 0.0 111.142 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -56.2 -14.32 2.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.768 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.08 166.37 23.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 82.1 mtt85 -96.72 127.8 43.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.711 0.767 . . . . 0.0 110.413 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 82.8 m95 -155.09 178.61 10.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.07 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 22.6 t70 -75.54 -170.49 1.27 Allowed 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.866 0.729 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.514 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -166.04 159.54 15.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 0.0 111.002 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.98 160.78 17.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 110.265 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.7 t -145.13 177.26 8.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.495 0.664 . . . . 0.0 110.212 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -146.59 130.43 17.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.149 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 96' ' ' HIS . 0.3 OUTLIER -148.62 157.55 41.16 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.336 -179.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.56 5.44 0.12 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.929 1.752 . . . . 0.0 112.238 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.517 ' H ' ' C ' ' A' ' 94' ' ' ASN . 83.9 t60 -109.99 94.34 4.97 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.614 0.721 . . . . 0.0 110.463 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.14 -120.49 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.106 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt . . . . . 0 C--N 1.29 -2.009 0 CA-C-O 117.194 -1.384 . . . . 0.0 108.582 175.931 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' N ' ' CE1' ' A' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.28 141.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 110.749 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -148.94 154.97 40.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -79.03 133.98 36.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.504 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -120.29 124.54 45.87 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -113.24 135.44 53.82 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.459 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 145.45 55.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.403 0.62 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -81.43 -50.12 9.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.5 p -113.14 34.56 4.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.487 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.18 -146.1 4.59 Favored Glycine 0 C--O 1.217 -0.928 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.709 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -175.9 -54.59 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -134.35 12.97 3.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -94.15 38.11 1.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.093 0.473 . . . . 0.0 110.442 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.94 131.88 55.34 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.501 0.667 . . . . 0.0 110.584 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.1 p -95.29 168.22 10.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.691 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -60.34 -41.14 93.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.37 66.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.1 -49.4 77.8 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.778 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.81 -30.29 63.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.018 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.3 tttp -69.85 -38.18 76.38 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 120.792 0.33 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.09 75.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.56 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.39 -41.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.631 0.729 . . . . 0.0 110.983 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.602 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.0 m -100.35 177.79 4.94 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.968 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 64.31 -15.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' H ' ' C ' ' A' ' 23' ' ' CYS . 67.7 t80 -62.92 -50.18 71.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.985 0.421 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.52 26.29 0.69 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.755 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.07 3.92 90.6 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.9 -151.81 2.83 Favored Glycine 0 C--O 1.219 -0.824 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -168.93 147.07 3.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.424 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.11 149.72 27.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.386 0.612 . . . . 0.0 110.252 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 146.47 53.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -124.63 178.17 5.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -58.27 -52.27 66.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.638 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -49.02 -47.23 44.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.17 -43.86 73.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.293 0.568 . . . . 0.0 110.737 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.58 -42.32 99.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.666 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -60.33 -30.42 69.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.558 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.01 -27.22 54.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.19 56.33 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.819 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -55.37 -30.99 61.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.376 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.63 -3.26 55.93 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.6 mm -105.81 6.2 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.519 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 17.99 52.98 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.19 126.57 26.72 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 110.546 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.446 ' HD1' ' N ' ' A' ' 46' ' ' VAL . 1.4 t60 -131.18 128.79 40.74 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.361 0.6 . . . . 0.0 110.577 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.446 ' N ' ' HD1' ' A' ' 45' ' ' HIS . 84.1 t -139.58 160.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.776 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 11.4 t -158.75 33.84 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.702 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.29 128.78 17.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.136 0.493 . . . . 0.0 110.533 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.26 131.68 44.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.01 144.05 10.08 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.739 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -65.68 158.11 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.585 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.8 mtm -151.22 -177.69 6.19 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.229 0.538 . . . . 0.0 110.195 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.38 128.54 3.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.576 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' A' ' 56' ' ' ARG . 72.4 tttt 66.11 37.56 5.12 Favored 'General case' 0 C--O 1.201 -1.481 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.047 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.89 5.87 0.1 Allowed Glycine 0 CA--C 1.54 1.614 0 O-C-N 121.764 -0.585 . . . . 0.0 112.39 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.536 ' H ' ' C ' ' A' ' 54' ' ' LYS . 67.7 ttt-85 -66.38 89.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.257 0.551 . . . . 0.0 110.445 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.1 134.48 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.76 0.79 . . . . 0.0 110.337 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.28 26.28 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.577 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.1 p90 -162.52 81.44 1.71 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.343 -0.429 . . . . 0.0 110.677 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 133.36 57.6 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.22 1.947 . . . . 0.0 112.57 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -118.3 109.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.369 0.604 . . . . 0.0 110.689 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.2 m -84.63 -15.32 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.167 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.87 142.6 2.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.133 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.32 149.75 2.48 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 121.067 1.178 . . . . 0.0 112.709 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -122.17 157.51 16.88 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.526 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.28 -43.21 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.351 1.367 . . . . 0.0 112.178 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.419 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -75.6 -21.3 57.92 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.347 0.594 . . . . 0.0 111.082 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.419 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.7 OUTLIER -124.86 144.0 50.54 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.062 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.44 -172.77 4.93 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.471 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.05 169.42 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.111 0.481 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.49 -25.14 0.07 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.24 -177.92 5.24 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 110.419 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 p -138.52 156.67 47.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.775 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 66.54 164.28 1.72 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' GLY . 76.6 mt -34.25 139.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 115.641 -0.28 . . . . 0.0 111.269 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.43 17.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.648 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 56' ' ' ARG . 2.4 p30 -61.34 126.83 28.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.967 0.413 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -68.73 -43.35 76.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.529 0.681 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.9 -128.4 3.58 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.21 108.46 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 122.243 1.021 . . . . 0.0 110.019 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.656 ' H ' ' NE ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.766 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 84' ' ' ARG . 69.2 mt -90.26 -2.78 58.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.842 0.354 . . . . 0.0 110.593 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -77.64 28.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.732 0.777 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.538 ' HE ' ' NH2' ' A' ' 81' ' ' ARG . 99.4 mtt180 -51.12 -1.22 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.733 -0.605 . . . . 0.0 111.73 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.623 ' H ' ' C ' ' A' ' 83' ' ' ASN . 9.2 m -96.9 2.26 51.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -87.02 -158.84 0.46 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.936 0.398 . . . . 0.0 110.564 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 33.4 ptt-85 -155.83 134.19 11.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.608 0.718 . . . . 0.0 110.802 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.2 m0 -147.46 -172.99 4.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.274 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 20.5 t0 -57.89 -148.28 0.0 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.967 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.56 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.77 130.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.641 0.734 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -122.9 157.96 31.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.471 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.9 t -140.86 -173.8 3.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.746 0.784 . . . . 0.0 110.296 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.421 ' CE1' ' N ' ' A' ' 1' ' ' GLY . 63.7 t80 -155.93 121.55 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.279 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -152.33 147.53 19.72 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.042 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.29 0.84 7.41 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.415 2.077 . . . . 0.0 111.886 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.637 ' N ' ' HD1' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -160.96 -113.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.294 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.608 ' H ' ' CG ' ' A' ' 96' ' ' HIS . . . 48.6 -103.0 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 C--N 1.29 -1.987 0 CA-C-O 117.735 -1.126 . . . . 0.0 109.901 175.623 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.25 154.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.128 0.49 . . . . 0.0 110.639 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 4' ' ' HIS . 75.1 t80 -118.98 139.16 52.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' O ' ' CE2' ' A' ' 3' ' ' TYR . 43.8 p-80 -74.77 130.63 39.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -141.23 136.43 31.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.078 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.13 177.49 6.19 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 126.61 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -70.28 -39.47 74.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -112.67 28.55 8.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.95 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.67 -139.05 2.61 Favored Glycine 0 C--O 1.216 -1.028 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.555 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -175.69 -66.98 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.272 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.5 47.61 0.87 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -132.29 31.05 4.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 120.937 0.399 . . . . 0.0 110.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp -118.32 126.09 51.42 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.54 0.686 . . . . 0.0 110.662 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.4 m -99.5 160.4 14.31 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.517 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 17' ' ' ALA . 41.2 p90 -53.38 -42.71 67.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' A' ' 16' ' ' TYR . . . -55.39 -42.91 74.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.868 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.18 -49.76 47.12 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.662 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.57 -37.84 58.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.037 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.9 tttm -71.34 -32.42 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 110.817 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.33 -54.39 17.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.569 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.21 -36.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.21 0.529 . . . . 0.0 111.029 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.596 ' C ' ' H ' ' A' ' 25' ' ' PHE . 2.0 t -103.31 176.23 5.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 20' ' ' LYS . 74.4 tt0 65.29 -15.83 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.035 -179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.596 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.3 t80 -61.57 -48.14 82.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 14.4 pt-20 -81.63 20.87 0.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.26 86.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.64 -155.16 1.09 Allowed Glycine 0 C--O 1.219 -0.796 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -170.54 145.26 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.449 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 mt -52.98 141.03 23.26 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.118 0.485 . . . . 0.0 110.564 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.28 106.55 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.9 m -69.92 146.99 50.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 5.4 p90 -53.55 -51.65 62.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.981 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 64.8 tttp -60.82 -45.47 94.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 110.558 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -68.46 -27.21 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -28.26 66.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -51.45 -31.06 21.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.1 73.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.18 -41.64 49.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.767 0.318 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.564 ' NH2' ' N ' ' A' ' 62' ' ' VAL . 37.2 mmm-85 -56.66 -31.86 64.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.83 -10.67 59.73 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.644 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.429 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 94.6 mt -101.75 4.95 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.558 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.7 14.14 47.92 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.37 128.31 35.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.905 0.383 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.701 ' HD1' ' H ' ' A' ' 62' ' ' VAL . 75.7 t60 -149.39 104.72 3.4 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.456 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.83 129.49 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.912 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -93.78 96.21 9.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.516 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.46 95.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.7 131.74 44.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.29 159.44 27.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.88 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -70.82 104.56 2.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 66.8 mtm -96.75 -175.56 3.33 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.219 0.533 . . . . 0.0 110.236 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.06 158.92 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.524 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.618 ' C ' ' H ' ' A' ' 56' ' ' ARG . 63.0 mttp 50.63 38.02 17.89 Favored 'General case' 0 C--O 1.2 -1.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.72 0.46 0.03 OUTLIER Glycine 0 CA--C 1.54 1.603 0 O-C-N 121.878 -0.514 . . . . 0.0 112.062 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.618 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.5 mtt180 -69.55 149.06 48.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.141 0.496 . . . . 0.0 110.475 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.63 141.63 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.441 1.115 . . . . 0.0 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.73 166.66 30.34 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.415 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -128.7 107.19 18.65 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.46 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.51 119.47 4.51 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.544 1.496 . . . . 0.0 112.486 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.482 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 4.4 pt -148.83 93.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.722 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.701 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 56.3 t -49.28 -21.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.282 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -142.92 146.28 36.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.12 154.51 0.79 Allowed 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.579 1.519 . . . . 0.0 112.622 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.25 154.5 26.0 Favored Glycine 0 CA--C 1.543 1.834 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.735 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.79 -41.47 1.07 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.079 1.852 . . . . 0.0 112.353 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.62 -40.68 92.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.64 145.05 25.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.665 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.23 176.92 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.619 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -70.79 139.74 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.471 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.4 135.41 1.88 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.615 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.09 -47.36 84.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.851 0.358 . . . . 0.0 110.177 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.404 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 62.6 p -132.66 165.17 25.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.284 0.564 . . . . 0.0 110.904 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 76' ' ' ILE . . . -84.28 -155.49 22.21 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 77' ' ' ASP . 40.5 mt 68.88 -7.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 74' ' ' GLY . 38.6 mt -63.55 67.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.623 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' ILE . 2.4 p30 -85.71 151.2 24.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.446 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -89.48 -139.38 0.13 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.628 0.727 . . . . 0.0 110.184 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.68 95.56 0.18 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.8 mt 45.27 96.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.62 0.248 . . . . 0.0 110.674 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.433 ' O ' ' NH1' ' A' ' 84' ' ' ARG . 78.9 mtp180 -94.78 141.29 28.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.033 0.444 . . . . 0.0 110.081 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.58 3.98 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.604 0.716 . . . . 0.0 110.6 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 85' ' ' SER . 31.9 t30 -80.19 15.22 1.61 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.801 0.81 . . . . 0.0 110.304 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH1' ' O ' ' A' ' 81' ' ' ARG . 88.8 mtm-85 -58.72 -5.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.593 -0.692 . . . . 0.0 110.868 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 83' ' ' ASN . 78.3 p -73.27 -35.58 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.646 0.26 . . . . 0.0 110.916 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -81.18 158.3 24.96 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.277 0.561 . . . . 0.0 110.617 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -86.84 149.11 25.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.734 0.778 . . . . 0.0 110.619 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -154.41 177.43 11.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.0 -172.56 2.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.647 0.737 . . . . 0.0 110.755 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -167.04 166.67 15.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.338 0.589 . . . . 0.0 111.053 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.88 156.86 46.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.953 0.882 . . . . 0.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.0 t -124.41 -167.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -159.21 145.96 16.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.999 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 26' ' ' GLU . 12.1 m120 -149.75 143.88 17.18 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.287 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.84 6.46 3.74 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.901 1.734 . . . . 0.0 111.93 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -56.93 -44.91 82.93 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.118 0.261 . . . . 0.0 110.67 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.69 -68.51 0.31 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 C--N 1.289 -2.057 0 CA-C-O 117.837 -1.078 . . . . 0.0 108.28 175.5 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 t -84.49 136.52 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.656 0.265 . . . . 0.0 110.798 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.509 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 22.2 p90 -146.94 159.39 43.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.811 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -74.9 148.82 39.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.381 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.509 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 25.5 mmt180 -123.55 157.34 33.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.228 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -157.93 120.68 3.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.191 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 166.57 12.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.907 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.51 -36.62 81.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -64.81 -32.92 74.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.367 0.604 . . . . 0.0 110.632 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.71 177.73 23.19 Favored Glycine 0 C--O 1.216 -0.994 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.661 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.07 -105.14 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.328 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -68.8 69.92 0.18 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.665 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -144.41 29.08 1.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.787 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' TRP . 23.5 mt -123.36 143.36 50.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.8 p -95.69 168.51 10.62 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.753 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.579 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 26.5 p90 -46.9 -56.15 6.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -53.07 -42.29 65.69 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.969 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.54 -26.73 68.02 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.947 0.404 . . . . 0.0 110.555 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.95 -36.97 67.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -71.05 -30.63 66.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.222 0.534 . . . . 0.0 110.555 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.01 -49.3 75.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.614 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.56 -28.9 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.352 0.596 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.613 ' C ' ' H ' ' A' ' 25' ' ' PHE . 82.2 m -105.28 179.16 4.35 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.029 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 15.3 mp0 64.6 -28.29 0.1 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.887 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' H ' ' C ' ' A' ' 23' ' ' CYS . 59.4 t80 -62.18 -45.26 94.18 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.803 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -95.71 9.18 41.26 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.97 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.42 -4.06 66.55 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.32 -175.16 44.75 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -154.33 162.41 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.831 -0.185 . . . . 0.0 110.705 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 30' ' ' LEU . 9.4 mp -71.09 147.23 48.68 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.087 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.71 151.31 38.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.075 0.464 . . . . 0.0 110.806 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 m -125.02 156.66 37.79 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.155 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -54.05 -21.31 8.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.397 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -76.01 -57.24 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.117 0.484 . . . . 0.0 110.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.73 -33.13 73.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.47 -42.46 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.59 -34.76 77.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.555 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.4 -33.9 73.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 110.957 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -23.62 28.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.599 ' HE ' ' HB2' ' A' ' 60' ' ' PRO . 3.8 tpt85 -60.85 -42.55 98.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.567 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -60.87 -2.45 0.57 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 40' ' ' ARG . 18.5 mm -101.23 17.19 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.33 19.99 79.79 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.37 105.03 0.3 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.156 0.478 . . . . 0.0 110.39 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -95.48 133.65 39.22 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.389 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.3 t -137.39 159.37 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 68' ' ' CYS . 2.9 t -156.11 42.03 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.752 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.68 125.18 3.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 110.723 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.38 138.74 45.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.38 152.79 24.81 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.924 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -68.07 101.96 1.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.062 0.458 . . . . 0.0 109.954 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 58' ' ' GLY . 1.4 mtp -91.38 166.29 12.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.649 0.738 . . . . 0.0 109.852 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' MET . . . -39.48 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.59 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt 58.68 7.52 0.76 Allowed 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.373 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 53' ' ' ALA . . . 77.68 8.89 87.17 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.814 -0.554 . . . . 0.0 112.106 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' MET . 62.2 ttt180 -76.29 131.93 39.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.005 0.403 . . . . 0.0 110.632 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.81 112.5 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.855 0.836 . . . . 0.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -166.53 177.85 41.22 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.541 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -167.84 142.28 2.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.745 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.599 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 72.8 Cg_endo -72.35 147.17 46.58 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.001 1.801 . . . . 0.0 112.651 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mt -139.68 93.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.842 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.61 -41.85 86.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.346 0.593 . . . . 0.0 110.542 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -136.95 101.42 9.46 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.73 130.04 14.91 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.815 1.677 . . . . 0.0 112.474 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.91 22.04 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.397 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.99 -51.75 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.335 2.023 . . . . 0.0 112.241 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -67.54 -37.24 82.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 1.5 p -152.24 123.05 7.45 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.361 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 178.69 -26.63 0.05 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 90.1 t80 52.9 -85.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 110.763 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -172.98 -172.99 39.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 54.08 -171.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 0.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 74' ' ' GLY . 35.6 m -144.86 167.24 23.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.207 0.527 . . . . 0.0 110.63 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' N ' ' CG2' ' A' ' 73' ' ' THR . . . 93.64 -151.7 20.45 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.1 mt -100.97 128.61 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.392 . . . . 0.0 110.39 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.7 mt -132.03 71.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.415 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.23 135.03 34.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.842 0.353 . . . . 0.0 110.579 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.39 110.67 22.67 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.059 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.92 95.95 0.01 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.5 mt 49.39 100.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.756 0.312 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.776 ' CZ ' HD22 ' A' ' 83' ' ' ASN . 70.6 mtp180 -68.81 148.07 50.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 84' ' ' ARG . 10.9 mp -74.95 -28.78 60.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.885 0.85 . . . . 0.0 110.555 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.776 HD22 ' CZ ' ' A' ' 81' ' ' ARG . 18.0 p30 -73.18 32.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.028 0.918 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 82' ' ' LEU . 66.0 mtp180 -48.65 -6.99 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.632 -0.667 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 83' ' ' ASN . 32.5 t -87.19 -8.2 57.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.987 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -91.39 147.57 22.94 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -83.31 152.36 25.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.266 0.555 . . . . 0.0 110.51 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.562 ' NE1' ' NH1' ' A' ' 81' ' ' ARG . 73.5 m95 -156.02 179.12 9.52 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.326 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 11.8 t70 -76.05 -161.54 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.826 0.822 . . . . 0.0 110.471 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.08 152.7 6.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.783 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.15 158.75 38.85 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.726 . . . . 0.0 110.408 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -133.11 -173.28 3.16 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.613 0.721 . . . . 0.0 110.138 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -155.29 113.4 3.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -117.41 85.81 20.95 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.85 10.29 3.57 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.48 2.12 . . . . 0.0 112.355 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.683 ' CG ' ' H ' ' A' ' 97' ' ' ALA . 2.0 p-80 -144.46 -62.92 0.37 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.683 ' H ' ' CG ' ' A' ' 96' ' ' HIS . . . -61.61 -33.39 73.84 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.2 tttp . . . . . 0 C--N 1.289 -2.035 0 CA-C-O 116.954 -1.498 . . . . 0.0 108.034 176.918 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 t -84.89 145.87 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.63 0.252 . . . . 0.0 111.094 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -161.23 156.54 24.31 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.032 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.69 116.23 25.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.486 0.66 . . . . 0.0 110.752 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -103.85 121.5 43.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -103.85 130.7 51.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.545 0.528 . . . . 0.0 110.362 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.23 172.5 13.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -60.32 -34.7 74.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.967 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.548 ' O ' ' C ' ' A' ' 10' ' ' GLY . 73.9 m -82.14 -20.21 38.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.513 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 16.57 81.79 0.01 OUTLIER Glycine 0 N--CA 1.494 2.541 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.267 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -172.52 37.67 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 120.923 0.392 . . . . 0.0 110.398 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 52.25 62.01 2.91 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -132.08 31.83 4.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.698 0.285 . . . . 0.0 110.694 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -122.09 128.24 51.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -98.16 170.55 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.642 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 30.3 p90 -51.45 -60.14 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.584 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.39 -37.28 56.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.883 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -67.97 -49.61 60.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -34.92 58.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.645 0.26 . . . . 0.0 110.861 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 23' ' ' CYS . 71.0 mmtt -61.84 -41.88 98.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.551 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.55 -49.43 77.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.63 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -58.1 -37.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.498 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.527 ' C ' ' H ' ' A' ' 25' ' ' PHE . 3.4 m -101.76 -179.27 3.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 94.4 mt-10 71.04 -18.79 0.26 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.5 t80 -60.39 -45.94 91.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.213 0.53 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -86.57 15.87 5.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.528 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 7.69 87.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.505 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -86.5 -158.55 31.77 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -162.96 156.51 19.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.735 -0.233 . . . . 0.0 110.409 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.16 136.66 52.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.116 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.45 122.52 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -103.83 178.72 4.48 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -52.49 -52.48 54.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -57.76 -44.94 86.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.568 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -70.37 -37.7 74.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.88 -43.01 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.414 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -55.69 -47.43 76.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.82 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -32.23 71.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.077 0.465 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.24 -29.14 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.516 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.447 ' C ' ' H ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -60.91 -40.52 93.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.502 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -60.49 -4.03 0.8 Allowed 'General case' 0 N--CA 1.458 -0.05 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 40' ' ' ARG . 16.8 mm -99.18 22.9 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.385 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.51 28.93 71.83 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -70.29 126.09 28.64 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.663 -0.316 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.465 ' CD2' ' CG2' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -149.98 103.69 3.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.175 0.512 . . . . 0.0 110.37 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -140.16 129.94 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 14.8 t -90.72 69.34 6.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.331 0.586 . . . . 0.0 110.279 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.63 95.26 2.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.653 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.97 153.2 36.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.75 171.76 36.94 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.889 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -85.37 105.0 15.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.528 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -93.27 176.52 6.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.145 0.497 . . . . 0.0 110.302 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -35.49 153.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 54.8 8.91 0.25 Allowed 'General case' 0 C--O 1.199 -1.562 0 CA-C-O 121.089 0.471 . . . . 0.0 110.12 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 53' ' ' ALA . . . 74.75 20.68 79.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.941 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.535 ' HE ' ' CG ' ' A' ' 77' ' ' ASP . 63.0 ttt180 -77.09 140.05 40.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.646 0.26 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.14 134.95 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.677 0.751 . . . . 0.0 110.972 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.36 113.95 0.7 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -109.27 156.27 39.64 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-O 120.415 0.15 . . . . 0.0 110.755 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.32 133.13 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.446 1.431 . . . . 0.0 112.044 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 73' ' ' THR . 3.4 mt -144.33 95.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.588 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.465 ' CG2' ' CD2' ' A' ' 45' ' ' HIS . 0.2 OUTLIER -47.11 -38.55 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.67 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -149.02 147.73 24.85 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.824 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -52.87 139.28 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.986 1.124 . . . . 0.0 112.456 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.46 177.9 22.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.862 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.63 -51.0 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.628 1.552 . . . . 0.0 112.153 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -66.92 -27.71 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.682 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.08 151.39 21.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.193 0.521 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.37 -5.56 0.04 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -68.33 -1.88 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.3 0.571 . . . . 0.0 110.315 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.3 -165.82 26.34 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.576 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.15 79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.614 0.245 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER 176.81 173.79 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.459 0.647 . . . . 0.0 110.319 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -46.7 -95.39 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.5 mt -99.34 108.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.477 0.656 . . . . 0.0 110.208 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 pt -105.87 45.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.834 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.535 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 34.7 t0 -89.0 118.98 29.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.025 0.441 . . . . 0.0 110.721 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -67.15 -64.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.553 0.692 . . . . 0.0 110.33 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 130.04 95.12 0.73 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 111.844 -0.503 . . . . 0.0 111.844 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 79' ' ' GLY . 70.1 mt 56.76 129.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.762 0.792 . . . . 0.0 110.993 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -111.61 143.04 43.13 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.512 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 82' ' ' LEU . 3.0 mm? -86.73 -8.5 57.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.377 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -108.55 23.79 14.0 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.49 0.716 . . . . 0.0 111.072 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 86' ' ' GLU . 80.4 mtm180 -44.37 -27.47 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.672 -0.643 . . . . 0.0 111.432 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -47.07 -17.09 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.004 0.19 . . . . 0.0 110.956 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -60.89 -176.64 0.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 179.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 68.5 mtp85 -125.19 136.63 53.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.026 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.2 m95 -153.01 -176.64 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.141 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -73.07 -167.58 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -153.23 146.97 25.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.141 0.496 . . . . 0.0 111.108 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.478 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 17.6 m-85 -140.61 160.74 39.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.775 0.798 . . . . 0.0 110.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.5 m -136.44 -165.8 1.78 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.108 0.956 . . . . 0.0 110.06 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -141.04 151.13 43.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.271 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 96' ' ' HIS . 4.2 m120 -134.34 149.21 70.58 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.856 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.79 23.93 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 121.564 1.509 . . . . 0.0 111.644 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.485 ' H ' ' C ' ' A' ' 94' ' ' ASN . 6.3 m-70 -80.21 -159.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.822 0.344 . . . . 0.0 110.329 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 52.74 77.43 0.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.185 0.517 . . . . 0.0 110.548 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.29 -2.015 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.828 177.197 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' H3 ' ' H ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.421 ' H ' ' H3 ' ' A' ' 1' ' ' GLY . 32.8 m -125.38 132.75 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' OH ' ' CZ ' ' A' ' 5' ' ' ARG . 31.4 p90 -103.03 155.24 18.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -73.02 126.12 29.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.498 0.666 . . . . 0.0 110.548 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' CZ ' ' OH ' ' A' ' 3' ' ' TYR . 89.5 mtt-85 -101.91 167.29 10.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.384 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -163.56 120.42 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.24 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.89 169.53 17.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.33 -40.64 81.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.597 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 t -70.85 -24.36 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.402 0.62 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.62 -170.82 22.9 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 13' ' ' LYS . 26.1 pttm -108.37 -173.39 2.27 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.559 ' HH ' ' H ' ' A' ' 49' ' ' ALA . 7.5 m-85 42.23 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.628 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' LYS . 64.9 mttm -133.28 28.86 4.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.66 0.384 . . . . 0.0 110.696 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 88' ' ' TRP . 33.1 mt -124.82 135.37 52.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.233 0.539 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.6 m -89.84 161.1 16.15 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.589 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -49.89 -59.52 3.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.22 75.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.22 -49.15 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.584 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.37 32.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 16.2 tptp -58.62 -40.19 82.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.116 0.484 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -48.25 78.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.316 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.58 -22.09 17.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.426 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 25' ' ' PHE . 53.3 m -103.94 179.48 4.26 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.567 0.698 . . . . 0.0 109.518 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 70.8 mt-10 70.6 -19.08 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.16 -46.29 91.13 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 110.837 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.2 5.46 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.9 51.42 2.64 Favored Glycine 0 N--CA 1.472 1.097 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.05 -152.87 5.73 Favored Glycine 0 N--CA 1.47 0.901 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.611 ' HE2' HE22 ' A' ' 35' ' ' GLN . 24.4 p-80 -163.02 179.02 7.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.92 142.49 51.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.29 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.93 148.04 48.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.24 0.543 . . . . 0.0 110.811 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -123.54 149.41 45.27 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.259 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CD1' ' NH2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -61.09 -20.89 63.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.215 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -75.87 -57.12 4.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.095 0.474 . . . . 0.0 110.739 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.611 HE22 ' HE2' ' A' ' 29' ' ' HIS . 11.3 pt20 -68.82 -31.86 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 111.015 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.5 -36.11 79.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.368 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -49.9 -29.41 8.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.002 0.429 . . . . 0.0 110.661 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.39 -25.57 33.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.413 0.625 . . . . 0.0 111.025 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.69 -42.53 17.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -56.04 -34.7 66.13 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.29 -23.57 56.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 mm -82.5 24.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.92 24.19 74.35 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.66 128.73 37.08 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.464 ' CE1' ' H ' ' A' ' 63' ' ' LYS . 58.4 t60 -135.74 110.25 8.54 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.445 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.21 112.3 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.738 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -93.72 73.75 4.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.09 118.99 8.7 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.228 0.537 . . . . 0.0 110.778 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.559 ' H ' ' HH ' ' A' ' 12' ' ' TYR . . . -80.25 134.19 36.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.814 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.54 -143.7 4.21 Favored Glycine 0 N--CA 1.476 1.3 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -130.8 105.93 8.11 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 15.1 mmt -91.54 156.13 17.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.267 0.556 . . . . 0.0 109.647 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.03 169.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.53 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.64 38.53 30.28 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.84 6.36 0.32 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' NH2' ' CD1' ' A' ' 33' ' ' TYR . 25.3 mtp180 -84.31 162.99 19.88 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.424 0.631 . . . . 0.0 110.598 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 p -142.2 135.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.723 0.773 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.01 157.15 26.78 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 26.9 p90 -165.89 80.82 1.11 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.795 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.95 143.82 59.14 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.026 1.817 . . . . 0.0 112.677 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -132.02 91.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.414 0.626 . . . . 0.0 110.707 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.434 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 40.8 t -80.41 -20.23 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.526 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 60.0 mttp -140.94 86.33 11.72 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.95 136.8 52.65 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.02 1.813 . . . . 0.0 112.218 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.26 173.91 15.2 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.405 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.46 -47.15 3.26 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.06 1.84 . . . . 0.0 112.284 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 68' ' ' CYS . 39.2 p-10 -66.71 -36.62 82.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.704 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 23.0 p -153.55 119.39 5.33 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.049 0.452 . . . . 0.0 110.477 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 88.54 0.09 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -64.97 161.23 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.946 0.403 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.55 99.71 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -70.62 166.65 20.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.871 0.367 . . . . 0.0 110.563 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.4 p -139.64 159.83 41.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.17 -140.66 15.17 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.9 mt -89.24 119.17 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.925 0.393 . . . . 0.0 110.556 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.73 98.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.407 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 59.3 t0 -98.39 141.79 30.83 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 110.322 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 25.3 m-85 -129.99 147.51 51.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.669 0.747 . . . . 0.0 110.05 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.79 -78.73 0.46 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.8 mt -157.81 108.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.547 ' CZ ' HD22 ' A' ' 83' ' ' ASN . 52.0 mtp180 -69.08 140.95 54.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.329 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.2 mt -85.49 -10.23 56.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.335 0.588 . . . . 0.0 110.777 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.547 HD22 ' CZ ' ' A' ' 81' ' ' ARG . 13.1 p30 -83.27 22.6 0.98 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.474 0.654 . . . . 0.0 110.379 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -52.0 -5.84 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.644 -0.66 . . . . 0.0 111.361 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 83' ' ' ASN . 62.8 m -91.89 -5.13 53.81 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.838 0.351 . . . . 0.0 110.856 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 87' ' ' ARG . 6.4 tp10 -85.29 -152.8 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.399 0.619 . . . . 0.0 110.422 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 83.3 mtt85 -142.94 151.2 40.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.817 0.818 . . . . 0.0 110.564 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 86.2 m95 -154.9 177.37 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.267 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.591 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 36.2 t0 -60.45 -156.06 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.816 0.698 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.591 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.68 141.95 2.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.168 0.509 . . . . 0.0 110.947 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.408 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 16.3 m-85 -140.34 142.25 35.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.52 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . 0.437 ' SG ' ' NE ' ' A' ' 5' ' ' ARG . 49.8 m -115.56 -167.33 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.827 0.822 . . . . 0.0 110.077 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -156.42 143.68 19.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.455 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.11 148.95 22.18 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -40.53 154.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.505 2.165 0 C-N-CA 122.345 2.03 . . . . 0.0 112.985 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -57.13 107.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.795 0.807 . . . . 0.0 110.66 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.19 -36.36 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.873 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt . . . . . 0 C--N 1.292 -1.91 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.13 176.485 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.06 148.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 110.815 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.62 162.51 35.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -73.51 132.63 43.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.637 HH21 ' N ' ' A' ' 91' ' ' TYR . 73.5 mtm180 -117.99 149.22 41.31 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.502 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -154.78 125.02 6.78 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.594 0.559 . . . . 0.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.08 179.11 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.461 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -61.07 -48.62 80.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.504 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -87.39 -2.8 58.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.205 0.526 . . . . 0.0 110.513 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.23 66.59 0.68 Allowed Glycine 0 N--CA 1.472 1.068 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -143.99 41.82 1.42 Allowed 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.747 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 45.78 28.98 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.678 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.48 39.87 0.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.283 0.563 . . . . 0.0 110.825 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' TRP . 6.1 tp -120.31 127.74 52.64 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.781 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.8 p -90.94 167.75 12.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.529 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -61.23 -48.01 83.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.337 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.92 71.47 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.05 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.7 -50.16 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.736 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.55 -31.6 24.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' CYS . 26.1 mtpp -64.6 -34.92 79.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.428 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.16 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.65 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.04 -40.87 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.323 0.582 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.62 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.2 t -100.53 175.69 5.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.907 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 63.22 -15.84 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.62 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.7 t80 -61.87 -49.1 77.61 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.92 22.52 0.38 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.765 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 25' ' ' PHE . . . 81.04 0.91 89.58 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.31 -148.8 4.7 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -164.66 152.97 12.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.666 0.27 . . . . 0.0 110.631 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.15 145.18 54.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.051 0.453 . . . . 0.0 110.224 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -64.03 107.33 1.23 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.903 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 p -88.01 167.14 13.95 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.485 ' CB ' ' HE ' ' A' ' 56' ' ' ARG . 69.6 t80 -54.66 -53.61 52.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.983 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -55.75 -43.86 77.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.993 0.425 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.26 -32.23 68.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -40.58 95.29 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -51.56 -49.38 62.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.25 64.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.431 . . . . 0.0 110.649 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.78 -37.02 31.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.2 -27.83 62.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -78.2 -4.55 48.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.67 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 76.9 mt -96.0 8.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.478 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.52 21.45 44.08 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -69.38 131.78 45.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 122.741 -0.27 . . . . 0.0 110.354 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -149.89 105.28 3.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.076 0.465 . . . . 0.0 110.469 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.19 118.02 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.83 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.4 t -91.88 84.05 5.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.191 0.52 . . . . 0.0 110.293 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.25 94.73 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.635 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.2 46.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.82 -172.42 13.92 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.931 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.7 156.74 17.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.527 0.679 . . . . 0.0 110.47 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 56' ' ' ARG . 67.4 mtm -148.09 175.02 11.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.99 147.74 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.299 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 56' ' ' ARG . 9.0 mtmp? 57.69 40.43 26.49 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.659 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.2 7.72 0.58 Allowed Glycine 0 CA--C 1.532 1.13 0 O-C-N 121.794 -0.566 . . . . 0.0 111.8 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HE ' ' CB ' ' A' ' 33' ' ' TYR . 32.2 ttt85 -68.14 146.42 53.45 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.321 0.581 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.15 162.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.668 0.747 . . . . 0.0 110.807 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.02 169.25 39.57 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.492 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 76' ' ' ILE . 3.8 p90 -154.95 79.89 4.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.386 -0.407 . . . . 0.0 110.322 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.44 128.97 32.67 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.21 1.94 . . . . 0.0 112.682 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.38 103.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.61 -24.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.304 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -161.76 143.81 8.72 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.567 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -41.23 166.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.717 1.612 . . . . 0.0 112.85 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.9 166.8 39.75 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.68 -41.89 13.53 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.403 2.068 . . . . 0.0 112.212 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -66.11 -36.06 82.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.43 . . . . 0.0 110.327 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.9 p -156.53 146.41 21.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.491 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -159.85 44.02 0.44 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -73.66 142.74 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.55 -104.69 0.89 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -162.95 -63.49 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.888 0.375 . . . . 0.0 110.469 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -145.72 171.1 15.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.387 0.613 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -153.33 20.46 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.6 mt -99.57 -60.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.755 0.312 . . . . 0.0 110.827 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.482 ' O ' ' CZ ' ' A' ' 59' ' ' TYR . 52.3 mt 56.88 105.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.317 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.467 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 4.8 p30 -136.37 148.98 48.11 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.03 0.443 . . . . 0.0 110.946 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -72.82 -72.4 0.25 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.619 0.723 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.05 -135.17 5.14 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -88.69 107.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.399 0.619 . . . . 0.0 110.151 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -94.16 129.79 40.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.44 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.17 0.14 54.35 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.424 0.631 . . . . 0.0 110.85 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.434 HD21 ' C ' ' A' ' 83' ' ' ASN . 0.4 OUTLIER -87.73 23.6 1.95 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.328 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -45.1 -24.32 0.23 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.617 -0.677 . . . . 0.0 111.662 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 m -50.54 -23.03 2.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.751 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.24 -168.26 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 0.0 110.813 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.25 139.22 44.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.391 0.615 . . . . 0.0 110.946 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' LEU . 86.8 m95 -154.18 176.2 12.54 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.451 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.0 t70 -71.23 -169.65 0.41 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.361 0.601 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.537 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.9 161.05 10.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.158 0.504 . . . . 0.0 111.002 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.637 ' N ' HH21 ' A' ' 5' ' ' ARG . 96.7 m-85 -138.57 152.81 48.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.636 0.732 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.2 t -129.99 144.48 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' OH ' ' CE1' ' A' ' 96' ' ' HIS . 85.0 t80 -119.48 122.0 40.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.359 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.467 ' N ' ' ND2' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -109.13 169.83 6.04 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.063 -179.049 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.55 140.29 75.27 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 121.942 1.761 . . . . 0.0 112.146 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.435 ' CE1' ' OH ' ' A' ' 93' ' ' TYR . 97.0 m-70 -46.84 122.72 4.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.32 0.581 . . . . 0.0 110.785 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.61 32.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.742 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 C--N 1.29 -1.997 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.153 176.816 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -83.8 151.92 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -126.75 126.94 44.29 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.559 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -76.02 148.48 38.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.48 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -133.18 143.19 49.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.07 146.64 30.05 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.263 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.93 132.4 46.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.95 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -81.04 -49.13 11.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.1 m -112.41 -33.85 6.06 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.61 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.57 177.75 53.98 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -134.69 95.82 3.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.453 0.644 . . . . 0.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 53.13 70.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.72 40.54 1.85 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.774 0.321 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 88' ' ' TRP . 46.3 mt -117.61 122.49 43.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -100.68 166.1 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.17 0.51 . . . . 0.0 110.723 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -49.11 -58.86 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -42.48 59.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.021 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.9 -26.56 66.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.526 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.46 76.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.038 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' CYS . 51.4 mtmt -67.17 -24.29 65.86 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.567 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.12 -55.46 9.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.634 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.77 -44.7 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 0.0 111.199 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' LYS . 3.7 m -114.31 162.09 17.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.308 0.575 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 23' ' ' CYS . 48.8 tt0 84.33 -46.11 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.813 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -62.73 -46.37 88.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.048 0.451 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.23 16.8 0.71 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.946 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.6 60.72 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -153.18 0.02 OUTLIER Glycine 0 C--O 1.218 -0.883 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.586 ' CD2' HE22 ' A' ' 35' ' ' GLN . 66.8 t60 -173.25 143.5 1.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.473 ' O ' ' CD2' ' A' ' 29' ' ' HIS . 73.6 mt -78.18 136.23 37.78 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.158 0.286 . . . . 0.0 110.541 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.32 132.38 48.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.252 0.549 . . . . 0.0 111.082 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.42 ' HG1' ' H ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -124.38 167.1 14.85 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.121 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -50.49 -22.21 1.83 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.693 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' H ' ' HG1' ' A' ' 32' ' ' THR . 37.6 ttmt -75.25 -57.96 3.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.172 0.51 . . . . 0.0 110.684 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.586 HE22 ' CD2' ' A' ' 29' ' ' HIS . 78.6 mt-30 -70.78 -34.87 72.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.7 mt -61.1 -39.76 91.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.441 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -57.78 -31.05 66.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.673 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 -24.33 48.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.338 0.589 . . . . 0.0 110.956 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.3 -45.31 33.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.414 HH21 HG11 ' A' ' 62' ' ' VAL . 20.2 mmm-85 -52.98 -31.55 41.41 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -69.46 -4.32 18.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.571 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.416 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 74.3 mt -108.86 15.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.443 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.16 16.75 71.12 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.29 143.06 58.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.904 0.352 . . . . 0.0 110.343 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -155.35 107.91 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.356 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.6 m -139.0 111.56 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.817 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.26 75.06 6.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.238 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.52 135.29 11.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.32 139.38 31.72 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.47 -174.26 21.41 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.804 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -94.12 143.27 26.52 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -145.3 173.41 12.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.142 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.78 142.86 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.685 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 62.17 14.95 7.05 Favored 'General case' 0 C--O 1.201 -1.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.48 16.98 68.15 Favored Glycine 0 CA--C 1.527 0.822 0 O-C-N 121.831 -0.543 . . . . 0.0 111.964 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.776 HH22 ' H ' ' A' ' 78' ' ' TYR . 51.6 ttt-85 -70.84 161.41 31.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.977 0.418 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.18 148.57 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 122.269 1.033 . . . . 0.0 110.458 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.77 168.28 40.57 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.405 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -154.64 76.79 5.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.334 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.77 133.1 49.02 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.474 2.116 . . . . 0.0 112.692 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.509 ' CD1' ' N ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -147.19 145.11 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.124 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG11 HH21 ' A' ' 40' ' ' ARG . 29.4 m -82.12 -30.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -152.68 152.15 28.11 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.427 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.3 151.32 2.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.026 1.818 . . . . 0.0 112.324 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.96 166.88 27.38 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.793 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.17 -48.44 19.45 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.833 1.689 . . . . 0.0 112.737 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -64.94 -27.34 68.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.5 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.43 144.93 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.94 -12.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -55.64 -36.42 66.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.408 . . . . 0.0 110.775 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.88 -166.39 6.64 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -73.43 -162.18 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.534 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 166.69 22.19 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.268 0.556 . . . . 0.0 110.819 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 67.76 67.03 2.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' O ' ' A' ' 74' ' ' GLY . 4.5 mt 53.23 125.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.572 -0.314 . . . . 0.0 111.071 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -119.91 91.03 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.569 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -66.89 143.39 56.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.924 0.392 . . . . 0.0 110.583 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.776 ' H ' HH22 ' A' ' 56' ' ' ARG . 59.2 m-85 -132.66 -96.59 0.31 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.523 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.42 -155.38 17.61 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.394 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.85 123.27 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.723 0.773 . . . . 0.0 110.079 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.48 141.92 34.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.186 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.47 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -82.65 -2.57 54.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.583 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -77.83 25.69 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.84 0.828 . . . . 0.0 110.649 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.439 ' H ' ' C ' ' A' ' 82' ' ' LEU . 33.4 mtp-105 -49.4 -4.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.599 -0.688 . . . . 0.0 111.783 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.583 ' H ' ' C ' ' A' ' 83' ' ' ASN . 72.2 p -83.1 -32.12 26.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -76.91 -163.65 0.37 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 110.692 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.432 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 60.9 mtt85 -139.27 154.24 47.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.52 0.676 . . . . 0.0 110.62 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' LEU . 81.1 m95 -154.13 174.99 13.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 23.9 t0 -61.06 -175.99 0.05 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.727 0.775 . . . . 0.0 110.972 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.516 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -157.23 150.85 24.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 111.069 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -118.94 159.58 23.55 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.525 0.679 . . . . 0.0 110.641 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -134.8 175.18 9.79 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.774 0.797 . . . . 0.0 110.216 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 4.6 t80 -159.9 134.48 7.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.825 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.426 ' C ' ' H ' ' A' ' 96' ' ' HIS . 29.7 m-80 -145.35 148.59 38.11 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.101 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -72.85 13.27 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.432 2.088 . . . . 0.0 111.753 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 94' ' ' ASN . 90.1 m-70 -140.8 21.7 2.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.678 0.275 . . . . 0.0 110.35 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.79 -68.71 0.3 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.056 0.931 . . . . 0.0 108.535 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? . . . . . 0 C--N 1.29 -2.004 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 176.219 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.467 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.6 m -154.19 137.73 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.779 0.324 . . . . 0.0 110.698 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -123.12 123.68 41.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.401 ' O ' ' ND1' ' A' ' 4' ' ' HIS . 5.1 p80 -86.86 149.32 24.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.507 HH22 HD22 ' A' ' 94' ' ' ASN . 75.4 mtt85 -143.77 147.62 34.43 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.228 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -146.43 158.33 43.88 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.26 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.41 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.06 -35.82 72.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.453 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 p -111.01 19.89 18.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.628 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.01 -137.6 2.92 Favored Glycine 0 C--O 1.216 -1.03 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.657 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -171.93 -42.67 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.301 -0.449 . . . . 0.0 110.468 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -143.3 67.34 1.3 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -137.02 37.59 2.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.254 0.221 . . . . 0.0 110.533 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -120.98 123.92 43.62 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.451 0.643 . . . . 0.0 110.384 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.4 m -100.37 163.19 12.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.581 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -51.45 -52.33 47.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.517 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.8 -42.03 83.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.88 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.64 -51.5 59.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.775 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.82 -30.71 15.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.014 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -70.51 -33.22 70.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.46 21.5 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.849 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.29 -26.61 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.084 0.469 . . . . 0.0 110.365 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.509 ' C ' ' H ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -104.75 177.28 4.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.593 0.711 . . . . 0.0 109.385 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 28' ' ' GLY . 96.5 mt-10 67.67 -10.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.705 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.8 t80 -62.57 -47.75 82.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 0.0 110.789 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.9 pm0 -92.16 9.45 33.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.772 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.77 -17.16 56.84 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -82.69 127.28 7.89 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -100.1 173.17 6.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.639 0.257 . . . . 0.0 110.538 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.0 mp -65.39 135.8 55.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.23 0.77 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.056 0.455 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 33' ' ' TYR . 1.5 t -72.43 179.85 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.778 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.471 ' N ' ' OG1' ' A' ' 32' ' ' THR . 64.4 t80 -56.0 -54.58 43.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.936 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -53.4 -50.47 65.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.845 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.556 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -66.18 -38.91 89.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.372 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 mt -61.67 -42.52 99.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.474 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.62 -50.46 73.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.717 0.294 . . . . 0.0 110.789 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.81 -33.13 55.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.33 -39.67 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.109 0.48 . . . . 0.0 111.226 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -30.16 21.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.286 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.16 -2.78 11.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.523 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 tp -92.45 9.46 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.112 0.258 . . . . 0.0 110.475 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.6 26.65 34.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -75.96 136.32 40.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.019 0.409 . . . . 0.0 110.449 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -154.02 103.04 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.55 129.05 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.757 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 t -93.96 83.46 4.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.494 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.54 95.79 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 134.91 54.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 0.0 110.779 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -140.85 170.64 24.43 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -81.51 156.75 25.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 4.8 mpp? -151.44 176.87 10.86 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 110.292 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.79 142.85 0.41 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.53 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 59.63 41.21 19.09 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.341 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.13 12.82 0.86 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.737 -0.602 . . . . 0.0 111.689 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' MET . 57.8 ttt180 -68.06 143.23 55.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 110.502 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.28 142.08 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.994 0.902 . . . . 0.0 110.928 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.01 -178.52 39.98 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.684 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 28.8 p90 -148.18 103.12 3.56 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.083 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.15 129.72 8.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.87 1.047 . . . . 0.0 112.308 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 pt -146.79 136.3 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.456 0.646 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.1 t -83.45 -26.49 7.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -156.03 150.5 20.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -42.24 130.64 4.75 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.508 1.472 . . . . 0.0 112.723 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.26 167.79 15.16 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.094 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.01 -34.54 16.85 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.937 1.758 . . . . 0.0 112.145 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -88.28 -10.16 50.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.435 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.2 p -170.54 141.35 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.612 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.18 9.36 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 54.5 p90 -62.63 -45.47 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 110.663 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . -60.58 -103.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -164.97 -151.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.78 0.324 . . . . 0.0 110.255 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.7 p -95.17 170.03 9.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.571 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.22 145.83 0.09 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mp -46.48 130.32 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -119.23 54.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 44.5 t0 -63.79 140.67 58.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 110.485 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.463 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 49.4 m-85 -92.31 4.51 53.19 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 58.66 84.48 0.04 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 79' ' ' GLY . 68.5 mt 50.32 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.079 0.466 . . . . 0.0 111.038 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -88.54 157.93 18.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.551 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 84' ' ' ARG . 9.9 mp -84.68 -6.67 59.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.216 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 85' ' ' SER . 49.8 p-10 -74.68 21.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.618 0.723 . . . . 0.0 110.606 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 82' ' ' LEU . 96.1 mtt180 -49.42 -10.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.6 -0.688 . . . . 0.0 111.052 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 83' ' ' ASN . 22.8 t -83.42 -36.22 24.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.624 0.249 . . . . 0.0 110.591 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -75.24 152.58 38.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.291 0.567 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -86.97 153.81 21.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.786 0.803 . . . . 0.0 110.566 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -153.86 174.92 13.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.125 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.58 -161.96 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.536 0.684 . . . . 0.0 110.996 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.06 141.98 12.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.284 0.564 . . . . 0.0 111.039 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -114.79 150.53 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.899 0.856 . . . . 0.0 110.261 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.5 m -142.26 -173.34 3.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.354 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 3.6 t80 -160.28 118.23 2.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.062 0.458 . . . . 0.0 109.993 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.507 HD22 HH22 ' A' ' 5' ' ' ARG . 3.0 m120 -103.61 150.69 38.36 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.992 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 97' ' ' ALA . 76.1 Cg_exo -50.0 138.27 35.48 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 121.285 1.323 . . . . 0.0 112.285 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 95' ' ' PRO . 95.1 m-70 31.62 -88.83 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.53 0.681 . . . . 0.0 111.403 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 95' ' ' PRO . . . 54.89 58.42 4.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.827 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 C--N 1.29 -1.996 0 CA-C-O 118.755 -0.641 . . . . 0.0 110.223 176.498 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.32 149.25 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.718 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -111.25 130.43 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -74.51 129.3 37.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.547 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.42 148.2 34.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.132 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.45 171.99 18.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.321 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.36 160.71 16.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.06 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.43 -27.73 46.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.301 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.6 p -72.6 -31.77 65.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.267 0.556 . . . . 0.0 110.966 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.09 160.19 12.21 Favored Glycine 0 C--O 1.216 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.633 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -68.06 -48.37 65.78 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.806 0.336 . . . . 0.0 110.673 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -98.52 49.35 0.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -136.44 24.23 3.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.944 0.402 . . . . 0.0 110.456 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 tp -120.68 129.96 53.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.807 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -85.14 161.33 19.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.66 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 50.0 p90 -60.16 -46.5 89.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.773 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -57.01 -40.71 77.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -66.08 -52.6 47.37 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.807 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.48 -31.62 56.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.231 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -68.15 -43.02 79.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 110.932 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.35 76.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.356 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 -26.27 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.396 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -105.35 174.79 5.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.401 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 39.2 mt-10 77.02 5.04 3.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.592 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -73.19 -37.74 66.37 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.157 0.503 . . . . 0.0 111.1 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -91.92 12.75 20.65 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.561 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 8.21 80.4 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.468 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -93.84 -157.25 33.0 Favored Glycine 0 C--O 1.218 -0.851 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -162.58 157.27 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.62 0.247 . . . . 0.0 110.721 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.69 147.76 3.41 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.498 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.65 91.9 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.029 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.9 t -74.48 179.16 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.961 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -58.36 -53.41 58.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -56.17 -47.57 78.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' ' CG ' ' A' ' 93' ' ' TYR . 54.3 tt0 -69.38 -37.56 77.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.957 0.408 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.49 -42.56 99.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.411 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -41.74 99.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 110.653 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.12 -36.98 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.797 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.52 -24.44 34.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.46 -30.64 65.21 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -79.17 -6.6 56.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 79.1 mt -94.04 1.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.525 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.41 9.52 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.31 135.29 47.32 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.662 0.268 . . . . 0.0 110.502 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.635 ' HD1' ' H ' ' A' ' 62' ' ' VAL . 79.0 t60 -155.87 102.67 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.88 117.89 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.927 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.86 94.88 9.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.75 115.15 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.559 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.05 142.2 52.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.457 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -157.28 170.81 34.51 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.803 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . 0.417 ' C ' ' SD ' ' A' ' 52' ' ' MET . 79.5 m95 -83.71 157.82 22.03 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.307 0.575 . . . . 0.0 110.185 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -152.8 177.45 10.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.281 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.0 145.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.372 0.606 . . . . 0.0 111.194 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' A' ' 56' ' ' ARG . 68.7 mttm 56.6 42.74 26.71 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.167 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.29 10.98 0.38 Allowed Glycine 0 C--N 1.314 -0.672 0 O-C-N 121.746 -0.596 . . . . 0.0 112.085 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.594 HH22 ' CB ' ' A' ' 77' ' ' ASP . 64.2 ttt-85 -65.05 143.56 57.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.333 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.8 148.44 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.447 1.118 . . . . 0.0 110.781 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.1 -172.98 39.82 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.313 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 40.7 p90 -155.36 102.72 2.22 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.8 132.16 11.72 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.759 1.639 . . . . 0.0 112.4 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt -145.92 147.33 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.826 . . . . 0.0 110.909 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.635 ' H ' ' HD1' ' A' ' 45' ' ' HIS . 14.8 t -116.06 -12.34 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.3 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -144.21 157.22 57.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.063 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -37.84 147.08 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.258 1.972 . . . . 0.0 112.548 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.64 79.82 0.35 Allowed Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.412 -0.66 . . . . 0.0 111.545 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 68' ' ' CYS . 73.1 Cg_exo -52.76 -48.12 23.73 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.439 2.093 . . . . 0.0 112.325 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -81.84 30.19 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.131 0.491 . . . . 0.0 110.472 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 70' ' ' PHE . 7.1 p -178.45 -165.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.56 86.23 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 68' ' ' CYS . 51.6 p90 -83.29 23.64 0.88 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.134 0.492 . . . . 0.0 110.494 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -131.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -79.14 -143.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 0.0 110.36 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 p -128.35 171.71 11.77 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.582 0.706 . . . . 0.0 110.39 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.6 155.25 0.76 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.1 mt -41.53 145.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.617 0.245 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mt -141.7 51.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.594 ' CB ' HH22 ' A' ' 56' ' ' ARG . 7.1 p-10 -60.62 151.77 28.08 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.643 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.73 -80.35 0.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.23 71.01 0.02 OUTLIER Glycine 0 N--CA 1.474 1.196 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.124 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.6 mt 53.99 91.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.333 0.587 . . . . 0.0 110.905 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 -87.8 155.93 19.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.506 0.669 . . . . 0.0 110.664 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 84' ' ' ARG . 53.5 mt -84.17 3.06 36.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.294 0.568 . . . . 0.0 110.281 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -72.99 18.57 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.214 1.006 . . . . 0.0 110.476 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.52 ' H ' ' C ' ' A' ' 82' ' ' LEU . 93.7 mtt-85 -49.74 -11.69 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.591 -0.693 . . . . 0.0 111.199 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 83' ' ' ASN . 64.7 m -87.09 -42.32 13.14 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -66.48 155.59 37.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.159 0.505 . . . . 0.0 110.403 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -90.72 148.96 22.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.215 0.531 . . . . 0.0 110.483 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -154.13 175.59 13.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.249 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 8.4 t70 -79.57 -169.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.713 . . . . 0.0 110.713 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.33 168.92 9.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.359 0.6 . . . . 0.0 110.928 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -135.68 141.57 44.98 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.536 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.57 143.53 45.49 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.737 0.78 . . . . 0.0 109.763 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CG ' ' NE2' ' A' ' 35' ' ' GLN . 74.4 t80 -115.63 150.63 36.39 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -139.36 153.02 70.5 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.09 160.57 48.14 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.826 2.35 . . . . 0.0 112.253 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -47.43 95.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.021 0.915 . . . . 0.0 110.932 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.16 -57.31 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.958 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' TYR . 40.6 t -81.98 161.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.617 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.479 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.1 p90 -154.81 154.23 32.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -96.99 149.03 22.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.646 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.505 HH12 HG21 ' A' ' 22' ' ' VAL . 14.6 ptp180 -136.66 149.02 47.73 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.427 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -144.61 159.18 43.23 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.86 140.43 36.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -83.31 -43.27 16.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 t -96.43 25.96 4.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.76 -126.92 0.95 Allowed Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.697 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -150.24 -90.13 0.07 Allowed 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 120.997 0.427 . . . . 0.0 110.334 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.75 80.64 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.16 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -130.31 32.57 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -116.63 121.1 40.72 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.249 0.547 . . . . 0.0 110.657 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 p -100.28 169.11 9.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.384 0.611 . . . . 0.0 110.502 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -56.79 -49.86 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.415 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.91 73.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.91 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -67.32 -49.98 61.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.422 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -33.54 52.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 7.0 tptm -71.48 -33.22 69.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.399 0.619 . . . . 0.0 110.748 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.43 27.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.805 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG21 HH12 ' A' ' 5' ' ' ARG . 7.2 p -60.11 -36.63 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.485 ' C ' ' H ' ' A' ' 25' ' ' PHE . 1.3 m -103.34 178.06 4.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.4 -14.48 0.33 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.656 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 23' ' ' CYS . 92.5 t80 -61.42 -47.99 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.685 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -89.64 20.35 4.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.91 79.75 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -72.01 -168.77 10.87 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 79.9 m80 -155.49 144.58 20.78 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.605 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.6 mm? -67.01 135.91 54.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -60.72 140.85 57.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.248 0.547 . . . . 0.0 110.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 p -122.1 178.29 4.98 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.924 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.21 -53.34 59.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.684 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -54.13 -49.28 69.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 110.472 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -66.88 -38.44 86.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.942 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.22 -43.77 98.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.364 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -55.26 -49.36 72.26 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.26 -29.63 10.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.836 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -37.13 36.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.511 ' NH2' ' C ' ' A' ' 61' ' ' ILE . 46.7 mmm-85 -55.82 -32.36 63.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.326 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -71.07 -4.22 23.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.739 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 42' ' ' ILE . 84.1 mt -108.41 9.18 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.392 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.61 17.91 53.39 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -72.44 123.23 22.66 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.81 0.338 . . . . 0.0 110.173 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -139.86 113.05 8.27 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.526 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -140.32 114.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.735 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -92.89 87.26 5.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.935 0.397 . . . . 0.0 110.242 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.85 138.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.604 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.02 132.53 39.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.637 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.48 148.99 21.08 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.903 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.69 152.24 39.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 75.6 mtm -153.08 -179.13 7.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.156 0.503 . . . . 0.0 110.319 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.8 143.61 0.34 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp 55.25 39.41 31.34 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.327 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.04 10.37 1.75 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.641 HH22 ' CG ' ' A' ' 77' ' ' ASP . 47.6 ttt-85 -65.98 142.23 57.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.424 0.63 . . . . 0.0 110.172 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -143.98 144.81 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.797 0.808 . . . . 0.0 110.818 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.82 167.59 40.64 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.523 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 25.2 p90 -133.3 78.47 63.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.512 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.16 139.61 71.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.095 1.864 . . . . 0.0 112.76 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' ' NH2' ' A' ' 40' ' ' ARG . 20.0 pt -150.83 134.39 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.858 0.837 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.429 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 61.2 t -62.8 -45.87 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.38 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 19.7 mtmt -158.41 -62.3 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 55.8 Cg_endo -63.49 143.17 87.4 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.866 1.711 . . . . 0.0 112.494 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.88 54.47 0.1 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.15 -49.59 0.49 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.645 2.23 . . . . 0.0 111.956 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -66.46 -39.09 88.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.81 132.68 36.77 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.246 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.14 50.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -159.88 103.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.435 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.31 -140.61 35.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 tttm 55.77 169.77 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.845 0.355 . . . . 0.0 110.469 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -136.31 157.25 47.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.52 151.3 6.37 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -40.3 144.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.689 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.16 45.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.535 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.641 ' CG ' HH22 ' A' ' 56' ' ' ARG . 1.9 p30 -68.71 145.77 53.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 110.472 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -90.24 -3.77 57.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.313 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 66.13 94.14 0.03 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 79' ' ' GLY . 63.5 mt 50.77 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -97.26 152.3 19.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.332 0.587 . . . . 0.0 110.173 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -85.45 -2.83 58.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.384 0.611 . . . . 0.0 110.277 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 85' ' ' SER . 97.7 m-20 -77.83 22.12 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.985 0.898 . . . . 0.0 110.561 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.2 mtt180 -51.68 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.125 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 83' ' ' ASN . 32.7 t -95.85 -25.62 15.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.638 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.04 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.458 0.646 . . . . 0.0 110.512 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 25.7 mtp180 -94.56 136.01 35.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 81.1 m95 -154.39 175.91 12.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -71.93 -164.44 0.13 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.511 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -162.41 149.74 13.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.465 0.65 . . . . 0.0 110.933 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -121.14 161.03 22.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.612 0.72 . . . . 0.0 110.451 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.91 -170.36 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.556 0.693 . . . . 0.0 110.182 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -161.23 151.48 17.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.368 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -145.11 146.33 30.33 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.288 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.496 1.656 0 C-N-CA 122.118 1.879 . . . . 0.0 112.084 179.326 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 144.01 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.276 0.56 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.89 161.3 26.88 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.72 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.61 140.19 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.75 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.52 HH21 ' ND2' ' A' ' 94' ' ' ASN . 38.3 mmt180 -103.59 161.9 13.5 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.454 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -142.37 134.2 27.03 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.379 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.69 166.74 15.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.716 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -68.38 -38.03 80.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.193 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -72.35 -18.3 61.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.34 0.591 . . . . 0.0 110.597 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 -154.7 16.78 Favored Glycine 0 N--CA 1.478 1.444 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 13' ' ' LYS . 68.8 mttm -115.33 -177.47 3.15 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.416 0.627 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 47.62 16.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.759 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' N ' ' C ' ' A' ' 11' ' ' LYS . 51.2 mtmt -128.52 26.35 5.65 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.777 0.322 . . . . 0.0 110.72 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 88' ' ' TRP . 48.4 mt -123.38 132.14 53.87 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.9 p -97.48 168.51 10.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.508 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 47.8 p90 -51.26 -54.21 28.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.973 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.78 -41.38 64.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.24 -51.45 37.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.755 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.27 13.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.07 -34.93 77.36 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.354 0.597 . . . . 0.0 110.663 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -53.03 59.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.886 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.4 -25.87 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.442 . . . . 0.0 110.506 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 25' ' ' PHE . 30.7 m -103.83 179.87 4.15 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.693 0.759 . . . . 0.0 109.247 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 67.17 -3.31 1.01 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.962 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 23' ' ' CYS . 89.7 t80 -61.82 -45.39 94.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.981 0.419 . . . . 0.0 110.869 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.4 pm0 -94.68 5.87 50.58 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.005 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.7 -22.52 39.36 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.5 143.1 38.25 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -98.72 153.38 18.77 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.742 0.305 . . . . 0.0 110.238 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.5 mp -56.52 143.02 36.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.395 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -52.05 139.19 23.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.117 0.484 . . . . 0.0 110.735 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 33' ' ' TYR . 43.0 m -121.93 171.64 8.78 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.838 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.614 ' N ' HG22 ' A' ' 32' ' ' THR . 11.3 t80 -53.76 -53.42 52.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -58.76 -48.01 82.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.64 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -67.49 -36.62 81.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.243 0.544 . . . . 0.0 110.795 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 17.9 mt -62.12 -42.86 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.162 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.09 -31.15 40.38 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.04 79.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.815 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.31 -25.34 42.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 7.5 mmm180 -58.8 -35.98 73.73 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -72.66 -10.59 59.98 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.13 4.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.451 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 33.21 16.69 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -66.04 129.23 39.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.83 0.348 . . . . 0.0 110.508 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -147.9 102.42 3.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.39 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.61 107.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.891 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -90.08 92.62 9.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.153 0.502 . . . . 0.0 110.106 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.71 109.84 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.08 138.92 56.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.92 163.84 34.44 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.25 160.42 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.277 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 77.3 mtm -156.12 -179.14 7.86 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.299 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.53 145.31 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.254 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 56' ' ' ARG . 55.5 tttm 56.95 42.51 26.16 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.99 10.94 0.5 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.79 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 54' ' ' LYS . 10.4 tpt180 -64.97 140.23 58.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.259 0.552 . . . . 0.0 110.47 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.11 161.98 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.106 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.4 177.44 37.77 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.854 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -145.37 81.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.329 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.41 135.5 60.91 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.185 1.923 . . . . 0.0 112.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -151.26 134.37 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.495 0.664 . . . . 0.0 110.833 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.21 -44.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.176 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -167.5 -61.46 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.064 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.61 156.5 65.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.771 1.648 . . . . 0.0 112.051 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' CA ' ' SG ' ' A' ' 68' ' ' CYS . . . -172.44 65.5 0.13 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.902 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.88 -44.97 35.69 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.268 1.979 . . . . 0.0 112.403 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.47 -24.76 45.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.719 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.421 ' SG ' ' CA ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -95.72 166.85 11.62 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.448 0.642 . . . . 0.0 110.031 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' GLY . . . -61.8 150.39 45.61 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.384 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 71' ' ' GLY . 45.3 p90 -76.29 29.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 110.581 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' GLY . . . -50.71 -105.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -141.9 -165.2 1.95 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.149 0.499 . . . . 0.0 110.322 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 p -94.67 160.84 14.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.467 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.55 168.69 0.44 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 54.0 mt -52.53 145.72 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.701 0.286 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.8 pt -149.85 -39.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -87.17 120.71 28.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.967 0.413 . . . . 0.0 110.613 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -145.05 -171.13 3.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.892 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.72 -179.69 48.99 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.3 mt -103.06 116.4 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -74.4 152.86 39.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.96 0.409 . . . . 0.0 110.051 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 84' ' ' ARG . 39.9 tp -84.45 -8.04 59.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.609 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 85' ' ' SER . 45.6 p-10 -74.66 23.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 110.64 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 82' ' ' LEU . 77.9 mtp180 -51.48 -5.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.594 -0.691 . . . . 0.0 111.448 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 83' ' ' ASN . 95.0 p -98.35 4.41 48.61 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -96.93 -140.0 0.28 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -158.23 147.04 19.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.494 0.664 . . . . 0.0 110.98 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.42 ' O ' ' O ' ' A' ' 14' ' ' LEU . 91.4 m95 -154.13 176.44 12.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.295 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.91 -165.21 0.2 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.889 0.852 . . . . 0.0 110.777 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -161.26 154.17 20.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.118 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 12.1 m-85 -148.24 156.21 42.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.467 0.651 . . . . 0.0 110.352 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 81.6 m -123.46 -166.69 1.5 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.778 0.799 . . . . 0.0 110.155 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -146.87 125.5 12.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' ND2' HH21 ' A' ' 5' ' ' ARG . 1.1 m-80 -103.31 154.03 38.03 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.874 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo . . . . . 0 N--CA 1.5 1.911 0 C-N-CA 121.75 1.633 . . . . 0.0 112.659 179.287 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 2' ' ' VAL . 18.7 m -85.39 154.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.008 0.433 . . . . 0.0 110.806 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.486 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 34.2 p90 -138.58 169.2 18.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.873 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -73.64 132.85 43.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.227 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.486 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 61.8 ttm-85 -135.16 131.26 36.58 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.274 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -165.0 159.18 17.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.232 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.83 137.52 56.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.929 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.18 -39.65 75.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.03 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.0 m -113.08 -32.92 6.19 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.793 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 -134.29 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.626 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 12' ' ' TYR . 24.6 pttm -173.28 -35.7 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.044 0.45 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.441 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 82.7 m-85 -159.53 80.78 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -147.19 42.52 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 0.0 110.353 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -117.25 126.44 52.74 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.315 0.579 . . . . 0.0 110.788 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 16' ' ' TYR . 91.6 m -103.68 164.66 11.53 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.855 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.59 ' N ' HG22 ' A' ' 15' ' ' THR . 59.5 t80 -54.31 -48.17 71.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.486 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' HB2' HH21 ' A' ' 84' ' ' ARG . . . -55.2 -45.76 75.89 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.898 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 8.3 mp0 -64.49 -45.41 87.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.49 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.28 -31.16 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.827 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.88 -51.32 41.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.598 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -59.72 -23.19 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.978 0.418 . . . . 0.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' C ' ' H ' ' A' ' 25' ' ' PHE . 57.4 m -104.89 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 109.59 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 68.2 mm-40 73.99 -26.12 0.19 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.873 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.0 t80 -59.78 -49.05 79.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.947 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.96 17.47 12.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.13 5.61 82.81 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -79.47 -175.53 47.67 Favored Glycine 0 C--O 1.219 -0.822 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 89.4 m-70 -154.96 158.52 39.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 136.93 57.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.044 0.449 . . . . 0.0 110.368 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 85.61 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 33' ' ' TYR . 40.9 m -71.05 170.36 13.02 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.611 ' N ' HG22 ' A' ' 32' ' ' THR . 26.1 t80 -55.37 -53.19 59.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.724 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.1 -49.14 77.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.577 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -66.34 -36.25 82.42 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.82 -43.75 98.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.541 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -49.72 -44.59 48.42 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.84 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.697 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.65 44.54 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.046 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.587 HH22 ' H ' ' A' ' 46' ' ' VAL . 12.1 mmm180 -56.93 -30.82 64.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.61 -6.6 57.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 42' ' ' ILE . 5.6 mm -103.02 4.98 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 5.28 53.75 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -68.79 119.41 13.12 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.44 0.62 . . . . 0.0 109.978 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.403 ' HA ' ' NH2' ' A' ' 40' ' ' ARG . 84.7 t60 -134.85 103.43 5.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.587 ' H ' HH22 ' A' ' 40' ' ' ARG . 39.7 t -141.27 132.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.728 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -114.36 92.69 4.05 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.69 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.39 127.29 4.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.22 104.78 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.405 0.621 . . . . 0.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -122.66 157.24 17.25 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.024 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.458 ' CE3' HG22 ' A' ' 57' ' ' VAL . 88.9 m95 -78.68 145.7 34.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.313 0.578 . . . . 0.0 110.143 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 2.1 mpp? -142.99 171.84 13.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.324 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -38.71 149.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.665 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 57.27 34.81 25.3 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.194 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.83 6.85 1.36 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.796 -0.565 . . . . 0.0 111.888 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 52' ' ' MET . 59.8 ttt85 -62.32 131.21 48.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 110.065 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.458 HG22 ' CE3' ' A' ' 51' ' ' TRP . 2.3 t -127.88 126.59 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.985 0.898 . . . . 0.0 110.728 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.06 -172.31 25.06 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.289 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 78' ' ' TYR . 7.8 p90 -152.5 84.83 4.62 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 114.934 -0.633 . . . . 0.0 110.344 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.15 145.04 67.2 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.36 2.04 . . . . 0.0 112.49 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -136.78 103.51 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.45 -53.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.266 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -95.09 145.9 30.35 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.327 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -39.89 140.54 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.067 1.844 . . . . 0.0 112.322 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.56 99.91 0.19 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.991 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -16.09 19.23 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.19 1.927 . . . . 0.0 112.108 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -70.83 -34.73 71.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.109 0.48 . . . . 0.0 110.687 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.7 137.25 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.236 0.541 . . . . 0.0 110.384 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.46 79.31 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 49.54 79.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.719 0.295 . . . . 0.0 110.714 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.05 -123.14 32.05 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 55.76 163.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 74' ' ' GLY . 89.1 m -138.99 164.31 30.09 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.676 0.75 . . . . 0.0 110.666 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.584 ' N ' HG22 ' A' ' 73' ' ' THR . . . 73.96 153.71 3.02 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.4 mt -53.32 126.17 9.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-O 120.974 0.416 . . . . 0.0 110.367 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.472 ' O ' ' CE2' ' A' ' 78' ' ' TYR . 37.2 mm -107.84 118.37 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.191 0.52 . . . . 0.0 110.424 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.58 149.73 43.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.384 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 98.5 m-85 -131.36 -16.51 3.08 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -170.0 34.63 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.1 mt -103.83 123.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.688 0.756 . . . . 0.0 110.504 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 81' ' ' ARG . 0.5 OUTLIER -98.37 130.13 45.02 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.39 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 84' ' ' ARG . 27.6 mt -83.0 8.58 12.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 85' ' ' SER . 47.7 p-10 -71.86 22.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.672 1.225 . . . . 0.0 110.981 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 82' ' ' LEU . 72.0 ttt180 -48.06 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.597 -0.689 . . . . 0.0 110.986 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 83' ' ' ASN . 57.3 m -68.22 -37.66 81.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.656 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.18 -169.17 1.94 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 110.645 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.448 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 92.0 mtt-85 -134.03 144.93 48.98 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.552 0.691 . . . . 0.0 110.721 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.448 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 60.3 m95 -150.32 175.42 11.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.971 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 42.5 t0 -59.86 -179.7 0.1 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 111.085 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.456 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -165.65 159.73 16.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.344 0.593 . . . . 0.0 110.884 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.11 160.54 38.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.637 0.732 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.8 t -141.95 148.54 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.159 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -115.42 141.93 47.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.124 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -147.26 148.52 32.04 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.196 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.496 1.627 0 C-N-CA 122.463 2.109 . . . . 0.0 111.897 179.145 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 t -82.96 157.15 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.665 0.269 . . . . 0.0 110.718 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -162.68 155.52 19.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.769 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -75.61 135.1 40.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.616 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -141.97 139.74 32.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.224 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -140.8 152.38 45.13 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.13 159.12 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.079 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -49.14 9.99 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.0 m -114.0 19.0 16.86 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.606 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.12 -176.25 14.38 Favored Glycine 0 C--O 1.215 -1.082 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -147.0 106.23 3.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.193 -0.504 . . . . 0.0 110.49 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 56.53 17.25 2.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.537 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -80.48 38.64 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.44 117.12 30.85 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.264 0.554 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.538 HG22 ' N ' ' A' ' 16' ' ' TYR . 61.9 m -101.58 163.62 12.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.538 ' N ' HG22 ' A' ' 15' ' ' THR . 62.4 t80 -53.85 -49.75 67.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.93 78.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.891 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.07 -49.28 70.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.713 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.6 -30.16 41.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' CYS . 44.1 tptt -60.93 -37.37 82.1 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.303 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.45 -54.2 13.3 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.449 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.49 -42.78 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.999 0.428 . . . . 0.0 110.788 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.525 ' C ' ' H ' ' A' ' 25' ' ' PHE . 62.1 m -100.51 173.42 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' OE1' ' NZ ' ' A' ' 20' ' ' LYS . 70.9 tt0 63.04 -7.98 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.93 -47.1 86.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.774 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -87.98 21.29 2.76 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.24 -1.2 84.33 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.81 -152.15 1.27 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 53.4 t-80 -168.67 152.74 5.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.642 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.465 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 44.0 mt -62.43 139.52 58.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.956 0.408 . . . . 0.0 110.438 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 103.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.998 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.8 t -77.45 179.02 6.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.045 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.461 ' N ' ' OG1' ' A' ' 32' ' ' THR . 50.7 t80 -54.81 -53.65 52.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.1 -44.75 91.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.734 0.302 . . . . 0.0 110.71 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.562 ' H ' HG23 ' A' ' 32' ' ' THR . 78.8 mt-30 -71.38 -30.85 66.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 111.066 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.8 mt -63.48 -41.91 98.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -30.64 67.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.216 0.531 . . . . 0.0 110.674 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.89 65.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.828 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.74 -42.18 42.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.546 HH22 ' CA ' ' A' ' 61' ' ' ILE . 17.2 mmm180 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.161 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.36 -11.53 60.07 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.456 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 42' ' ' ILE . 99.1 mt -96.71 4.13 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.21 9.6 55.44 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -66.85 125.36 25.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.949 0.374 . . . . 0.0 110.392 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -143.64 103.06 4.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.485 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.0 132.75 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.699 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.18 91.31 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.3 149.73 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.99 136.91 52.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.466 0.65 . . . . 0.0 110.884 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.89 -178.58 21.47 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.547 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -84.32 156.13 22.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.39 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.5 ptt? -158.16 -175.28 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.551 0.691 . . . . 0.0 110.101 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -30.71 144.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.574 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 55.35 15.46 1.39 Allowed 'General case' 0 C--O 1.2 -1.505 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.776 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 65.8 16.26 63.45 Favored Glycine 0 C--N 1.315 -0.623 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -66.59 154.5 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 0.0 110.007 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 57' ' ' VAL . 11.5 p -129.9 118.12 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.862 0.839 . . . . 0.0 110.942 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 59' ' ' TYR . . . -113.73 -175.86 19.14 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 6.1 m-85 -141.66 69.72 25.34 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 115.065 -0.568 . . . . 0.0 110.291 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -52.62 115.32 2.15 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.72 1.614 . . . . 0.0 112.559 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.546 ' CA ' HH22 ' A' ' 40' ' ' ARG . 97.8 mt -145.58 118.23 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.607 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 66.8 t -74.73 -22.33 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 0.0 110.083 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -165.65 148.24 6.59 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.312 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -39.63 143.87 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.878 1.719 . . . . 0.0 112.926 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.91 167.79 25.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.457 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.97 -43.29 0.8 Allowed 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.164 1.91 . . . . 0.0 112.317 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -64.88 -35.21 80.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.46 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.17 113.47 25.74 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.216 0.531 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 145.65 29.03 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 45.5 -97.32 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.46 104.5 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.81 -161.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 110.148 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.2 p -94.59 150.62 20.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.429 0.633 . . . . 0.0 110.423 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 167.48 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.91 131.7 28.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 110.17 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.6 mt -86.64 126.0 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -66.66 133.68 50.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.486 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -143.81 156.45 44.49 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.754 0.787 . . . . 0.0 110.227 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.38 -161.0 34.67 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 85.6 mt -97.77 96.88 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.44 0.638 . . . . 0.0 110.193 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -71.52 141.94 50.12 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.262 0.553 . . . . 0.0 110.423 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 84' ' ' ARG . 24.1 tp -82.11 3.8 25.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.14 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 85' ' ' SER . 38.7 p-10 -76.06 20.44 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.916 0.865 . . . . 0.0 110.574 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 82' ' ' LEU . 80.9 mtp180 -54.94 -1.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.782 -0.574 . . . . 0.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 83' ' ' ASN . 96.7 p -94.94 -4.6 46.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.454 ' CD ' ' HE1' ' A' ' 88' ' ' TRP . 80.7 tt0 -94.98 154.08 17.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 83.4 mtm180 -86.17 136.81 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 110.651 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.1 m95 -153.2 176.84 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.328 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 30.9 t0 -73.55 -169.29 0.66 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.565 0.698 . . . . 0.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.47 153.88 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.499 0.666 . . . . 0.0 110.873 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.28 157.36 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.757 0.789 . . . . 0.0 110.371 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.53 -173.62 3.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.496 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -160.04 113.56 2.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.181 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -153.81 150.95 23.95 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.306 -1.688 0 C-N-CA 121.902 1.735 . . . . 0.0 111.581 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -147.47 130.14 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.89 0.376 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -105.35 129.55 53.66 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.831 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -79.36 149.34 31.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.759 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -128.43 154.52 45.97 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -160.94 133.14 5.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.394 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.88 31.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -75.7 -42.35 51.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.532 0.682 . . . . 0.0 110.997 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 p -109.58 25.75 11.43 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.624 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.68 -142.95 3.54 Favored Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.743 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -162.38 87.09 0.61 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.111 0.481 . . . . 0.0 110.526 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 2.3 m-85 72.39 21.71 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -74.1 48.04 0.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.408 -0.183 . . . . 0.0 110.758 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.99 130.12 52.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.543 0.687 . . . . 0.0 110.904 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.0 p -101.38 170.23 8.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -56.26 -50.19 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.91 86.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.041 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -51.74 39.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.71 -30.34 13.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' CYS . 28.8 ttpt -67.92 -33.6 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.514 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -51.91 63.32 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 111.56 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.24 -38.72 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.207 0.527 . . . . 0.0 110.71 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 20' ' ' LYS . 56.8 m -101.17 178.8 4.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.871 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' GLY . 36.1 tt0 72.68 -27.28 0.18 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.7 t80 -61.27 -46.62 89.58 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 110.799 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.1 pm0 -86.49 11.74 11.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -23.1 33.79 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -78.51 134.27 13.91 Favored Glycine 0 C--O 1.22 -0.738 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.44 173.34 6.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.83 137.61 56.73 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.244 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.97 139.54 46.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.429 0.633 . . . . 0.0 110.819 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -122.27 174.35 7.04 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.921 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -59.71 -52.83 63.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.91 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.87 -45.25 95.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.927 0.394 . . . . 0.0 110.485 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.11 -34.73 75.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.639 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 40' ' ' ARG . 10.7 mt -62.53 -41.14 98.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.467 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -53.89 -40.82 66.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.755 0.312 . . . . 0.0 110.884 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.83 97.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.081 0.467 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -85.56 -25.47 26.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 61' ' ' ILE . 1.1 tpt85 -56.41 -25.74 51.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.593 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -81.49 -1.35 45.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.508 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 39' ' ' ALA . 4.4 tt -91.65 6.31 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.506 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.13 26.24 34.62 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -70.55 131.23 43.67 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.83 0.315 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.65 101.77 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -143.43 133.07 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.14 78.74 6.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.862 0.363 . . . . 0.0 110.027 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.38 92.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.472 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.07 39.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.628 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.05 165.59 20.97 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.814 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -72.14 104.97 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.385 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 55' ' ' GLY . 71.4 mtm -97.31 -178.33 4.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.25 0.548 . . . . 0.0 110.418 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -32.07 144.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.769 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 mttp 54.4 9.27 0.24 Allowed 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.224 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 81.86 20.87 62.49 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.045 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.438 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 69.2 ttt180 -70.38 130.01 40.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.428 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.2 p -116.57 133.09 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.806 0.812 . . . . 0.0 110.745 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.46 157.18 28.81 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -113.11 106.07 55.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.448 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.51 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 87.8 Cg_endo -79.05 126.93 7.36 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.101 1.201 . . . . 0.0 112.234 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 17.1 pt -145.97 137.95 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.831 0.824 . . . . 0.0 110.875 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.77 -45.36 98.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.285 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.636 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -168.5 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.636 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 31.8 Cg_exo -60.64 147.95 93.04 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.231 1.954 . . . . 0.0 112.164 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.461 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -156.73 50.53 0.44 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.371 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.3 Cg_endo -66.55 -53.41 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.321 2.014 . . . . 0.0 111.943 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.77 -23.19 31.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.56 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 12.1 p -151.03 124.94 9.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.56 110.5 0.25 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -144.09 -53.1 0.33 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.14 -72.7 0.58 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -172.36 -157.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 0.0 110.669 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 p -114.89 166.37 11.85 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 68.41 68.32 1.69 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' GLY . 71.9 mt 56.44 128.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.587 -0.307 . . . . 0.0 110.899 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.46 118.15 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 120.992 0.425 . . . . 0.0 110.379 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 91.9 m-20 -92.54 108.1 19.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.496 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CE1' ' OH ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -95.93 -11.55 26.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.1 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.98 -174.51 44.16 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.5 mp -96.61 116.87 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.212 0.53 . . . . 0.0 110.556 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.531 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 79.8 mtp180 -92.91 133.85 35.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.112 0.482 . . . . 0.0 110.162 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 tp -83.35 4.65 26.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 110.308 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.531 HD21 ' CZ ' ' A' ' 81' ' ' ARG . 51.4 p30 -85.66 23.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.487 0.661 . . . . 0.0 110.537 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -44.31 -32.08 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.566 -0.709 . . . . 0.0 111.261 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.1 p -49.08 -21.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.009 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -70.51 -169.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.12 0.486 . . . . 0.0 110.743 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 84.1 mtt85 -130.2 129.81 43.87 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.373 0.606 . . . . 0.0 110.776 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.428 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.4 m95 -150.1 175.71 11.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.908 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD2' ' CD1' ' A' ' 12' ' ' TYR . 1.3 m-20 -55.69 -174.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.86 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.47 143.07 18.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.425 0.631 . . . . 0.0 110.935 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -115.43 160.08 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.008 0.909 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.88 179.71 6.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -133.36 116.7 16.4 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.183 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -149.41 88.47 5.0 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.045 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.307 -1.607 0 C-N-CA 121.398 1.399 . . . . 0.0 111.559 -179.68 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.98 136.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 110.742 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.6 162.41 37.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.972 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -74.91 129.06 37.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -135.03 133.3 39.25 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.216 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -157.05 156.03 32.17 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.65 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.16 -37.02 34.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.094 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.3 m -84.71 -5.21 59.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.63 -118.65 0.81 Allowed Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.159 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -167.53 -39.94 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.36 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -146.76 67.16 1.16 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.978 0.418 . . . . 0.0 110.517 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.09 32.92 3.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.3 118.72 32.0 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.649 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -90.32 168.31 11.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.656 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 38.5 p90 -51.64 -60.23 3.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -53.16 -40.24 64.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -66.24 -47.96 72.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.64 -35.87 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.795 0.331 . . . . 0.0 110.849 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' CYS . 56.6 mtpt -68.9 -31.31 70.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.86 45.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.884 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.82 -33.87 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.709 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -104.71 -178.45 3.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 109.586 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 96.4 mt-10 69.77 -10.28 0.62 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.923 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' CYS . 90.5 t80 -60.48 -47.25 86.95 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 18.0 pt-20 -87.39 21.37 2.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.46 76.26 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.11 -171.28 40.45 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -163.45 121.07 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.679 0.276 . . . . 0.0 110.451 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -42.15 136.98 2.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.701 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -66.12 144.66 56.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -123.21 177.3 5.63 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.075 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -51.6 -26.74 9.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.474 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -70.66 -56.33 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.76 -35.29 74.82 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.7 mt -61.07 -40.85 95.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.419 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.72 -34.14 71.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.541 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.2 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 110.785 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.97 66.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -56.59 -43.47 80.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.402 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.77 -11.4 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 42' ' ' ILE . 79.2 mt -98.54 7.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.49 22.08 52.05 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.47 132.78 46.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.751 0.31 . . . . 0.0 110.585 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -154.23 105.38 2.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 46' ' ' VAL . 14.9 p -141.71 127.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.879 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.38 82.56 1.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.82 118.21 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.721 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.99 151.04 21.19 Favored Glycine 0 N--CA 1.476 1.336 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.12 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -73.13 147.5 44.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.166 0.508 . . . . 0.0 110.258 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 48.9 mtm -150.0 179.96 7.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.018 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.8 141.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.835 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 55.39 12.37 0.72 Allowed 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.179 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 75.62 21.59 76.75 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.808 -0.558 . . . . 0.0 112.158 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -74.36 135.89 42.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.209 0.528 . . . . 0.0 110.579 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.482 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 3.1 p -143.41 156.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.667 0.746 . . . . 0.0 110.783 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 57' ' ' VAL . . . -174.69 -178.47 44.6 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.271 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -116.46 67.04 3.51 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.879 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.29 118.78 5.68 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.762 1.642 . . . . 0.0 112.419 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.2 pt -145.02 147.98 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.682 0.753 . . . . 0.0 110.88 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.71 -66.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.338 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.767 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 17.7 mttt -144.76 -43.07 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.303 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.767 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 28.0 Cg_exo -63.32 150.14 89.36 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.211 1.941 . . . . 0.0 112.371 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -168.88 49.32 0.22 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.493 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.8 Cg_endo -66.73 -53.19 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.428 2.085 . . . . 0.0 112.118 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -74.4 -17.05 60.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.24 132.1 1.02 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.95 41.4 0.03 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.64 -41.82 98.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 110.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.47 -84.67 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -170.93 -156.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.213 . . . . 0.0 110.472 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.3 p -95.3 162.22 13.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.328 0.585 . . . . 0.0 110.597 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.22 19.97 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.2 mt -102.67 123.34 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.097 0.475 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.9 mt -93.88 131.21 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.351 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.51 97.33 9.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.373 0.606 . . . . 0.0 110.067 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.1 41.79 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.301 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 80' ' ' ILE . . . -91.06 -147.34 19.26 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 79' ' ' GLY . 11.5 mt 15.72 58.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.435 0.636 . . . . 0.0 111.238 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 79' ' ' GLY . 82.3 mtp180 -71.08 150.78 45.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.2 mp -77.24 -16.6 58.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.14 0.495 . . . . 0.0 109.958 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -91.52 25.18 2.73 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.381 0.61 . . . . 0.0 110.616 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -52.88 5.04 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.719 -0.613 . . . . 0.0 111.712 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.641 ' H ' ' C ' ' A' ' 83' ' ' ASN . 47.7 t -92.61 -8.47 44.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.413 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -85.97 -165.27 1.2 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.005 0.431 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -131.27 141.25 49.95 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.005 0.907 . . . . 0.0 110.849 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 61.7 m95 -153.07 177.26 10.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.862 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 12.4 t70 -60.71 -163.67 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -170.35 149.35 3.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.22 0.533 . . . . 0.0 110.759 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -118.21 135.32 54.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.458 0.647 . . . . 0.0 110.253 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.9 m -114.08 177.33 4.68 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.023 0.916 . . . . 0.0 109.637 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -150.43 151.41 32.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.441 ' ND2' ' OE2' ' A' ' 26' ' ' GLU . 29.8 t-20 -143.11 132.77 11.87 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.362 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.505 2.168 0 C-N-CA 122.05 1.834 . . . . 0.0 112.275 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 3' ' ' TYR . 97.2 t -85.1 155.51 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.637 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.402 ' N ' HG12 ' A' ' 2' ' ' VAL . 89.9 t80 -117.79 129.24 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -74.09 127.53 33.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 90' ' ' ALA . 24.0 ttm180 -146.06 128.78 16.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.037 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.9 pm0 -146.41 -176.82 5.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.468 0.48 . . . . 0.0 110.392 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.67 127.1 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -78.39 -33.96 48.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.846 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.82 -4.09 41.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.531 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.47 -95.16 0.1 Allowed Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.873 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -171.34 -81.5 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.917 0.389 . . . . 0.0 110.311 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.02 80.15 3.28 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.001 0.429 . . . . 0.0 110.622 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -137.61 34.62 2.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.153 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.519 0.676 . . . . 0.0 110.258 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 p -99.03 168.27 10.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.245 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.543 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 31.9 p90 -53.68 -53.56 50.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.543 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -55.12 -45.97 75.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.47 69.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.5 mttt -71.87 -40.27 69.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 0.0 110.715 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -46.64 84.53 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.33 -42.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.529 0.68 . . . . 0.0 110.94 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 20' ' ' LYS . 17.6 m -101.47 178.79 4.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.736 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 70.04 -45.78 0.59 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -62.71 -48.02 81.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.41 21.82 3.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.022 0.439 . . . . 0.0 110.871 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.15 1.48 84.33 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.23 -171.38 9.54 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -168.41 137.03 2.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.557 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 30' ' ' LEU . 10.3 mp -72.94 141.27 47.82 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 110.25 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.3 93.96 0.35 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.291 0.567 . . . . 0.0 110.726 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 33' ' ' TYR . 34.0 m -86.01 171.66 11.24 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.898 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.616 ' N ' HG22 ' A' ' 32' ' ' THR . 66.7 t80 -55.53 -53.98 49.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.22 -45.05 84.21 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.542 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -70.05 -34.93 73.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 110.858 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.15 -40.87 98.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.15 -37.31 82.41 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.5 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.09 -39.77 93.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.71 -27.62 31.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.365 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -56.96 -25.0 57.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.268 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.56 -6.24 59.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 42' ' ' ILE . 78.1 mt -94.36 4.52 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.521 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.29 25.09 24.86 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -66.31 128.66 37.02 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.701 0.251 . . . . 0.0 110.59 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.403 ' CG ' HG22 ' A' ' 62' ' ' VAL . 1.8 t60 -150.03 103.19 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.278 0.561 . . . . 0.0 110.468 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 46' ' ' VAL . 11.4 p -143.65 117.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.023 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.87 89.73 6.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.11 112.5 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.118 0.485 . . . . 0.0 110.618 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.45 137.21 52.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.905 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.98 -172.83 19.13 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.689 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.73 150.81 19.82 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.1 mtm -143.73 168.86 18.9 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.35 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.19 156.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.17 40.77 31.85 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.273 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.26 6.61 0.16 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.008 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 56.5 ttt180 -68.81 144.72 54.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.61 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.29 130.19 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.771 0.795 . . . . 0.0 110.786 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.76 175.59 45.08 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.433 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.596 ' CE2' HD11 ' A' ' 61' ' ' ILE . 13.6 p90 -167.55 143.19 3.33 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.724 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.11 146.68 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.184 1.922 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 59' ' ' TYR . 16.2 mt -141.8 93.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.556 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG22 ' CG ' ' A' ' 45' ' ' HIS . 18.9 m -69.24 -36.76 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.031 0.443 . . . . 0.0 110.278 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -137.7 154.39 74.79 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.33 144.77 59.2 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.362 2.041 . . . . 0.0 112.0 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.75 179.72 20.76 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.37 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.8 -47.63 26.14 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 122.174 1.916 . . . . 0.0 112.598 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.41 28.69 2.47 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.3 p -151.34 150.5 30.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.381 0.61 . . . . 0.0 110.273 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.0 93.77 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.43 -44.7 96.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 110.597 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.21 -8.96 0.05 OUTLIER Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.16 155.78 38.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.708 0.289 . . . . 0.0 110.287 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -140.5 130.31 24.47 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.794 0.807 . . . . 0.0 110.598 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 75' ' ' ILE . . . 144.77 -47.02 0.78 Allowed Glycine 0 N--CA 1.465 0.625 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.195 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.438 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER 159.26 131.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 120.868 0.366 . . . . 0.0 110.607 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mm -111.24 62.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.58 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 44.5 p-10 -99.67 103.61 15.3 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.95 0.405 . . . . 0.0 110.296 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -71.17 -61.62 1.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.45 -147.44 13.09 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.515 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.0 mt -97.63 117.39 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.368 . . . . 0.0 110.074 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 50.8 mtp85 -94.24 133.5 37.7 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.7 mp -82.54 3.34 28.96 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.592 0.71 . . . . 0.0 109.831 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 52.2 p-10 -81.66 26.2 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.846 0.832 . . . . 0.0 110.479 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -45.38 -36.35 4.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.543 -0.723 . . . . 0.0 111.262 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -45.57 -26.99 0.67 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.563 0.221 . . . . 0.0 110.99 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 8.7 mp0 -74.13 -173.08 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.932 0.872 . . . . 0.0 109.988 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -128.49 145.7 51.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.917 0.865 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -155.05 175.91 13.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.343 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 28.0 t0 -79.82 -168.36 1.57 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.72 0.771 . . . . 0.0 110.604 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.443 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -167.98 164.58 13.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.455 0.645 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.93 151.52 49.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.534 0.683 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.53 142.45 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.227 0.537 . . . . 0.0 110.308 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 94' ' ' ASN . 10.9 t80 -134.34 149.91 50.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.274 0.559 . . . . 0.0 110.312 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.482 ' N ' ' CD1' ' A' ' 93' ' ' TYR . 11.8 m120 -117.71 89.97 34.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.505 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo . . . . . 0 N--CA 1.501 1.932 0 C-N-CA 122.272 1.982 . . . . 0.0 112.537 -179.864 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 3' ' ' TYR . 10.2 p -81.66 163.32 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.543 ' N ' HG22 ' A' ' 2' ' ' VAL . 24.6 p90 -146.71 127.89 14.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.804 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -73.79 138.44 44.53 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 92' ' ' CYS . 52.5 ptt85 -145.62 160.96 40.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.496 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.4 pm0 -160.92 -177.48 6.16 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.81 124.66 17.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -66.24 -39.62 89.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.018 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m -109.72 33.08 4.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.507 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.36 -134.1 1.63 Allowed Glycine 0 C--O 1.216 -1.002 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.798 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -154.87 -83.16 0.07 Allowed 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.325 -0.438 . . . . 0.0 110.424 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.61 28.78 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -94.81 33.74 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.903 0.382 . . . . 0.0 110.604 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.47 124.54 49.03 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.534 0.683 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 16' ' ' TYR . 32.3 m -87.97 161.3 17.5 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.472 ' N ' HG22 ' A' ' 15' ' ' THR . 31.8 t80 -60.5 -43.74 96.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.388 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.24 62.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.957 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.46 -51.15 62.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -31.77 18.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 23' ' ' CYS . 10.5 mtpm? -70.59 -33.8 71.46 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 120.576 0.227 . . . . 0.0 110.567 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.54 74.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.133 0.492 . . . . 0.0 111.765 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.68 -44.31 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.251 0.548 . . . . 0.0 111.173 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' O ' ' O ' ' A' ' 20' ' ' LYS . 7.4 m -102.26 178.25 4.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.085 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 67.45 -39.32 0.37 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.9 t80 -60.0 -47.03 87.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.658 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.67 19.76 5.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.676 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.95 77.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.57 -165.75 22.11 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -167.95 137.89 2.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.201 . . . . 0.0 110.523 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 30' ' ' LEU . 10.7 mp -70.54 137.4 50.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.917 0.389 . . . . 0.0 110.144 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.42 138.64 55.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 36' ' ' LEU . 11.1 p -100.31 163.71 12.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 22.9 p90 -54.4 -53.37 54.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.943 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.57 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 39.0 ttmt -62.28 -44.38 96.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.986 0.422 . . . . 0.0 110.334 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -67.06 -30.05 70.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.4 mt -62.41 -29.9 70.83 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.346 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.77 -39.36 58.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.407 . . . . 0.0 110.909 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.29 -38.03 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.83 28.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 42' ' ' ILE . 3.8 tpt85 -56.77 -37.47 71.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -63.48 -2.09 1.45 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.509 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 42' ' ' ILE . 24.5 mm -106.39 13.46 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.347 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 18.93 66.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.77 127.49 33.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.885 0.343 . . . . 0.0 110.181 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -140.93 104.43 4.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.506 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.53 125.4 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.023 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -93.84 91.51 6.98 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.887 0.375 . . . . 0.0 110.303 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.28 93.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . . . -72.11 121.37 19.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.59 162.6 25.82 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.961 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -80.29 109.34 14.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.39 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 40.1 mtm -97.87 -172.61 2.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.248 0.547 . . . . 0.0 110.251 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.02 152.93 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.583 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' ARG . 68.6 mttm 47.19 41.03 11.13 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.96 5.68 0.1 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.892 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' LYS . 54.8 mtp180 -68.37 128.91 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.3 122.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.806 0.812 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.81 150.74 12.16 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.516 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 49' ' ' ALA . 11.2 p90 -160.53 140.36 8.26 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.607 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 143.37 31.59 Favored 'Trans proline' 0 N--CA 1.505 2.198 0 C-N-CA 121.632 1.555 . . . . 0.0 112.784 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.5 pt -149.49 96.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.435 0.636 . . . . 0.0 111.08 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -139.18 80.34 23.69 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.64 131.22 32.57 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 121.851 1.701 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.41 169.13 28.71 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.048 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.79 -18.4 47.43 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.504 2.136 . . . . 0.0 112.056 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -102.84 30.77 4.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.019 0.438 . . . . 0.0 110.537 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.42 -174.02 3.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.2 0.524 . . . . 0.0 110.502 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.21 135.87 34.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -73.19 134.0 44.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 72' ' ' LYS . . . 65.01 -154.93 49.37 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 71' ' ' GLY . 56.7 mtpt 54.15 109.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.197 . . . . 0.0 110.875 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -139.12 170.75 15.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.285 0.564 . . . . 0.0 110.824 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.04 68.66 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.7 mt 59.98 145.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.776 0.322 . . . . 0.0 110.39 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.43 136.28 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.11 0.481 . . . . 0.0 110.626 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -133.36 137.74 46.01 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.539 ' CZ ' ' NH2' ' A' ' 81' ' ' ARG . 9.2 t80 -143.21 -179.0 6.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.638 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.48 -69.06 1.17 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER 173.79 135.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.3 0.571 . . . . 0.0 109.98 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.539 ' NH2' ' CZ ' ' A' ' 78' ' ' TYR . 86.9 mtt-85 -111.4 133.49 53.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.232 0.539 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 mt -82.39 2.35 32.87 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.481 0.658 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -83.42 21.66 1.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.837 0.827 . . . . 0.0 110.656 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -48.91 -36.07 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.572 -0.705 . . . . 0.0 111.182 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -47.56 -30.8 3.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.564 0.221 . . . . 0.0 110.869 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.93 147.62 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.777 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 81.8 mtt85 -92.61 133.15 36.26 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.261 0.553 . . . . 0.0 110.569 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 66.6 m95 -151.53 175.62 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.17 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -63.64 -169.0 0.03 OUTLIER 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.726 0.641 . . . . 0.0 111.007 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.34 159.75 8.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.414 0.626 . . . . 0.0 111.106 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.55 156.95 40.01 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.592 0.711 . . . . 0.0 110.576 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.406 ' HB2' ' HE ' ' A' ' 5' ' ' ARG . 1.1 m -147.5 142.28 26.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.631 0.729 . . . . 0.0 110.002 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.32 114.67 13.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.833 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -102.96 105.96 48.14 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 118.079 -0.963 . . . . 0.0 111.163 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--N 1.308 -1.603 0 C-N-CA 121.063 1.176 . . . . 0.0 112.081 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.01 150.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -158.84 154.19 25.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -83.17 142.3 31.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -145.87 134.57 22.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 79.2 tt0 -134.48 161.03 36.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.11 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.11 133.69 38.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.525 0.678 . . . . 0.0 110.977 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 6' ' ' GLU . 86.2 mmt-85 -75.66 -39.37 57.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.834 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -113.53 -30.34 6.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.86 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.59 -170.22 43.71 Favored Glycine 0 C--O 1.216 -0.975 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -167.23 99.45 0.52 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 55.12 60.76 3.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.936 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -142.48 42.97 1.63 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.719 0.295 . . . . 0.0 110.683 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.15 137.91 53.62 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.405 0.622 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.4 p -101.65 166.62 10.6 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.766 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.583 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 33.0 p90 -51.89 -60.52 3.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -56.29 -36.36 68.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.918 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.81 -48.85 65.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.83 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.22 -30.64 7.36 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.025 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.5 mtpt -65.03 -26.37 68.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 -53.69 30.79 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.555 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.98 -33.7 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.994 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.595 ' C ' ' H ' ' A' ' 25' ' ' PHE . 56.1 m -102.88 176.11 5.26 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 64.7 -26.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.6 t80 -61.14 -47.83 84.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.854 0.359 . . . . 0.0 110.728 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.21 23.67 4.26 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.6 -5.15 84.48 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.56 -158.96 3.52 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -173.28 161.29 4.18 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.51 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.22 145.87 55.27 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.602 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . . . -64.03 81.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.433 0.635 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -62.45 152.24 34.95 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -57.93 -52.62 64.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.757 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -50.72 -49.69 57.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.587 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.17 -40.44 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.714 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.21 -40.65 96.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.3 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -63.89 -33.38 75.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.485 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.0 63.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -87.25 -32.32 19.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.262 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -52.47 -19.91 2.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.428 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -3.4 37.19 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.809 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.8 tt -101.84 13.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.625 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 18.84 70.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.84 145.23 20.31 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.239 0.519 . . . . 0.0 110.326 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -140.85 132.56 27.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.708 0.766 . . . . 0.0 110.352 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 47' ' ' CYS . 38.6 t -132.97 159.48 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.784 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.464 ' N ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -156.24 41.48 0.37 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.523 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' H ' HG12 ' A' ' 46' ' ' VAL . . . -145.17 144.01 30.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.23 0.538 . . . . 0.0 110.595 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.46 34.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.618 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 57' ' ' VAL . . . -133.32 -171.34 12.66 Favored Glycine 0 N--CA 1.48 1.598 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.05 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -99.12 150.04 22.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 110.054 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 42.2 ttm -134.44 161.19 35.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.117 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.8 136.93 1.84 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.2 mttp 56.77 38.03 29.21 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.598 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.84 15.47 2.29 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.836 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -75.12 50.94 0.5 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.69 0.281 . . . . 0.0 110.651 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 50' ' ' GLY . 2.2 p -54.81 132.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.086 0.946 . . . . 0.0 110.765 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.27 71.71 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -71.23 142.99 87.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 121.161 -0.215 . . . . 0.0 111.546 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 156.47 53.75 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.511 1.474 . . . . 0.0 112.501 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.6 mt -144.13 94.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.64 -72.92 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -71.82 155.37 92.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -61.76 145.56 97.22 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.381 2.054 . . . . 0.0 111.899 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.61 83.97 0.24 Allowed Glycine 0 N--CA 1.472 1.058 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.91 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.36 -42.14 56.02 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.237 1.958 . . . . 0.0 112.322 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -98.13 23.75 7.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.701 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 4.2 p -177.7 111.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.393 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 72.21 16.61 77.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 50.85 -88.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.438 0.637 . . . . 0.0 110.803 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -158.74 18.99 0.29 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.74 126.77 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 110.164 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -94.18 172.36 8.27 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.07 -170.9 54.2 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.82 123.35 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.97 0.414 . . . . 0.0 110.714 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.9 mm -95.97 74.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.615 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -75.84 109.59 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.332 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -75.04 -4.3 37.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 50.22 69.53 1.05 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 79' ' ' GLY . 75.8 mt 56.04 120.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.071 0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -104.64 152.76 22.08 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.108 0.48 . . . . 0.0 110.388 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 84' ' ' ARG . 48.5 tp -85.93 -11.03 54.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 110.491 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 85' ' ' SER . 51.4 p30 -73.48 23.61 0.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.856 0.836 . . . . 0.0 110.508 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.3 mtt180 -47.95 -13.61 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.587 -0.696 . . . . 0.0 111.114 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.24 -32.23 26.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.717 0.294 . . . . 0.0 110.669 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.61 149.06 44.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.609 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -85.79 158.25 20.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.431 0.634 . . . . 0.0 110.507 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -155.43 179.81 8.82 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.249 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 43.6 t0 -75.31 -177.08 3.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.645 0.736 . . . . 0.0 110.765 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.454 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.82 158.19 30.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -151.32 159.0 44.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.672 0.749 . . . . 0.0 110.504 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.5 m -125.59 148.09 49.07 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.083 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -138.45 126.8 23.06 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 56.9 m-80 -68.41 148.83 98.18 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.709 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo . . . . . 0 C--N 1.307 -1.623 0 C-N-CA 121.993 1.795 . . . . 0.0 111.466 179.207 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -83.14 155.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.802 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -146.99 148.67 31.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 110.794 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.74 136.8 34.62 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.754 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -102.63 158.78 16.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -141.1 113.79 8.28 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.448 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 173.75 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.61 86.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.074 0.464 . . . . 0.0 111.157 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.0 p -75.92 -7.18 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.445 0.641 . . . . 0.0 110.759 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 40.44 45.21 3.32 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 12' ' ' TYR . 53.3 tttp -152.8 46.56 0.71 Allowed 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 121.011 0.434 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.405 ' O ' ' O ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER 44.95 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -141.4 36.85 1.68 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.758 0.313 . . . . 0.0 110.486 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' TRP . 50.6 mt -123.88 137.94 54.56 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 16' ' ' TYR . 87.2 m -100.47 164.77 11.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.568 ' N ' HG22 ' A' ' 15' ' ' THR . 32.2 t80 -52.01 -58.5 6.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.51 84.83 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.957 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.06 -46.54 89.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.989 0.423 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.77 -29.68 60.02 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.796 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 23' ' ' CYS . 5.1 ttpm? -70.31 -31.32 68.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.975 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.19 70.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.482 . . . . 0.0 111.598 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 m -68.16 -33.84 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.462 0.648 . . . . 0.0 111.284 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 25' ' ' PHE . 12.3 t -103.85 176.89 5.0 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.012 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 62.59 -3.64 0.28 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.714 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 23' ' ' CYS . 82.5 t80 -58.88 -46.2 88.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.067 0.46 . . . . 0.0 110.485 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.0 pm0 -83.38 -16.94 44.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.53 -16.37 5.65 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.477 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -60.52 -162.5 0.13 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 99.5 m-70 -156.87 148.99 22.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.567 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 37.5 mt -51.29 137.04 23.74 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.471 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.14 103.63 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.201 0.524 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.2 t -80.61 169.82 17.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -54.94 -52.2 63.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.076 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -57.64 -42.46 83.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.541 ' H ' HG23 ' A' ' 32' ' ' THR . 7.1 tp-100 -69.48 -40.39 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.96 -44.91 94.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.235 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.76 -38.35 69.75 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.803 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.21 74.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.109 0.48 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -43.77 36.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.155 0.502 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.64 HH12 ' H ' ' A' ' 46' ' ' VAL . 18.3 mmm180 -55.48 -29.27 58.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -70.73 -10.2 58.93 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.432 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 42' ' ' ILE . 22.1 mm -104.98 13.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.36 11.1 78.76 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -59.12 104.22 0.23 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.023 0.412 . . . . 0.0 110.252 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -88.72 129.16 35.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.421 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.64 ' H ' HH12 ' A' ' 40' ' ' ARG . 39.2 t -136.65 157.36 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.953 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.427 ' N ' HG12 ' A' ' 46' ' ' VAL . 4.2 t -158.49 46.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.14 146.1 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 110.65 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.87 115.16 29.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.602 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.35 160.02 20.71 Favored Glycine 0 N--CA 1.475 1.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.889 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -78.14 107.47 10.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.324 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.0 mtp -98.04 177.06 5.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.211 0.529 . . . . 0.0 110.134 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.79 144.54 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.721 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.6 tttt 59.88 12.47 3.08 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.202 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.21 78.65 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.914 -0.491 . . . . 0.0 111.929 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 58.8 ttt180 -73.33 135.94 44.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.713 0.292 . . . . 0.0 110.53 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.97 154.51 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.252 0.549 . . . . 0.0 110.672 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.05 139.5 5.81 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.664 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 24.4 p90 -148.03 70.44 11.08 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-N 115.635 -0.282 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.4 141.55 95.9 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.23 1.953 . . . . 0.0 112.449 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -133.42 129.0 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.544 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.0 t -64.52 -43.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 21.8 ttpt -177.37 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 60.9 Cg_endo -65.38 145.28 82.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.505 1.47 . . . . 0.0 112.305 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -165.14 51.98 0.28 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 59.6 Cg_endo -67.4 -49.63 1.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.476 2.117 . . . . 0.0 112.032 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.435 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -87.95 -27.12 22.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.984 0.421 . . . . 0.0 110.812 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.435 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -139.17 144.05 38.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.266 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' PHE . . . 79.01 156.46 10.01 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.431 ' CG ' ' O ' ' A' ' 69' ' ' GLY . 97.0 m-85 -157.1 105.4 2.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.858 -0.171 . . . . 0.0 110.673 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.52 -42.1 1.94 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -69.7 142.05 53.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.6 p -144.54 168.91 19.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.847 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 61.6 153.16 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 74' ' ' GLY . 82.7 mt -31.55 125.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 120.724 0.297 . . . . 0.0 111.26 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.96 126.2 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.228 0.537 . . . . 0.0 110.601 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 56.1 t0 -94.82 107.02 19.03 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.77 -15.7 23.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.04 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.51 -91.07 1.64 Allowed Glycine 0 N--CA 1.466 0.676 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.7 mt -154.61 140.53 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.614 0.721 . . . . 0.0 110.046 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.614 ' HE ' HD21 ' A' ' 83' ' ' ASN . 18.5 mmm180 -102.85 117.74 35.28 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.765 0.793 . . . . 0.0 110.456 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.577 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -80.79 -6.76 58.95 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.845 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.614 HD21 ' HE ' ' A' ' 81' ' ' ARG . 51.2 p30 -75.61 22.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.659 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 82' ' ' LEU . 8.1 ptm180 -48.08 -12.02 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.662 -0.649 . . . . 0.0 111.266 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 83' ' ' ASN . 99.7 p -80.92 -7.78 59.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -98.82 -151.78 0.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.416 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.42 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 82.4 mtt85 -144.85 147.71 33.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.312 0.577 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' LEU . 82.3 m95 -153.88 178.96 9.34 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.427 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -59.81 -170.24 0.01 OUTLIER 'General case' 0 C--O 1.235 0.328 0 O-C-N 123.77 0.669 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.0 151.07 5.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.05 0.452 . . . . 0.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.97 158.61 37.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.558 0.694 . . . . 0.0 110.594 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 t -152.75 149.43 28.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.871 0.843 . . . . 0.0 110.49 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -141.06 149.96 42.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.598 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -151.43 149.72 25.06 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 N--CA 1.503 2.076 0 C-N-CA 122.388 2.059 . . . . 0.0 112.013 179.605 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 t -82.62 148.01 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.789 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -136.07 134.92 38.92 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.699 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.96 138.29 42.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.5 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -118.15 131.27 56.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.252 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -139.3 146.04 39.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.44 124.65 23.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.916 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.28 -33.87 67.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -110.03 32.57 5.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.3 -136.22 2.07 Favored Glycine 0 C--O 1.218 -0.882 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.641 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -171.75 -30.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 120.949 0.404 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -153.86 61.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.17 32.76 3.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.042 0.449 . . . . 0.0 110.578 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' TRP . 41.8 mt -115.64 111.62 20.9 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.681 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.432 ' OG1' ' OE1' ' A' ' 18' ' ' GLU . 54.2 p -100.03 174.33 6.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 11.5 p90 -51.02 -52.62 41.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.891 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -55.09 -49.28 72.08 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.128 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 21.0 mp0 -66.58 -33.13 74.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.65 83.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.975 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.9 mttt -71.48 -31.67 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.679 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.7 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.512 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -77.84 -24.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.931 0.395 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 25' ' ' PHE . 64.6 m -104.41 177.11 4.94 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 109.809 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' GLY . 78.9 tt0 67.53 -29.15 0.15 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.216 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.8 t80 -60.79 -48.49 81.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 110.734 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 3.4 pm0 -78.68 11.69 2.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.111 0.482 . . . . 0.0 110.916 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.18 -24.67 23.93 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -86.29 133.79 12.06 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -98.31 176.78 5.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.4 148.59 48.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.34 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.92 141.06 40.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -123.52 158.38 31.46 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.022 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -55.16 -28.78 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.439 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -68.66 -52.7 28.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.045 0.45 . . . . 0.0 110.85 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.5 -37.35 74.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.998 0.428 . . . . 0.0 110.606 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.6 mt -62.73 -39.77 95.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.92 -40.09 72.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.01 -23.96 48.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.7 -19.99 60.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.945 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.588 HH12 ' CB ' ' A' ' 60' ' ' PRO . 10.2 mmm180 -60.79 -41.86 96.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.663 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.36 -5.0 39.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 42' ' ' ILE . 46.6 mm -95.78 0.15 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.519 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.37 19.3 46.03 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.619 -0.593 . . . . 0.0 111.619 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -61.49 121.24 12.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.558 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -155.79 103.3 2.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.302 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.95 126.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.745 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.86 76.21 2.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.895 0.378 . . . . 0.0 110.417 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.03 94.04 2.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 106.27 0.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.351 0.596 . . . . 0.0 110.645 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.36 151.98 20.28 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.943 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -64.01 153.46 37.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.535 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.9 ptp -155.34 -173.8 4.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -34.57 125.1 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.542 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttp 57.35 31.86 20.84 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.529 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 55.43 21.42 27.14 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.713 -0.617 . . . . 0.0 111.708 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' O ' ' SD ' ' A' ' 52' ' ' MET . 29.9 ttp85 -73.31 59.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.115 0.458 . . . . 0.0 110.888 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.47 151.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.253 0.549 . . . . 0.0 111.312 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.59 169.69 41.81 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.534 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.6 p90 -158.16 76.88 3.56 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.45 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' CB ' HH12 ' A' ' 40' ' ' ARG . 50.3 Cg_exo -56.38 143.61 85.98 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.476 2.117 . . . . 0.0 112.541 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.6 mt -137.66 96.61 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.516 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 m -64.79 -28.54 45.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 110.292 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -150.93 146.72 19.58 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -41.68 151.73 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.895 1.73 . . . . 0.0 112.656 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.05 27.94 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.552 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.27 -38.96 3.23 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.992 1.795 . . . . 0.0 112.323 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.43 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.5 p30 -66.7 -21.63 66.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.643 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.43 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 9.7 p -162.62 133.71 4.97 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.436 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.75 177.72 1.34 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 40.1 p90 -58.5 -52.63 64.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.569 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . 43.22 74.09 0.21 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt 53.23 -175.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.936 0.398 . . . . 0.0 110.668 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.2 p -148.83 172.93 13.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 73.99 77.08 0.66 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 74' ' ' GLY . 76.8 mt 50.34 103.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.755 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.3 mm -104.84 123.63 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -136.38 142.97 43.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.679 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.6 9.66 8.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.924 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.71 -92.52 1.8 Allowed Glycine 0 C--O 1.224 -0.47 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.0 mt -156.95 124.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 110.005 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -102.76 126.84 50.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.974 0.416 . . . . 0.0 110.382 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -87.57 2.65 50.22 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.445 0.641 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.33 26.02 6.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.805 0.812 . . . . 0.0 110.708 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -43.9 -26.07 0.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.656 -0.652 . . . . 0.0 111.142 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -56.2 -14.32 2.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.768 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.08 166.37 23.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 82.1 mtt85 -96.72 127.8 43.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.711 0.767 . . . . 0.0 110.413 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 82.8 m95 -155.09 178.61 10.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.07 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 22.6 t70 -75.54 -170.49 1.27 Allowed 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.866 0.729 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.47 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -166.04 159.54 15.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 0.0 111.002 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.98 160.78 17.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 110.265 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.7 t -145.13 177.26 8.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.495 0.664 . . . . 0.0 110.212 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -146.59 130.43 17.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.149 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.62 157.55 41.16 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.336 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.501 1.927 0 C-N-CA 121.929 1.752 . . . . 0.0 112.238 178.743 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.28 141.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 110.749 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -148.94 154.97 40.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -79.03 133.98 36.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.504 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -120.29 124.54 45.87 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -113.24 135.44 53.82 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.459 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 145.45 55.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.403 0.62 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -81.43 -50.12 9.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.5 p -113.14 34.56 4.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.487 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.18 -146.1 4.59 Favored Glycine 0 C--O 1.217 -0.928 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.709 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -175.9 -54.59 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -134.35 12.97 3.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -94.15 38.11 1.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.093 0.473 . . . . 0.0 110.442 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.94 131.88 55.34 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.501 0.667 . . . . 0.0 110.584 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.1 p -95.29 168.22 10.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.691 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -60.34 -41.14 93.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.37 66.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.1 -49.4 77.8 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.778 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.81 -30.29 63.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.018 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.3 tttp -69.85 -38.18 76.38 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 120.792 0.33 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.09 75.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.56 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.39 -41.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.631 0.729 . . . . 0.0 110.983 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.0 m -100.35 177.79 4.94 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.968 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 64.31 -15.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' H ' ' C ' ' A' ' 23' ' ' CYS . 67.7 t80 -62.92 -50.18 71.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.985 0.421 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.52 26.29 0.69 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.755 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.07 3.92 90.6 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.9 -151.81 2.83 Favored Glycine 0 C--O 1.219 -0.824 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -168.93 147.07 3.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.424 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.11 149.72 27.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.386 0.612 . . . . 0.0 110.252 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 146.47 53.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -124.63 178.17 5.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -58.27 -52.27 66.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.638 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -49.02 -47.23 44.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.17 -43.86 73.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.293 0.568 . . . . 0.0 110.737 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.58 -42.32 99.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.666 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -60.33 -30.42 69.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.558 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.01 -27.22 54.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.19 56.33 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.819 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -55.37 -30.99 61.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.376 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.63 -3.26 55.93 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 42' ' ' ILE . 33.6 mm -105.81 6.2 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.519 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 17.99 52.98 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.19 126.57 26.72 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 110.546 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.18 128.79 40.74 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.361 0.6 . . . . 0.0 110.577 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 47' ' ' CYS . 84.1 t -139.58 160.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.776 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.505 ' N ' HG12 ' A' ' 46' ' ' VAL . 11.4 t -158.75 33.84 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.702 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' H ' HG12 ' A' ' 46' ' ' VAL . . . -145.29 128.78 17.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.136 0.493 . . . . 0.0 110.533 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.26 131.68 44.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.01 144.05 10.08 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.739 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.464 ' HE1' ' H ' ' A' ' 88' ' ' TRP . 9.4 m95 -65.68 158.11 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.585 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.8 mtm -151.22 -177.69 6.19 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.229 0.538 . . . . 0.0 110.195 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.38 128.54 3.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.576 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 56' ' ' ARG . 72.4 tttt 66.11 37.56 5.12 Favored 'General case' 0 C--O 1.201 -1.481 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.047 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.89 5.87 0.1 Allowed Glycine 0 CA--C 1.54 1.614 0 O-C-N 121.764 -0.585 . . . . 0.0 112.39 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 67.7 ttt-85 -66.38 89.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.257 0.551 . . . . 0.0 110.445 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.1 134.48 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.76 0.79 . . . . 0.0 110.337 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.28 26.28 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.577 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.1 p90 -162.52 81.44 1.71 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.343 -0.429 . . . . 0.0 110.677 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 133.36 57.6 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.22 1.947 . . . . 0.0 112.57 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -118.3 109.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.369 0.604 . . . . 0.0 110.689 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.2 m -84.63 -15.32 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.167 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.87 142.6 2.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.133 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.32 149.75 2.48 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 121.067 1.178 . . . . 0.0 112.709 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -122.17 157.51 16.88 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.526 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.28 -43.21 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.351 1.367 . . . . 0.0 112.178 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.419 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -75.6 -21.3 57.92 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.347 0.594 . . . . 0.0 111.082 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.419 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.7 OUTLIER -124.86 144.0 50.54 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.062 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.44 -172.77 4.93 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.471 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.05 169.42 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.111 0.481 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.49 -25.14 0.07 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.24 -177.92 5.24 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 110.419 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 p -138.52 156.67 47.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.775 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 66.54 164.28 1.72 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' GLY . 76.6 mt -34.25 139.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 115.641 -0.28 . . . . 0.0 111.269 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.43 17.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.648 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 56' ' ' ARG . 2.4 p30 -61.34 126.83 28.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.967 0.413 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -68.73 -43.35 76.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.529 0.681 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.9 -128.4 3.58 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.21 108.46 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 122.243 1.021 . . . . 0.0 110.019 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.71 ' H ' ' NE ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.766 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 84' ' ' ARG . 69.2 mt -90.26 -2.78 58.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.842 0.354 . . . . 0.0 110.593 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -77.64 28.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.732 0.777 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.598 ' HE ' ' NH2' ' A' ' 81' ' ' ARG . 99.4 mtt180 -51.12 -1.22 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.733 -0.605 . . . . 0.0 111.73 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 83' ' ' ASN . 9.2 m -96.9 2.26 51.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -87.02 -158.84 0.46 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.936 0.398 . . . . 0.0 110.564 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 33.4 ptt-85 -155.83 134.19 11.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.608 0.718 . . . . 0.0 110.802 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.2 m0 -147.46 -172.99 4.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.274 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 20.5 t0 -57.89 -148.28 0.0 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.967 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.52 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.77 130.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.641 0.734 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -122.9 157.96 31.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.471 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 93' ' ' TYR . 6.9 t -140.86 -173.8 3.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.746 0.784 . . . . 0.0 110.296 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.402 ' N ' ' SG ' ' A' ' 92' ' ' CYS . 63.7 t80 -155.93 121.55 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.279 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -152.33 147.53 19.72 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.042 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 N--CA 1.5 1.906 0 C-N-CA 122.415 2.077 . . . . 0.0 111.886 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.25 154.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.128 0.49 . . . . 0.0 110.639 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 4' ' ' HIS . 75.1 t80 -118.98 139.16 52.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.477 ' O ' ' CE2' ' A' ' 3' ' ' TYR . 43.8 p-80 -74.77 130.63 39.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -141.23 136.43 31.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.078 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.13 177.49 6.19 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 126.61 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -70.28 -39.47 74.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -112.67 28.55 8.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.95 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.67 -139.05 2.61 Favored Glycine 0 C--O 1.216 -1.028 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.555 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -175.69 -66.98 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.272 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.5 47.61 0.87 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -132.29 31.05 4.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 120.937 0.399 . . . . 0.0 110.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp -118.32 126.09 51.42 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.54 0.686 . . . . 0.0 110.662 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 16' ' ' TYR . 45.4 m -99.5 160.4 14.31 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' N ' HG22 ' A' ' 15' ' ' THR . 41.2 p90 -53.38 -42.71 67.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' A' ' 16' ' ' TYR . . . -55.39 -42.91 74.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.868 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.18 -49.76 47.12 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.662 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.57 -37.84 58.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.037 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.9 tttm -71.34 -32.42 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 110.817 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.33 -54.39 17.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.569 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.21 -36.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.21 0.529 . . . . 0.0 111.029 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 25' ' ' PHE . 2.0 t -103.31 176.23 5.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 65.29 -15.83 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.035 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.3 t80 -61.57 -48.14 82.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 14.4 pt-20 -81.63 20.87 0.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.26 86.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.64 -155.16 1.09 Allowed Glycine 0 C--O 1.219 -0.796 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -170.54 145.26 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.449 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 mt -52.98 141.03 23.26 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.118 0.485 . . . . 0.0 110.564 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.28 106.55 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.9 m -69.92 146.99 50.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 5.4 p90 -53.55 -51.65 62.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.981 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.578 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 64.8 tttp -60.82 -45.47 94.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 110.558 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -68.46 -27.21 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -28.26 66.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -51.45 -31.06 21.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.1 73.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.18 -41.64 49.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.767 0.318 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.564 ' NH2' ' N ' ' A' ' 62' ' ' VAL . 37.2 mmm-85 -56.66 -31.86 64.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.83 -10.67 59.73 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.644 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 42' ' ' ILE . 94.6 mt -101.75 4.95 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.558 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.7 14.14 47.92 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.37 128.31 35.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.905 0.383 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -149.39 104.72 3.4 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.456 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.83 129.49 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.912 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -93.78 96.21 9.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.516 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.46 95.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.7 131.74 44.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.29 159.44 27.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.88 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -70.82 104.56 2.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 66.8 mtm -96.75 -175.56 3.33 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.219 0.533 . . . . 0.0 110.236 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.06 158.92 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.524 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 56' ' ' ARG . 63.0 mttp 50.63 38.02 17.89 Favored 'General case' 0 C--O 1.2 -1.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.72 0.46 0.03 OUTLIER Glycine 0 CA--C 1.54 1.603 0 O-C-N 121.878 -0.514 . . . . 0.0 112.062 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.5 mtt180 -69.55 149.06 48.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.141 0.496 . . . . 0.0 110.475 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.63 141.63 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.441 1.115 . . . . 0.0 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.73 166.66 30.34 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.415 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -128.7 107.19 18.65 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.46 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.51 119.47 4.51 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.544 1.496 . . . . 0.0 112.486 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.516 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 4.4 pt -148.83 93.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.722 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.564 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 56.3 t -49.28 -21.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.282 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -142.92 146.28 36.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.12 154.51 0.79 Allowed 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.579 1.519 . . . . 0.0 112.622 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.25 154.5 26.0 Favored Glycine 0 CA--C 1.543 1.834 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.735 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.79 -41.47 1.07 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.079 1.852 . . . . 0.0 112.353 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.62 -40.68 92.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.64 145.05 25.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.665 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.23 176.92 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.619 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -70.79 139.74 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.471 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.4 135.41 1.88 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.615 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.09 -47.36 84.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.851 0.358 . . . . 0.0 110.177 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.484 ' O ' HD11 ' A' ' 76' ' ' ILE . 62.6 p -132.66 165.17 25.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.284 0.564 . . . . 0.0 110.904 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . -84.28 -155.49 22.21 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 77' ' ' ASP . 40.5 mt 68.88 -7.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' O ' ' A' ' 73' ' ' THR . 38.6 mt -63.55 67.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.623 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' ILE . 2.4 p30 -85.71 151.2 24.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.446 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -89.48 -139.38 0.13 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.628 0.727 . . . . 0.0 110.184 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.68 95.56 0.18 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.8 mt 45.27 96.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.62 0.248 . . . . 0.0 110.674 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.433 ' O ' ' NH1' ' A' ' 84' ' ' ARG . 78.9 mtp180 -94.78 141.29 28.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.033 0.444 . . . . 0.0 110.081 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -79.58 3.98 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.604 0.716 . . . . 0.0 110.6 -179.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.466 ' N ' HD12 ' A' ' 82' ' ' LEU . 31.9 t30 -80.19 15.22 1.61 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.801 0.81 . . . . 0.0 110.304 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH1' ' O ' ' A' ' 81' ' ' ARG . 88.8 mtm-85 -58.72 -5.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.593 -0.692 . . . . 0.0 110.868 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -73.27 -35.58 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.646 0.26 . . . . 0.0 110.916 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -81.18 158.3 24.96 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.277 0.561 . . . . 0.0 110.617 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -86.84 149.11 25.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.734 0.778 . . . . 0.0 110.619 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -154.41 177.43 11.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.0 -172.56 2.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.647 0.737 . . . . 0.0 110.755 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -167.04 166.67 15.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.338 0.589 . . . . 0.0 111.053 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.88 156.86 46.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.953 0.882 . . . . 0.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.0 t -124.41 -167.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -159.21 145.96 16.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.999 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 26' ' ' GLU . 12.1 m120 -149.75 143.88 17.18 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.287 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 C--N 1.308 -1.593 0 C-N-CA 121.901 1.734 . . . . 0.0 111.93 179.217 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 t -84.49 136.52 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.656 0.265 . . . . 0.0 110.798 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.509 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 22.2 p90 -146.94 159.39 43.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.811 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -74.9 148.82 39.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.381 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.509 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 25.5 mmt180 -123.55 157.34 33.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.228 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -157.93 120.68 3.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.191 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 166.57 12.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.907 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.51 -36.62 81.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -64.81 -32.92 74.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.367 0.604 . . . . 0.0 110.632 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.71 177.73 23.19 Favored Glycine 0 C--O 1.216 -0.994 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.661 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.07 -105.14 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.328 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -68.8 69.92 0.18 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.665 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -144.41 29.08 1.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.787 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' TRP . 23.5 mt -123.36 143.36 50.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.8 p -95.69 168.51 10.62 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.753 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.579 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 26.5 p90 -46.9 -56.15 6.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -53.07 -42.29 65.69 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.969 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.54 -26.73 68.02 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.947 0.404 . . . . 0.0 110.555 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.95 -36.97 67.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -71.05 -30.63 66.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.222 0.534 . . . . 0.0 110.555 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.01 -49.3 75.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.614 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.56 -28.9 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.352 0.596 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.598 ' C ' ' H ' ' A' ' 25' ' ' PHE . 82.2 m -105.28 179.16 4.35 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.029 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 15.3 mp0 64.6 -28.29 0.1 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.887 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' H ' ' C ' ' A' ' 23' ' ' CYS . 59.4 t80 -62.18 -45.26 94.18 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.803 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -95.71 9.18 41.26 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.97 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.42 -4.06 66.55 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.32 -175.16 44.75 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -154.33 162.41 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.831 -0.185 . . . . 0.0 110.705 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 30' ' ' LEU . 9.4 mp -71.09 147.23 48.68 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.087 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.71 151.31 38.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.075 0.464 . . . . 0.0 110.806 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 m -125.02 156.66 37.79 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.155 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -54.05 -21.31 8.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.397 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -76.01 -57.24 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.117 0.484 . . . . 0.0 110.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.73 -33.13 73.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.47 -42.46 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.59 -34.76 77.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.555 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.4 -33.9 73.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 110.957 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -23.62 28.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.695 ' HE ' ' HB2' ' A' ' 60' ' ' PRO . 3.8 tpt85 -60.85 -42.55 98.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.567 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -60.87 -2.45 0.57 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 40' ' ' ARG . 18.5 mm -101.23 17.19 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.33 19.99 79.79 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.37 105.03 0.3 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.156 0.478 . . . . 0.0 110.39 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -95.48 133.65 39.22 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.389 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 47' ' ' CYS . 18.3 t -137.39 159.37 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 68' ' ' CYS . 2.9 t -156.11 42.03 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.752 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.68 125.18 3.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 110.723 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.38 138.74 45.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.38 152.79 24.81 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.924 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -68.07 101.96 1.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.062 0.458 . . . . 0.0 109.954 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 58' ' ' GLY . 1.4 mtp -91.38 166.29 12.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.649 0.738 . . . . 0.0 109.852 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' MET . . . -39.48 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.59 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt 58.68 7.52 0.76 Allowed 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.373 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.89 87.17 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.814 -0.554 . . . . 0.0 112.106 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -76.29 131.93 39.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.005 0.403 . . . . 0.0 110.632 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.81 112.5 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.855 0.836 . . . . 0.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -166.53 177.85 41.22 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.541 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 61' ' ' ILE . 7.1 p90 -167.84 142.28 2.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.745 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.695 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 72.8 Cg_endo -72.35 147.17 46.58 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.001 1.801 . . . . 0.0 112.651 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.447 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 17.7 mt -139.68 93.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.842 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.61 -41.85 86.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.346 0.593 . . . . 0.0 110.542 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -136.95 101.42 9.46 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.73 130.04 14.91 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.815 1.677 . . . . 0.0 112.474 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.91 22.04 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.397 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.99 -51.75 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.335 2.023 . . . . 0.0 112.241 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -67.54 -37.24 82.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 1.5 p -152.24 123.05 7.45 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.361 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 178.69 -26.63 0.05 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 90.1 t80 52.9 -85.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 110.763 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -172.98 -172.99 39.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 54.08 -171.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 0.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.58 HG22 ' N ' ' A' ' 74' ' ' GLY . 35.6 m -144.86 167.24 23.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.207 0.527 . . . . 0.0 110.63 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.58 ' N ' HG22 ' A' ' 73' ' ' THR . . . 93.64 -151.7 20.45 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.1 mt -100.97 128.61 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.392 . . . . 0.0 110.39 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.7 mt -132.03 71.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.415 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.23 135.03 34.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.842 0.353 . . . . 0.0 110.579 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.39 110.67 22.67 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.059 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.92 95.95 0.01 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.5 mt 49.39 100.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.756 0.312 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.562 ' NH1' ' NE1' ' A' ' 88' ' ' TRP . 70.6 mtp180 -68.81 148.07 50.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 84' ' ' ARG . 10.9 mp -74.95 -28.78 60.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.885 0.85 . . . . 0.0 110.555 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 85' ' ' SER . 0.7 OUTLIER -73.18 32.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.028 0.918 . . . . 0.0 110.759 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' LEU . 66.0 mtp180 -48.65 -6.99 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.632 -0.667 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 83' ' ' ASN . 32.5 t -87.19 -8.2 57.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.987 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -91.39 147.57 22.94 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -83.31 152.36 25.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.266 0.555 . . . . 0.0 110.51 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.562 ' NE1' ' NH1' ' A' ' 81' ' ' ARG . 73.5 m95 -156.02 179.12 9.52 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.326 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 11.8 t70 -76.05 -161.54 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.826 0.822 . . . . 0.0 110.471 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.419 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.08 152.7 6.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.783 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.15 158.75 38.85 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.726 . . . . 0.0 110.408 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -133.11 -173.28 3.16 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.613 0.721 . . . . 0.0 110.138 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -155.29 113.4 3.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -117.41 85.81 20.95 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 N--CA 1.499 1.845 0 C-N-CA 122.48 2.12 . . . . 0.0 112.355 -179.885 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 t -84.89 145.87 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.63 0.252 . . . . 0.0 111.094 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -161.23 156.54 24.31 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.032 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.69 116.23 25.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.486 0.66 . . . . 0.0 110.752 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -103.85 121.5 43.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -103.85 130.7 51.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.545 0.528 . . . . 0.0 110.362 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.23 172.5 13.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -60.32 -34.7 74.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.967 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.548 ' O ' ' C ' ' A' ' 10' ' ' GLY . 73.9 m -82.14 -20.21 38.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.513 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 16.57 81.79 0.01 OUTLIER Glycine 0 N--CA 1.494 2.541 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.267 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -172.52 37.67 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 120.923 0.392 . . . . 0.0 110.398 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 52.25 62.01 2.91 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -132.08 31.83 4.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.698 0.285 . . . . 0.0 110.694 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -122.09 128.24 51.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -98.16 170.55 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.642 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 30.3 p90 -51.45 -60.14 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.584 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.39 -37.28 56.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.883 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -67.97 -49.61 60.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -34.92 58.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.645 0.26 . . . . 0.0 110.861 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 23' ' ' CYS . 71.0 mmtt -61.84 -41.88 98.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.551 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.55 -49.43 77.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.63 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -58.1 -37.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.498 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 25' ' ' PHE . 3.4 m -101.76 -179.27 3.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 94.4 mt-10 71.04 -18.79 0.26 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.5 t80 -60.39 -45.94 91.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.213 0.53 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -86.57 15.87 5.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.528 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 7.69 87.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -86.5 -158.55 31.77 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -162.96 156.51 19.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.735 -0.233 . . . . 0.0 110.409 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.6 mp -69.16 136.66 52.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.116 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.45 122.52 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 35' ' ' GLN . 9.0 t -103.83 178.72 4.48 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -52.49 -52.48 54.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -57.76 -44.94 86.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.568 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.405 ' H ' HG23 ' A' ' 32' ' ' THR . 69.2 tp60 -70.37 -37.7 74.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.88 -43.01 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.414 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -55.69 -47.43 76.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.82 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -32.23 71.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.077 0.465 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.24 -29.14 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.516 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.477 HH22 HG12 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -60.91 -40.52 93.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.502 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -60.49 -4.03 0.8 Allowed 'General case' 0 N--CA 1.458 -0.05 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 40' ' ' ARG . 16.8 mm -99.18 22.9 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.385 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.51 28.93 71.83 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -70.29 126.09 28.64 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.663 -0.316 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.465 ' CD2' ' CG2' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -149.98 103.69 3.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.175 0.512 . . . . 0.0 110.37 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -140.16 129.94 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 14.8 t -90.72 69.34 6.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.331 0.586 . . . . 0.0 110.279 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB1' ' OH ' ' A' ' 91' ' ' TYR . . . -148.63 95.26 2.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.653 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.97 153.2 36.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.75 171.76 36.94 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.889 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -85.37 105.0 15.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.528 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -93.27 176.52 6.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.145 0.497 . . . . 0.0 110.302 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -35.49 153.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 54.8 8.91 0.25 Allowed 'General case' 0 C--O 1.199 -1.562 0 CA-C-O 121.089 0.471 . . . . 0.0 110.12 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 53' ' ' ALA . . . 74.75 20.68 79.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.941 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.566 ' HE ' ' CG ' ' A' ' 77' ' ' ASP . 63.0 ttt180 -77.09 140.05 40.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.646 0.26 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.14 134.95 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.677 0.751 . . . . 0.0 110.972 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.36 113.95 0.7 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -109.27 156.27 39.64 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-O 120.415 0.15 . . . . 0.0 110.755 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.32 133.13 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.446 1.431 . . . . 0.0 112.044 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 73' ' ' THR . 3.4 mt -144.33 95.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.588 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.477 HG12 HH22 ' A' ' 40' ' ' ARG . 0.2 OUTLIER -47.11 -38.55 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.67 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -149.02 147.73 24.85 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.824 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -52.87 139.28 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.986 1.124 . . . . 0.0 112.456 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.46 177.9 22.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.862 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.63 -51.0 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.628 1.552 . . . . 0.0 112.153 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -66.92 -27.71 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.682 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.08 151.39 21.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.193 0.521 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 70' ' ' PHE . . . -164.37 -5.56 0.04 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.407 ' H ' ' H ' ' A' ' 69' ' ' GLY . 42.3 t80 -68.33 -1.88 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.3 0.571 . . . . 0.0 110.315 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.3 -165.82 26.34 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.576 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.15 79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.614 0.245 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER 176.81 173.79 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.459 0.647 . . . . 0.0 110.319 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -46.7 -95.39 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.5 mt -99.34 108.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.477 0.656 . . . . 0.0 110.208 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 pt -105.87 45.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.834 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 34.7 t0 -89.0 118.98 29.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.025 0.441 . . . . 0.0 110.721 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -67.15 -64.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.553 0.692 . . . . 0.0 110.33 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 130.04 95.12 0.73 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 111.844 -0.503 . . . . 0.0 111.844 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 79' ' ' GLY . 70.1 mt 56.76 129.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.762 0.792 . . . . 0.0 110.993 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -111.61 143.04 43.13 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.512 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.0 mm? -86.73 -8.5 57.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.377 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -108.55 23.79 14.0 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.49 0.716 . . . . 0.0 111.072 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 86' ' ' GLU . 80.4 mtm180 -44.37 -27.47 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.672 -0.643 . . . . 0.0 111.432 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -47.07 -17.09 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.004 0.19 . . . . 0.0 110.956 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -60.89 -176.64 0.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 179.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 68.5 mtp85 -125.19 136.63 53.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.026 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.2 m95 -153.01 -176.64 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.141 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -73.07 -167.58 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -153.23 146.97 25.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.141 0.496 . . . . 0.0 111.108 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.499 ' OH ' ' HB1' ' A' ' 48' ' ' ALA . 17.6 m-85 -140.61 160.74 39.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.775 0.798 . . . . 0.0 110.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.5 m -136.44 -165.8 1.78 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.108 0.956 . . . . 0.0 110.06 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -141.04 151.13 43.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.271 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.34 149.21 70.58 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.856 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 C--N 1.306 -1.693 0 C-N-CA 121.564 1.509 . . . . 0.0 111.644 179.771 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.38 132.75 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' OH ' ' CZ ' ' A' ' 5' ' ' ARG . 31.4 p90 -103.03 155.24 18.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -73.02 126.12 29.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.498 0.666 . . . . 0.0 110.548 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' CZ ' ' OH ' ' A' ' 3' ' ' TYR . 89.5 mtt-85 -101.91 167.29 10.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.384 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -163.56 120.42 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.24 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.89 169.53 17.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.33 -40.64 81.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.597 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 t -70.85 -24.36 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.402 0.62 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.62 -170.82 22.9 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 13' ' ' LYS . 26.1 pttm -108.37 -173.39 2.27 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 42.23 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' LYS . 64.9 mttm -133.28 28.86 4.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.66 0.384 . . . . 0.0 110.696 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 88' ' ' TRP . 33.1 mt -124.82 135.37 52.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.233 0.539 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 16' ' ' TYR . 85.6 m -89.84 161.1 16.15 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.589 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.518 ' N ' HG22 ' A' ' 15' ' ' THR . 32.6 t80 -49.89 -59.52 3.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.22 75.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.22 -49.15 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.584 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.37 32.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 16.2 tptp -58.62 -40.19 82.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.116 0.484 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -48.25 78.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.316 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.58 -22.09 17.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.426 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.505 ' C ' ' H ' ' A' ' 25' ' ' PHE . 53.3 m -103.94 179.48 4.26 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.567 0.698 . . . . 0.0 109.518 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 70.8 mt-10 70.6 -19.08 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.16 -46.29 91.13 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 110.837 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.2 5.46 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.9 51.42 2.64 Favored Glycine 0 N--CA 1.472 1.097 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.05 -152.87 5.73 Favored Glycine 0 N--CA 1.47 0.901 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.02 179.02 7.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.92 142.49 51.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.29 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.93 148.04 48.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.24 0.543 . . . . 0.0 110.811 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 34' ' ' LYS . 7.2 m -123.54 149.41 45.27 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CD1' ' NH2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -61.09 -20.89 63.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.215 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' H ' HG22 ' A' ' 32' ' ' THR . 37.0 ttmt -75.87 -57.12 4.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.095 0.474 . . . . 0.0 110.739 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -68.82 -31.86 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 111.015 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.5 -36.11 79.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.368 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -49.9 -29.41 8.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.002 0.429 . . . . 0.0 110.661 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.39 -25.57 33.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.413 0.625 . . . . 0.0 111.025 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.69 -42.53 17.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -56.04 -34.7 66.13 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.29 -23.57 56.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 mm -82.5 24.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.92 24.19 74.35 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.66 128.73 37.08 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.517 ' CE1' ' H ' ' A' ' 63' ' ' LYS . 58.4 t60 -135.74 110.25 8.54 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.445 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.21 112.3 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.738 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -93.72 73.75 4.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.09 118.99 8.7 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.228 0.537 . . . . 0.0 110.778 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.25 134.19 36.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.54 -143.7 4.21 Favored Glycine 0 N--CA 1.476 1.3 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -130.8 105.93 8.11 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 15.1 mmt -91.54 156.13 17.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.267 0.556 . . . . 0.0 109.647 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.03 169.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.53 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.64 38.53 30.28 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.84 6.36 0.32 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' NH2' ' CD1' ' A' ' 33' ' ' TYR . 25.3 mtp180 -84.31 162.99 19.88 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.424 0.631 . . . . 0.0 110.598 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 p -142.2 135.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.723 0.773 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.01 157.15 26.78 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 26.9 p90 -165.89 80.82 1.11 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.795 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.95 143.82 59.14 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.026 1.817 . . . . 0.0 112.677 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -132.02 91.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.414 0.626 . . . . 0.0 110.707 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.41 -20.23 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 60.0 mttp -140.94 86.33 11.72 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.95 136.8 52.65 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.02 1.813 . . . . 0.0 112.218 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.26 173.91 15.2 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.405 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.46 -47.15 3.26 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.06 1.84 . . . . 0.0 112.284 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 68' ' ' CYS . 39.2 p-10 -66.71 -36.62 82.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.704 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 23.0 p -153.55 119.39 5.33 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.049 0.452 . . . . 0.0 110.477 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 88.54 0.09 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -64.97 161.23 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.946 0.403 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.55 99.71 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -70.62 166.65 20.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.871 0.367 . . . . 0.0 110.563 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.4 p -139.64 159.83 41.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.17 -140.66 15.17 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.9 mt -89.24 119.17 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.925 0.393 . . . . 0.0 110.556 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.73 98.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.407 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 59.3 t0 -98.39 141.79 30.83 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 110.322 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 25.3 m-85 -129.99 147.51 51.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.669 0.747 . . . . 0.0 110.05 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.79 -78.73 0.46 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.8 mt -157.81 108.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -69.08 140.95 54.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.329 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.2 mt -85.49 -10.23 56.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.335 0.588 . . . . 0.0 110.777 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.62 ' C ' HD21 ' A' ' 83' ' ' ASN . 0.2 OUTLIER -83.27 22.6 0.98 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.474 0.654 . . . . 0.0 110.379 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -52.0 -5.84 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.644 -0.66 . . . . 0.0 111.361 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 83' ' ' ASN . 62.8 m -91.89 -5.13 53.81 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.838 0.351 . . . . 0.0 110.856 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.29 -152.8 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.399 0.619 . . . . 0.0 110.422 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 83.3 mtt85 -142.94 151.2 40.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.817 0.818 . . . . 0.0 110.564 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 86.2 m95 -154.9 177.37 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.267 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 36.2 t0 -60.45 -156.06 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.816 0.698 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.541 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.68 141.95 2.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.168 0.509 . . . . 0.0 110.947 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.408 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 16.3 m-85 -140.34 142.25 35.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.52 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.437 ' SG ' ' NE ' ' A' ' 5' ' ' ARG . 49.8 m -115.56 -167.33 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.827 0.822 . . . . 0.0 110.077 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -156.42 143.68 19.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.455 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.11 148.95 22.18 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo . . . . . 0 N--CA 1.505 2.165 0 C-N-CA 122.345 2.03 . . . . 0.0 112.985 179.488 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.06 148.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 110.815 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.62 162.51 35.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -73.51 132.63 43.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.656 HH21 ' N ' ' A' ' 91' ' ' TYR . 73.5 mtm180 -117.99 149.22 41.31 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.502 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -154.78 125.02 6.78 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.594 0.559 . . . . 0.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.08 179.11 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.461 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -61.07 -48.62 80.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.504 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -87.39 -2.8 58.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.205 0.526 . . . . 0.0 110.513 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.23 66.59 0.68 Allowed Glycine 0 N--CA 1.472 1.068 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -143.99 41.82 1.42 Allowed 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.747 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 45.78 28.98 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.678 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.48 39.87 0.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.283 0.563 . . . . 0.0 110.825 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' TRP . 6.1 tp -120.31 127.74 52.64 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.781 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.8 p -90.94 167.75 12.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.529 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -61.23 -48.01 83.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.337 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.92 71.47 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.05 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.7 -50.16 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.736 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.55 -31.6 24.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' CYS . 26.1 mtpp -64.6 -34.92 79.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.428 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.16 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.65 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.04 -40.87 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.323 0.582 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.586 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.2 t -100.53 175.69 5.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.907 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 63.22 -15.84 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.7 t80 -61.87 -49.1 77.61 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.92 22.52 0.38 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.765 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.91 89.58 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.31 -148.8 4.7 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -164.66 152.97 12.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.666 0.27 . . . . 0.0 110.631 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.15 145.18 54.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.051 0.453 . . . . 0.0 110.224 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -64.03 107.33 1.23 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.903 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 p -88.01 167.14 13.95 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.552 ' HB2' ' HE ' ' A' ' 56' ' ' ARG . 69.6 t80 -54.66 -53.61 52.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.983 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -55.75 -43.86 77.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.993 0.425 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.26 -32.23 68.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -40.58 95.29 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -51.56 -49.38 62.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.25 64.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.431 . . . . 0.0 110.649 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.78 -37.02 31.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.2 -27.83 62.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -78.2 -4.55 48.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.67 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 42' ' ' ILE . 76.9 mt -96.0 8.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.478 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.52 21.45 44.08 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -69.38 131.78 45.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 122.741 -0.27 . . . . 0.0 110.354 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -149.89 105.28 3.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.076 0.465 . . . . 0.0 110.469 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.19 118.02 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.83 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.4 t -91.88 84.05 5.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.191 0.52 . . . . 0.0 110.293 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.25 94.73 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.635 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.2 46.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.82 -172.42 13.92 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.931 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.7 156.74 17.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.527 0.679 . . . . 0.0 110.47 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 56' ' ' ARG . 67.4 mtm -148.09 175.02 11.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.99 147.74 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.299 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 56' ' ' ARG . 9.0 mtmp? 57.69 40.43 26.49 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.659 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.2 7.72 0.58 Allowed Glycine 0 CA--C 1.532 1.13 0 O-C-N 121.794 -0.566 . . . . 0.0 111.8 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.552 ' HE ' ' HB2' ' A' ' 33' ' ' TYR . 32.2 ttt85 -68.14 146.42 53.45 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.321 0.581 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.15 162.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.668 0.747 . . . . 0.0 110.807 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.02 169.25 39.57 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.492 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 76' ' ' ILE . 3.8 p90 -154.95 79.89 4.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.386 -0.407 . . . . 0.0 110.322 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.44 128.97 32.67 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.21 1.94 . . . . 0.0 112.682 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.38 103.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.61 -24.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.304 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -161.76 143.81 8.72 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.567 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -41.23 166.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.717 1.612 . . . . 0.0 112.85 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.9 166.8 39.75 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.68 -41.89 13.53 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.403 2.068 . . . . 0.0 112.212 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -66.11 -36.06 82.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.43 . . . . 0.0 110.327 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.9 p -156.53 146.41 21.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.491 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -159.85 44.02 0.44 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -73.66 142.74 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.55 -104.69 0.89 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -162.95 -63.49 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.888 0.375 . . . . 0.0 110.469 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -145.72 171.1 15.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.387 0.613 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -153.33 20.46 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.6 mt -99.57 -60.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.755 0.312 . . . . 0.0 110.827 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.482 ' O ' ' CZ ' ' A' ' 59' ' ' TYR . 52.3 mt 56.88 105.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.317 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.467 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 4.8 p30 -136.37 148.98 48.11 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.03 0.443 . . . . 0.0 110.946 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -72.82 -72.4 0.25 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.619 0.723 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.05 -135.17 5.14 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -88.69 107.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.399 0.619 . . . . 0.0 110.151 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -94.16 129.79 40.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.44 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.17 0.14 54.35 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.424 0.631 . . . . 0.0 110.85 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.452 HD22 ' C ' ' A' ' 83' ' ' ASN . 0.4 OUTLIER -87.73 23.6 1.95 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.328 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -45.1 -24.32 0.23 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.617 -0.677 . . . . 0.0 111.662 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 m -50.54 -23.03 2.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.751 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.24 -168.26 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 0.0 110.813 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.25 139.22 44.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.391 0.615 . . . . 0.0 110.946 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' LEU . 86.8 m95 -154.18 176.2 12.54 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.451 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.0 t70 -71.23 -169.65 0.41 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.361 0.601 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.9 161.05 10.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.158 0.504 . . . . 0.0 111.002 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.656 ' N ' HH21 ' A' ' 5' ' ' ARG . 96.7 m-85 -138.57 152.81 48.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.636 0.732 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.2 t -129.99 144.48 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -119.48 122.0 40.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.359 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.467 ' N ' ' ND2' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -109.13 169.83 6.04 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.063 -179.049 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.503 2.037 0 C-N-CA 121.942 1.761 . . . . 0.0 112.146 179.062 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -83.8 151.92 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -126.75 126.94 44.29 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.559 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -76.02 148.48 38.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.48 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -133.18 143.19 49.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.07 146.64 30.05 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.263 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.93 132.4 46.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.95 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -81.04 -49.13 11.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.1 m -112.41 -33.85 6.06 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.61 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.57 177.75 53.98 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -134.69 95.82 3.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.453 0.644 . . . . 0.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 53.13 70.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.72 40.54 1.85 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.774 0.321 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 88' ' ' TRP . 46.3 mt -117.61 122.49 43.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -100.68 166.1 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.17 0.51 . . . . 0.0 110.723 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -49.11 -58.86 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -42.48 59.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.021 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.9 -26.56 66.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.526 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.46 76.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.038 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' CYS . 51.4 mtmt -67.17 -24.29 65.86 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.567 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.12 -55.46 9.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.634 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 23' ' ' CYS . 8.5 p -67.77 -44.7 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 0.0 111.199 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' LYS . 3.7 m -114.31 162.09 17.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.308 0.575 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 23' ' ' CYS . 48.8 tt0 84.33 -46.11 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.813 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -62.73 -46.37 88.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.048 0.451 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.23 16.8 0.71 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.946 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.6 60.72 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -153.18 0.02 OUTLIER Glycine 0 C--O 1.218 -0.883 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -173.25 143.5 1.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.6 mt -78.18 136.23 37.78 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.158 0.286 . . . . 0.0 110.541 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.32 132.38 48.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.252 0.549 . . . . 0.0 111.082 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.38 167.1 14.85 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.121 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -50.49 -22.21 1.83 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.693 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -75.25 -57.96 3.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.172 0.51 . . . . 0.0 110.684 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.458 ' NE2' ' CG ' ' A' ' 93' ' ' TYR . 33.1 mt-30 -70.78 -34.87 72.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.7 mt -61.1 -39.76 91.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.441 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -57.78 -31.05 66.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.673 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 -24.33 48.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.338 0.589 . . . . 0.0 110.956 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.3 -45.31 33.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.45 HH21 HG12 ' A' ' 62' ' ' VAL . 20.2 mmm-85 -52.98 -31.55 41.41 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -69.46 -4.32 18.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.571 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.654 HG22 ' O ' ' A' ' 42' ' ' ILE . 74.3 mt -108.86 15.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.443 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.16 16.75 71.12 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.29 143.06 58.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.904 0.352 . . . . 0.0 110.343 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -155.35 107.91 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.356 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 46' ' ' VAL . 17.6 m -139.0 111.56 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.817 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.26 75.06 6.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.238 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.52 135.29 11.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.32 139.38 31.72 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.47 -174.26 21.41 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.804 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -94.12 143.27 26.52 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -145.3 173.41 12.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.142 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.78 142.86 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.685 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 62.17 14.95 7.05 Favored 'General case' 0 C--O 1.201 -1.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.48 16.98 68.15 Favored Glycine 0 CA--C 1.527 0.822 0 O-C-N 121.831 -0.543 . . . . 0.0 111.964 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.745 HH22 ' H ' ' A' ' 78' ' ' TYR . 51.6 ttt-85 -70.84 161.41 31.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.977 0.418 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.18 148.57 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 122.269 1.033 . . . . 0.0 110.458 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.77 168.28 40.57 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.405 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -154.64 76.79 5.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.334 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.77 133.1 49.02 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.474 2.116 . . . . 0.0 112.692 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -147.19 145.11 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.124 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.45 HG12 HH21 ' A' ' 40' ' ' ARG . 29.4 m -82.12 -30.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -152.68 152.15 28.11 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.427 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.3 151.32 2.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.026 1.818 . . . . 0.0 112.324 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.96 166.88 27.38 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.793 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.17 -48.44 19.45 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.833 1.689 . . . . 0.0 112.737 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -64.94 -27.34 68.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.5 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.43 144.93 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.94 -12.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -55.64 -36.42 66.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.408 . . . . 0.0 110.775 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.88 -166.39 6.64 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -73.43 -162.18 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.534 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 166.69 22.19 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.268 0.556 . . . . 0.0 110.819 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 67.76 67.03 2.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' O ' ' A' ' 74' ' ' GLY . 4.5 mt 53.23 125.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.572 -0.314 . . . . 0.0 111.071 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -119.91 91.03 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.569 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -66.89 143.39 56.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.924 0.392 . . . . 0.0 110.583 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.745 ' H ' HH22 ' A' ' 56' ' ' ARG . 59.2 m-85 -132.66 -96.59 0.31 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.523 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.42 -155.38 17.61 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.394 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.85 123.27 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.723 0.773 . . . . 0.0 110.079 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.48 141.92 34.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.186 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -82.65 -2.57 54.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 85' ' ' SER . 47.4 p-10 -77.83 25.69 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.84 0.828 . . . . 0.0 110.649 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 82' ' ' LEU . 33.4 mtp-105 -49.4 -4.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.599 -0.688 . . . . 0.0 111.783 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 83' ' ' ASN . 72.2 p -83.1 -32.12 26.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -76.91 -163.65 0.37 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 110.692 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.432 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 60.9 mtt85 -139.27 154.24 47.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.52 0.676 . . . . 0.0 110.62 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' LEU . 81.1 m95 -154.13 174.99 13.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 23.9 t0 -61.06 -175.99 0.05 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.727 0.775 . . . . 0.0 110.972 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -157.23 150.85 24.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 111.069 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -118.94 159.58 23.55 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.525 0.679 . . . . 0.0 110.641 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -134.8 175.18 9.79 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.774 0.797 . . . . 0.0 110.216 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CG ' ' NE2' ' A' ' 35' ' ' GLN . 4.6 t80 -159.9 134.48 7.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.825 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -145.35 148.59 38.11 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.101 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 C-N-CA 122.432 2.088 . . . . 0.0 111.753 179.234 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.467 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.6 m -154.19 137.73 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.779 0.324 . . . . 0.0 110.698 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -123.12 123.68 41.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.401 ' O ' ' ND1' ' A' ' 4' ' ' HIS . 5.1 p80 -86.86 149.32 24.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.527 HH22 HD21 ' A' ' 94' ' ' ASN . 75.4 mtt85 -143.77 147.62 34.43 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.228 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -146.43 158.33 43.88 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.26 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.41 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.06 -35.82 72.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.453 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 p -111.01 19.89 18.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.628 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.01 -137.6 2.92 Favored Glycine 0 C--O 1.216 -1.03 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.657 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -171.93 -42.67 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.301 -0.449 . . . . 0.0 110.468 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -143.3 67.34 1.3 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -137.02 37.59 2.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.254 0.221 . . . . 0.0 110.533 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -120.98 123.92 43.62 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.451 0.643 . . . . 0.0 110.384 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 16' ' ' TYR . 52.4 m -100.37 163.19 12.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.581 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.516 ' N ' HG22 ' A' ' 15' ' ' THR . 13.5 t80 -51.45 -52.33 47.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.8 -42.03 83.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.88 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.64 -51.5 59.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.775 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.82 -30.71 15.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.014 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -70.51 -33.22 70.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.46 21.5 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.849 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.29 -26.61 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.084 0.469 . . . . 0.0 110.365 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' C ' ' H ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -104.75 177.28 4.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.593 0.711 . . . . 0.0 109.385 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 28' ' ' GLY . 96.5 mt-10 67.67 -10.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.705 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.8 t80 -62.57 -47.75 82.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 0.0 110.789 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.9 pm0 -92.16 9.45 33.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.772 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.77 -17.16 56.84 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -82.69 127.28 7.89 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -100.1 173.17 6.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.639 0.257 . . . . 0.0 110.538 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.457 ' H ' HD12 ' A' ' 30' ' ' LEU . 2.0 mp -65.39 135.8 55.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.23 0.77 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.056 0.455 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.566 ' CG2' ' NE2' ' A' ' 35' ' ' GLN . 1.5 t -72.43 179.85 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.778 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.471 ' N ' ' OG1' ' A' ' 32' ' ' THR . 64.4 t80 -56.0 -54.58 43.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.936 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -53.4 -50.47 65.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.845 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.566 ' NE2' ' CG2' ' A' ' 32' ' ' THR . 1.4 mp0 -66.18 -38.91 89.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.372 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 mt -61.67 -42.52 99.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.474 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.62 -50.46 73.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.717 0.294 . . . . 0.0 110.789 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.81 -33.13 55.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -84.33 -39.67 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.109 0.48 . . . . 0.0 111.226 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -30.16 21.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.286 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.16 -2.78 11.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.523 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.6 tp -92.45 9.46 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.112 0.258 . . . . 0.0 110.475 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.6 26.65 34.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -75.96 136.32 40.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.019 0.409 . . . . 0.0 110.449 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -154.02 103.04 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.55 129.05 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.757 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 t -93.96 83.46 4.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.494 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.54 95.79 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 134.91 54.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 0.0 110.779 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -140.85 170.64 24.43 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -81.51 156.75 25.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 4.8 mpp? -151.44 176.87 10.86 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 110.292 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.79 142.85 0.41 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.53 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 59.63 41.21 19.09 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.341 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.13 12.82 0.86 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.737 -0.602 . . . . 0.0 111.689 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' MET . 57.8 ttt180 -68.06 143.23 55.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 110.502 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.28 142.08 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.994 0.902 . . . . 0.0 110.928 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.01 -178.52 39.98 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.684 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 28.8 p90 -148.18 103.12 3.56 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.083 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.15 129.72 8.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.87 1.047 . . . . 0.0 112.308 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 pt -146.79 136.3 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.456 0.646 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.1 t -83.45 -26.49 7.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -156.03 150.5 20.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -42.24 130.64 4.75 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.508 1.472 . . . . 0.0 112.723 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.26 167.79 15.16 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.094 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.01 -34.54 16.85 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.937 1.758 . . . . 0.0 112.145 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -88.28 -10.16 50.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.435 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.2 p -170.54 141.35 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.612 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.18 9.36 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 54.5 p90 -62.63 -45.47 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 110.663 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . -60.58 -103.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -164.97 -151.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.78 0.324 . . . . 0.0 110.255 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.7 p -95.17 170.03 9.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.571 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.22 145.83 0.09 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.645 ' H ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -46.48 130.32 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -119.23 54.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 44.5 t0 -63.79 140.67 58.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 110.485 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.463 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 49.4 m-85 -92.31 4.51 53.19 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 58.66 84.48 0.04 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 79' ' ' GLY . 68.5 mt 50.32 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.079 0.466 . . . . 0.0 111.038 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -88.54 157.93 18.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.551 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -84.68 -6.67 59.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.216 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 85' ' ' SER . 49.8 p-10 -74.68 21.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.618 0.723 . . . . 0.0 110.606 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 82' ' ' LEU . 96.1 mtt180 -49.42 -10.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.6 -0.688 . . . . 0.0 111.052 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.42 -36.22 24.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.624 0.249 . . . . 0.0 110.591 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -75.24 152.58 38.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.291 0.567 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -86.97 153.81 21.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.786 0.803 . . . . 0.0 110.566 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -153.86 174.92 13.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.125 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.58 -161.96 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.536 0.684 . . . . 0.0 110.996 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.06 141.98 12.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.284 0.564 . . . . 0.0 111.039 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -114.79 150.53 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.899 0.856 . . . . 0.0 110.261 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' CYS . . . . . 0.444 ' HB2' HH11 ' A' ' 5' ' ' ARG . 1.5 m -142.26 -173.34 3.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.354 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 3.6 t80 -160.28 118.23 2.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.062 0.458 . . . . 0.0 109.993 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.527 HD21 HH22 ' A' ' 5' ' ' ARG . 3.0 m120 -103.61 150.69 38.36 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.992 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 N--CA 1.501 1.938 0 C-N-CA 121.285 1.323 . . . . 0.0 112.285 178.537 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.32 149.25 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.718 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -111.25 130.43 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -74.51 129.3 37.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.547 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.42 148.2 34.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.132 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.45 171.99 18.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.321 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.36 160.71 16.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.06 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.43 -27.73 46.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.301 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.6 p -72.6 -31.77 65.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.267 0.556 . . . . 0.0 110.966 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.09 160.19 12.21 Favored Glycine 0 C--O 1.216 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.633 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -68.06 -48.37 65.78 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.806 0.336 . . . . 0.0 110.673 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -98.52 49.35 0.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -136.44 24.23 3.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.944 0.402 . . . . 0.0 110.456 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 tp -120.68 129.96 53.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.807 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -85.14 161.33 19.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.66 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 50.0 p90 -60.16 -46.5 89.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.773 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -57.01 -40.71 77.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -66.08 -52.6 47.37 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.807 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.48 -31.62 56.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.231 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -68.15 -43.02 79.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 110.932 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.35 76.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.356 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 -26.27 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.396 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -105.35 174.79 5.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.401 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 39.2 mt-10 77.02 5.04 3.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.592 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -73.19 -37.74 66.37 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.157 0.503 . . . . 0.0 111.1 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -91.92 12.75 20.65 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.561 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 8.21 80.4 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.519 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -93.84 -157.25 33.0 Favored Glycine 0 C--O 1.218 -0.851 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -162.58 157.27 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.62 0.247 . . . . 0.0 110.721 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.69 147.76 3.41 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.498 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.65 91.9 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.029 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 35' ' ' GLN . 11.9 t -74.48 179.16 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.961 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -58.36 -53.41 58.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -56.17 -47.57 78.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' ' CG ' ' A' ' 93' ' ' TYR . 54.3 tt0 -69.38 -37.56 77.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.957 0.408 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.49 -42.56 99.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.411 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -41.74 99.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 110.653 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.12 -36.98 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.797 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.52 -24.44 34.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.46 -30.64 65.21 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -79.17 -6.6 56.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 42' ' ' ILE . 79.1 mt -94.04 1.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.41 9.52 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.31 135.29 47.32 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.662 0.268 . . . . 0.0 110.502 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.44 ' CE1' ' H ' ' A' ' 62' ' ' VAL . 79.0 t60 -155.87 102.67 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.88 117.89 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.927 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.86 94.88 9.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.75 115.15 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.559 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.05 142.2 52.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.457 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -157.28 170.81 34.51 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.803 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.417 ' C ' ' SD ' ' A' ' 52' ' ' MET . 79.5 m95 -83.71 157.82 22.03 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.307 0.575 . . . . 0.0 110.185 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -152.8 177.45 10.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.281 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.0 145.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.372 0.606 . . . . 0.0 111.194 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 56' ' ' ARG . 68.7 mttm 56.6 42.74 26.71 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.167 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.29 10.98 0.38 Allowed Glycine 0 C--N 1.314 -0.672 0 O-C-N 121.746 -0.596 . . . . 0.0 112.085 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.623 HH22 ' CB ' ' A' ' 77' ' ' ASP . 64.2 ttt-85 -65.05 143.56 57.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.333 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.8 148.44 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.447 1.118 . . . . 0.0 110.781 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.1 -172.98 39.82 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.313 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 40.7 p90 -155.36 102.72 2.22 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.8 132.16 11.72 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.759 1.639 . . . . 0.0 112.4 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt -145.92 147.33 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.826 . . . . 0.0 110.909 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.44 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 14.8 t -116.06 -12.34 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.3 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -144.21 157.22 57.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.063 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -37.84 147.08 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.258 1.972 . . . . 0.0 112.548 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.64 79.82 0.35 Allowed Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.412 -0.66 . . . . 0.0 111.545 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.76 -48.12 23.73 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.439 2.093 . . . . 0.0 112.325 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -81.84 30.19 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.131 0.491 . . . . 0.0 110.472 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 70' ' ' PHE . 7.1 p -178.45 -165.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.56 86.23 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 68' ' ' CYS . 51.6 p90 -83.29 23.64 0.88 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.134 0.492 . . . . 0.0 110.494 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -131.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -79.14 -143.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 0.0 110.36 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 p -128.35 171.71 11.77 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.582 0.706 . . . . 0.0 110.39 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.6 155.25 0.76 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.1 mt -41.53 145.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.617 0.245 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mt -141.7 51.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.623 ' CB ' HH22 ' A' ' 56' ' ' ARG . 7.1 p-10 -60.62 151.77 28.08 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.643 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.73 -80.35 0.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.23 71.01 0.02 OUTLIER Glycine 0 N--CA 1.474 1.196 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.124 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.6 mt 53.99 91.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.333 0.587 . . . . 0.0 110.905 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 -87.8 155.93 19.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.506 0.669 . . . . 0.0 110.664 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 84' ' ' ARG . 53.5 mt -84.17 3.06 36.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.294 0.568 . . . . 0.0 110.281 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -72.99 18.57 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.214 1.006 . . . . 0.0 110.476 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' LEU . 93.7 mtt-85 -49.74 -11.69 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.591 -0.693 . . . . 0.0 111.199 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' ASN . 64.7 m -87.09 -42.32 13.14 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -66.48 155.59 37.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.159 0.505 . . . . 0.0 110.403 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -90.72 148.96 22.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.215 0.531 . . . . 0.0 110.483 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -154.13 175.59 13.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.249 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 8.4 t70 -79.57 -169.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.713 . . . . 0.0 110.713 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.447 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.33 168.92 9.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.359 0.6 . . . . 0.0 110.928 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -135.68 141.57 44.98 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.536 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.57 143.53 45.49 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.737 0.78 . . . . 0.0 109.763 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CG ' ' NE2' ' A' ' 35' ' ' GLN . 74.4 t80 -115.63 150.63 36.39 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -139.36 153.02 70.5 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.502 2.02 0 C-N-CA 122.826 2.35 . . . . 0.0 112.253 179.426 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' TYR . 40.6 t -81.98 161.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.617 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.479 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.1 p90 -154.81 154.23 32.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -96.99 149.03 22.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.646 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.505 HH12 HG21 ' A' ' 22' ' ' VAL . 14.6 ptp180 -136.66 149.02 47.73 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.427 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -144.61 159.18 43.23 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.86 140.43 36.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -83.31 -43.27 16.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 t -96.43 25.96 4.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.76 -126.92 0.95 Allowed Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.697 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -150.24 -90.13 0.07 Allowed 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 120.997 0.427 . . . . 0.0 110.334 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.75 80.64 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.16 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -130.31 32.57 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -116.63 121.1 40.72 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.249 0.547 . . . . 0.0 110.657 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 p -100.28 169.11 9.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.384 0.611 . . . . 0.0 110.502 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -56.79 -49.86 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.415 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.91 73.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.91 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -67.32 -49.98 61.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.422 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -33.54 52.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 7.0 tptm -71.48 -33.22 69.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.399 0.619 . . . . 0.0 110.748 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.43 27.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.805 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG21 HH12 ' A' ' 5' ' ' ARG . 7.2 p -60.11 -36.63 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.485 ' C ' ' H ' ' A' ' 25' ' ' PHE . 1.3 m -103.34 178.06 4.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.4 -14.48 0.33 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.656 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 23' ' ' CYS . 92.5 t80 -61.42 -47.99 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.685 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -89.64 20.35 4.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.91 79.75 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -72.01 -168.77 10.87 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 79.9 m80 -155.49 144.58 20.78 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.605 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.6 mm? -67.01 135.91 54.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -60.72 140.85 57.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.248 0.547 . . . . 0.0 110.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 p -122.1 178.29 4.98 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.924 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.21 -53.34 59.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.684 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -54.13 -49.28 69.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 110.472 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -66.88 -38.44 86.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.942 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.22 -43.77 98.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.364 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -55.26 -49.36 72.26 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.26 -29.63 10.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.836 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -37.13 36.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.511 ' NH2' ' C ' ' A' ' 61' ' ' ILE . 46.7 mmm-85 -55.82 -32.36 63.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.326 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -71.07 -4.22 23.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.739 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 42' ' ' ILE . 84.1 mt -108.41 9.18 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.392 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.61 17.91 53.39 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -72.44 123.23 22.66 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.81 0.338 . . . . 0.0 110.173 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -139.86 113.05 8.27 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.526 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -140.32 114.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.735 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -92.89 87.26 5.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.935 0.397 . . . . 0.0 110.242 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.85 138.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.604 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.02 132.53 39.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.637 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.48 148.99 21.08 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.903 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.69 152.24 39.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 75.6 mtm -153.08 -179.13 7.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.156 0.503 . . . . 0.0 110.319 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.8 143.61 0.34 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp 55.25 39.41 31.34 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.327 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.04 10.37 1.75 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.641 HH22 ' CG ' ' A' ' 77' ' ' ASP . 47.6 ttt-85 -65.98 142.23 57.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.424 0.63 . . . . 0.0 110.172 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -143.98 144.81 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.797 0.808 . . . . 0.0 110.818 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.82 167.59 40.64 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.523 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 25.2 p90 -133.3 78.47 63.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.512 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.16 139.61 71.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.095 1.864 . . . . 0.0 112.76 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' ' NH2' ' A' ' 40' ' ' ARG . 20.0 pt -150.83 134.39 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.858 0.837 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.429 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 61.2 t -62.8 -45.87 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.38 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 19.7 mtmt -158.41 -62.3 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 55.8 Cg_endo -63.49 143.17 87.4 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.866 1.711 . . . . 0.0 112.494 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.88 54.47 0.1 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.15 -49.59 0.49 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.645 2.23 . . . . 0.0 111.956 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -66.46 -39.09 88.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.81 132.68 36.77 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.246 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.14 50.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -159.88 103.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.435 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.31 -140.61 35.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 tttm 55.77 169.77 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.845 0.355 . . . . 0.0 110.469 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -136.31 157.25 47.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.52 151.3 6.37 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -40.3 144.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.689 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.16 45.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.535 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.641 ' CG ' HH22 ' A' ' 56' ' ' ARG . 1.9 p30 -68.71 145.77 53.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 110.472 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -90.24 -3.77 57.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.313 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 66.13 94.14 0.03 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 79' ' ' GLY . 63.5 mt 50.77 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -97.26 152.3 19.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.332 0.587 . . . . 0.0 110.173 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -85.45 -2.83 58.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.384 0.611 . . . . 0.0 110.277 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 85' ' ' SER . 97.7 m-20 -77.83 22.12 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.985 0.898 . . . . 0.0 110.561 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.2 mtt180 -51.68 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.125 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 83' ' ' ASN . 32.7 t -95.85 -25.62 15.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.638 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.04 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.458 0.646 . . . . 0.0 110.512 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 25.7 mtp180 -94.56 136.01 35.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 81.1 m95 -154.39 175.91 12.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -71.93 -164.44 0.13 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.511 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -162.41 149.74 13.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.465 0.65 . . . . 0.0 110.933 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -121.14 161.03 22.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.612 0.72 . . . . 0.0 110.451 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.91 -170.36 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.556 0.693 . . . . 0.0 110.182 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -161.23 151.48 17.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.368 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.457 ' O ' ' ND1' ' A' ' 96' ' ' HIS . 6.9 m120 -145.11 146.33 30.33 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.288 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.63 7.6 2.64 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.118 1.879 . . . . 0.0 112.084 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 94' ' ' ASN . 6.5 p-80 -53.96 -41.93 68.35 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.582 0.706 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' A' ' 96' ' ' HIS . . . -150.92 147.42 27.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.933 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 C--N 1.29 -1.982 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.97 177.01 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 144.01 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.276 0.56 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.89 161.3 26.88 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.72 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.61 140.19 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.75 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.52 HH21 ' ND2' ' A' ' 94' ' ' ASN . 38.3 mmt180 -103.59 161.9 13.5 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.454 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -142.37 134.2 27.03 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.379 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.69 166.74 15.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.716 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -68.38 -38.03 80.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.193 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -72.35 -18.3 61.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.34 0.591 . . . . 0.0 110.597 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 -154.7 16.78 Favored Glycine 0 N--CA 1.478 1.444 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 13' ' ' LYS . 68.8 mttm -115.33 -177.47 3.15 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.416 0.627 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 47.62 16.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.759 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' N ' ' C ' ' A' ' 11' ' ' LYS . 51.2 mtmt -128.52 26.35 5.65 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.777 0.322 . . . . 0.0 110.72 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 88' ' ' TRP . 48.4 mt -123.38 132.14 53.87 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.9 p -97.48 168.51 10.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.508 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 47.8 p90 -51.26 -54.21 28.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.973 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.78 -41.38 64.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.24 -51.45 37.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.755 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.27 13.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.07 -34.93 77.36 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.354 0.597 . . . . 0.0 110.663 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -53.03 59.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.886 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.4 -25.87 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.442 . . . . 0.0 110.506 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 25' ' ' PHE . 30.7 m -103.83 179.87 4.15 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.693 0.759 . . . . 0.0 109.247 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 67.17 -3.31 1.01 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.962 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 23' ' ' CYS . 89.7 t80 -61.82 -45.39 94.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.981 0.419 . . . . 0.0 110.869 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.4 pm0 -94.68 5.87 50.58 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.005 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.7 -22.52 39.36 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.5 143.1 38.25 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -98.72 153.38 18.77 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.742 0.305 . . . . 0.0 110.238 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.5 mp -56.52 143.02 36.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.395 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -52.05 139.19 23.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.117 0.484 . . . . 0.0 110.735 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 33' ' ' TYR . 43.0 m -121.93 171.64 8.78 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.838 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.614 ' N ' HG22 ' A' ' 32' ' ' THR . 11.3 t80 -53.76 -53.42 52.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -58.76 -48.01 82.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.64 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -67.49 -36.62 81.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.243 0.544 . . . . 0.0 110.795 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 17.9 mt -62.12 -42.86 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.162 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.09 -31.15 40.38 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.04 79.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.815 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.31 -25.34 42.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 7.5 mmm180 -58.8 -35.98 73.73 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -72.66 -10.59 59.98 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.13 4.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.451 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 33.21 16.69 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -66.04 129.23 39.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.83 0.348 . . . . 0.0 110.508 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -147.9 102.42 3.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.39 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.61 107.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.891 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -90.08 92.62 9.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.153 0.502 . . . . 0.0 110.106 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.71 109.84 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.08 138.92 56.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.92 163.84 34.44 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.25 160.42 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.277 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 77.3 mtm -156.12 -179.14 7.86 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.299 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.53 145.31 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.254 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 56' ' ' ARG . 55.5 tttm 56.95 42.51 26.16 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.99 10.94 0.5 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.79 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 54' ' ' LYS . 10.4 tpt180 -64.97 140.23 58.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.259 0.552 . . . . 0.0 110.47 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.11 161.98 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.106 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.4 177.44 37.77 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.854 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -145.37 81.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.329 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.41 135.5 60.91 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.185 1.923 . . . . 0.0 112.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -151.26 134.37 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.495 0.664 . . . . 0.0 110.833 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.21 -44.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.176 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -167.5 -61.46 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.064 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.61 156.5 65.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.771 1.648 . . . . 0.0 112.051 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' CA ' ' SG ' ' A' ' 68' ' ' CYS . . . -172.44 65.5 0.13 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.902 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.88 -44.97 35.69 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.268 1.979 . . . . 0.0 112.403 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.47 -24.76 45.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.719 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.421 ' SG ' ' CA ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -95.72 166.85 11.62 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.448 0.642 . . . . 0.0 110.031 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' GLY . . . -61.8 150.39 45.61 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.384 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 71' ' ' GLY . 45.3 p90 -76.29 29.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 110.581 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' GLY . . . -50.71 -105.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -141.9 -165.2 1.95 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.149 0.499 . . . . 0.0 110.322 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 p -94.67 160.84 14.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.467 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.55 168.69 0.44 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 54.0 mt -52.53 145.72 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.701 0.286 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.8 pt -149.85 -39.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -87.17 120.71 28.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.967 0.413 . . . . 0.0 110.613 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -145.05 -171.13 3.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.892 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.72 -179.69 48.99 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.3 mt -103.06 116.4 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -74.4 152.86 39.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.96 0.409 . . . . 0.0 110.051 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 84' ' ' ARG . 39.9 tp -84.45 -8.04 59.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.609 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 85' ' ' SER . 45.6 p-10 -74.66 23.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 110.64 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 82' ' ' LEU . 77.9 mtp180 -51.48 -5.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.594 -0.691 . . . . 0.0 111.448 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 83' ' ' ASN . 95.0 p -98.35 4.41 48.61 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -96.93 -140.0 0.28 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -158.23 147.04 19.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.494 0.664 . . . . 0.0 110.98 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.42 ' O ' ' O ' ' A' ' 14' ' ' LEU . 91.4 m95 -154.13 176.44 12.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.295 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.91 -165.21 0.2 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.889 0.852 . . . . 0.0 110.777 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -161.26 154.17 20.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.118 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 12.1 m-85 -148.24 156.21 42.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.467 0.651 . . . . 0.0 110.352 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 81.6 m -123.46 -166.69 1.5 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.778 0.799 . . . . 0.0 110.155 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -146.87 125.5 12.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' ND2' HH21 ' A' ' 5' ' ' ARG . 1.1 m-80 -103.31 154.03 38.03 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.874 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -41.89 -47.31 6.52 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.75 1.633 . . . . 0.0 112.659 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.622 ' CG ' ' H ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -149.94 -105.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.48 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.622 ' H ' ' CG ' ' A' ' 96' ' ' HIS . . . -151.62 150.04 29.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.152 0.501 . . . . 0.0 110.096 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 C--N 1.288 -2.075 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.215 176.842 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 2' ' ' VAL . 18.7 m -85.39 154.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.008 0.433 . . . . 0.0 110.806 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.486 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 34.2 p90 -138.58 169.2 18.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.873 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -73.64 132.85 43.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.227 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.486 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 61.8 ttm-85 -135.16 131.26 36.58 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.274 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -165.0 159.18 17.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.232 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.83 137.52 56.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.929 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.18 -39.65 75.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.03 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.0 m -113.08 -32.92 6.19 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.793 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 -134.29 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.626 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 12' ' ' TYR . 24.6 pttm -173.28 -35.7 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.044 0.45 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.441 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 82.7 m-85 -159.53 80.78 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -147.19 42.52 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 0.0 110.353 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -117.25 126.44 52.74 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.315 0.579 . . . . 0.0 110.788 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 16' ' ' TYR . 91.6 m -103.68 164.66 11.53 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.855 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.59 ' N ' HG22 ' A' ' 15' ' ' THR . 59.5 t80 -54.31 -48.17 71.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.486 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' HB2' HH21 ' A' ' 84' ' ' ARG . . . -55.2 -45.76 75.89 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.898 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 8.3 mp0 -64.49 -45.41 87.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.49 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.28 -31.16 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.827 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.88 -51.32 41.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.598 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -59.72 -23.19 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.978 0.418 . . . . 0.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' C ' ' H ' ' A' ' 25' ' ' PHE . 57.4 m -104.89 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 109.59 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 68.2 mm-40 73.99 -26.12 0.19 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.873 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.0 t80 -59.78 -49.05 79.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.947 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.96 17.47 12.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.13 5.61 82.81 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -79.47 -175.53 47.67 Favored Glycine 0 C--O 1.219 -0.822 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 89.4 m-70 -154.96 158.52 39.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 136.93 57.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.044 0.449 . . . . 0.0 110.368 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 85.61 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 33' ' ' TYR . 40.9 m -71.05 170.36 13.02 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.611 ' N ' HG22 ' A' ' 32' ' ' THR . 26.1 t80 -55.37 -53.19 59.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.724 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.1 -49.14 77.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.577 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -66.34 -36.25 82.42 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.82 -43.75 98.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.541 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -49.72 -44.59 48.42 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.84 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.697 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.65 44.54 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.046 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.587 HH22 ' H ' ' A' ' 46' ' ' VAL . 12.1 mmm180 -56.93 -30.82 64.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.61 -6.6 57.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 42' ' ' ILE . 5.6 mm -103.02 4.98 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 5.28 53.75 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -68.79 119.41 13.12 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.44 0.62 . . . . 0.0 109.978 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.403 ' HA ' ' NH2' ' A' ' 40' ' ' ARG . 84.7 t60 -134.85 103.43 5.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.587 ' H ' HH22 ' A' ' 40' ' ' ARG . 39.7 t -141.27 132.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.728 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -114.36 92.69 4.05 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.69 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.39 127.29 4.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.22 104.78 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.405 0.621 . . . . 0.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -122.66 157.24 17.25 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.024 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.458 ' CE3' HG22 ' A' ' 57' ' ' VAL . 88.9 m95 -78.68 145.7 34.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.313 0.578 . . . . 0.0 110.143 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 2.1 mpp? -142.99 171.84 13.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.324 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -38.71 149.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.665 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 57.27 34.81 25.3 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.194 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.83 6.85 1.36 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.796 -0.565 . . . . 0.0 111.888 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 52' ' ' MET . 59.8 ttt85 -62.32 131.21 48.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 110.065 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.458 HG22 ' CE3' ' A' ' 51' ' ' TRP . 2.3 t -127.88 126.59 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.985 0.898 . . . . 0.0 110.728 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.06 -172.31 25.06 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.289 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 78' ' ' TYR . 7.8 p90 -152.5 84.83 4.62 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 114.934 -0.633 . . . . 0.0 110.344 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.15 145.04 67.2 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.36 2.04 . . . . 0.0 112.49 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -136.78 103.51 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.45 -53.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.266 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -95.09 145.9 30.35 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.327 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -39.89 140.54 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.067 1.844 . . . . 0.0 112.322 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.56 99.91 0.19 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.991 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -16.09 19.23 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.19 1.927 . . . . 0.0 112.108 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -70.83 -34.73 71.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.109 0.48 . . . . 0.0 110.687 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.7 137.25 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.236 0.541 . . . . 0.0 110.384 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.46 79.31 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 49.54 79.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.719 0.295 . . . . 0.0 110.714 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.05 -123.14 32.05 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 55.76 163.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 74' ' ' GLY . 89.1 m -138.99 164.31 30.09 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.676 0.75 . . . . 0.0 110.666 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.584 ' N ' HG22 ' A' ' 73' ' ' THR . . . 73.96 153.71 3.02 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.4 mt -53.32 126.17 9.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-O 120.974 0.416 . . . . 0.0 110.367 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.472 ' O ' ' CE2' ' A' ' 78' ' ' TYR . 37.2 mm -107.84 118.37 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.191 0.52 . . . . 0.0 110.424 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.58 149.73 43.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.384 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 98.5 m-85 -131.36 -16.51 3.08 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -170.0 34.63 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.1 mt -103.83 123.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.688 0.756 . . . . 0.0 110.504 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 81' ' ' ARG . 0.5 OUTLIER -98.37 130.13 45.02 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.39 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 84' ' ' ARG . 27.6 mt -83.0 8.58 12.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 85' ' ' SER . 47.7 p-10 -71.86 22.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.672 1.225 . . . . 0.0 110.981 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 82' ' ' LEU . 72.0 ttt180 -48.06 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.597 -0.689 . . . . 0.0 110.986 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 83' ' ' ASN . 57.3 m -68.22 -37.66 81.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.656 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.18 -169.17 1.94 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 110.645 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.448 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 92.0 mtt-85 -134.03 144.93 48.98 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.552 0.691 . . . . 0.0 110.721 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.448 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 60.3 m95 -150.32 175.42 11.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.971 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 42.5 t0 -59.86 -179.7 0.1 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 111.085 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.456 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -165.65 159.73 16.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.344 0.593 . . . . 0.0 110.884 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.11 160.54 38.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.637 0.732 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.8 t -141.95 148.54 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.159 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -115.42 141.93 47.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.124 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -147.26 148.52 32.04 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.196 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.68 154.83 59.4 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.463 2.109 . . . . 0.0 111.897 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 m80 52.46 20.54 1.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.427 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.07 -68.98 0.26 Allowed 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.359 1.076 . . . . 0.0 108.594 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 C--N 1.291 -1.974 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 174.472 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 t -82.96 157.15 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.665 0.269 . . . . 0.0 110.718 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -162.68 155.52 19.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.769 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -75.61 135.1 40.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.616 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -141.97 139.74 32.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.224 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -140.8 152.38 45.13 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.13 159.12 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.079 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -49.14 9.99 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.0 m -114.0 19.0 16.86 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.606 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.12 -176.25 14.38 Favored Glycine 0 C--O 1.215 -1.082 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -147.0 106.23 3.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.193 -0.504 . . . . 0.0 110.49 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 56.53 17.25 2.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.537 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -80.48 38.64 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.44 117.12 30.85 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.264 0.554 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.538 HG22 ' N ' ' A' ' 16' ' ' TYR . 61.9 m -101.58 163.62 12.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.538 ' N ' HG22 ' A' ' 15' ' ' THR . 62.4 t80 -53.85 -49.75 67.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.93 78.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.891 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.07 -49.28 70.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.713 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.6 -30.16 41.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' CYS . 44.1 tptt -60.93 -37.37 82.1 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.303 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.45 -54.2 13.3 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.449 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.49 -42.78 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.999 0.428 . . . . 0.0 110.788 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.525 ' C ' ' H ' ' A' ' 25' ' ' PHE . 62.1 m -100.51 173.42 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' OE1' ' NZ ' ' A' ' 20' ' ' LYS . 70.9 tt0 63.04 -7.98 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.93 -47.1 86.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.774 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -87.98 21.29 2.76 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.24 -1.2 84.33 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.81 -152.15 1.27 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 53.4 t-80 -168.67 152.74 5.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.642 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.465 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 44.0 mt -62.43 139.52 58.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.956 0.408 . . . . 0.0 110.438 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 103.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.998 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.8 t -77.45 179.02 6.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.045 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.461 ' N ' ' OG1' ' A' ' 32' ' ' THR . 50.7 t80 -54.81 -53.65 52.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.1 -44.75 91.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.734 0.302 . . . . 0.0 110.71 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.562 ' H ' HG23 ' A' ' 32' ' ' THR . 78.8 mt-30 -71.38 -30.85 66.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 111.066 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.8 mt -63.48 -41.91 98.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -30.64 67.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.216 0.531 . . . . 0.0 110.674 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.89 65.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.828 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.74 -42.18 42.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.546 HH22 ' CA ' ' A' ' 61' ' ' ILE . 17.2 mmm180 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.161 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.36 -11.53 60.07 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.456 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 42' ' ' ILE . 99.1 mt -96.71 4.13 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.21 9.6 55.44 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -66.85 125.36 25.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.949 0.374 . . . . 0.0 110.392 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -143.64 103.06 4.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.485 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.0 132.75 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.699 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.18 91.31 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.3 149.73 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.99 136.91 52.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.466 0.65 . . . . 0.0 110.884 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.89 -178.58 21.47 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.547 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -84.32 156.13 22.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.39 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.5 ptt? -158.16 -175.28 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.551 0.691 . . . . 0.0 110.101 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -30.71 144.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.574 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 55.35 15.46 1.39 Allowed 'General case' 0 C--O 1.2 -1.505 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.776 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 65.8 16.26 63.45 Favored Glycine 0 C--N 1.315 -0.623 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -66.59 154.5 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 0.0 110.007 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 57' ' ' VAL . 11.5 p -129.9 118.12 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.862 0.839 . . . . 0.0 110.942 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 59' ' ' TYR . . . -113.73 -175.86 19.14 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 6.1 m-85 -141.66 69.72 25.34 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 115.065 -0.568 . . . . 0.0 110.291 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -52.62 115.32 2.15 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.72 1.614 . . . . 0.0 112.559 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.546 ' CA ' HH22 ' A' ' 40' ' ' ARG . 97.8 mt -145.58 118.23 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.607 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 66.8 t -74.73 -22.33 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 0.0 110.083 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -165.65 148.24 6.59 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.312 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -39.63 143.87 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.878 1.719 . . . . 0.0 112.926 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.91 167.79 25.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.457 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.97 -43.29 0.8 Allowed 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.164 1.91 . . . . 0.0 112.317 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -64.88 -35.21 80.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.46 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.17 113.47 25.74 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.216 0.531 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 145.65 29.03 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 45.5 -97.32 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.46 104.5 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.81 -161.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 110.148 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.2 p -94.59 150.62 20.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.429 0.633 . . . . 0.0 110.423 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 167.48 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.91 131.7 28.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 110.17 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.6 mt -86.64 126.0 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -66.66 133.68 50.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.486 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -143.81 156.45 44.49 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.754 0.787 . . . . 0.0 110.227 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.38 -161.0 34.67 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 85.6 mt -97.77 96.88 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.44 0.638 . . . . 0.0 110.193 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -71.52 141.94 50.12 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.262 0.553 . . . . 0.0 110.423 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 84' ' ' ARG . 24.1 tp -82.11 3.8 25.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.14 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 85' ' ' SER . 38.7 p-10 -76.06 20.44 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.916 0.865 . . . . 0.0 110.574 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 82' ' ' LEU . 80.9 mtp180 -54.94 -1.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.782 -0.574 . . . . 0.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 83' ' ' ASN . 96.7 p -94.94 -4.6 46.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.454 ' CD ' ' HE1' ' A' ' 88' ' ' TRP . 80.7 tt0 -94.98 154.08 17.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 83.4 mtm180 -86.17 136.81 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 110.651 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.1 m95 -153.2 176.84 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.328 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 30.9 t0 -73.55 -169.29 0.66 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.565 0.698 . . . . 0.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.47 153.88 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.499 0.666 . . . . 0.0 110.873 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.28 157.36 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.757 0.789 . . . . 0.0 110.371 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.53 -173.62 3.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.496 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -160.04 113.56 2.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.181 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -153.81 150.95 23.95 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.16 2.58 4.18 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 121.902 1.735 . . . . 0.0 111.581 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -86.95 -174.0 4.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.974 0.416 . . . . 0.0 110.377 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 58.3 -151.87 0.41 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.98 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.9 tttt . . . . . 0 C--N 1.29 -1.985 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.559 176.765 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -147.47 130.14 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.89 0.376 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -105.35 129.55 53.66 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.831 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -79.36 149.34 31.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.759 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -128.43 154.52 45.97 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -160.94 133.14 5.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.394 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.88 31.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -75.7 -42.35 51.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.532 0.682 . . . . 0.0 110.997 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 p -109.58 25.75 11.43 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.624 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.68 -142.95 3.54 Favored Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.743 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -162.38 87.09 0.61 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.111 0.481 . . . . 0.0 110.526 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 2.3 m-85 72.39 21.71 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -74.1 48.04 0.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.408 -0.183 . . . . 0.0 110.758 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.99 130.12 52.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.543 0.687 . . . . 0.0 110.904 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.0 p -101.38 170.23 8.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -56.26 -50.19 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.91 86.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.041 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -51.74 39.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.71 -30.34 13.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' CYS . 28.8 ttpt -67.92 -33.6 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.514 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -51.91 63.32 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 111.56 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.24 -38.72 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.207 0.527 . . . . 0.0 110.71 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 20' ' ' LYS . 56.8 m -101.17 178.8 4.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.871 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' GLY . 36.1 tt0 72.68 -27.28 0.18 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.7 t80 -61.27 -46.62 89.58 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 110.799 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.1 pm0 -86.49 11.74 11.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -23.1 33.79 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -78.51 134.27 13.91 Favored Glycine 0 C--O 1.22 -0.738 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.44 173.34 6.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.83 137.61 56.73 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.244 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.97 139.54 46.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.429 0.633 . . . . 0.0 110.819 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -122.27 174.35 7.04 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.921 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -59.71 -52.83 63.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.91 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.87 -45.25 95.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.927 0.394 . . . . 0.0 110.485 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.11 -34.73 75.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.639 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 40' ' ' ARG . 10.7 mt -62.53 -41.14 98.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.467 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -53.89 -40.82 66.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.755 0.312 . . . . 0.0 110.884 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.83 97.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.081 0.467 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -85.56 -25.47 26.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 61' ' ' ILE . 1.1 tpt85 -56.41 -25.74 51.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.593 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -81.49 -1.35 45.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.508 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 39' ' ' ALA . 4.4 tt -91.65 6.31 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.506 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.13 26.24 34.62 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -70.55 131.23 43.67 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.83 0.315 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.65 101.77 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -143.43 133.07 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.14 78.74 6.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.862 0.363 . . . . 0.0 110.027 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.38 92.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.472 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.07 39.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.628 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.05 165.59 20.97 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.814 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -72.14 104.97 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.385 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 55' ' ' GLY . 71.4 mtm -97.31 -178.33 4.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.25 0.548 . . . . 0.0 110.418 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -32.07 144.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.769 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 mttp 54.4 9.27 0.24 Allowed 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.224 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 81.86 20.87 62.49 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.045 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 69.2 ttt180 -70.38 130.01 40.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.428 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.2 p -116.57 133.09 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.806 0.812 . . . . 0.0 110.745 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.46 157.18 28.81 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -113.11 106.07 55.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.448 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 87.8 Cg_endo -79.05 126.93 7.36 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.101 1.201 . . . . 0.0 112.234 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 17.1 pt -145.97 137.95 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.831 0.824 . . . . 0.0 110.875 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.77 -45.36 98.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.285 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.636 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -168.5 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.636 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 31.8 Cg_exo -60.64 147.95 93.04 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.231 1.954 . . . . 0.0 112.164 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.461 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -156.73 50.53 0.44 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.371 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.3 Cg_endo -66.55 -53.41 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.321 2.014 . . . . 0.0 111.943 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.77 -23.19 31.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.56 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 12.1 p -151.03 124.94 9.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.56 110.5 0.25 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -144.09 -53.1 0.33 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.14 -72.7 0.58 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -172.36 -157.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 0.0 110.669 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 p -114.89 166.37 11.85 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 68.41 68.32 1.69 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' GLY . 71.9 mt 56.44 128.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.587 -0.307 . . . . 0.0 110.899 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.46 118.15 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 120.992 0.425 . . . . 0.0 110.379 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 91.9 m-20 -92.54 108.1 19.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.496 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CE1' ' OH ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -95.93 -11.55 26.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.1 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.98 -174.51 44.16 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.5 mp -96.61 116.87 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.212 0.53 . . . . 0.0 110.556 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.531 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 79.8 mtp180 -92.91 133.85 35.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.112 0.482 . . . . 0.0 110.162 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 tp -83.35 4.65 26.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 110.308 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.531 HD21 ' CZ ' ' A' ' 81' ' ' ARG . 51.4 p30 -85.66 23.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.487 0.661 . . . . 0.0 110.537 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -44.31 -32.08 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.566 -0.709 . . . . 0.0 111.261 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.1 p -49.08 -21.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.009 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -70.51 -169.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.12 0.486 . . . . 0.0 110.743 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 84.1 mtt85 -130.2 129.81 43.87 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.373 0.606 . . . . 0.0 110.776 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.428 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.4 m95 -150.1 175.71 11.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.908 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD2' ' CD1' ' A' ' 12' ' ' TYR . 1.3 m-20 -55.69 -174.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.86 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.47 143.07 18.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.425 0.631 . . . . 0.0 110.935 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -115.43 160.08 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.008 0.909 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.88 179.71 6.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -133.36 116.7 16.4 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.183 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -149.41 88.47 5.0 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.045 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.89 85.49 1.7 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.398 1.399 . . . . 0.0 111.559 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -133.75 -42.88 0.83 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.19 -73.02 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.83 0.824 . . . . 0.0 108.849 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt . . . . . 0 C--N 1.291 -1.95 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.007 176.186 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.98 136.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 110.742 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.6 162.41 37.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.972 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -74.91 129.06 37.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -135.03 133.3 39.25 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.216 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -157.05 156.03 32.17 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.65 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.16 -37.02 34.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.094 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.3 m -84.71 -5.21 59.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.63 -118.65 0.81 Allowed Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.159 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -167.53 -39.94 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.36 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -146.76 67.16 1.16 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.978 0.418 . . . . 0.0 110.517 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.09 32.92 3.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.3 118.72 32.0 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.649 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -90.32 168.31 11.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.656 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 38.5 p90 -51.64 -60.23 3.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -53.16 -40.24 64.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -66.24 -47.96 72.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.64 -35.87 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.795 0.331 . . . . 0.0 110.849 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' CYS . 56.6 mtpt -68.9 -31.31 70.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.86 45.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.884 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.82 -33.87 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.709 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -104.71 -178.45 3.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 109.586 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 96.4 mt-10 69.77 -10.28 0.62 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.923 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' CYS . 90.5 t80 -60.48 -47.25 86.95 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 18.0 pt-20 -87.39 21.37 2.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.46 76.26 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.11 -171.28 40.45 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -163.45 121.07 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.679 0.276 . . . . 0.0 110.451 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -42.15 136.98 2.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.701 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -66.12 144.66 56.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -123.21 177.3 5.63 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.075 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -51.6 -26.74 9.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.474 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -70.66 -56.33 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.76 -35.29 74.82 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.7 mt -61.07 -40.85 95.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.419 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.72 -34.14 71.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.541 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.2 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 110.785 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.97 66.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -56.59 -43.47 80.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.402 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.77 -11.4 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 42' ' ' ILE . 79.2 mt -98.54 7.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.49 22.08 52.05 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.47 132.78 46.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.751 0.31 . . . . 0.0 110.585 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -154.23 105.38 2.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 46' ' ' VAL . 14.9 p -141.71 127.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.879 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.38 82.56 1.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.82 118.21 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.721 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.99 151.04 21.19 Favored Glycine 0 N--CA 1.476 1.336 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.12 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -73.13 147.5 44.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.166 0.508 . . . . 0.0 110.258 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 48.9 mtm -150.0 179.96 7.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.018 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.8 141.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.835 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 55.39 12.37 0.72 Allowed 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.179 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 75.62 21.59 76.75 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.808 -0.558 . . . . 0.0 112.158 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -74.36 135.89 42.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.209 0.528 . . . . 0.0 110.579 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.482 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 3.1 p -143.41 156.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.667 0.746 . . . . 0.0 110.783 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 57' ' ' VAL . . . -174.69 -178.47 44.6 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.271 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -116.46 67.04 3.51 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.879 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.29 118.78 5.68 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.762 1.642 . . . . 0.0 112.419 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.2 pt -145.02 147.98 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.682 0.753 . . . . 0.0 110.88 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.71 -66.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.338 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.767 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 17.7 mttt -144.76 -43.07 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.303 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.767 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 28.0 Cg_exo -63.32 150.14 89.36 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.211 1.941 . . . . 0.0 112.371 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -168.88 49.32 0.22 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.493 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.8 Cg_endo -66.73 -53.19 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.428 2.085 . . . . 0.0 112.118 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -74.4 -17.05 60.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.24 132.1 1.02 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.95 41.4 0.03 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.64 -41.82 98.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 110.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.47 -84.67 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -170.93 -156.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.213 . . . . 0.0 110.472 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.3 p -95.3 162.22 13.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.328 0.585 . . . . 0.0 110.597 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.22 19.97 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.2 mt -102.67 123.34 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.097 0.475 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.9 mt -93.88 131.21 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.351 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.51 97.33 9.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.373 0.606 . . . . 0.0 110.067 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.1 41.79 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.301 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 80' ' ' ILE . . . -91.06 -147.34 19.26 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 79' ' ' GLY . 11.5 mt 15.72 58.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.435 0.636 . . . . 0.0 111.238 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 79' ' ' GLY . 82.3 mtp180 -71.08 150.78 45.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.2 mp -77.24 -16.6 58.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.14 0.495 . . . . 0.0 109.958 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.4 OUTLIER -91.52 25.18 2.73 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.381 0.61 . . . . 0.0 110.616 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -52.88 5.04 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.719 -0.613 . . . . 0.0 111.712 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.641 ' H ' ' C ' ' A' ' 83' ' ' ASN . 47.7 t -92.61 -8.47 44.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.413 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -85.97 -165.27 1.2 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.005 0.431 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.47 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -131.27 141.25 49.95 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.005 0.907 . . . . 0.0 110.849 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 61.7 m95 -153.07 177.26 10.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.862 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 12.4 t70 -60.71 -163.67 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -170.35 149.35 3.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.22 0.533 . . . . 0.0 110.759 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -118.21 135.32 54.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.458 0.647 . . . . 0.0 110.253 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.9 m -114.08 177.33 4.68 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.023 0.916 . . . . 0.0 109.637 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -150.43 151.41 32.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 96' ' ' HIS . 29.8 t-20 -143.11 132.77 11.87 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.362 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.8 11.66 1.62 Allowed 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 122.05 1.834 . . . . 0.0 112.275 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.479 ' N ' ' OD1' ' A' ' 94' ' ' ASN . 71.3 t60 -160.11 77.99 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.04 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.5 155.8 28.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.972 0.415 . . . . 0.0 110.25 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.945 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.056 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 3' ' ' TYR . 97.2 t -85.1 155.51 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.637 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.402 ' N ' HG12 ' A' ' 2' ' ' VAL . 89.9 t80 -117.79 129.24 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -74.09 127.53 33.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 90' ' ' ALA . 24.0 ttm180 -146.06 128.78 16.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.037 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.9 pm0 -146.41 -176.82 5.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.468 0.48 . . . . 0.0 110.392 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.67 127.1 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -78.39 -33.96 48.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.846 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.82 -4.09 41.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.531 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.47 -95.16 0.1 Allowed Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.873 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -171.34 -81.5 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.917 0.389 . . . . 0.0 110.311 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.02 80.15 3.28 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.001 0.429 . . . . 0.0 110.622 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -137.61 34.62 2.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.153 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.519 0.676 . . . . 0.0 110.258 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 p -99.03 168.27 10.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.245 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.543 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 31.9 p90 -53.68 -53.56 50.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.543 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -55.12 -45.97 75.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.47 69.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.5 mttt -71.87 -40.27 69.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 0.0 110.715 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -46.64 84.53 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.33 -42.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.529 0.68 . . . . 0.0 110.94 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 20' ' ' LYS . 17.6 m -101.47 178.79 4.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.736 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 70.04 -45.78 0.59 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -62.71 -48.02 81.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.41 21.82 3.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.022 0.439 . . . . 0.0 110.871 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.15 1.48 84.33 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.23 -171.38 9.54 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -168.41 137.03 2.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.557 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 30' ' ' LEU . 10.3 mp -72.94 141.27 47.82 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 110.25 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.3 93.96 0.35 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.291 0.567 . . . . 0.0 110.726 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 33' ' ' TYR . 34.0 m -86.01 171.66 11.24 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.898 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.616 ' N ' HG22 ' A' ' 32' ' ' THR . 66.7 t80 -55.53 -53.98 49.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.22 -45.05 84.21 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.542 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -70.05 -34.93 73.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 110.858 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.15 -40.87 98.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.15 -37.31 82.41 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.5 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.09 -39.77 93.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.71 -27.62 31.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.365 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -56.96 -25.0 57.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.268 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.56 -6.24 59.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 42' ' ' ILE . 78.1 mt -94.36 4.52 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.521 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.29 25.09 24.86 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -66.31 128.66 37.02 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.701 0.251 . . . . 0.0 110.59 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.403 ' CG ' HG22 ' A' ' 62' ' ' VAL . 1.8 t60 -150.03 103.19 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.278 0.561 . . . . 0.0 110.468 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 46' ' ' VAL . 11.4 p -143.65 117.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.023 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.87 89.73 6.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.11 112.5 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.118 0.485 . . . . 0.0 110.618 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.45 137.21 52.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.905 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.98 -172.83 19.13 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.689 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.73 150.81 19.82 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.1 mtm -143.73 168.86 18.9 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.35 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.19 156.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.17 40.77 31.85 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.273 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.26 6.61 0.16 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.008 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 56.5 ttt180 -68.81 144.72 54.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.61 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.29 130.19 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.771 0.795 . . . . 0.0 110.786 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.76 175.59 45.08 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.433 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.596 ' CE2' HD11 ' A' ' 61' ' ' ILE . 13.6 p90 -167.55 143.19 3.33 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.724 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.11 146.68 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.184 1.922 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 59' ' ' TYR . 16.2 mt -141.8 93.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.556 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG22 ' CG ' ' A' ' 45' ' ' HIS . 18.9 m -69.24 -36.76 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.031 0.443 . . . . 0.0 110.278 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -137.7 154.39 74.79 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.33 144.77 59.2 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.362 2.041 . . . . 0.0 112.0 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.75 179.72 20.76 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.37 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.8 -47.63 26.14 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 122.174 1.916 . . . . 0.0 112.598 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.41 28.69 2.47 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.3 p -151.34 150.5 30.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.381 0.61 . . . . 0.0 110.273 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.0 93.77 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.43 -44.7 96.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 110.597 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.21 -8.96 0.05 OUTLIER Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.16 155.78 38.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.708 0.289 . . . . 0.0 110.287 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -140.5 130.31 24.47 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.794 0.807 . . . . 0.0 110.598 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 75' ' ' ILE . . . 144.77 -47.02 0.78 Allowed Glycine 0 N--CA 1.465 0.625 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.195 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.438 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER 159.26 131.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 120.868 0.366 . . . . 0.0 110.607 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mm -111.24 62.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.58 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 44.5 p-10 -99.67 103.61 15.3 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.95 0.405 . . . . 0.0 110.296 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -71.17 -61.62 1.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.45 -147.44 13.09 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.515 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.0 mt -97.63 117.39 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.368 . . . . 0.0 110.074 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 50.8 mtp85 -94.24 133.5 37.7 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.7 mp -82.54 3.34 28.96 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.592 0.71 . . . . 0.0 109.831 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 52.2 p-10 -81.66 26.2 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.846 0.832 . . . . 0.0 110.479 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -45.38 -36.35 4.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.543 -0.723 . . . . 0.0 111.262 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -45.57 -26.99 0.67 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.563 0.221 . . . . 0.0 110.99 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 8.7 mp0 -74.13 -173.08 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.932 0.872 . . . . 0.0 109.988 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -128.49 145.7 51.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.917 0.865 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -155.05 175.91 13.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.343 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 28.0 t0 -79.82 -168.36 1.57 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.72 0.771 . . . . 0.0 110.604 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -167.98 164.58 13.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.455 0.645 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.93 151.52 49.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.534 0.683 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.53 142.45 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.227 0.537 . . . . 0.0 110.308 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 94' ' ' ASN . 10.9 t80 -134.34 149.91 50.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.274 0.559 . . . . 0.0 110.312 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.482 ' N ' ' CD1' ' A' ' 93' ' ' TYR . 11.8 m120 -117.71 89.97 34.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.505 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.54 132.02 34.35 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.272 1.982 . . . . 0.0 112.537 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 96' ' ' HIS . 16.3 t-80 39.63 42.7 0.98 Allowed 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 122.387 0.275 . . . . 0.0 110.287 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 56.27 -135.2 1.27 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 122.171 0.986 . . . . 0.0 109.047 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.0 tttm . . . . . 0 C--N 1.29 -1.98 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 176.024 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 3' ' ' TYR . 10.2 p -81.66 163.32 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.543 ' N ' HG22 ' A' ' 2' ' ' VAL . 24.6 p90 -146.71 127.89 14.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.804 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -73.79 138.44 44.53 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 92' ' ' CYS . 52.5 ptt85 -145.62 160.96 40.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.496 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.4 pm0 -160.92 -177.48 6.16 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.81 124.66 17.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -66.24 -39.62 89.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.018 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m -109.72 33.08 4.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.507 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.36 -134.1 1.63 Allowed Glycine 0 C--O 1.216 -1.002 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.798 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -154.87 -83.16 0.07 Allowed 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.325 -0.438 . . . . 0.0 110.424 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.61 28.78 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -94.81 33.74 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.903 0.382 . . . . 0.0 110.604 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.47 124.54 49.03 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.534 0.683 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 16' ' ' TYR . 32.3 m -87.97 161.3 17.5 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.472 ' N ' HG22 ' A' ' 15' ' ' THR . 31.8 t80 -60.5 -43.74 96.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.388 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.24 62.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.957 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.46 -51.15 62.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -31.77 18.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 23' ' ' CYS . 10.5 mtpm? -70.59 -33.8 71.46 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 120.576 0.227 . . . . 0.0 110.567 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.54 74.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.133 0.492 . . . . 0.0 111.765 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.68 -44.31 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.251 0.548 . . . . 0.0 111.173 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.578 ' O ' ' O ' ' A' ' 20' ' ' LYS . 7.4 m -102.26 178.25 4.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.085 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 67.45 -39.32 0.37 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.9 t80 -60.0 -47.03 87.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.658 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.67 19.76 5.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.676 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.95 77.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.57 -165.75 22.11 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -167.95 137.89 2.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.201 . . . . 0.0 110.523 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 30' ' ' LEU . 10.7 mp -70.54 137.4 50.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.917 0.389 . . . . 0.0 110.144 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.42 138.64 55.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 36' ' ' LEU . 11.1 p -100.31 163.71 12.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 22.9 p90 -54.4 -53.37 54.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.943 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 39.0 ttmt -62.28 -44.38 96.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.986 0.422 . . . . 0.0 110.334 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -67.06 -30.05 70.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.4 mt -62.41 -29.9 70.83 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.346 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.77 -39.36 58.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.407 . . . . 0.0 110.909 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.29 -38.03 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.83 28.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 42' ' ' ILE . 3.8 tpt85 -56.77 -37.47 71.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -63.48 -2.09 1.45 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.509 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 42' ' ' ILE . 24.5 mm -106.39 13.46 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.347 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 18.93 66.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.77 127.49 33.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.885 0.343 . . . . 0.0 110.181 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -140.93 104.43 4.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.506 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.53 125.4 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.023 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -93.84 91.51 6.98 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.887 0.375 . . . . 0.0 110.303 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.28 93.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . . . -72.11 121.37 19.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.59 162.6 25.82 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.961 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -80.29 109.34 14.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.39 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 40.1 mtm -97.87 -172.61 2.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.248 0.547 . . . . 0.0 110.251 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.02 152.93 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.583 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' ARG . 68.6 mttm 47.19 41.03 11.13 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.96 5.68 0.1 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.892 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' LYS . 54.8 mtp180 -68.37 128.91 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.3 122.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.806 0.812 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.81 150.74 12.16 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.516 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 49' ' ' ALA . 11.2 p90 -160.53 140.36 8.26 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.607 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 143.37 31.59 Favored 'Trans proline' 0 N--CA 1.505 2.198 0 C-N-CA 121.632 1.555 . . . . 0.0 112.784 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.5 pt -149.49 96.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.435 0.636 . . . . 0.0 111.08 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -139.18 80.34 23.69 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.64 131.22 32.57 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 121.851 1.701 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.41 169.13 28.71 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.048 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.79 -18.4 47.43 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.504 2.136 . . . . 0.0 112.056 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -102.84 30.77 4.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.019 0.438 . . . . 0.0 110.537 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.42 -174.02 3.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.2 0.524 . . . . 0.0 110.502 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.21 135.87 34.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -73.19 134.0 44.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 72' ' ' LYS . . . 65.01 -154.93 49.37 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 71' ' ' GLY . 56.7 mtpt 54.15 109.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.197 . . . . 0.0 110.875 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -139.12 170.75 15.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.285 0.564 . . . . 0.0 110.824 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.04 68.66 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.7 mt 59.98 145.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.776 0.322 . . . . 0.0 110.39 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.43 136.28 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.11 0.481 . . . . 0.0 110.626 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -133.36 137.74 46.01 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.539 ' CZ ' ' NH2' ' A' ' 81' ' ' ARG . 9.2 t80 -143.21 -179.0 6.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.638 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.48 -69.06 1.17 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER 173.79 135.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.3 0.571 . . . . 0.0 109.98 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.539 ' NH2' ' CZ ' ' A' ' 78' ' ' TYR . 86.9 mtt-85 -111.4 133.49 53.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.232 0.539 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 mt -82.39 2.35 32.87 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.481 0.658 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -83.42 21.66 1.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.837 0.827 . . . . 0.0 110.656 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -48.91 -36.07 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.572 -0.705 . . . . 0.0 111.182 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -47.56 -30.8 3.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.564 0.221 . . . . 0.0 110.869 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.93 147.62 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.777 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 81.8 mtt85 -92.61 133.15 36.26 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.261 0.553 . . . . 0.0 110.569 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 66.6 m95 -151.53 175.62 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.17 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -63.64 -169.0 0.03 OUTLIER 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.726 0.641 . . . . 0.0 111.007 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.34 159.75 8.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.414 0.626 . . . . 0.0 111.106 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.55 156.95 40.01 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.592 0.711 . . . . 0.0 110.576 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.406 ' HB2' ' HE ' ' A' ' 5' ' ' ARG . 1.1 m -147.5 142.28 26.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.631 0.729 . . . . 0.0 110.002 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.32 114.67 13.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.833 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -102.96 105.96 48.14 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 118.079 -0.963 . . . . 0.0 111.163 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.32 -11.49 17.45 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.063 1.176 . . . . 0.0 112.081 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' A' ' 96' ' ' HIS . 84.8 t60 -94.79 42.46 1.09 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.516 0.674 . . . . 0.0 111.008 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.3 -61.18 0.06 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 C--N 1.289 -2.041 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.518 176.402 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.01 150.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -158.84 154.19 25.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -83.17 142.3 31.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -145.87 134.57 22.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 79.2 tt0 -134.48 161.03 36.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.11 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.11 133.69 38.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.525 0.678 . . . . 0.0 110.977 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 6' ' ' GLU . 86.2 mmt-85 -75.66 -39.37 57.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.834 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -113.53 -30.34 6.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.86 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.59 -170.22 43.71 Favored Glycine 0 C--O 1.216 -0.975 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -167.23 99.45 0.52 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 55.12 60.76 3.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.936 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -142.48 42.97 1.63 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.719 0.295 . . . . 0.0 110.683 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.15 137.91 53.62 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.405 0.622 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.4 p -101.65 166.62 10.6 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.766 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.583 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 33.0 p90 -51.89 -60.52 3.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -56.29 -36.36 68.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.918 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.81 -48.85 65.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.83 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.22 -30.64 7.36 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.025 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.5 mtpt -65.03 -26.37 68.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 -53.69 30.79 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.555 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.98 -33.7 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.994 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.595 ' C ' ' H ' ' A' ' 25' ' ' PHE . 56.1 m -102.88 176.11 5.26 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 64.7 -26.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.6 t80 -61.14 -47.83 84.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.854 0.359 . . . . 0.0 110.728 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.21 23.67 4.26 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.6 -5.15 84.48 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.56 -158.96 3.52 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -173.28 161.29 4.18 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.51 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.22 145.87 55.27 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.602 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . . . -64.03 81.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.433 0.635 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -62.45 152.24 34.95 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -57.93 -52.62 64.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.757 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -50.72 -49.69 57.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.587 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.17 -40.44 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.714 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.21 -40.65 96.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.3 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -63.89 -33.38 75.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.485 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.0 63.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -87.25 -32.32 19.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.262 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -52.47 -19.91 2.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.428 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -3.4 37.19 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.809 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.8 tt -101.84 13.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.625 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 18.84 70.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.84 145.23 20.31 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.239 0.519 . . . . 0.0 110.326 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -140.85 132.56 27.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.708 0.766 . . . . 0.0 110.352 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 47' ' ' CYS . 38.6 t -132.97 159.48 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.784 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.464 ' N ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -156.24 41.48 0.37 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.523 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' H ' HG12 ' A' ' 46' ' ' VAL . . . -145.17 144.01 30.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.23 0.538 . . . . 0.0 110.595 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.46 34.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.618 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 57' ' ' VAL . . . -133.32 -171.34 12.66 Favored Glycine 0 N--CA 1.48 1.598 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.05 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -99.12 150.04 22.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 110.054 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 42.2 ttm -134.44 161.19 35.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.117 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.8 136.93 1.84 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.2 mttp 56.77 38.03 29.21 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.598 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.84 15.47 2.29 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.836 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -75.12 50.94 0.5 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.69 0.281 . . . . 0.0 110.651 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 50' ' ' GLY . 2.2 p -54.81 132.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.086 0.946 . . . . 0.0 110.765 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.27 71.71 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -71.23 142.99 87.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 121.161 -0.215 . . . . 0.0 111.546 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 156.47 53.75 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.511 1.474 . . . . 0.0 112.501 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.6 mt -144.13 94.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.64 -72.92 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -71.82 155.37 92.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -61.76 145.56 97.22 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.381 2.054 . . . . 0.0 111.899 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.61 83.97 0.24 Allowed Glycine 0 N--CA 1.472 1.058 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.91 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.36 -42.14 56.02 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.237 1.958 . . . . 0.0 112.322 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -98.13 23.75 7.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.701 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 4.2 p -177.7 111.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.393 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 72.21 16.61 77.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 50.85 -88.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.438 0.637 . . . . 0.0 110.803 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -158.74 18.99 0.29 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.74 126.77 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 110.164 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -94.18 172.36 8.27 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.07 -170.9 54.2 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.82 123.35 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.97 0.414 . . . . 0.0 110.714 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.9 mm -95.97 74.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.615 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -75.84 109.59 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.332 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -75.04 -4.3 37.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 50.22 69.53 1.05 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 79' ' ' GLY . 75.8 mt 56.04 120.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.071 0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -104.64 152.76 22.08 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.108 0.48 . . . . 0.0 110.388 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 84' ' ' ARG . 48.5 tp -85.93 -11.03 54.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 110.491 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 85' ' ' SER . 51.4 p30 -73.48 23.61 0.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.856 0.836 . . . . 0.0 110.508 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.3 mtt180 -47.95 -13.61 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.587 -0.696 . . . . 0.0 111.114 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.24 -32.23 26.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.717 0.294 . . . . 0.0 110.669 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.61 149.06 44.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.609 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -85.79 158.25 20.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.431 0.634 . . . . 0.0 110.507 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -155.43 179.81 8.82 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.249 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 43.6 t0 -75.31 -177.08 3.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.645 0.736 . . . . 0.0 110.765 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.82 158.19 30.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -151.32 159.0 44.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.672 0.749 . . . . 0.0 110.504 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.5 m -125.59 148.09 49.07 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.083 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -138.45 126.8 23.06 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 56.9 m-80 -68.41 148.83 98.18 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.709 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.49 -18.14 38.41 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.993 1.795 . . . . 0.0 111.466 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -52.84 -89.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 50.62 -168.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.165 0.507 . . . . 0.0 110.172 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.225 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -83.14 155.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.802 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -146.99 148.67 31.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 110.794 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.74 136.8 34.62 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.754 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -102.63 158.78 16.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -141.1 113.79 8.28 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.448 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 173.75 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.61 86.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.074 0.464 . . . . 0.0 111.157 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.0 p -75.92 -7.18 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.445 0.641 . . . . 0.0 110.759 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 40.44 45.21 3.32 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 12' ' ' TYR . 53.3 tttp -152.8 46.56 0.71 Allowed 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 121.011 0.434 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.405 ' O ' ' O ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER 44.95 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -141.4 36.85 1.68 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.758 0.313 . . . . 0.0 110.486 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' TRP . 50.6 mt -123.88 137.94 54.56 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 16' ' ' TYR . 87.2 m -100.47 164.77 11.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.568 ' N ' HG22 ' A' ' 15' ' ' THR . 32.2 t80 -52.01 -58.5 6.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.51 84.83 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.957 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.06 -46.54 89.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.989 0.423 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.77 -29.68 60.02 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.796 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 23' ' ' CYS . 5.1 ttpm? -70.31 -31.32 68.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.975 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.19 70.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.482 . . . . 0.0 111.598 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 m -68.16 -33.84 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.462 0.648 . . . . 0.0 111.284 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 25' ' ' PHE . 12.3 t -103.85 176.89 5.0 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.012 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 62.59 -3.64 0.28 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.714 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 23' ' ' CYS . 82.5 t80 -58.88 -46.2 88.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.067 0.46 . . . . 0.0 110.485 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.0 pm0 -83.38 -16.94 44.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.53 -16.37 5.65 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.477 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -60.52 -162.5 0.13 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 99.5 m-70 -156.87 148.99 22.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.567 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 37.5 mt -51.29 137.04 23.74 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.471 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.14 103.63 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.201 0.524 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.2 t -80.61 169.82 17.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -54.94 -52.2 63.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.076 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -57.64 -42.46 83.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.541 ' H ' HG23 ' A' ' 32' ' ' THR . 7.1 tp-100 -69.48 -40.39 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.96 -44.91 94.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.235 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.76 -38.35 69.75 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.803 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.21 74.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.109 0.48 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -43.77 36.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.155 0.502 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.64 HH12 ' H ' ' A' ' 46' ' ' VAL . 18.3 mmm180 -55.48 -29.27 58.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -70.73 -10.2 58.93 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.432 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 42' ' ' ILE . 22.1 mm -104.98 13.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.36 11.1 78.76 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -59.12 104.22 0.23 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.023 0.412 . . . . 0.0 110.252 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -88.72 129.16 35.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.421 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.64 ' H ' HH12 ' A' ' 40' ' ' ARG . 39.2 t -136.65 157.36 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.953 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.427 ' N ' HG12 ' A' ' 46' ' ' VAL . 4.2 t -158.49 46.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.14 146.1 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 110.65 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.87 115.16 29.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.602 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.35 160.02 20.71 Favored Glycine 0 N--CA 1.475 1.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.889 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -78.14 107.47 10.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.324 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.0 mtp -98.04 177.06 5.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.211 0.529 . . . . 0.0 110.134 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.79 144.54 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.721 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.6 tttt 59.88 12.47 3.08 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.202 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.21 78.65 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.914 -0.491 . . . . 0.0 111.929 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 58.8 ttt180 -73.33 135.94 44.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.713 0.292 . . . . 0.0 110.53 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.97 154.51 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.252 0.549 . . . . 0.0 110.672 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.05 139.5 5.81 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.664 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 24.4 p90 -148.03 70.44 11.08 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-N 115.635 -0.282 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.4 141.55 95.9 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.23 1.953 . . . . 0.0 112.449 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -133.42 129.0 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.544 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.0 t -64.52 -43.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 21.8 ttpt -177.37 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 60.9 Cg_endo -65.38 145.28 82.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.505 1.47 . . . . 0.0 112.305 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -165.14 51.98 0.28 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 59.6 Cg_endo -67.4 -49.63 1.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.476 2.117 . . . . 0.0 112.032 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.435 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -87.95 -27.12 22.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.984 0.421 . . . . 0.0 110.812 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.435 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -139.17 144.05 38.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.266 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' PHE . . . 79.01 156.46 10.01 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.431 ' CG ' ' O ' ' A' ' 69' ' ' GLY . 97.0 m-85 -157.1 105.4 2.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.858 -0.171 . . . . 0.0 110.673 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.52 -42.1 1.94 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -69.7 142.05 53.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.6 p -144.54 168.91 19.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.847 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 61.6 153.16 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 74' ' ' GLY . 82.7 mt -31.55 125.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 120.724 0.297 . . . . 0.0 111.26 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.96 126.2 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.228 0.537 . . . . 0.0 110.601 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 56.1 t0 -94.82 107.02 19.03 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.77 -15.7 23.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.04 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.51 -91.07 1.64 Allowed Glycine 0 N--CA 1.466 0.676 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.7 mt -154.61 140.53 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.614 0.721 . . . . 0.0 110.046 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.614 ' HE ' HD21 ' A' ' 83' ' ' ASN . 18.5 mmm180 -102.85 117.74 35.28 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.765 0.793 . . . . 0.0 110.456 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.577 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -80.79 -6.76 58.95 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.845 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.614 HD21 ' HE ' ' A' ' 81' ' ' ARG . 51.2 p30 -75.61 22.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.659 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 82' ' ' LEU . 8.1 ptm180 -48.08 -12.02 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.662 -0.649 . . . . 0.0 111.266 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 83' ' ' ASN . 99.7 p -80.92 -7.78 59.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -98.82 -151.78 0.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.416 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.42 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 82.4 mtt85 -144.85 147.71 33.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.312 0.577 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' LEU . 82.3 m95 -153.88 178.96 9.34 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.427 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -59.81 -170.24 0.01 OUTLIER 'General case' 0 C--O 1.235 0.328 0 O-C-N 123.77 0.669 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.0 151.07 5.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.05 0.452 . . . . 0.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.97 158.61 37.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.558 0.694 . . . . 0.0 110.594 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 t -152.75 149.43 28.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.871 0.843 . . . . 0.0 110.49 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -141.06 149.96 42.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.598 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -151.43 149.72 25.06 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.3 -10.14 26.6 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.388 2.059 . . . . 0.0 112.013 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -152.14 165.37 34.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.53 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 53.59 -175.5 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp . . . . . 0 C--N 1.291 -1.965 0 CA-C-O 117.806 -1.092 . . . . 0.0 110.012 177.339 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 t -82.62 148.01 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.789 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -136.07 134.92 38.92 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.699 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.96 138.29 42.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.5 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -118.15 131.27 56.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.252 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -139.3 146.04 39.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.44 124.65 23.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.916 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.28 -33.87 67.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -110.03 32.57 5.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.3 -136.22 2.07 Favored Glycine 0 C--O 1.218 -0.882 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.641 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -171.75 -30.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 120.949 0.404 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -153.86 61.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.17 32.76 3.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.042 0.449 . . . . 0.0 110.578 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' TRP . 41.8 mt -115.64 111.62 20.9 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.681 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.432 ' OG1' ' OE1' ' A' ' 18' ' ' GLU . 54.2 p -100.03 174.33 6.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 11.5 p90 -51.02 -52.62 41.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.891 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -55.09 -49.28 72.08 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.128 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 21.0 mp0 -66.58 -33.13 74.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.65 83.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.975 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.9 mttt -71.48 -31.67 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.679 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.7 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.512 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -77.84 -24.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.931 0.395 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 25' ' ' PHE . 64.6 m -104.41 177.11 4.94 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 109.809 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' GLY . 78.9 tt0 67.53 -29.15 0.15 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.216 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.8 t80 -60.79 -48.49 81.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 110.734 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 3.4 pm0 -78.68 11.69 2.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.111 0.482 . . . . 0.0 110.916 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.18 -24.67 23.93 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -86.29 133.79 12.06 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -98.31 176.78 5.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.4 148.59 48.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.34 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.92 141.06 40.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -123.52 158.38 31.46 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.022 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -55.16 -28.78 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.439 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -68.66 -52.7 28.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.045 0.45 . . . . 0.0 110.85 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.5 -37.35 74.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.998 0.428 . . . . 0.0 110.606 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.6 mt -62.73 -39.77 95.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.92 -40.09 72.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.01 -23.96 48.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.7 -19.99 60.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.945 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.588 HH12 ' CB ' ' A' ' 60' ' ' PRO . 10.2 mmm180 -60.79 -41.86 96.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.663 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.36 -5.0 39.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 42' ' ' ILE . 46.6 mm -95.78 0.15 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.519 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.37 19.3 46.03 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.619 -0.593 . . . . 0.0 111.619 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -61.49 121.24 12.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.558 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -155.79 103.3 2.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.302 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.95 126.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.745 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.86 76.21 2.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.895 0.378 . . . . 0.0 110.417 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.03 94.04 2.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 106.27 0.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.351 0.596 . . . . 0.0 110.645 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.36 151.98 20.28 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.943 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -64.01 153.46 37.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.535 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.9 ptp -155.34 -173.8 4.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -34.57 125.1 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.542 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttp 57.35 31.86 20.84 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.529 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 55.43 21.42 27.14 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.713 -0.617 . . . . 0.0 111.708 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' O ' ' SD ' ' A' ' 52' ' ' MET . 29.9 ttp85 -73.31 59.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.115 0.458 . . . . 0.0 110.888 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.47 151.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.253 0.549 . . . . 0.0 111.312 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.59 169.69 41.81 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.534 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.6 p90 -158.16 76.88 3.56 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.45 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' CB ' HH12 ' A' ' 40' ' ' ARG . 50.3 Cg_exo -56.38 143.61 85.98 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.476 2.117 . . . . 0.0 112.541 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.6 mt -137.66 96.61 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.516 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 m -64.79 -28.54 45.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 110.292 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -150.93 146.72 19.58 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -41.68 151.73 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.895 1.73 . . . . 0.0 112.656 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.05 27.94 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.552 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.27 -38.96 3.23 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.992 1.795 . . . . 0.0 112.323 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.43 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.5 p30 -66.7 -21.63 66.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.643 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.43 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 9.7 p -162.62 133.71 4.97 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.436 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.75 177.72 1.34 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 40.1 p90 -58.5 -52.63 64.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.569 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . 43.22 74.09 0.21 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt 53.23 -175.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.936 0.398 . . . . 0.0 110.668 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.2 p -148.83 172.93 13.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 73.99 77.08 0.66 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 74' ' ' GLY . 76.8 mt 50.34 103.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.755 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.3 mm -104.84 123.63 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -136.38 142.97 43.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.679 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.6 9.66 8.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.924 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.71 -92.52 1.8 Allowed Glycine 0 C--O 1.224 -0.47 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.0 mt -156.95 124.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 110.005 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -102.76 126.84 50.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.974 0.416 . . . . 0.0 110.382 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -87.57 2.65 50.22 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.445 0.641 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.33 26.02 6.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.805 0.812 . . . . 0.0 110.708 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -43.9 -26.07 0.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.656 -0.652 . . . . 0.0 111.142 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -56.2 -14.32 2.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.768 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.08 166.37 23.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 82.1 mtt85 -96.72 127.8 43.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.711 0.767 . . . . 0.0 110.413 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 82.8 m95 -155.09 178.61 10.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.07 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 22.6 t70 -75.54 -170.49 1.27 Allowed 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.866 0.729 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.47 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -166.04 159.54 15.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 0.0 111.002 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.98 160.78 17.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 110.265 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.7 t -145.13 177.26 8.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.495 0.664 . . . . 0.0 110.212 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -146.59 130.43 17.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.149 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 96' ' ' HIS . 0.3 OUTLIER -148.62 157.55 41.16 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.336 -179.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.56 5.44 0.12 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.929 1.752 . . . . 0.0 112.238 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 94' ' ' ASN . 83.9 t60 -109.99 94.34 4.97 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.614 0.721 . . . . 0.0 110.463 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.14 -120.49 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.106 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt . . . . . 0 C--N 1.29 -2.009 0 CA-C-O 117.194 -1.384 . . . . 0.0 108.582 175.931 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.28 141.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 110.749 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -148.94 154.97 40.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -79.03 133.98 36.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.504 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -120.29 124.54 45.87 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -113.24 135.44 53.82 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.459 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 145.45 55.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.403 0.62 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -81.43 -50.12 9.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.5 p -113.14 34.56 4.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.487 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.18 -146.1 4.59 Favored Glycine 0 C--O 1.217 -0.928 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.709 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -175.9 -54.59 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -134.35 12.97 3.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -94.15 38.11 1.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.093 0.473 . . . . 0.0 110.442 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.94 131.88 55.34 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.501 0.667 . . . . 0.0 110.584 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.1 p -95.29 168.22 10.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.691 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -60.34 -41.14 93.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.37 66.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.1 -49.4 77.8 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.778 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.81 -30.29 63.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.018 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.3 tttp -69.85 -38.18 76.38 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 120.792 0.33 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.09 75.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.56 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.39 -41.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.631 0.729 . . . . 0.0 110.983 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.0 m -100.35 177.79 4.94 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.968 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 64.31 -15.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' H ' ' C ' ' A' ' 23' ' ' CYS . 67.7 t80 -62.92 -50.18 71.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.985 0.421 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.52 26.29 0.69 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.755 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.07 3.92 90.6 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.9 -151.81 2.83 Favored Glycine 0 C--O 1.219 -0.824 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -168.93 147.07 3.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.424 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.11 149.72 27.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.386 0.612 . . . . 0.0 110.252 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 146.47 53.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -124.63 178.17 5.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -58.27 -52.27 66.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.638 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -49.02 -47.23 44.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.17 -43.86 73.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.293 0.568 . . . . 0.0 110.737 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.58 -42.32 99.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.666 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -60.33 -30.42 69.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.558 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.01 -27.22 54.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.19 56.33 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.819 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -55.37 -30.99 61.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.376 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.63 -3.26 55.93 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 42' ' ' ILE . 33.6 mm -105.81 6.2 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.519 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 17.99 52.98 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.19 126.57 26.72 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 110.546 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.18 128.79 40.74 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.361 0.6 . . . . 0.0 110.577 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 47' ' ' CYS . 84.1 t -139.58 160.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.776 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.505 ' N ' HG12 ' A' ' 46' ' ' VAL . 11.4 t -158.75 33.84 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.702 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' H ' HG12 ' A' ' 46' ' ' VAL . . . -145.29 128.78 17.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.136 0.493 . . . . 0.0 110.533 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.26 131.68 44.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.01 144.05 10.08 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.739 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.464 ' HE1' ' H ' ' A' ' 88' ' ' TRP . 9.4 m95 -65.68 158.11 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.585 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.8 mtm -151.22 -177.69 6.19 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.229 0.538 . . . . 0.0 110.195 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.38 128.54 3.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.576 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 56' ' ' ARG . 72.4 tttt 66.11 37.56 5.12 Favored 'General case' 0 C--O 1.201 -1.481 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.047 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.89 5.87 0.1 Allowed Glycine 0 CA--C 1.54 1.614 0 O-C-N 121.764 -0.585 . . . . 0.0 112.39 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 67.7 ttt-85 -66.38 89.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.257 0.551 . . . . 0.0 110.445 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.1 134.48 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.76 0.79 . . . . 0.0 110.337 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.28 26.28 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.577 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.1 p90 -162.52 81.44 1.71 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.343 -0.429 . . . . 0.0 110.677 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 133.36 57.6 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.22 1.947 . . . . 0.0 112.57 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -118.3 109.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.369 0.604 . . . . 0.0 110.689 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.2 m -84.63 -15.32 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.167 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.87 142.6 2.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.133 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.32 149.75 2.48 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 121.067 1.178 . . . . 0.0 112.709 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -122.17 157.51 16.88 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.526 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.28 -43.21 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.351 1.367 . . . . 0.0 112.178 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.419 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -75.6 -21.3 57.92 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.347 0.594 . . . . 0.0 111.082 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.419 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.7 OUTLIER -124.86 144.0 50.54 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.062 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.44 -172.77 4.93 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.471 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.05 169.42 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.111 0.481 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.49 -25.14 0.07 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.24 -177.92 5.24 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 110.419 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 p -138.52 156.67 47.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.775 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 66.54 164.28 1.72 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' GLY . 76.6 mt -34.25 139.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 115.641 -0.28 . . . . 0.0 111.269 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.43 17.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.648 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 56' ' ' ARG . 2.4 p30 -61.34 126.83 28.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.967 0.413 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -68.73 -43.35 76.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.529 0.681 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.9 -128.4 3.58 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.21 108.46 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 122.243 1.021 . . . . 0.0 110.019 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.71 ' H ' ' NE ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.766 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 84' ' ' ARG . 69.2 mt -90.26 -2.78 58.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.842 0.354 . . . . 0.0 110.593 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -77.64 28.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.732 0.777 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.598 ' HE ' ' NH2' ' A' ' 81' ' ' ARG . 99.4 mtt180 -51.12 -1.22 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.733 -0.605 . . . . 0.0 111.73 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 83' ' ' ASN . 9.2 m -96.9 2.26 51.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -87.02 -158.84 0.46 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.936 0.398 . . . . 0.0 110.564 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 33.4 ptt-85 -155.83 134.19 11.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.608 0.718 . . . . 0.0 110.802 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.2 m0 -147.46 -172.99 4.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.274 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 20.5 t0 -57.89 -148.28 0.0 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.967 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.52 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.77 130.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.641 0.734 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -122.9 157.96 31.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.471 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 93' ' ' TYR . 6.9 t -140.86 -173.8 3.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.746 0.784 . . . . 0.0 110.296 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.402 ' N ' ' SG ' ' A' ' 92' ' ' CYS . 63.7 t80 -155.93 121.55 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.279 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -152.33 147.53 19.72 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.042 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.29 0.84 7.41 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.415 2.077 . . . . 0.0 111.886 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.589 ' CG ' ' H ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -160.96 -113.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.294 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.589 ' H ' ' CG ' ' A' ' 96' ' ' HIS . . . 48.6 -103.0 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 C--N 1.29 -1.987 0 CA-C-O 117.735 -1.126 . . . . 0.0 109.901 175.623 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.25 154.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.128 0.49 . . . . 0.0 110.639 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 4' ' ' HIS . 75.1 t80 -118.98 139.16 52.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' O ' ' CE2' ' A' ' 3' ' ' TYR . 43.8 p-80 -74.77 130.63 39.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -141.23 136.43 31.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.078 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.13 177.49 6.19 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 126.61 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -70.28 -39.47 74.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -112.67 28.55 8.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.95 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.67 -139.05 2.61 Favored Glycine 0 C--O 1.216 -1.028 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.555 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -175.69 -66.98 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.272 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.5 47.61 0.87 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -132.29 31.05 4.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 120.937 0.399 . . . . 0.0 110.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp -118.32 126.09 51.42 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.54 0.686 . . . . 0.0 110.662 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 16' ' ' TYR . 45.4 m -99.5 160.4 14.31 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' N ' HG22 ' A' ' 15' ' ' THR . 41.2 p90 -53.38 -42.71 67.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' A' ' 16' ' ' TYR . . . -55.39 -42.91 74.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.868 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.18 -49.76 47.12 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.662 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.57 -37.84 58.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.037 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.9 tttm -71.34 -32.42 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 110.817 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.33 -54.39 17.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.569 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.21 -36.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.21 0.529 . . . . 0.0 111.029 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 25' ' ' PHE . 2.0 t -103.31 176.23 5.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 65.29 -15.83 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.035 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.3 t80 -61.57 -48.14 82.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 14.4 pt-20 -81.63 20.87 0.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.26 86.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.64 -155.16 1.09 Allowed Glycine 0 C--O 1.219 -0.796 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -170.54 145.26 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.449 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 mt -52.98 141.03 23.26 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.118 0.485 . . . . 0.0 110.564 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.28 106.55 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.9 m -69.92 146.99 50.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 5.4 p90 -53.55 -51.65 62.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.981 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 64.8 tttp -60.82 -45.47 94.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 110.558 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -68.46 -27.21 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -28.26 66.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -51.45 -31.06 21.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.1 73.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.18 -41.64 49.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.767 0.318 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.564 ' NH2' ' N ' ' A' ' 62' ' ' VAL . 37.2 mmm-85 -56.66 -31.86 64.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.83 -10.67 59.73 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.644 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 42' ' ' ILE . 94.6 mt -101.75 4.95 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.558 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.7 14.14 47.92 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.37 128.31 35.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.905 0.383 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -149.39 104.72 3.4 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.456 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.83 129.49 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.912 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -93.78 96.21 9.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.516 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.46 95.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.7 131.74 44.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.29 159.44 27.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.88 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -70.82 104.56 2.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 66.8 mtm -96.75 -175.56 3.33 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.219 0.533 . . . . 0.0 110.236 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.06 158.92 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.524 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 56' ' ' ARG . 63.0 mttp 50.63 38.02 17.89 Favored 'General case' 0 C--O 1.2 -1.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.72 0.46 0.03 OUTLIER Glycine 0 CA--C 1.54 1.603 0 O-C-N 121.878 -0.514 . . . . 0.0 112.062 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.5 mtt180 -69.55 149.06 48.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.141 0.496 . . . . 0.0 110.475 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.63 141.63 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.441 1.115 . . . . 0.0 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.73 166.66 30.34 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.415 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -128.7 107.19 18.65 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.46 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.51 119.47 4.51 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.544 1.496 . . . . 0.0 112.486 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.516 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 4.4 pt -148.83 93.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.722 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.564 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 56.3 t -49.28 -21.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.282 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -142.92 146.28 36.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.12 154.51 0.79 Allowed 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.579 1.519 . . . . 0.0 112.622 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.25 154.5 26.0 Favored Glycine 0 CA--C 1.543 1.834 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.735 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.79 -41.47 1.07 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.079 1.852 . . . . 0.0 112.353 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.62 -40.68 92.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.64 145.05 25.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.665 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.23 176.92 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.619 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -70.79 139.74 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.471 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.4 135.41 1.88 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.615 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.09 -47.36 84.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.851 0.358 . . . . 0.0 110.177 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.484 ' O ' HD11 ' A' ' 76' ' ' ILE . 62.6 p -132.66 165.17 25.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.284 0.564 . . . . 0.0 110.904 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . -84.28 -155.49 22.21 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 77' ' ' ASP . 40.5 mt 68.88 -7.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' O ' ' A' ' 73' ' ' THR . 38.6 mt -63.55 67.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.623 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' ILE . 2.4 p30 -85.71 151.2 24.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.446 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -89.48 -139.38 0.13 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.628 0.727 . . . . 0.0 110.184 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.68 95.56 0.18 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.8 mt 45.27 96.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.62 0.248 . . . . 0.0 110.674 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.433 ' O ' ' NH1' ' A' ' 84' ' ' ARG . 78.9 mtp180 -94.78 141.29 28.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.033 0.444 . . . . 0.0 110.081 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -79.58 3.98 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.604 0.716 . . . . 0.0 110.6 -179.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.466 ' N ' HD12 ' A' ' 82' ' ' LEU . 31.9 t30 -80.19 15.22 1.61 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.801 0.81 . . . . 0.0 110.304 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH1' ' O ' ' A' ' 81' ' ' ARG . 88.8 mtm-85 -58.72 -5.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.593 -0.692 . . . . 0.0 110.868 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -73.27 -35.58 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.646 0.26 . . . . 0.0 110.916 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -81.18 158.3 24.96 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.277 0.561 . . . . 0.0 110.617 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -86.84 149.11 25.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.734 0.778 . . . . 0.0 110.619 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -154.41 177.43 11.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.0 -172.56 2.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.647 0.737 . . . . 0.0 110.755 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -167.04 166.67 15.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.338 0.589 . . . . 0.0 111.053 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.88 156.86 46.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.953 0.882 . . . . 0.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.0 t -124.41 -167.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -159.21 145.96 16.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.999 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 26' ' ' GLU . 12.1 m120 -149.75 143.88 17.18 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.287 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.84 6.46 3.74 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.901 1.734 . . . . 0.0 111.93 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -56.93 -44.91 82.93 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.118 0.261 . . . . 0.0 110.67 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.69 -68.51 0.31 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 C--N 1.289 -2.057 0 CA-C-O 117.837 -1.078 . . . . 0.0 108.28 175.5 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 t -84.49 136.52 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.656 0.265 . . . . 0.0 110.798 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.509 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 22.2 p90 -146.94 159.39 43.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.811 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -74.9 148.82 39.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.381 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.509 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 25.5 mmt180 -123.55 157.34 33.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.228 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -157.93 120.68 3.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.191 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 166.57 12.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.907 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.51 -36.62 81.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -64.81 -32.92 74.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.367 0.604 . . . . 0.0 110.632 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.71 177.73 23.19 Favored Glycine 0 C--O 1.216 -0.994 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.661 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.07 -105.14 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.328 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -68.8 69.92 0.18 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.665 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -144.41 29.08 1.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.787 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' TRP . 23.5 mt -123.36 143.36 50.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.8 p -95.69 168.51 10.62 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.753 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.579 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 26.5 p90 -46.9 -56.15 6.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -53.07 -42.29 65.69 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.969 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.54 -26.73 68.02 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.947 0.404 . . . . 0.0 110.555 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.95 -36.97 67.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -71.05 -30.63 66.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.222 0.534 . . . . 0.0 110.555 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.01 -49.3 75.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.614 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.56 -28.9 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.352 0.596 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.598 ' C ' ' H ' ' A' ' 25' ' ' PHE . 82.2 m -105.28 179.16 4.35 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.029 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 15.3 mp0 64.6 -28.29 0.1 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.887 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' H ' ' C ' ' A' ' 23' ' ' CYS . 59.4 t80 -62.18 -45.26 94.18 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.803 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -95.71 9.18 41.26 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.97 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.42 -4.06 66.55 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.32 -175.16 44.75 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -154.33 162.41 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.831 -0.185 . . . . 0.0 110.705 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 30' ' ' LEU . 9.4 mp -71.09 147.23 48.68 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.087 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.71 151.31 38.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.075 0.464 . . . . 0.0 110.806 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 m -125.02 156.66 37.79 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.155 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -54.05 -21.31 8.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.397 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -76.01 -57.24 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.117 0.484 . . . . 0.0 110.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.73 -33.13 73.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.47 -42.46 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.59 -34.76 77.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.555 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.4 -33.9 73.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 110.957 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -23.62 28.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.695 ' HE ' ' HB2' ' A' ' 60' ' ' PRO . 3.8 tpt85 -60.85 -42.55 98.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.567 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -60.87 -2.45 0.57 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 40' ' ' ARG . 18.5 mm -101.23 17.19 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.33 19.99 79.79 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.37 105.03 0.3 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.156 0.478 . . . . 0.0 110.39 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -95.48 133.65 39.22 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.389 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 47' ' ' CYS . 18.3 t -137.39 159.37 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 68' ' ' CYS . 2.9 t -156.11 42.03 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.752 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.68 125.18 3.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 110.723 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.38 138.74 45.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.38 152.79 24.81 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.924 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -68.07 101.96 1.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.062 0.458 . . . . 0.0 109.954 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 58' ' ' GLY . 1.4 mtp -91.38 166.29 12.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.649 0.738 . . . . 0.0 109.852 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' MET . . . -39.48 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.59 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt 58.68 7.52 0.76 Allowed 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.373 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.89 87.17 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.814 -0.554 . . . . 0.0 112.106 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -76.29 131.93 39.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.005 0.403 . . . . 0.0 110.632 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.81 112.5 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.855 0.836 . . . . 0.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -166.53 177.85 41.22 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.541 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 61' ' ' ILE . 7.1 p90 -167.84 142.28 2.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.745 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.695 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 72.8 Cg_endo -72.35 147.17 46.58 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.001 1.801 . . . . 0.0 112.651 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.447 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 17.7 mt -139.68 93.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.842 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.61 -41.85 86.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.346 0.593 . . . . 0.0 110.542 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -136.95 101.42 9.46 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.73 130.04 14.91 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.815 1.677 . . . . 0.0 112.474 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.91 22.04 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.397 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.99 -51.75 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.335 2.023 . . . . 0.0 112.241 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -67.54 -37.24 82.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 1.5 p -152.24 123.05 7.45 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.361 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 178.69 -26.63 0.05 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 90.1 t80 52.9 -85.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 110.763 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -172.98 -172.99 39.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 54.08 -171.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 0.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.58 HG22 ' N ' ' A' ' 74' ' ' GLY . 35.6 m -144.86 167.24 23.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.207 0.527 . . . . 0.0 110.63 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.58 ' N ' HG22 ' A' ' 73' ' ' THR . . . 93.64 -151.7 20.45 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.1 mt -100.97 128.61 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.392 . . . . 0.0 110.39 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.7 mt -132.03 71.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.415 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.23 135.03 34.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.842 0.353 . . . . 0.0 110.579 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.39 110.67 22.67 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.059 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.92 95.95 0.01 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.5 mt 49.39 100.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.756 0.312 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.562 ' NH1' ' NE1' ' A' ' 88' ' ' TRP . 70.6 mtp180 -68.81 148.07 50.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 84' ' ' ARG . 10.9 mp -74.95 -28.78 60.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.885 0.85 . . . . 0.0 110.555 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 85' ' ' SER . 0.7 OUTLIER -73.18 32.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.028 0.918 . . . . 0.0 110.759 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' LEU . 66.0 mtp180 -48.65 -6.99 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.632 -0.667 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 83' ' ' ASN . 32.5 t -87.19 -8.2 57.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.987 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -91.39 147.57 22.94 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -83.31 152.36 25.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.266 0.555 . . . . 0.0 110.51 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.562 ' NE1' ' NH1' ' A' ' 81' ' ' ARG . 73.5 m95 -156.02 179.12 9.52 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.326 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 11.8 t70 -76.05 -161.54 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.826 0.822 . . . . 0.0 110.471 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.08 152.7 6.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.783 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.15 158.75 38.85 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.726 . . . . 0.0 110.408 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -133.11 -173.28 3.16 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.613 0.721 . . . . 0.0 110.138 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -155.29 113.4 3.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -117.41 85.81 20.95 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.85 10.29 3.57 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.48 2.12 . . . . 0.0 112.355 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.635 ' CG ' ' H ' ' A' ' 97' ' ' ALA . 2.0 p-80 -144.46 -62.92 0.37 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.635 ' H ' ' CG ' ' A' ' 96' ' ' HIS . . . -61.61 -33.39 73.84 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.2 tttp . . . . . 0 C--N 1.289 -2.035 0 CA-C-O 116.954 -1.498 . . . . 0.0 108.034 176.918 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 t -84.89 145.87 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.63 0.252 . . . . 0.0 111.094 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -161.23 156.54 24.31 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.032 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.69 116.23 25.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.486 0.66 . . . . 0.0 110.752 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -103.85 121.5 43.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -103.85 130.7 51.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.545 0.528 . . . . 0.0 110.362 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.23 172.5 13.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -60.32 -34.7 74.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.967 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.548 ' O ' ' C ' ' A' ' 10' ' ' GLY . 73.9 m -82.14 -20.21 38.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.513 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 16.57 81.79 0.01 OUTLIER Glycine 0 N--CA 1.494 2.541 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.267 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -172.52 37.67 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 120.923 0.392 . . . . 0.0 110.398 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 52.25 62.01 2.91 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -132.08 31.83 4.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.698 0.285 . . . . 0.0 110.694 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -122.09 128.24 51.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -98.16 170.55 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.642 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 30.3 p90 -51.45 -60.14 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.584 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.39 -37.28 56.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.883 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -67.97 -49.61 60.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -34.92 58.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.645 0.26 . . . . 0.0 110.861 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 23' ' ' CYS . 71.0 mmtt -61.84 -41.88 98.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.551 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.55 -49.43 77.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.63 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -58.1 -37.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.498 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 25' ' ' PHE . 3.4 m -101.76 -179.27 3.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 94.4 mt-10 71.04 -18.79 0.26 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.5 t80 -60.39 -45.94 91.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.213 0.53 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -86.57 15.87 5.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.528 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 7.69 87.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -86.5 -158.55 31.77 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -162.96 156.51 19.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.735 -0.233 . . . . 0.0 110.409 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.6 mp -69.16 136.66 52.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.116 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.45 122.52 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 35' ' ' GLN . 9.0 t -103.83 178.72 4.48 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -52.49 -52.48 54.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -57.76 -44.94 86.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.568 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.405 ' H ' HG23 ' A' ' 32' ' ' THR . 69.2 tp60 -70.37 -37.7 74.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.88 -43.01 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.414 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -55.69 -47.43 76.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.82 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -32.23 71.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.077 0.465 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.24 -29.14 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.516 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.477 HH22 HG12 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -60.91 -40.52 93.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.502 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -60.49 -4.03 0.8 Allowed 'General case' 0 N--CA 1.458 -0.05 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 40' ' ' ARG . 16.8 mm -99.18 22.9 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.385 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.51 28.93 71.83 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -70.29 126.09 28.64 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.663 -0.316 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.465 ' CD2' ' CG2' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -149.98 103.69 3.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.175 0.512 . . . . 0.0 110.37 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -140.16 129.94 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 14.8 t -90.72 69.34 6.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.331 0.586 . . . . 0.0 110.279 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB1' ' OH ' ' A' ' 91' ' ' TYR . . . -148.63 95.26 2.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.653 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.97 153.2 36.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.75 171.76 36.94 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.889 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -85.37 105.0 15.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.528 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -93.27 176.52 6.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.145 0.497 . . . . 0.0 110.302 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -35.49 153.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 54.8 8.91 0.25 Allowed 'General case' 0 C--O 1.199 -1.562 0 CA-C-O 121.089 0.471 . . . . 0.0 110.12 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 53' ' ' ALA . . . 74.75 20.68 79.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.941 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.566 ' HE ' ' CG ' ' A' ' 77' ' ' ASP . 63.0 ttt180 -77.09 140.05 40.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.646 0.26 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.14 134.95 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.677 0.751 . . . . 0.0 110.972 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.36 113.95 0.7 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -109.27 156.27 39.64 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-O 120.415 0.15 . . . . 0.0 110.755 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.32 133.13 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.446 1.431 . . . . 0.0 112.044 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 73' ' ' THR . 3.4 mt -144.33 95.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.588 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.477 HG12 HH22 ' A' ' 40' ' ' ARG . 0.2 OUTLIER -47.11 -38.55 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.67 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -149.02 147.73 24.85 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.824 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -52.87 139.28 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.986 1.124 . . . . 0.0 112.456 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.46 177.9 22.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.862 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.63 -51.0 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.628 1.552 . . . . 0.0 112.153 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -66.92 -27.71 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.682 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.08 151.39 21.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.193 0.521 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 70' ' ' PHE . . . -164.37 -5.56 0.04 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.407 ' H ' ' H ' ' A' ' 69' ' ' GLY . 42.3 t80 -68.33 -1.88 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.3 0.571 . . . . 0.0 110.315 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.3 -165.82 26.34 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.576 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.15 79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.614 0.245 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER 176.81 173.79 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.459 0.647 . . . . 0.0 110.319 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -46.7 -95.39 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.5 mt -99.34 108.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.477 0.656 . . . . 0.0 110.208 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 pt -105.87 45.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.834 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 34.7 t0 -89.0 118.98 29.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.025 0.441 . . . . 0.0 110.721 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -67.15 -64.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.553 0.692 . . . . 0.0 110.33 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 130.04 95.12 0.73 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 111.844 -0.503 . . . . 0.0 111.844 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 79' ' ' GLY . 70.1 mt 56.76 129.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.762 0.792 . . . . 0.0 110.993 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -111.61 143.04 43.13 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.512 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.0 mm? -86.73 -8.5 57.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.377 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -108.55 23.79 14.0 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.49 0.716 . . . . 0.0 111.072 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 86' ' ' GLU . 80.4 mtm180 -44.37 -27.47 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.672 -0.643 . . . . 0.0 111.432 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -47.07 -17.09 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.004 0.19 . . . . 0.0 110.956 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -60.89 -176.64 0.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 179.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 68.5 mtp85 -125.19 136.63 53.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.026 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.2 m95 -153.01 -176.64 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.141 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -73.07 -167.58 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -153.23 146.97 25.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.141 0.496 . . . . 0.0 111.108 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.499 ' OH ' ' HB1' ' A' ' 48' ' ' ALA . 17.6 m-85 -140.61 160.74 39.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.775 0.798 . . . . 0.0 110.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.5 m -136.44 -165.8 1.78 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.108 0.956 . . . . 0.0 110.06 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -141.04 151.13 43.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.271 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 96' ' ' HIS . 4.2 m120 -134.34 149.21 70.58 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.856 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.79 23.93 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 121.564 1.509 . . . . 0.0 111.644 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 94' ' ' ASN . 6.3 m-70 -80.21 -159.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.822 0.344 . . . . 0.0 110.329 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 52.74 77.43 0.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.185 0.517 . . . . 0.0 110.548 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.29 -2.015 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.828 177.197 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.38 132.75 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' OH ' ' CZ ' ' A' ' 5' ' ' ARG . 31.4 p90 -103.03 155.24 18.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -73.02 126.12 29.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.498 0.666 . . . . 0.0 110.548 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' CZ ' ' OH ' ' A' ' 3' ' ' TYR . 89.5 mtt-85 -101.91 167.29 10.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.384 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -163.56 120.42 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.24 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.89 169.53 17.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.33 -40.64 81.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.597 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 t -70.85 -24.36 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.402 0.62 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.62 -170.82 22.9 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 13' ' ' LYS . 26.1 pttm -108.37 -173.39 2.27 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 42.23 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' LYS . 64.9 mttm -133.28 28.86 4.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.66 0.384 . . . . 0.0 110.696 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 88' ' ' TRP . 33.1 mt -124.82 135.37 52.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.233 0.539 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 16' ' ' TYR . 85.6 m -89.84 161.1 16.15 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.589 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.518 ' N ' HG22 ' A' ' 15' ' ' THR . 32.6 t80 -49.89 -59.52 3.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.22 75.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.22 -49.15 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.584 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.37 32.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 16.2 tptp -58.62 -40.19 82.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.116 0.484 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -48.25 78.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.316 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.58 -22.09 17.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.426 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.505 ' C ' ' H ' ' A' ' 25' ' ' PHE . 53.3 m -103.94 179.48 4.26 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.567 0.698 . . . . 0.0 109.518 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 70.8 mt-10 70.6 -19.08 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.16 -46.29 91.13 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 110.837 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.2 5.46 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.9 51.42 2.64 Favored Glycine 0 N--CA 1.472 1.097 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.05 -152.87 5.73 Favored Glycine 0 N--CA 1.47 0.901 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.02 179.02 7.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.92 142.49 51.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.29 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.93 148.04 48.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.24 0.543 . . . . 0.0 110.811 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 34' ' ' LYS . 7.2 m -123.54 149.41 45.27 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CD1' ' NH2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -61.09 -20.89 63.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.215 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' H ' HG22 ' A' ' 32' ' ' THR . 37.0 ttmt -75.87 -57.12 4.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.095 0.474 . . . . 0.0 110.739 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -68.82 -31.86 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 111.015 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.5 -36.11 79.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.368 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -49.9 -29.41 8.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.002 0.429 . . . . 0.0 110.661 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.39 -25.57 33.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.413 0.625 . . . . 0.0 111.025 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.69 -42.53 17.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -56.04 -34.7 66.13 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.29 -23.57 56.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 mm -82.5 24.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.92 24.19 74.35 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.66 128.73 37.08 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.517 ' CE1' ' H ' ' A' ' 63' ' ' LYS . 58.4 t60 -135.74 110.25 8.54 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.445 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.21 112.3 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.738 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -93.72 73.75 4.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.09 118.99 8.7 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.228 0.537 . . . . 0.0 110.778 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.25 134.19 36.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.54 -143.7 4.21 Favored Glycine 0 N--CA 1.476 1.3 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -130.8 105.93 8.11 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 15.1 mmt -91.54 156.13 17.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.267 0.556 . . . . 0.0 109.647 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.03 169.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.53 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.64 38.53 30.28 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.84 6.36 0.32 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' NH2' ' CD1' ' A' ' 33' ' ' TYR . 25.3 mtp180 -84.31 162.99 19.88 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.424 0.631 . . . . 0.0 110.598 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 p -142.2 135.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.723 0.773 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.01 157.15 26.78 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 26.9 p90 -165.89 80.82 1.11 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.795 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.95 143.82 59.14 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.026 1.817 . . . . 0.0 112.677 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -132.02 91.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.414 0.626 . . . . 0.0 110.707 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.41 -20.23 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 60.0 mttp -140.94 86.33 11.72 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.95 136.8 52.65 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.02 1.813 . . . . 0.0 112.218 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.26 173.91 15.2 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.405 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.46 -47.15 3.26 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.06 1.84 . . . . 0.0 112.284 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 68' ' ' CYS . 39.2 p-10 -66.71 -36.62 82.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.704 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 23.0 p -153.55 119.39 5.33 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.049 0.452 . . . . 0.0 110.477 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 88.54 0.09 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -64.97 161.23 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.946 0.403 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.55 99.71 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -70.62 166.65 20.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.871 0.367 . . . . 0.0 110.563 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.4 p -139.64 159.83 41.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.17 -140.66 15.17 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.9 mt -89.24 119.17 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.925 0.393 . . . . 0.0 110.556 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.73 98.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.407 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 59.3 t0 -98.39 141.79 30.83 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 110.322 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 25.3 m-85 -129.99 147.51 51.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.669 0.747 . . . . 0.0 110.05 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.79 -78.73 0.46 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.8 mt -157.81 108.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -69.08 140.95 54.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.329 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.2 mt -85.49 -10.23 56.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.335 0.588 . . . . 0.0 110.777 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.62 ' C ' HD21 ' A' ' 83' ' ' ASN . 0.2 OUTLIER -83.27 22.6 0.98 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.474 0.654 . . . . 0.0 110.379 179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -52.0 -5.84 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.644 -0.66 . . . . 0.0 111.361 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 83' ' ' ASN . 62.8 m -91.89 -5.13 53.81 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.838 0.351 . . . . 0.0 110.856 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.29 -152.8 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.399 0.619 . . . . 0.0 110.422 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 83.3 mtt85 -142.94 151.2 40.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.817 0.818 . . . . 0.0 110.564 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 86.2 m95 -154.9 177.37 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.267 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 36.2 t0 -60.45 -156.06 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.816 0.698 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.541 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.68 141.95 2.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.168 0.509 . . . . 0.0 110.947 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.408 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 16.3 m-85 -140.34 142.25 35.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.52 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.437 ' SG ' ' NE ' ' A' ' 5' ' ' ARG . 49.8 m -115.56 -167.33 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.827 0.822 . . . . 0.0 110.077 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -156.42 143.68 19.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.455 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.11 148.95 22.18 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -40.53 154.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.505 2.165 0 C-N-CA 122.345 2.03 . . . . 0.0 112.985 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -57.13 107.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.795 0.807 . . . . 0.0 110.66 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.19 -36.36 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.873 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt . . . . . 0 C--N 1.292 -1.91 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.13 176.485 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.06 148.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 110.815 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.62 162.51 35.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -73.51 132.63 43.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.656 HH21 ' N ' ' A' ' 91' ' ' TYR . 73.5 mtm180 -117.99 149.22 41.31 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.502 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -154.78 125.02 6.78 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.594 0.559 . . . . 0.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.08 179.11 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.461 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -61.07 -48.62 80.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.504 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -87.39 -2.8 58.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.205 0.526 . . . . 0.0 110.513 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.23 66.59 0.68 Allowed Glycine 0 N--CA 1.472 1.068 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -143.99 41.82 1.42 Allowed 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.747 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 45.78 28.98 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.678 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.48 39.87 0.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.283 0.563 . . . . 0.0 110.825 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' TRP . 6.1 tp -120.31 127.74 52.64 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.781 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.8 p -90.94 167.75 12.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.529 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -61.23 -48.01 83.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.337 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.92 71.47 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.05 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.7 -50.16 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.736 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.55 -31.6 24.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' CYS . 26.1 mtpp -64.6 -34.92 79.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.428 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.16 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.65 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.04 -40.87 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.323 0.582 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.586 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.2 t -100.53 175.69 5.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.907 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 63.22 -15.84 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.7 t80 -61.87 -49.1 77.61 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.92 22.52 0.38 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.765 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.91 89.58 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.31 -148.8 4.7 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -164.66 152.97 12.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.666 0.27 . . . . 0.0 110.631 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.15 145.18 54.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.051 0.453 . . . . 0.0 110.224 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -64.03 107.33 1.23 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.903 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 p -88.01 167.14 13.95 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.552 ' HB2' ' HE ' ' A' ' 56' ' ' ARG . 69.6 t80 -54.66 -53.61 52.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.983 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -55.75 -43.86 77.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.993 0.425 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.26 -32.23 68.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -40.58 95.29 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -51.56 -49.38 62.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.25 64.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.431 . . . . 0.0 110.649 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.78 -37.02 31.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.2 -27.83 62.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -78.2 -4.55 48.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.67 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 42' ' ' ILE . 76.9 mt -96.0 8.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.478 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.52 21.45 44.08 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -69.38 131.78 45.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 122.741 -0.27 . . . . 0.0 110.354 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -149.89 105.28 3.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.076 0.465 . . . . 0.0 110.469 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.19 118.02 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.83 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.4 t -91.88 84.05 5.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.191 0.52 . . . . 0.0 110.293 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.25 94.73 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.635 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.2 46.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.82 -172.42 13.92 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.931 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.7 156.74 17.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.527 0.679 . . . . 0.0 110.47 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 56' ' ' ARG . 67.4 mtm -148.09 175.02 11.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.99 147.74 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.299 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 56' ' ' ARG . 9.0 mtmp? 57.69 40.43 26.49 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.659 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.2 7.72 0.58 Allowed Glycine 0 CA--C 1.532 1.13 0 O-C-N 121.794 -0.566 . . . . 0.0 111.8 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.552 ' HE ' ' HB2' ' A' ' 33' ' ' TYR . 32.2 ttt85 -68.14 146.42 53.45 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.321 0.581 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.15 162.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.668 0.747 . . . . 0.0 110.807 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.02 169.25 39.57 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.492 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 76' ' ' ILE . 3.8 p90 -154.95 79.89 4.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.386 -0.407 . . . . 0.0 110.322 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.44 128.97 32.67 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.21 1.94 . . . . 0.0 112.682 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.38 103.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.61 -24.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.304 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -161.76 143.81 8.72 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.567 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -41.23 166.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.717 1.612 . . . . 0.0 112.85 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.9 166.8 39.75 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.68 -41.89 13.53 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.403 2.068 . . . . 0.0 112.212 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -66.11 -36.06 82.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.43 . . . . 0.0 110.327 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.9 p -156.53 146.41 21.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.491 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -159.85 44.02 0.44 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -73.66 142.74 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.55 -104.69 0.89 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -162.95 -63.49 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.888 0.375 . . . . 0.0 110.469 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -145.72 171.1 15.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.387 0.613 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -153.33 20.46 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.6 mt -99.57 -60.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.755 0.312 . . . . 0.0 110.827 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.482 ' O ' ' CZ ' ' A' ' 59' ' ' TYR . 52.3 mt 56.88 105.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.317 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.467 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 4.8 p30 -136.37 148.98 48.11 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.03 0.443 . . . . 0.0 110.946 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -72.82 -72.4 0.25 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.619 0.723 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.05 -135.17 5.14 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -88.69 107.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.399 0.619 . . . . 0.0 110.151 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -94.16 129.79 40.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.44 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.17 0.14 54.35 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.424 0.631 . . . . 0.0 110.85 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.452 HD22 ' C ' ' A' ' 83' ' ' ASN . 0.4 OUTLIER -87.73 23.6 1.95 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.328 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -45.1 -24.32 0.23 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.617 -0.677 . . . . 0.0 111.662 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 m -50.54 -23.03 2.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.751 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.24 -168.26 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 0.0 110.813 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.25 139.22 44.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.391 0.615 . . . . 0.0 110.946 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' LEU . 86.8 m95 -154.18 176.2 12.54 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.451 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.0 t70 -71.23 -169.65 0.41 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.361 0.601 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.9 161.05 10.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.158 0.504 . . . . 0.0 111.002 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.656 ' N ' HH21 ' A' ' 5' ' ' ARG . 96.7 m-85 -138.57 152.81 48.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.636 0.732 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.2 t -129.99 144.48 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.431 ' OH ' ' CE1' ' A' ' 96' ' ' HIS . 85.0 t80 -119.48 122.0 40.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.359 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -109.13 169.83 6.04 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.063 -179.049 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.55 140.29 75.27 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 121.942 1.761 . . . . 0.0 112.146 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.431 ' CE1' ' OH ' ' A' ' 93' ' ' TYR . 69.9 m80 -46.84 122.72 4.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.32 0.581 . . . . 0.0 110.785 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.61 32.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.742 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.554 ' HZ1' HG21 ' A' ' 42' ' ' ILE . 19.9 ptmt . . . . . 0 C--N 1.29 -1.997 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.153 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -83.8 151.92 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -126.75 126.94 44.29 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.559 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -76.02 148.48 38.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.48 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -133.18 143.19 49.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.07 146.64 30.05 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.263 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.93 132.4 46.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.95 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -81.04 -49.13 11.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.1 m -112.41 -33.85 6.06 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.61 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.57 177.75 53.98 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -134.69 95.82 3.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.453 0.644 . . . . 0.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 53.13 70.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.72 40.54 1.85 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.774 0.321 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 88' ' ' TRP . 46.3 mt -117.61 122.49 43.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -100.68 166.1 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.17 0.51 . . . . 0.0 110.723 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -49.11 -58.86 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -42.48 59.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.021 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.9 -26.56 66.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.526 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.46 76.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.038 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' CYS . 51.4 mtmt -67.17 -24.29 65.86 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.567 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.12 -55.46 9.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.634 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 23' ' ' CYS . 8.5 p -67.77 -44.7 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 0.0 111.199 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' LYS . 3.7 m -114.31 162.09 17.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.308 0.575 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 23' ' ' CYS . 48.8 tt0 84.33 -46.11 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.813 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -62.73 -46.37 88.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.048 0.451 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.23 16.8 0.71 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.946 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.6 60.72 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -153.18 0.02 OUTLIER Glycine 0 C--O 1.218 -0.883 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -173.25 143.5 1.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 73.6 mt -78.18 136.23 37.78 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.158 0.286 . . . . 0.0 110.541 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.32 132.38 48.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.252 0.549 . . . . 0.0 111.082 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.38 167.1 14.85 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.121 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -50.49 -22.21 1.83 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.693 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -75.25 -57.96 3.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.172 0.51 . . . . 0.0 110.684 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.458 ' NE2' ' CG ' ' A' ' 93' ' ' TYR . 33.1 mt-30 -70.78 -34.87 72.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.7 mt -61.1 -39.76 91.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.441 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -57.78 -31.05 66.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.673 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 -24.33 48.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.338 0.589 . . . . 0.0 110.956 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.3 -45.31 33.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.45 HH21 HG12 ' A' ' 62' ' ' VAL . 20.2 mmm-85 -52.98 -31.55 41.41 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -69.46 -4.32 18.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.571 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.654 HG22 ' O ' ' A' ' 42' ' ' ILE . 74.3 mt -108.86 15.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.443 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.16 16.75 71.12 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.29 143.06 58.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.904 0.352 . . . . 0.0 110.343 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -155.35 107.91 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.356 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 46' ' ' VAL . 17.6 m -139.0 111.56 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.817 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.26 75.06 6.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.238 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.52 135.29 11.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.32 139.38 31.72 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.47 -174.26 21.41 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.804 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -94.12 143.27 26.52 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -145.3 173.41 12.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.142 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.78 142.86 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.685 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 62.17 14.95 7.05 Favored 'General case' 0 C--O 1.201 -1.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.48 16.98 68.15 Favored Glycine 0 CA--C 1.527 0.822 0 O-C-N 121.831 -0.543 . . . . 0.0 111.964 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.745 HH22 ' H ' ' A' ' 78' ' ' TYR . 51.6 ttt-85 -70.84 161.41 31.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.977 0.418 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.18 148.57 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 122.269 1.033 . . . . 0.0 110.458 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.77 168.28 40.57 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.405 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -154.64 76.79 5.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.334 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.77 133.1 49.02 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.474 2.116 . . . . 0.0 112.692 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -147.19 145.11 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.124 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.45 HG12 HH21 ' A' ' 40' ' ' ARG . 29.4 m -82.12 -30.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -152.68 152.15 28.11 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.427 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.3 151.32 2.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.026 1.818 . . . . 0.0 112.324 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.96 166.88 27.38 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.793 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.17 -48.44 19.45 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.833 1.689 . . . . 0.0 112.737 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -64.94 -27.34 68.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.5 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.43 144.93 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.94 -12.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -55.64 -36.42 66.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.408 . . . . 0.0 110.775 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.88 -166.39 6.64 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -73.43 -162.18 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.534 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 166.69 22.19 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.268 0.556 . . . . 0.0 110.819 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 67.76 67.03 2.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' O ' ' A' ' 74' ' ' GLY . 4.5 mt 53.23 125.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.572 -0.314 . . . . 0.0 111.071 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -119.91 91.03 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.569 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -66.89 143.39 56.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.924 0.392 . . . . 0.0 110.583 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.745 ' H ' HH22 ' A' ' 56' ' ' ARG . 59.2 m-85 -132.66 -96.59 0.31 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.523 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.42 -155.38 17.61 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.394 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.85 123.27 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.723 0.773 . . . . 0.0 110.079 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.48 141.92 34.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.186 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -82.65 -2.57 54.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 85' ' ' SER . 47.4 p-10 -77.83 25.69 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.84 0.828 . . . . 0.0 110.649 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 82' ' ' LEU . 33.4 mtp-105 -49.4 -4.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.599 -0.688 . . . . 0.0 111.783 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 83' ' ' ASN . 72.2 p -83.1 -32.12 26.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -76.91 -163.65 0.37 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 110.692 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.432 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 60.9 mtt85 -139.27 154.24 47.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.52 0.676 . . . . 0.0 110.62 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' LEU . 81.1 m95 -154.13 174.99 13.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 23.9 t0 -61.06 -175.99 0.05 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.727 0.775 . . . . 0.0 110.972 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -157.23 150.85 24.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 111.069 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -118.94 159.58 23.55 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.525 0.679 . . . . 0.0 110.641 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -134.8 175.18 9.79 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.774 0.797 . . . . 0.0 110.216 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CG ' ' NE2' ' A' ' 35' ' ' GLN . 4.6 t80 -159.9 134.48 7.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.825 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -145.35 148.59 38.11 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.101 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -72.85 13.27 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.432 2.088 . . . . 0.0 111.753 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -140.8 21.7 2.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.678 0.275 . . . . 0.0 110.35 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.79 -68.71 0.3 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.056 0.931 . . . . 0.0 108.535 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? . . . . . 0 C--N 1.29 -2.004 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 176.219 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.467 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.6 m -154.19 137.73 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.779 0.324 . . . . 0.0 110.698 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -123.12 123.68 41.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.401 ' O ' ' ND1' ' A' ' 4' ' ' HIS . 5.1 p80 -86.86 149.32 24.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.527 HH22 HD21 ' A' ' 94' ' ' ASN . 75.4 mtt85 -143.77 147.62 34.43 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.228 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -146.43 158.33 43.88 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.26 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.41 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.06 -35.82 72.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.453 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 p -111.01 19.89 18.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.628 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.01 -137.6 2.92 Favored Glycine 0 C--O 1.216 -1.03 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.657 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -171.93 -42.67 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.301 -0.449 . . . . 0.0 110.468 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -143.3 67.34 1.3 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -137.02 37.59 2.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.254 0.221 . . . . 0.0 110.533 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -120.98 123.92 43.62 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.451 0.643 . . . . 0.0 110.384 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 16' ' ' TYR . 52.4 m -100.37 163.19 12.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.581 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.516 ' N ' HG22 ' A' ' 15' ' ' THR . 13.5 t80 -51.45 -52.33 47.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.8 -42.03 83.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.88 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.64 -51.5 59.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.775 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.82 -30.71 15.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.014 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -70.51 -33.22 70.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.46 21.5 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.849 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.29 -26.61 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.084 0.469 . . . . 0.0 110.365 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.491 ' C ' ' H ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -104.75 177.28 4.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.593 0.711 . . . . 0.0 109.385 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 28' ' ' GLY . 96.5 mt-10 67.67 -10.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.705 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.8 t80 -62.57 -47.75 82.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 0.0 110.789 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.9 pm0 -92.16 9.45 33.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.772 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.77 -17.16 56.84 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -82.69 127.28 7.89 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -100.1 173.17 6.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.639 0.257 . . . . 0.0 110.538 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' H ' HD12 ' A' ' 30' ' ' LEU . 2.0 mp -65.39 135.8 55.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.23 0.77 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.056 0.455 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.566 ' CG2' ' NE2' ' A' ' 35' ' ' GLN . 1.5 t -72.43 179.85 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.778 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.471 ' N ' ' OG1' ' A' ' 32' ' ' THR . 64.4 t80 -56.0 -54.58 43.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.936 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -53.4 -50.47 65.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.845 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.566 ' NE2' ' CG2' ' A' ' 32' ' ' THR . 1.4 mp0 -66.18 -38.91 89.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.372 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 mt -61.67 -42.52 99.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.474 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.62 -50.46 73.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.717 0.294 . . . . 0.0 110.789 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.81 -33.13 55.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -84.33 -39.67 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.109 0.48 . . . . 0.0 111.226 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -30.16 21.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.286 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.16 -2.78 11.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.523 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.6 tp -92.45 9.46 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.112 0.258 . . . . 0.0 110.475 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.6 26.65 34.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -75.96 136.32 40.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.019 0.409 . . . . 0.0 110.449 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -154.02 103.04 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.55 129.05 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.757 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 t -93.96 83.46 4.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.494 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.54 95.79 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 134.91 54.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 0.0 110.779 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -140.85 170.64 24.43 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -81.51 156.75 25.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 4.8 mpp? -151.44 176.87 10.86 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 110.292 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.79 142.85 0.41 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.53 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 59.63 41.21 19.09 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.341 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.13 12.82 0.86 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.737 -0.602 . . . . 0.0 111.689 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' MET . 57.8 ttt180 -68.06 143.23 55.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 110.502 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.28 142.08 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.994 0.902 . . . . 0.0 110.928 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.01 -178.52 39.98 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.684 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 28.8 p90 -148.18 103.12 3.56 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.083 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.15 129.72 8.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.87 1.047 . . . . 0.0 112.308 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 pt -146.79 136.3 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.456 0.646 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.1 t -83.45 -26.49 7.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -156.03 150.5 20.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -42.24 130.64 4.75 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.508 1.472 . . . . 0.0 112.723 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.26 167.79 15.16 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.094 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.01 -34.54 16.85 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.937 1.758 . . . . 0.0 112.145 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -88.28 -10.16 50.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.435 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.2 p -170.54 141.35 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.612 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.18 9.36 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 54.5 p90 -62.63 -45.47 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 110.663 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . -60.58 -103.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -164.97 -151.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.78 0.324 . . . . 0.0 110.255 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.7 p -95.17 170.03 9.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.571 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.22 145.83 0.09 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.645 ' H ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -46.48 130.32 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -119.23 54.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 44.5 t0 -63.79 140.67 58.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 110.485 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.463 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 49.4 m-85 -92.31 4.51 53.19 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 58.66 84.48 0.04 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 79' ' ' GLY . 68.5 mt 50.32 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.079 0.466 . . . . 0.0 111.038 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -88.54 157.93 18.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.551 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -84.68 -6.67 59.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.216 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 85' ' ' SER . 49.8 p-10 -74.68 21.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.618 0.723 . . . . 0.0 110.606 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 82' ' ' LEU . 96.1 mtt180 -49.42 -10.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.6 -0.688 . . . . 0.0 111.052 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.42 -36.22 24.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.624 0.249 . . . . 0.0 110.591 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -75.24 152.58 38.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.291 0.567 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -86.97 153.81 21.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.786 0.803 . . . . 0.0 110.566 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -153.86 174.92 13.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.125 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.58 -161.96 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.536 0.684 . . . . 0.0 110.996 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.06 141.98 12.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.284 0.564 . . . . 0.0 111.039 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -114.79 150.53 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.899 0.856 . . . . 0.0 110.261 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' CYS . . . . . 0.444 ' HB2' HH11 ' A' ' 5' ' ' ARG . 1.5 m -142.26 -173.34 3.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.354 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 3.6 t80 -160.28 118.23 2.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.062 0.458 . . . . 0.0 109.993 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.527 HD21 HH22 ' A' ' 5' ' ' ARG . 3.0 m120 -103.61 150.69 38.36 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.992 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 97' ' ' ALA . 76.1 Cg_exo -50.0 138.27 35.48 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 121.285 1.323 . . . . 0.0 112.285 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 95' ' ' PRO . 95.1 m-70 31.62 -88.83 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.53 0.681 . . . . 0.0 111.403 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 95' ' ' PRO . . . 54.89 58.42 4.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.827 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 C--N 1.29 -1.996 0 CA-C-O 118.755 -0.641 . . . . 0.0 110.223 176.498 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.32 149.25 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.718 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -111.25 130.43 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -74.51 129.3 37.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.547 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.42 148.2 34.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.132 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.45 171.99 18.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.321 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.36 160.71 16.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.06 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.43 -27.73 46.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.301 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.6 p -72.6 -31.77 65.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.267 0.556 . . . . 0.0 110.966 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.09 160.19 12.21 Favored Glycine 0 C--O 1.216 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.633 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -68.06 -48.37 65.78 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.806 0.336 . . . . 0.0 110.673 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -98.52 49.35 0.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -136.44 24.23 3.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.944 0.402 . . . . 0.0 110.456 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 tp -120.68 129.96 53.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.807 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -85.14 161.33 19.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.66 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 50.0 p90 -60.16 -46.5 89.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.773 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -57.01 -40.71 77.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -66.08 -52.6 47.37 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.807 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.48 -31.62 56.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.231 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -68.15 -43.02 79.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 110.932 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.35 76.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.356 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 -26.27 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.396 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -105.35 174.79 5.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.401 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 39.2 mt-10 77.02 5.04 3.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.592 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -73.19 -37.74 66.37 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.157 0.503 . . . . 0.0 111.1 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -91.92 12.75 20.65 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.561 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 8.21 80.4 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.519 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -93.84 -157.25 33.0 Favored Glycine 0 C--O 1.218 -0.851 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -162.58 157.27 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.62 0.247 . . . . 0.0 110.721 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.69 147.76 3.41 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.498 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.65 91.9 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.029 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 35' ' ' GLN . 11.9 t -74.48 179.16 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.961 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -58.36 -53.41 58.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -56.17 -47.57 78.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' ' CG ' ' A' ' 93' ' ' TYR . 54.3 tt0 -69.38 -37.56 77.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.957 0.408 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.49 -42.56 99.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.411 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -41.74 99.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 110.653 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.12 -36.98 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.797 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.52 -24.44 34.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.46 -30.64 65.21 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -79.17 -6.6 56.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 42' ' ' ILE . 79.1 mt -94.04 1.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.41 9.52 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.31 135.29 47.32 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.662 0.268 . . . . 0.0 110.502 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.44 ' CE1' ' H ' ' A' ' 62' ' ' VAL . 79.0 t60 -155.87 102.67 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.88 117.89 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.927 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.86 94.88 9.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.75 115.15 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.559 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.05 142.2 52.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.457 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -157.28 170.81 34.51 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.803 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.417 ' C ' ' SD ' ' A' ' 52' ' ' MET . 79.5 m95 -83.71 157.82 22.03 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.307 0.575 . . . . 0.0 110.185 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -152.8 177.45 10.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.281 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.0 145.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.372 0.606 . . . . 0.0 111.194 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 56' ' ' ARG . 68.7 mttm 56.6 42.74 26.71 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.167 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.29 10.98 0.38 Allowed Glycine 0 C--N 1.314 -0.672 0 O-C-N 121.746 -0.596 . . . . 0.0 112.085 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.623 HH22 ' CB ' ' A' ' 77' ' ' ASP . 64.2 ttt-85 -65.05 143.56 57.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.333 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.8 148.44 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.447 1.118 . . . . 0.0 110.781 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.1 -172.98 39.82 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.313 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 40.7 p90 -155.36 102.72 2.22 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.8 132.16 11.72 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.759 1.639 . . . . 0.0 112.4 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt -145.92 147.33 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.826 . . . . 0.0 110.909 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.44 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 14.8 t -116.06 -12.34 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.3 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -144.21 157.22 57.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.063 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -37.84 147.08 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.258 1.972 . . . . 0.0 112.548 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.64 79.82 0.35 Allowed Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.412 -0.66 . . . . 0.0 111.545 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.76 -48.12 23.73 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.439 2.093 . . . . 0.0 112.325 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -81.84 30.19 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.131 0.491 . . . . 0.0 110.472 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 70' ' ' PHE . 7.1 p -178.45 -165.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.56 86.23 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 68' ' ' CYS . 51.6 p90 -83.29 23.64 0.88 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.134 0.492 . . . . 0.0 110.494 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -131.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -79.14 -143.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 0.0 110.36 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 p -128.35 171.71 11.77 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.582 0.706 . . . . 0.0 110.39 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.6 155.25 0.76 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.1 mt -41.53 145.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.617 0.245 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mt -141.7 51.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.623 ' CB ' HH22 ' A' ' 56' ' ' ARG . 7.1 p-10 -60.62 151.77 28.08 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.643 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.73 -80.35 0.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.23 71.01 0.02 OUTLIER Glycine 0 N--CA 1.474 1.196 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.124 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.6 mt 53.99 91.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.333 0.587 . . . . 0.0 110.905 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 -87.8 155.93 19.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.506 0.669 . . . . 0.0 110.664 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 84' ' ' ARG . 53.5 mt -84.17 3.06 36.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.294 0.568 . . . . 0.0 110.281 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -72.99 18.57 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.214 1.006 . . . . 0.0 110.476 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' LEU . 93.7 mtt-85 -49.74 -11.69 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.591 -0.693 . . . . 0.0 111.199 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' ASN . 64.7 m -87.09 -42.32 13.14 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -66.48 155.59 37.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.159 0.505 . . . . 0.0 110.403 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -90.72 148.96 22.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.215 0.531 . . . . 0.0 110.483 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -154.13 175.59 13.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.249 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 8.4 t70 -79.57 -169.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.713 . . . . 0.0 110.713 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.33 168.92 9.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.359 0.6 . . . . 0.0 110.928 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -135.68 141.57 44.98 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.536 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.57 143.53 45.49 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.737 0.78 . . . . 0.0 109.763 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CG ' ' NE2' ' A' ' 35' ' ' GLN . 74.4 t80 -115.63 150.63 36.39 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -139.36 153.02 70.5 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.09 160.57 48.14 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.826 2.35 . . . . 0.0 112.253 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -47.43 95.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.021 0.915 . . . . 0.0 110.932 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.16 -57.31 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.958 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' TYR . 40.6 t -81.98 161.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.617 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.479 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.1 p90 -154.81 154.23 32.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -96.99 149.03 22.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.646 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.505 HH12 HG21 ' A' ' 22' ' ' VAL . 14.6 ptp180 -136.66 149.02 47.73 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.427 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -144.61 159.18 43.23 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.86 140.43 36.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -83.31 -43.27 16.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 t -96.43 25.96 4.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.76 -126.92 0.95 Allowed Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.697 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -150.24 -90.13 0.07 Allowed 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 120.997 0.427 . . . . 0.0 110.334 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.75 80.64 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.16 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -130.31 32.57 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -116.63 121.1 40.72 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.249 0.547 . . . . 0.0 110.657 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 p -100.28 169.11 9.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.384 0.611 . . . . 0.0 110.502 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -56.79 -49.86 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.415 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.91 73.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.91 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -67.32 -49.98 61.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.422 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -33.54 52.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 7.0 tptm -71.48 -33.22 69.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.399 0.619 . . . . 0.0 110.748 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.43 27.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.805 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.505 HG21 HH12 ' A' ' 5' ' ' ARG . 7.2 p -60.11 -36.63 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.485 ' C ' ' H ' ' A' ' 25' ' ' PHE . 1.3 m -103.34 178.06 4.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.4 -14.48 0.33 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.656 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 23' ' ' CYS . 92.5 t80 -61.42 -47.99 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.685 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -89.64 20.35 4.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.91 79.75 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -72.01 -168.77 10.87 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 79.9 m80 -155.49 144.58 20.78 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.605 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.6 mm? -67.01 135.91 54.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -60.72 140.85 57.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.248 0.547 . . . . 0.0 110.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 p -122.1 178.29 4.98 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.924 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.21 -53.34 59.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.684 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -54.13 -49.28 69.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 110.472 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -66.88 -38.44 86.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.942 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.22 -43.77 98.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.364 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -55.26 -49.36 72.26 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.26 -29.63 10.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.836 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -37.13 36.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.511 ' NH2' ' C ' ' A' ' 61' ' ' ILE . 46.7 mmm-85 -55.82 -32.36 63.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.326 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -71.07 -4.22 23.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.739 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 42' ' ' ILE . 84.1 mt -108.41 9.18 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.392 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.61 17.91 53.39 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -72.44 123.23 22.66 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.81 0.338 . . . . 0.0 110.173 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -139.86 113.05 8.27 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.526 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -140.32 114.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.735 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -92.89 87.26 5.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.935 0.397 . . . . 0.0 110.242 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.85 138.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.604 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.02 132.53 39.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.637 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.48 148.99 21.08 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.903 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.69 152.24 39.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 75.6 mtm -153.08 -179.13 7.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.156 0.503 . . . . 0.0 110.319 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.8 143.61 0.34 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp 55.25 39.41 31.34 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.327 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.04 10.37 1.75 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.641 HH22 ' CG ' ' A' ' 77' ' ' ASP . 47.6 ttt-85 -65.98 142.23 57.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.424 0.63 . . . . 0.0 110.172 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -143.98 144.81 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.797 0.808 . . . . 0.0 110.818 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.82 167.59 40.64 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.523 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 25.2 p90 -133.3 78.47 63.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.512 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.16 139.61 71.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.095 1.864 . . . . 0.0 112.76 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' ' NH2' ' A' ' 40' ' ' ARG . 20.0 pt -150.83 134.39 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.858 0.837 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.429 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 61.2 t -62.8 -45.87 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.38 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 19.7 mtmt -158.41 -62.3 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 55.8 Cg_endo -63.49 143.17 87.4 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.866 1.711 . . . . 0.0 112.494 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.88 54.47 0.1 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.15 -49.59 0.49 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.645 2.23 . . . . 0.0 111.956 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -66.46 -39.09 88.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.81 132.68 36.77 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.246 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.14 50.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -159.88 103.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.435 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.31 -140.61 35.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 tttm 55.77 169.77 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.845 0.355 . . . . 0.0 110.469 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -136.31 157.25 47.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.52 151.3 6.37 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -40.3 144.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.689 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.16 45.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.535 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.641 ' CG ' HH22 ' A' ' 56' ' ' ARG . 1.9 p30 -68.71 145.77 53.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 110.472 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -90.24 -3.77 57.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.313 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 66.13 94.14 0.03 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 79' ' ' GLY . 63.5 mt 50.77 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -97.26 152.3 19.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.332 0.587 . . . . 0.0 110.173 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -85.45 -2.83 58.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.384 0.611 . . . . 0.0 110.277 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 85' ' ' SER . 97.7 m-20 -77.83 22.12 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.985 0.898 . . . . 0.0 110.561 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.2 mtt180 -51.68 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.125 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 83' ' ' ASN . 32.7 t -95.85 -25.62 15.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.638 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.04 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.458 0.646 . . . . 0.0 110.512 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 25.7 mtp180 -94.56 136.01 35.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 81.1 m95 -154.39 175.91 12.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -71.93 -164.44 0.13 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.511 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -162.41 149.74 13.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.465 0.65 . . . . 0.0 110.933 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -121.14 161.03 22.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.612 0.72 . . . . 0.0 110.451 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.91 -170.36 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.556 0.693 . . . . 0.0 110.182 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -161.23 151.48 17.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.368 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -145.11 146.33 30.33 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.288 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.496 1.656 0 C-N-CA 122.118 1.879 . . . . 0.0 112.084 179.326 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 144.01 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.276 0.56 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.89 161.3 26.88 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.72 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.61 140.19 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.75 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.52 HH21 ' ND2' ' A' ' 94' ' ' ASN . 38.3 mmt180 -103.59 161.9 13.5 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.454 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -142.37 134.2 27.03 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.379 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.69 166.74 15.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.716 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -68.38 -38.03 80.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.193 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -72.35 -18.3 61.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.34 0.591 . . . . 0.0 110.597 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 -154.7 16.78 Favored Glycine 0 N--CA 1.478 1.444 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 13' ' ' LYS . 68.8 mttm -115.33 -177.47 3.15 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.416 0.627 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 47.62 16.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.759 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' N ' ' C ' ' A' ' 11' ' ' LYS . 51.2 mtmt -128.52 26.35 5.65 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.777 0.322 . . . . 0.0 110.72 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 88' ' ' TRP . 48.4 mt -123.38 132.14 53.87 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.9 p -97.48 168.51 10.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.508 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 47.8 p90 -51.26 -54.21 28.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.973 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.78 -41.38 64.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.24 -51.45 37.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.755 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.27 13.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.07 -34.93 77.36 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.354 0.597 . . . . 0.0 110.663 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -53.03 59.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.886 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.4 -25.87 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.442 . . . . 0.0 110.506 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 25' ' ' PHE . 30.7 m -103.83 179.87 4.15 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.693 0.759 . . . . 0.0 109.247 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 67.17 -3.31 1.01 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.962 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 23' ' ' CYS . 89.7 t80 -61.82 -45.39 94.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.981 0.419 . . . . 0.0 110.869 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.4 pm0 -94.68 5.87 50.58 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.005 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.7 -22.52 39.36 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.5 143.1 38.25 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -98.72 153.38 18.77 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.742 0.305 . . . . 0.0 110.238 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.5 mp -56.52 143.02 36.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.395 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -52.05 139.19 23.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.117 0.484 . . . . 0.0 110.735 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 33' ' ' TYR . 43.0 m -121.93 171.64 8.78 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.838 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.614 ' N ' HG22 ' A' ' 32' ' ' THR . 11.3 t80 -53.76 -53.42 52.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -58.76 -48.01 82.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.64 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.49 -36.62 81.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.243 0.544 . . . . 0.0 110.795 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 17.9 mt -62.12 -42.86 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.162 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.09 -31.15 40.38 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.04 79.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.815 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.31 -25.34 42.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 7.5 mmm180 -58.8 -35.98 73.73 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -72.66 -10.59 59.98 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.13 4.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.451 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 33.21 16.69 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -66.04 129.23 39.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.83 0.348 . . . . 0.0 110.508 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -147.9 102.42 3.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.39 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.61 107.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.891 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -90.08 92.62 9.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.153 0.502 . . . . 0.0 110.106 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.71 109.84 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.08 138.92 56.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.92 163.84 34.44 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.25 160.42 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.277 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 77.3 mtm -156.12 -179.14 7.86 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.299 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.53 145.31 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.254 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 56' ' ' ARG . 55.5 tttm 56.95 42.51 26.16 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.99 10.94 0.5 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.79 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 54' ' ' LYS . 10.4 tpt180 -64.97 140.23 58.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.259 0.552 . . . . 0.0 110.47 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.11 161.98 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.106 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.4 177.44 37.77 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.854 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -145.37 81.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.329 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.41 135.5 60.91 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.185 1.923 . . . . 0.0 112.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -151.26 134.37 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.495 0.664 . . . . 0.0 110.833 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.21 -44.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.176 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -167.5 -61.46 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.064 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.61 156.5 65.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.771 1.648 . . . . 0.0 112.051 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' CA ' ' SG ' ' A' ' 68' ' ' CYS . . . -172.44 65.5 0.13 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.902 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.88 -44.97 35.69 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.268 1.979 . . . . 0.0 112.403 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.47 -24.76 45.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.719 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.421 ' SG ' ' CA ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -95.72 166.85 11.62 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.448 0.642 . . . . 0.0 110.031 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' GLY . . . -61.8 150.39 45.61 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.384 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 71' ' ' GLY . 45.3 p90 -76.29 29.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 110.581 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' GLY . . . -50.71 -105.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -141.9 -165.2 1.95 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.149 0.499 . . . . 0.0 110.322 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 p -94.67 160.84 14.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.467 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.55 168.69 0.44 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 54.0 mt -52.53 145.72 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.701 0.286 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.8 pt -149.85 -39.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -87.17 120.71 28.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.967 0.413 . . . . 0.0 110.613 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -145.05 -171.13 3.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.892 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.72 -179.69 48.99 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.3 mt -103.06 116.4 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -74.4 152.86 39.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.96 0.409 . . . . 0.0 110.051 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 84' ' ' ARG . 39.9 tp -84.45 -8.04 59.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.609 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 85' ' ' SER . 45.6 p-10 -74.66 23.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 110.64 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 82' ' ' LEU . 77.9 mtp180 -51.48 -5.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.594 -0.691 . . . . 0.0 111.448 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 83' ' ' ASN . 95.0 p -98.35 4.41 48.61 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -96.93 -140.0 0.28 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -158.23 147.04 19.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.494 0.664 . . . . 0.0 110.98 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.42 ' O ' ' O ' ' A' ' 14' ' ' LEU . 91.4 m95 -154.13 176.44 12.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.295 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.91 -165.21 0.2 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.889 0.852 . . . . 0.0 110.777 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -161.26 154.17 20.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.118 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 12.1 m-85 -148.24 156.21 42.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.467 0.651 . . . . 0.0 110.352 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 81.6 m -123.46 -166.69 1.5 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.778 0.799 . . . . 0.0 110.155 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -146.87 125.5 12.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' ND2' HH21 ' A' ' 5' ' ' ARG . 1.1 m-80 -103.31 154.03 38.03 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.874 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo . . . . . 0 N--CA 1.5 1.911 0 C-N-CA 121.75 1.633 . . . . 0.0 112.659 179.287 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 2' ' ' VAL . 18.7 m -85.39 154.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.008 0.433 . . . . 0.0 110.806 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.486 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 34.2 p90 -138.58 169.2 18.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.873 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -73.64 132.85 43.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.227 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.486 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 61.8 ttm-85 -135.16 131.26 36.58 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.274 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -165.0 159.18 17.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.232 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.83 137.52 56.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.929 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.18 -39.65 75.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.03 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.0 m -113.08 -32.92 6.19 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.793 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 -134.29 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.626 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 12' ' ' TYR . 24.6 pttm -173.28 -35.7 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.044 0.45 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.441 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 82.7 m-85 -159.53 80.78 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -147.19 42.52 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 0.0 110.353 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -117.25 126.44 52.74 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.315 0.579 . . . . 0.0 110.788 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 16' ' ' TYR . 91.6 m -103.68 164.66 11.53 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.855 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.59 ' N ' HG22 ' A' ' 15' ' ' THR . 59.5 t80 -54.31 -48.17 71.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.486 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' HB2' HH21 ' A' ' 84' ' ' ARG . . . -55.2 -45.76 75.89 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.898 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 8.3 mp0 -64.49 -45.41 87.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.49 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.28 -31.16 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.827 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.88 -51.32 41.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.598 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -59.72 -23.19 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.978 0.418 . . . . 0.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' C ' ' H ' ' A' ' 25' ' ' PHE . 57.4 m -104.89 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 109.59 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 68.2 mm-40 73.99 -26.12 0.19 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.873 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.0 t80 -59.78 -49.05 79.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.947 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.96 17.47 12.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.13 5.61 82.81 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -79.47 -175.53 47.67 Favored Glycine 0 C--O 1.219 -0.822 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 89.4 m-70 -154.96 158.52 39.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 136.93 57.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.044 0.449 . . . . 0.0 110.368 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 85.61 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 33' ' ' TYR . 40.9 m -71.05 170.36 13.02 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.611 ' N ' HG22 ' A' ' 32' ' ' THR . 26.1 t80 -55.37 -53.19 59.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.724 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.1 -49.14 77.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.577 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -66.34 -36.25 82.42 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.82 -43.75 98.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.541 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -49.72 -44.59 48.42 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.84 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.697 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.65 44.54 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.046 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.587 HH22 ' H ' ' A' ' 46' ' ' VAL . 12.1 mmm180 -56.93 -30.82 64.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.61 -6.6 57.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 42' ' ' ILE . 5.6 mm -103.02 4.98 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 5.28 53.75 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -68.79 119.41 13.12 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.44 0.62 . . . . 0.0 109.978 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.403 ' HA ' ' NH2' ' A' ' 40' ' ' ARG . 84.7 t60 -134.85 103.43 5.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.587 ' H ' HH22 ' A' ' 40' ' ' ARG . 39.7 t -141.27 132.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.728 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -114.36 92.69 4.05 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.69 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.39 127.29 4.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.22 104.78 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.405 0.621 . . . . 0.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -122.66 157.24 17.25 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.024 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.458 ' CE3' HG22 ' A' ' 57' ' ' VAL . 88.9 m95 -78.68 145.7 34.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.313 0.578 . . . . 0.0 110.143 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 2.1 mpp? -142.99 171.84 13.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.324 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -38.71 149.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.665 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 57.27 34.81 25.3 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.194 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.83 6.85 1.36 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.796 -0.565 . . . . 0.0 111.888 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 52' ' ' MET . 59.8 ttt85 -62.32 131.21 48.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 110.065 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.458 HG22 ' CE3' ' A' ' 51' ' ' TRP . 2.3 t -127.88 126.59 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.985 0.898 . . . . 0.0 110.728 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.06 -172.31 25.06 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.289 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 78' ' ' TYR . 7.8 p90 -152.5 84.83 4.62 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 114.934 -0.633 . . . . 0.0 110.344 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.15 145.04 67.2 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.36 2.04 . . . . 0.0 112.49 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -136.78 103.51 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.45 -53.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.266 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -95.09 145.9 30.35 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.327 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -39.89 140.54 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.067 1.844 . . . . 0.0 112.322 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.56 99.91 0.19 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.991 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -16.09 19.23 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.19 1.927 . . . . 0.0 112.108 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -70.83 -34.73 71.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.109 0.48 . . . . 0.0 110.687 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.7 137.25 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.236 0.541 . . . . 0.0 110.384 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.46 79.31 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 49.54 79.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.719 0.295 . . . . 0.0 110.714 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.05 -123.14 32.05 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 55.76 163.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 74' ' ' GLY . 89.1 m -138.99 164.31 30.09 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.676 0.75 . . . . 0.0 110.666 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.584 ' N ' HG22 ' A' ' 73' ' ' THR . . . 73.96 153.71 3.02 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.4 mt -53.32 126.17 9.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-O 120.974 0.416 . . . . 0.0 110.367 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.472 ' O ' ' CE2' ' A' ' 78' ' ' TYR . 37.2 mm -107.84 118.37 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.191 0.52 . . . . 0.0 110.424 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.58 149.73 43.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.384 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 98.5 m-85 -131.36 -16.51 3.08 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -170.0 34.63 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.1 mt -103.83 123.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.688 0.756 . . . . 0.0 110.504 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 81' ' ' ARG . 0.5 OUTLIER -98.37 130.13 45.02 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.39 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 84' ' ' ARG . 27.6 mt -83.0 8.58 12.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 85' ' ' SER . 47.7 p-10 -71.86 22.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.672 1.225 . . . . 0.0 110.981 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 82' ' ' LEU . 72.0 ttt180 -48.06 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.597 -0.689 . . . . 0.0 110.986 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 83' ' ' ASN . 57.3 m -68.22 -37.66 81.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.656 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.18 -169.17 1.94 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 110.645 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.448 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 92.0 mtt-85 -134.03 144.93 48.98 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.552 0.691 . . . . 0.0 110.721 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.448 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 60.3 m95 -150.32 175.42 11.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.971 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 42.5 t0 -59.86 -179.7 0.1 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 111.085 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.456 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -165.65 159.73 16.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.344 0.593 . . . . 0.0 110.884 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.11 160.54 38.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.637 0.732 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.8 t -141.95 148.54 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.159 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -115.42 141.93 47.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.124 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -147.26 148.52 32.04 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.196 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.496 1.627 0 C-N-CA 122.463 2.109 . . . . 0.0 111.897 179.145 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 t -82.96 157.15 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.665 0.269 . . . . 0.0 110.718 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -162.68 155.52 19.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.769 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -75.61 135.1 40.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.616 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -141.97 139.74 32.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.224 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -140.8 152.38 45.13 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.13 159.12 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.079 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -49.14 9.99 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.0 m -114.0 19.0 16.86 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.606 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.12 -176.25 14.38 Favored Glycine 0 C--O 1.215 -1.082 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -147.0 106.23 3.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.193 -0.504 . . . . 0.0 110.49 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 56.53 17.25 2.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.537 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -80.48 38.64 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.44 117.12 30.85 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.264 0.554 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.538 HG22 ' N ' ' A' ' 16' ' ' TYR . 61.9 m -101.58 163.62 12.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.538 ' N ' HG22 ' A' ' 15' ' ' THR . 62.4 t80 -53.85 -49.75 67.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.93 78.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.891 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.07 -49.28 70.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.713 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.6 -30.16 41.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' CYS . 44.1 tptt -60.93 -37.37 82.1 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.303 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.45 -54.2 13.3 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.449 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.49 -42.78 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.999 0.428 . . . . 0.0 110.788 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.525 ' C ' ' H ' ' A' ' 25' ' ' PHE . 62.1 m -100.51 173.42 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' OE1' ' NZ ' ' A' ' 20' ' ' LYS . 70.9 tt0 63.04 -7.98 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.93 -47.1 86.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.774 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -87.98 21.29 2.76 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.24 -1.2 84.33 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.81 -152.15 1.27 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 53.4 t-80 -168.67 152.74 5.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.642 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.465 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 44.0 mt -62.43 139.52 58.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.956 0.408 . . . . 0.0 110.438 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 103.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.998 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.8 t -77.45 179.02 6.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.045 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.461 ' N ' ' OG1' ' A' ' 32' ' ' THR . 50.7 t80 -54.81 -53.65 52.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.1 -44.75 91.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.734 0.302 . . . . 0.0 110.71 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.562 ' H ' HG23 ' A' ' 32' ' ' THR . 78.8 mt-30 -71.38 -30.85 66.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 111.066 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.8 mt -63.48 -41.91 98.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -30.64 67.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.216 0.531 . . . . 0.0 110.674 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.89 65.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.828 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.74 -42.18 42.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.546 HH22 ' CA ' ' A' ' 61' ' ' ILE . 17.2 mmm180 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.161 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.36 -11.53 60.07 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.456 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 42' ' ' ILE . 99.1 mt -96.71 4.13 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.21 9.6 55.44 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -66.85 125.36 25.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.949 0.374 . . . . 0.0 110.392 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -143.64 103.06 4.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.485 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.0 132.75 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.699 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.18 91.31 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.3 149.73 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.99 136.91 52.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.466 0.65 . . . . 0.0 110.884 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.89 -178.58 21.47 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.547 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -84.32 156.13 22.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.39 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.5 ptt? -158.16 -175.28 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.551 0.691 . . . . 0.0 110.101 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -30.71 144.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.574 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 55.35 15.46 1.39 Allowed 'General case' 0 C--O 1.2 -1.505 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.776 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 65.8 16.26 63.45 Favored Glycine 0 C--N 1.315 -0.623 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -66.59 154.5 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 0.0 110.007 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 57' ' ' VAL . 11.5 p -129.9 118.12 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.862 0.839 . . . . 0.0 110.942 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 59' ' ' TYR . . . -113.73 -175.86 19.14 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 6.1 m-85 -141.66 69.72 25.34 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 115.065 -0.568 . . . . 0.0 110.291 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -52.62 115.32 2.15 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.72 1.614 . . . . 0.0 112.559 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.546 ' CA ' HH22 ' A' ' 40' ' ' ARG . 97.8 mt -145.58 118.23 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.607 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 66.8 t -74.73 -22.33 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 0.0 110.083 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -165.65 148.24 6.59 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.312 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -39.63 143.87 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.878 1.719 . . . . 0.0 112.926 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.91 167.79 25.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.457 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.97 -43.29 0.8 Allowed 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.164 1.91 . . . . 0.0 112.317 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -64.88 -35.21 80.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.46 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.17 113.47 25.74 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.216 0.531 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 145.65 29.03 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 45.5 -97.32 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.46 104.5 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.81 -161.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 110.148 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.2 p -94.59 150.62 20.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.429 0.633 . . . . 0.0 110.423 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 167.48 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.91 131.7 28.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 110.17 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.6 mt -86.64 126.0 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -66.66 133.68 50.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.486 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -143.81 156.45 44.49 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.754 0.787 . . . . 0.0 110.227 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.38 -161.0 34.67 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 85.6 mt -97.77 96.88 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.44 0.638 . . . . 0.0 110.193 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -71.52 141.94 50.12 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.262 0.553 . . . . 0.0 110.423 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 84' ' ' ARG . 24.1 tp -82.11 3.8 25.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.14 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 85' ' ' SER . 38.7 p-10 -76.06 20.44 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.916 0.865 . . . . 0.0 110.574 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 82' ' ' LEU . 80.9 mtp180 -54.94 -1.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.782 -0.574 . . . . 0.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 83' ' ' ASN . 96.7 p -94.94 -4.6 46.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.454 ' CD ' ' HE1' ' A' ' 88' ' ' TRP . 80.7 tt0 -94.98 154.08 17.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 83.4 mtm180 -86.17 136.81 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 110.651 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.1 m95 -153.2 176.84 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.328 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 30.9 t0 -73.55 -169.29 0.66 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.565 0.698 . . . . 0.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.47 153.88 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.499 0.666 . . . . 0.0 110.873 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.28 157.36 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.757 0.789 . . . . 0.0 110.371 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.53 -173.62 3.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.496 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -160.04 113.56 2.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.181 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -153.81 150.95 23.95 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 C--N 1.306 -1.688 0 C-N-CA 121.902 1.735 . . . . 0.0 111.581 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -147.47 130.14 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.89 0.376 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -105.35 129.55 53.66 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.831 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -79.36 149.34 31.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.759 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -128.43 154.52 45.97 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -160.94 133.14 5.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.394 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.88 31.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -75.7 -42.35 51.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.532 0.682 . . . . 0.0 110.997 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 p -109.58 25.75 11.43 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.624 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.68 -142.95 3.54 Favored Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.743 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -162.38 87.09 0.61 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.111 0.481 . . . . 0.0 110.526 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.471 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 2.3 m-85 72.39 21.71 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -74.1 48.04 0.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.408 -0.183 . . . . 0.0 110.758 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.99 130.12 52.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.543 0.687 . . . . 0.0 110.904 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.0 p -101.38 170.23 8.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -56.26 -50.19 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.91 86.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.041 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -51.74 39.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.71 -30.34 13.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' CYS . 28.8 ttpt -67.92 -33.6 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.514 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -51.91 63.32 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 111.56 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.24 -38.72 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.207 0.527 . . . . 0.0 110.71 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 20' ' ' LYS . 56.8 m -101.17 178.8 4.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.871 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' GLY . 36.1 tt0 72.68 -27.28 0.18 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.7 t80 -61.27 -46.62 89.58 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 110.799 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.1 pm0 -86.49 11.74 11.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -23.1 33.79 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -78.51 134.27 13.91 Favored Glycine 0 C--O 1.22 -0.738 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.44 173.34 6.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.83 137.61 56.73 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.244 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.97 139.54 46.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.429 0.633 . . . . 0.0 110.819 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -122.27 174.35 7.04 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.921 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -59.71 -52.83 63.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.91 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.87 -45.25 95.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.927 0.394 . . . . 0.0 110.485 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.11 -34.73 75.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.639 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 40' ' ' ARG . 10.7 mt -62.53 -41.14 98.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.467 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -53.89 -40.82 66.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.755 0.312 . . . . 0.0 110.884 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.83 97.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.081 0.467 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -85.56 -25.47 26.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 61' ' ' ILE . 1.1 tpt85 -56.41 -25.74 51.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.593 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -81.49 -1.35 45.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.508 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 39' ' ' ALA . 4.4 tt -91.65 6.31 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.506 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.13 26.24 34.62 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -70.55 131.23 43.67 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.83 0.315 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.65 101.77 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -143.43 133.07 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.14 78.74 6.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.862 0.363 . . . . 0.0 110.027 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.38 92.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.472 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.07 39.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.628 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.05 165.59 20.97 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.814 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -72.14 104.97 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.385 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 55' ' ' GLY . 71.4 mtm -97.31 -178.33 4.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.25 0.548 . . . . 0.0 110.418 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -32.07 144.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.769 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 mttp 54.4 9.27 0.24 Allowed 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.224 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 81.86 20.87 62.49 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.045 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.438 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 69.2 ttt180 -70.38 130.01 40.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.428 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.2 p -116.57 133.09 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.806 0.812 . . . . 0.0 110.745 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.46 157.18 28.81 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -113.11 106.07 55.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.448 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.51 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 87.8 Cg_endo -79.05 126.93 7.36 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.101 1.201 . . . . 0.0 112.234 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 17.1 pt -145.97 137.95 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.831 0.824 . . . . 0.0 110.875 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.77 -45.36 98.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.285 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.636 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -168.5 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.636 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 31.8 Cg_exo -60.64 147.95 93.04 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.231 1.954 . . . . 0.0 112.164 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.461 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -156.73 50.53 0.44 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.371 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.3 Cg_endo -66.55 -53.41 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.321 2.014 . . . . 0.0 111.943 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.77 -23.19 31.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.56 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 12.1 p -151.03 124.94 9.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.56 110.5 0.25 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -144.09 -53.1 0.33 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.14 -72.7 0.58 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -172.36 -157.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 0.0 110.669 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 p -114.89 166.37 11.85 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 68.41 68.32 1.69 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' GLY . 71.9 mt 56.44 128.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.587 -0.307 . . . . 0.0 110.899 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.46 118.15 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 120.992 0.425 . . . . 0.0 110.379 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 91.9 m-20 -92.54 108.1 19.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.496 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CE1' ' OH ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -95.93 -11.55 26.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.1 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.98 -174.51 44.16 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.5 mp -96.61 116.87 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.212 0.53 . . . . 0.0 110.556 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.531 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 79.8 mtp180 -92.91 133.85 35.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.112 0.482 . . . . 0.0 110.162 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 tp -83.35 4.65 26.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 110.308 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.531 HD21 ' CZ ' ' A' ' 81' ' ' ARG . 51.4 p30 -85.66 23.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.487 0.661 . . . . 0.0 110.537 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -44.31 -32.08 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.566 -0.709 . . . . 0.0 111.261 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.1 p -49.08 -21.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.009 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -70.51 -169.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.12 0.486 . . . . 0.0 110.743 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 84.1 mtt85 -130.2 129.81 43.87 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.373 0.606 . . . . 0.0 110.776 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.428 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.4 m95 -150.1 175.71 11.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.908 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD2' ' CD1' ' A' ' 12' ' ' TYR . 1.3 m-20 -55.69 -174.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.86 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.47 143.07 18.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.425 0.631 . . . . 0.0 110.935 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -115.43 160.08 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.008 0.909 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.88 179.71 6.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -133.36 116.7 16.4 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.183 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -149.41 88.47 5.0 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.045 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 C--N 1.307 -1.607 0 C-N-CA 121.398 1.399 . . . . 0.0 111.559 -179.68 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.98 136.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 110.742 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.6 162.41 37.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.972 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -74.91 129.06 37.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -135.03 133.3 39.25 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.216 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -157.05 156.03 32.17 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.65 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.16 -37.02 34.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.094 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.3 m -84.71 -5.21 59.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.63 -118.65 0.81 Allowed Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.159 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -167.53 -39.94 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.36 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -146.76 67.16 1.16 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.978 0.418 . . . . 0.0 110.517 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.09 32.92 3.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.3 118.72 32.0 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.649 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -90.32 168.31 11.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.656 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 38.5 p90 -51.64 -60.23 3.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -53.16 -40.24 64.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -66.24 -47.96 72.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.64 -35.87 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.795 0.331 . . . . 0.0 110.849 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' CYS . 56.6 mtpt -68.9 -31.31 70.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.86 45.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.884 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.82 -33.87 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.709 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -104.71 -178.45 3.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 109.586 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 96.4 mt-10 69.77 -10.28 0.62 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.923 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' CYS . 90.5 t80 -60.48 -47.25 86.95 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 18.0 pt-20 -87.39 21.37 2.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.46 76.26 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.11 -171.28 40.45 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -163.45 121.07 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.679 0.276 . . . . 0.0 110.451 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -42.15 136.98 2.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.701 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -66.12 144.66 56.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -123.21 177.3 5.63 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.075 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -51.6 -26.74 9.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.474 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -70.66 -56.33 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.76 -35.29 74.82 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.7 mt -61.07 -40.85 95.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.419 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.72 -34.14 71.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.541 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.2 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 110.785 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.97 66.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -56.59 -43.47 80.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.402 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.77 -11.4 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 42' ' ' ILE . 79.2 mt -98.54 7.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.49 22.08 52.05 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.47 132.78 46.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.751 0.31 . . . . 0.0 110.585 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -154.23 105.38 2.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 46' ' ' VAL . 14.9 p -141.71 127.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.879 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.38 82.56 1.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.82 118.21 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.721 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.99 151.04 21.19 Favored Glycine 0 N--CA 1.476 1.336 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.12 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -73.13 147.5 44.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.166 0.508 . . . . 0.0 110.258 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 48.9 mtm -150.0 179.96 7.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.018 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.8 141.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.835 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 55.39 12.37 0.72 Allowed 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.179 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 75.62 21.59 76.75 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.808 -0.558 . . . . 0.0 112.158 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -74.36 135.89 42.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.209 0.528 . . . . 0.0 110.579 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.482 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 3.1 p -143.41 156.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.667 0.746 . . . . 0.0 110.783 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 57' ' ' VAL . . . -174.69 -178.47 44.6 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.271 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -116.46 67.04 3.51 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.879 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.29 118.78 5.68 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.762 1.642 . . . . 0.0 112.419 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.2 pt -145.02 147.98 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.682 0.753 . . . . 0.0 110.88 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.71 -66.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.338 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.767 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 17.7 mttt -144.76 -43.07 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.303 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.767 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 28.0 Cg_exo -63.32 150.14 89.36 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.211 1.941 . . . . 0.0 112.371 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -168.88 49.32 0.22 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.493 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.8 Cg_endo -66.73 -53.19 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.428 2.085 . . . . 0.0 112.118 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -74.4 -17.05 60.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.24 132.1 1.02 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.95 41.4 0.03 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.64 -41.82 98.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 110.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.47 -84.67 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -170.93 -156.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.213 . . . . 0.0 110.472 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.3 p -95.3 162.22 13.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.328 0.585 . . . . 0.0 110.597 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.22 19.97 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.2 mt -102.67 123.34 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.097 0.475 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.9 mt -93.88 131.21 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.351 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.51 97.33 9.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.373 0.606 . . . . 0.0 110.067 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.1 41.79 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.301 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 80' ' ' ILE . . . -91.06 -147.34 19.26 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 79' ' ' GLY . 11.5 mt 15.72 58.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.435 0.636 . . . . 0.0 111.238 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.611 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 82.3 mtp180 -71.08 150.78 45.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.2 mp -77.24 -16.6 58.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.14 0.495 . . . . 0.0 109.958 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 85' ' ' SER . 9.1 p30 -91.52 25.18 2.73 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.381 0.61 . . . . 0.0 110.616 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -52.88 5.04 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.719 -0.613 . . . . 0.0 111.712 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.641 ' H ' ' C ' ' A' ' 83' ' ' ASN . 47.7 t -92.61 -8.47 44.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.413 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -85.97 -165.27 1.2 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.005 0.431 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -131.27 141.25 49.95 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.005 0.907 . . . . 0.0 110.849 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 61.7 m95 -153.07 177.26 10.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.862 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 12.4 t70 -60.71 -163.67 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -170.35 149.35 3.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.22 0.533 . . . . 0.0 110.759 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -118.21 135.32 54.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.458 0.647 . . . . 0.0 110.253 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.9 m -114.08 177.33 4.68 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.023 0.916 . . . . 0.0 109.637 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -150.43 151.41 32.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.441 ' ND2' ' OE2' ' A' ' 26' ' ' GLU . 29.8 t-20 -143.11 132.77 11.87 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.362 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.505 2.168 0 C-N-CA 122.05 1.834 . . . . 0.0 112.275 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 3' ' ' TYR . 97.2 t -85.1 155.51 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.637 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.402 ' N ' HG12 ' A' ' 2' ' ' VAL . 89.9 t80 -117.79 129.24 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -74.09 127.53 33.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 90' ' ' ALA . 24.0 ttm180 -146.06 128.78 16.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.037 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.9 pm0 -146.41 -176.82 5.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.468 0.48 . . . . 0.0 110.392 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.67 127.1 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -78.39 -33.96 48.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.846 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.82 -4.09 41.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.531 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.47 -95.16 0.1 Allowed Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.873 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -171.34 -81.5 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.917 0.389 . . . . 0.0 110.311 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.02 80.15 3.28 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.001 0.429 . . . . 0.0 110.622 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -137.61 34.62 2.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.153 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.519 0.676 . . . . 0.0 110.258 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 p -99.03 168.27 10.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.245 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.543 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 31.9 p90 -53.68 -53.56 50.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.543 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -55.12 -45.97 75.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.47 69.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.5 mttt -71.87 -40.27 69.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 0.0 110.715 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -46.64 84.53 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.33 -42.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.529 0.68 . . . . 0.0 110.94 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 20' ' ' LYS . 17.6 m -101.47 178.79 4.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.736 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 70.04 -45.78 0.59 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -62.71 -48.02 81.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.41 21.82 3.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.022 0.439 . . . . 0.0 110.871 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.15 1.48 84.33 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.23 -171.38 9.54 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -168.41 137.03 2.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.557 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 30' ' ' LEU . 10.3 mp -72.94 141.27 47.82 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 110.25 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.3 93.96 0.35 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.291 0.567 . . . . 0.0 110.726 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 33' ' ' TYR . 34.0 m -86.01 171.66 11.24 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.898 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.616 ' N ' HG22 ' A' ' 32' ' ' THR . 66.7 t80 -55.53 -53.98 49.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.22 -45.05 84.21 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.542 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -70.05 -34.93 73.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 110.858 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.15 -40.87 98.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.15 -37.31 82.41 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.5 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.09 -39.77 93.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.71 -27.62 31.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.365 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -56.96 -25.0 57.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.268 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.56 -6.24 59.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 42' ' ' ILE . 78.1 mt -94.36 4.52 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.521 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.29 25.09 24.86 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -66.31 128.66 37.02 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.701 0.251 . . . . 0.0 110.59 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.403 ' CG ' HG22 ' A' ' 62' ' ' VAL . 1.8 t60 -150.03 103.19 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.278 0.561 . . . . 0.0 110.468 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 46' ' ' VAL . 11.4 p -143.65 117.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.023 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.87 89.73 6.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.11 112.5 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.118 0.485 . . . . 0.0 110.618 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.45 137.21 52.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.905 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.98 -172.83 19.13 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.689 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.73 150.81 19.82 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.1 mtm -143.73 168.86 18.9 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.35 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.19 156.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.17 40.77 31.85 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.273 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.26 6.61 0.16 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.008 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 56.5 ttt180 -68.81 144.72 54.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.61 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.29 130.19 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.771 0.795 . . . . 0.0 110.786 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.76 175.59 45.08 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.433 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.596 ' CE2' HD11 ' A' ' 61' ' ' ILE . 13.6 p90 -167.55 143.19 3.33 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.724 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.11 146.68 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.184 1.922 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 59' ' ' TYR . 16.2 mt -141.8 93.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.556 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG22 ' CG ' ' A' ' 45' ' ' HIS . 18.9 m -69.24 -36.76 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.031 0.443 . . . . 0.0 110.278 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -137.7 154.39 74.79 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.33 144.77 59.2 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.362 2.041 . . . . 0.0 112.0 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.75 179.72 20.76 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.37 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.8 -47.63 26.14 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 122.174 1.916 . . . . 0.0 112.598 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -138.41 28.69 2.47 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.3 p -151.34 150.5 30.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.381 0.61 . . . . 0.0 110.273 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.0 93.77 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.43 -44.7 96.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 110.597 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.21 -8.96 0.05 OUTLIER Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.16 155.78 38.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.708 0.289 . . . . 0.0 110.287 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -140.5 130.31 24.47 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.794 0.807 . . . . 0.0 110.598 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 75' ' ' ILE . . . 144.77 -47.02 0.78 Allowed Glycine 0 N--CA 1.465 0.625 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.195 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.438 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER 159.26 131.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 120.868 0.366 . . . . 0.0 110.607 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mm -111.24 62.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.58 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 44.5 p-10 -99.67 103.61 15.3 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.95 0.405 . . . . 0.0 110.296 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -71.17 -61.62 1.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.45 -147.44 13.09 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.515 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.0 mt -97.63 117.39 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.368 . . . . 0.0 110.074 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 50.8 mtp85 -94.24 133.5 37.7 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.7 mp -82.54 3.34 28.96 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.592 0.71 . . . . 0.0 109.831 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 52.2 p-10 -81.66 26.2 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.846 0.832 . . . . 0.0 110.479 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -45.38 -36.35 4.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.543 -0.723 . . . . 0.0 111.262 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -45.57 -26.99 0.67 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.563 0.221 . . . . 0.0 110.99 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 8.7 mp0 -74.13 -173.08 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.932 0.872 . . . . 0.0 109.988 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -128.49 145.7 51.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.917 0.865 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -155.05 175.91 13.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.343 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 28.0 t0 -79.82 -168.36 1.57 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.72 0.771 . . . . 0.0 110.604 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.443 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -167.98 164.58 13.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.455 0.645 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.93 151.52 49.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.534 0.683 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.53 142.45 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.227 0.537 . . . . 0.0 110.308 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 94' ' ' ASN . 10.9 t80 -134.34 149.91 50.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.274 0.559 . . . . 0.0 110.312 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.482 ' N ' ' CD1' ' A' ' 93' ' ' TYR . 11.8 m120 -117.71 89.97 34.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.505 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo . . . . . 0 N--CA 1.501 1.932 0 C-N-CA 122.272 1.982 . . . . 0.0 112.537 -179.864 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 3' ' ' TYR . 10.2 p -81.66 163.32 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.543 ' N ' HG22 ' A' ' 2' ' ' VAL . 24.6 p90 -146.71 127.89 14.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.804 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -73.79 138.44 44.53 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 92' ' ' CYS . 52.5 ptt85 -145.62 160.96 40.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.496 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.4 pm0 -160.92 -177.48 6.16 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.81 124.66 17.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -66.24 -39.62 89.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.018 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m -109.72 33.08 4.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.507 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.36 -134.1 1.63 Allowed Glycine 0 C--O 1.216 -1.002 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.798 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -154.87 -83.16 0.07 Allowed 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.325 -0.438 . . . . 0.0 110.424 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.61 28.78 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -94.81 33.74 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.903 0.382 . . . . 0.0 110.604 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.47 124.54 49.03 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.534 0.683 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 16' ' ' TYR . 32.3 m -87.97 161.3 17.5 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.472 ' N ' HG22 ' A' ' 15' ' ' THR . 31.8 t80 -60.5 -43.74 96.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.388 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.24 62.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.957 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.46 -51.15 62.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -31.77 18.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 23' ' ' CYS . 10.5 mtpm? -70.59 -33.8 71.46 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 120.576 0.227 . . . . 0.0 110.567 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.54 74.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.133 0.492 . . . . 0.0 111.765 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.68 -44.31 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.251 0.548 . . . . 0.0 111.173 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' O ' ' O ' ' A' ' 20' ' ' LYS . 7.4 m -102.26 178.25 4.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.085 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 67.45 -39.32 0.37 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.9 t80 -60.0 -47.03 87.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.658 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.67 19.76 5.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.676 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.95 77.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.57 -165.75 22.11 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -167.95 137.89 2.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.201 . . . . 0.0 110.523 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 30' ' ' LEU . 10.7 mp -70.54 137.4 50.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.917 0.389 . . . . 0.0 110.144 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.42 138.64 55.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 36' ' ' LEU . 11.1 p -100.31 163.71 12.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 22.9 p90 -54.4 -53.37 54.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.943 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.57 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 39.0 ttmt -62.28 -44.38 96.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.986 0.422 . . . . 0.0 110.334 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -67.06 -30.05 70.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.4 mt -62.41 -29.9 70.83 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.346 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.77 -39.36 58.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.407 . . . . 0.0 110.909 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.29 -38.03 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.83 28.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 42' ' ' ILE . 3.8 tpt85 -56.77 -37.47 71.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -63.48 -2.09 1.45 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.509 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 42' ' ' ILE . 24.5 mm -106.39 13.46 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.347 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 18.93 66.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.77 127.49 33.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.885 0.343 . . . . 0.0 110.181 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -140.93 104.43 4.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.506 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.53 125.4 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.023 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -93.84 91.51 6.98 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.887 0.375 . . . . 0.0 110.303 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.28 93.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . . . -72.11 121.37 19.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.59 162.6 25.82 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.961 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -80.29 109.34 14.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.39 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 40.1 mtm -97.87 -172.61 2.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.248 0.547 . . . . 0.0 110.251 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.02 152.93 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.583 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' ARG . 68.6 mttm 47.19 41.03 11.13 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.96 5.68 0.1 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.892 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' LYS . 54.8 mtp180 -68.37 128.91 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.3 122.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.806 0.812 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.81 150.74 12.16 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.516 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 49' ' ' ALA . 11.2 p90 -160.53 140.36 8.26 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.607 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 143.37 31.59 Favored 'Trans proline' 0 N--CA 1.505 2.198 0 C-N-CA 121.632 1.555 . . . . 0.0 112.784 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.5 pt -149.49 96.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.435 0.636 . . . . 0.0 111.08 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -139.18 80.34 23.69 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.64 131.22 32.57 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 121.851 1.701 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.41 169.13 28.71 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.048 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.79 -18.4 47.43 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.504 2.136 . . . . 0.0 112.056 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -102.84 30.77 4.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.019 0.438 . . . . 0.0 110.537 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.42 -174.02 3.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.2 0.524 . . . . 0.0 110.502 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.21 135.87 34.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -73.19 134.0 44.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 72' ' ' LYS . . . 65.01 -154.93 49.37 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 71' ' ' GLY . 56.7 mtpt 54.15 109.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.197 . . . . 0.0 110.875 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -139.12 170.75 15.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.285 0.564 . . . . 0.0 110.824 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.04 68.66 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.7 mt 59.98 145.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.776 0.322 . . . . 0.0 110.39 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.43 136.28 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.11 0.481 . . . . 0.0 110.626 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -133.36 137.74 46.01 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.539 ' CZ ' ' NH2' ' A' ' 81' ' ' ARG . 9.2 t80 -143.21 -179.0 6.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.638 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.48 -69.06 1.17 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER 173.79 135.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.3 0.571 . . . . 0.0 109.98 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.539 ' NH2' ' CZ ' ' A' ' 78' ' ' TYR . 86.9 mtt-85 -111.4 133.49 53.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.232 0.539 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 mt -82.39 2.35 32.87 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.481 0.658 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -83.42 21.66 1.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.837 0.827 . . . . 0.0 110.656 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -48.91 -36.07 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.572 -0.705 . . . . 0.0 111.182 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -47.56 -30.8 3.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.564 0.221 . . . . 0.0 110.869 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.93 147.62 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.777 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 81.8 mtt85 -92.61 133.15 36.26 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.261 0.553 . . . . 0.0 110.569 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 66.6 m95 -151.53 175.62 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.17 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -63.64 -169.0 0.03 OUTLIER 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.726 0.641 . . . . 0.0 111.007 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.34 159.75 8.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.414 0.626 . . . . 0.0 111.106 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.55 156.95 40.01 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.592 0.711 . . . . 0.0 110.576 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.406 ' HB2' ' HE ' ' A' ' 5' ' ' ARG . 1.1 m -147.5 142.28 26.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.631 0.729 . . . . 0.0 110.002 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.32 114.67 13.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.833 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -102.96 105.96 48.14 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 118.079 -0.963 . . . . 0.0 111.163 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--N 1.308 -1.603 0 C-N-CA 121.063 1.176 . . . . 0.0 112.081 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.01 150.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -158.84 154.19 25.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -83.17 142.3 31.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -145.87 134.57 22.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 79.2 tt0 -134.48 161.03 36.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.11 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.11 133.69 38.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.525 0.678 . . . . 0.0 110.977 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 6' ' ' GLU . 86.2 mmt-85 -75.66 -39.37 57.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.834 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -113.53 -30.34 6.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.86 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.59 -170.22 43.71 Favored Glycine 0 C--O 1.216 -0.975 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -167.23 99.45 0.52 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 55.12 60.76 3.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.936 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -142.48 42.97 1.63 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.719 0.295 . . . . 0.0 110.683 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.15 137.91 53.62 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.405 0.622 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.4 p -101.65 166.62 10.6 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.766 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.583 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 33.0 p90 -51.89 -60.52 3.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -56.29 -36.36 68.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.918 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.81 -48.85 65.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.83 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.22 -30.64 7.36 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.025 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.5 mtpt -65.03 -26.37 68.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 -53.69 30.79 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.555 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.98 -33.7 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.994 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.595 ' C ' ' H ' ' A' ' 25' ' ' PHE . 56.1 m -102.88 176.11 5.26 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 64.7 -26.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.6 t80 -61.14 -47.83 84.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.854 0.359 . . . . 0.0 110.728 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.21 23.67 4.26 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.6 -5.15 84.48 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.56 -158.96 3.52 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -173.28 161.29 4.18 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.51 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.22 145.87 55.27 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.602 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . . . -64.03 81.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.433 0.635 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -62.45 152.24 34.95 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -57.93 -52.62 64.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.757 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -50.72 -49.69 57.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.587 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.17 -40.44 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.714 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.21 -40.65 96.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.3 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -63.89 -33.38 75.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.485 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.0 63.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -87.25 -32.32 19.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.262 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -52.47 -19.91 2.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.428 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -3.4 37.19 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.809 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.8 tt -101.84 13.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.625 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 18.84 70.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.84 145.23 20.31 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.239 0.519 . . . . 0.0 110.326 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -140.85 132.56 27.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.708 0.766 . . . . 0.0 110.352 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 47' ' ' CYS . 38.6 t -132.97 159.48 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.784 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.464 ' N ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -156.24 41.48 0.37 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.523 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' H ' HG12 ' A' ' 46' ' ' VAL . . . -145.17 144.01 30.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.23 0.538 . . . . 0.0 110.595 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.46 34.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.618 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 57' ' ' VAL . . . -133.32 -171.34 12.66 Favored Glycine 0 N--CA 1.48 1.598 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.05 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -99.12 150.04 22.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 110.054 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 42.2 ttm -134.44 161.19 35.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.117 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.8 136.93 1.84 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.2 mttp 56.77 38.03 29.21 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.598 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.84 15.47 2.29 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.836 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -75.12 50.94 0.5 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.69 0.281 . . . . 0.0 110.651 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 50' ' ' GLY . 2.2 p -54.81 132.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.086 0.946 . . . . 0.0 110.765 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.27 71.71 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -71.23 142.99 87.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 121.161 -0.215 . . . . 0.0 111.546 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 156.47 53.75 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.511 1.474 . . . . 0.0 112.501 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.6 mt -144.13 94.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.64 -72.92 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -71.82 155.37 92.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -61.76 145.56 97.22 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.381 2.054 . . . . 0.0 111.899 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.61 83.97 0.24 Allowed Glycine 0 N--CA 1.472 1.058 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.91 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.36 -42.14 56.02 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.237 1.958 . . . . 0.0 112.322 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -98.13 23.75 7.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.701 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 4.2 p -177.7 111.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.393 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 72.21 16.61 77.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 50.85 -88.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.438 0.637 . . . . 0.0 110.803 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -158.74 18.99 0.29 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.74 126.77 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 110.164 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -94.18 172.36 8.27 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.07 -170.9 54.2 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.82 123.35 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.97 0.414 . . . . 0.0 110.714 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.9 mm -95.97 74.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.615 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -75.84 109.59 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.332 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -75.04 -4.3 37.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 50.22 69.53 1.05 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 79' ' ' GLY . 75.8 mt 56.04 120.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.071 0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -104.64 152.76 22.08 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.108 0.48 . . . . 0.0 110.388 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 84' ' ' ARG . 48.5 tp -85.93 -11.03 54.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 110.491 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 85' ' ' SER . 51.4 p30 -73.48 23.61 0.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.856 0.836 . . . . 0.0 110.508 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.3 mtt180 -47.95 -13.61 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.587 -0.696 . . . . 0.0 111.114 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.24 -32.23 26.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.717 0.294 . . . . 0.0 110.669 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.61 149.06 44.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.609 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -85.79 158.25 20.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.431 0.634 . . . . 0.0 110.507 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -155.43 179.81 8.82 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.249 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 43.6 t0 -75.31 -177.08 3.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.645 0.736 . . . . 0.0 110.765 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.454 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.82 158.19 30.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -151.32 159.0 44.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.672 0.749 . . . . 0.0 110.504 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.5 m -125.59 148.09 49.07 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.083 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -138.45 126.8 23.06 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 56.9 m-80 -68.41 148.83 98.18 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.709 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo . . . . . 0 C--N 1.307 -1.623 0 C-N-CA 121.993 1.795 . . . . 0.0 111.466 179.207 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -83.14 155.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.802 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -146.99 148.67 31.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 110.794 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.74 136.8 34.62 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.754 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -102.63 158.78 16.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -141.1 113.79 8.28 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.448 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 173.75 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.61 86.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.074 0.464 . . . . 0.0 111.157 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.0 p -75.92 -7.18 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.445 0.641 . . . . 0.0 110.759 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 40.44 45.21 3.32 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 12' ' ' TYR . 53.3 tttp -152.8 46.56 0.71 Allowed 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 121.011 0.434 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.405 ' O ' ' O ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER 44.95 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -141.4 36.85 1.68 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.758 0.313 . . . . 0.0 110.486 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' TRP . 50.6 mt -123.88 137.94 54.56 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 16' ' ' TYR . 87.2 m -100.47 164.77 11.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.568 ' N ' HG22 ' A' ' 15' ' ' THR . 32.2 t80 -52.01 -58.5 6.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.51 84.83 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.957 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.06 -46.54 89.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.989 0.423 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.77 -29.68 60.02 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.796 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 23' ' ' CYS . 5.1 ttpm? -70.31 -31.32 68.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.975 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.19 70.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.482 . . . . 0.0 111.598 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 m -68.16 -33.84 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.462 0.648 . . . . 0.0 111.284 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 25' ' ' PHE . 12.3 t -103.85 176.89 5.0 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.012 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 62.59 -3.64 0.28 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.714 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 23' ' ' CYS . 82.5 t80 -58.88 -46.2 88.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.067 0.46 . . . . 0.0 110.485 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.0 pm0 -83.38 -16.94 44.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.53 -16.37 5.65 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.477 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -60.52 -162.5 0.13 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 99.5 m-70 -156.87 148.99 22.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.567 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 37.5 mt -51.29 137.04 23.74 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.471 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.14 103.63 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.201 0.524 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.2 t -80.61 169.82 17.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -54.94 -52.2 63.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.076 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -57.64 -42.46 83.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.541 ' H ' HG23 ' A' ' 32' ' ' THR . 7.1 tp-100 -69.48 -40.39 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.96 -44.91 94.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.235 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.76 -38.35 69.75 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.803 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.21 74.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.109 0.48 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -43.77 36.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.155 0.502 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.64 HH12 ' H ' ' A' ' 46' ' ' VAL . 18.3 mmm180 -55.48 -29.27 58.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -70.73 -10.2 58.93 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.432 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 42' ' ' ILE . 22.1 mm -104.98 13.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.36 11.1 78.76 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -59.12 104.22 0.23 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.023 0.412 . . . . 0.0 110.252 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -88.72 129.16 35.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.421 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.64 ' H ' HH12 ' A' ' 40' ' ' ARG . 39.2 t -136.65 157.36 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.953 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.427 ' N ' HG12 ' A' ' 46' ' ' VAL . 4.2 t -158.49 46.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.14 146.1 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 110.65 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.87 115.16 29.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.602 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.35 160.02 20.71 Favored Glycine 0 N--CA 1.475 1.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.889 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -78.14 107.47 10.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.324 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.0 mtp -98.04 177.06 5.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.211 0.529 . . . . 0.0 110.134 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.79 144.54 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.721 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.6 tttt 59.88 12.47 3.08 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.202 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.21 78.65 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.914 -0.491 . . . . 0.0 111.929 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 58.8 ttt180 -73.33 135.94 44.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.713 0.292 . . . . 0.0 110.53 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.97 154.51 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.252 0.549 . . . . 0.0 110.672 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.05 139.5 5.81 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.664 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 24.4 p90 -148.03 70.44 11.08 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-N 115.635 -0.282 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.4 141.55 95.9 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.23 1.953 . . . . 0.0 112.449 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -133.42 129.0 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.544 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.0 t -64.52 -43.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 21.8 ttpt -177.37 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 60.9 Cg_endo -65.38 145.28 82.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.505 1.47 . . . . 0.0 112.305 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -165.14 51.98 0.28 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 59.6 Cg_endo -67.4 -49.63 1.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.476 2.117 . . . . 0.0 112.032 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.435 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -87.95 -27.12 22.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.984 0.421 . . . . 0.0 110.812 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.435 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -139.17 144.05 38.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.266 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' PHE . . . 79.01 156.46 10.01 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.431 ' CG ' ' O ' ' A' ' 69' ' ' GLY . 97.0 m-85 -157.1 105.4 2.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.858 -0.171 . . . . 0.0 110.673 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.52 -42.1 1.94 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -69.7 142.05 53.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.6 p -144.54 168.91 19.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.847 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 61.6 153.16 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 74' ' ' GLY . 82.7 mt -31.55 125.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 120.724 0.297 . . . . 0.0 111.26 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.96 126.2 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.228 0.537 . . . . 0.0 110.601 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.401 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 56.1 t0 -94.82 107.02 19.03 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.77 -15.7 23.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.04 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.51 -91.07 1.64 Allowed Glycine 0 N--CA 1.466 0.676 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.7 mt -154.61 140.53 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.614 0.721 . . . . 0.0 110.046 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.614 ' HE ' HD21 ' A' ' 83' ' ' ASN . 18.5 mmm180 -102.85 117.74 35.28 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.765 0.793 . . . . 0.0 110.456 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.577 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -80.79 -6.76 58.95 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.845 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.614 HD21 ' HE ' ' A' ' 81' ' ' ARG . 51.2 p30 -75.61 22.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.659 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 82' ' ' LEU . 8.1 ptm180 -48.08 -12.02 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.662 -0.649 . . . . 0.0 111.266 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 83' ' ' ASN . 99.7 p -80.92 -7.78 59.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -98.82 -151.78 0.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.416 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.42 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 82.4 mtt85 -144.85 147.71 33.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.312 0.577 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' LEU . 82.3 m95 -153.88 178.96 9.34 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.427 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -59.81 -170.24 0.01 OUTLIER 'General case' 0 C--O 1.235 0.328 0 O-C-N 123.77 0.669 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.0 151.07 5.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.05 0.452 . . . . 0.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.97 158.61 37.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.558 0.694 . . . . 0.0 110.594 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 t -152.75 149.43 28.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.871 0.843 . . . . 0.0 110.49 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -141.06 149.96 42.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.598 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -151.43 149.72 25.06 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 N--CA 1.503 2.076 0 C-N-CA 122.388 2.059 . . . . 0.0 112.013 179.605 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 t -82.62 148.01 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.789 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -136.07 134.92 38.92 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.699 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.96 138.29 42.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.5 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -118.15 131.27 56.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.252 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -139.3 146.04 39.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.44 124.65 23.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.916 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.28 -33.87 67.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -110.03 32.57 5.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.3 -136.22 2.07 Favored Glycine 0 C--O 1.218 -0.882 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.641 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -171.75 -30.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 120.949 0.404 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -153.86 61.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.17 32.76 3.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.042 0.449 . . . . 0.0 110.578 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' TRP . 41.8 mt -115.64 111.62 20.9 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.681 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.432 ' OG1' ' OE1' ' A' ' 18' ' ' GLU . 54.2 p -100.03 174.33 6.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 11.5 p90 -51.02 -52.62 41.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.891 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.421 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -55.09 -49.28 72.08 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.128 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 21.0 mp0 -66.58 -33.13 74.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.65 83.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.975 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.9 mttt -71.48 -31.67 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.679 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.7 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.512 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -77.84 -24.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.931 0.395 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 25' ' ' PHE . 64.6 m -104.41 177.11 4.94 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 109.809 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' GLY . 78.9 tt0 67.53 -29.15 0.15 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.216 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.8 t80 -60.79 -48.49 81.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 110.734 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 3.4 pm0 -78.68 11.69 2.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.111 0.482 . . . . 0.0 110.916 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.18 -24.67 23.93 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -86.29 133.79 12.06 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -98.31 176.78 5.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.4 148.59 48.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.34 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.92 141.06 40.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -123.52 158.38 31.46 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.022 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -55.16 -28.78 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.439 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -68.66 -52.7 28.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.045 0.45 . . . . 0.0 110.85 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.5 -37.35 74.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.998 0.428 . . . . 0.0 110.606 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.6 mt -62.73 -39.77 95.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.92 -40.09 72.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.01 -23.96 48.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.7 -19.99 60.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.945 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.588 HH12 ' CB ' ' A' ' 60' ' ' PRO . 10.2 mmm180 -60.79 -41.86 96.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.663 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.36 -5.0 39.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 42' ' ' ILE . 46.6 mm -95.78 0.15 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.519 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.37 19.3 46.03 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.619 -0.593 . . . . 0.0 111.619 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -61.49 121.24 12.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.558 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -155.79 103.3 2.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.302 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.95 126.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.745 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.86 76.21 2.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.895 0.378 . . . . 0.0 110.417 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.03 94.04 2.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 106.27 0.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.351 0.596 . . . . 0.0 110.645 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.36 151.98 20.28 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.943 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -64.01 153.46 37.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.535 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.9 ptp -155.34 -173.8 4.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -34.57 125.1 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.542 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttp 57.35 31.86 20.84 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.529 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 55.43 21.42 27.14 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.713 -0.617 . . . . 0.0 111.708 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.44 ' O ' ' SD ' ' A' ' 52' ' ' MET . 29.9 ttp85 -73.31 59.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.115 0.458 . . . . 0.0 110.888 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.47 151.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.253 0.549 . . . . 0.0 111.312 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.59 169.69 41.81 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.534 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.6 p90 -158.16 76.88 3.56 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.45 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' CB ' HH12 ' A' ' 40' ' ' ARG . 50.3 Cg_exo -56.38 143.61 85.98 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.476 2.117 . . . . 0.0 112.541 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.6 mt -137.66 96.61 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.516 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 m -64.79 -28.54 45.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 110.292 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -150.93 146.72 19.58 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -41.68 151.73 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.895 1.73 . . . . 0.0 112.656 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.05 27.94 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.552 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.27 -38.96 3.23 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.992 1.795 . . . . 0.0 112.323 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.43 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.5 p30 -66.7 -21.63 66.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.643 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.43 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 9.7 p -162.62 133.71 4.97 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.436 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.75 177.72 1.34 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 40.1 p90 -58.5 -52.63 64.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.569 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . 43.22 74.09 0.21 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt 53.23 -175.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.936 0.398 . . . . 0.0 110.668 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.2 p -148.83 172.93 13.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 73.99 77.08 0.66 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 74' ' ' GLY . 76.8 mt 50.34 103.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.755 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.3 mm -104.84 123.63 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -136.38 142.97 43.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.679 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.6 9.66 8.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.924 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.71 -92.52 1.8 Allowed Glycine 0 C--O 1.224 -0.47 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.0 mt -156.95 124.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 110.005 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -102.76 126.84 50.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.974 0.416 . . . . 0.0 110.382 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -87.57 2.65 50.22 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.445 0.641 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.33 26.02 6.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.805 0.812 . . . . 0.0 110.708 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -43.9 -26.07 0.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.656 -0.652 . . . . 0.0 111.142 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -56.2 -14.32 2.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.768 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.08 166.37 23.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 82.1 mtt85 -96.72 127.8 43.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.711 0.767 . . . . 0.0 110.413 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 82.8 m95 -155.09 178.61 10.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.07 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 22.6 t70 -75.54 -170.49 1.27 Allowed 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.866 0.729 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.47 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -166.04 159.54 15.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 0.0 111.002 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.98 160.78 17.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 110.265 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.7 t -145.13 177.26 8.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.495 0.664 . . . . 0.0 110.212 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -146.59 130.43 17.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.149 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.62 157.55 41.16 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.336 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.501 1.927 0 C-N-CA 121.929 1.752 . . . . 0.0 112.238 178.743 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.28 141.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 110.749 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -148.94 154.97 40.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -79.03 133.98 36.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.504 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -120.29 124.54 45.87 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -113.24 135.44 53.82 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.459 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 145.45 55.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.403 0.62 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -81.43 -50.12 9.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.5 p -113.14 34.56 4.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.487 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.18 -146.1 4.59 Favored Glycine 0 C--O 1.217 -0.928 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.709 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -175.9 -54.59 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -134.35 12.97 3.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -94.15 38.11 1.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.093 0.473 . . . . 0.0 110.442 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.94 131.88 55.34 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.501 0.667 . . . . 0.0 110.584 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.1 p -95.29 168.22 10.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.691 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -60.34 -41.14 93.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.37 66.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.1 -49.4 77.8 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.778 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.81 -30.29 63.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.018 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.3 tttp -69.85 -38.18 76.38 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 120.792 0.33 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.09 75.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.56 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.39 -41.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.631 0.729 . . . . 0.0 110.983 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.0 m -100.35 177.79 4.94 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.968 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 64.31 -15.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' H ' ' C ' ' A' ' 23' ' ' CYS . 67.7 t80 -62.92 -50.18 71.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.985 0.421 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.52 26.29 0.69 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.755 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.07 3.92 90.6 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.9 -151.81 2.83 Favored Glycine 0 C--O 1.219 -0.824 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -168.93 147.07 3.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.424 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.11 149.72 27.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.386 0.612 . . . . 0.0 110.252 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 146.47 53.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -124.63 178.17 5.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -58.27 -52.27 66.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.638 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -49.02 -47.23 44.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.17 -43.86 73.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.293 0.568 . . . . 0.0 110.737 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.58 -42.32 99.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.666 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -60.33 -30.42 69.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.558 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.01 -27.22 54.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.19 56.33 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.819 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -55.37 -30.99 61.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.376 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.63 -3.26 55.93 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 42' ' ' ILE . 33.6 mm -105.81 6.2 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.519 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 17.99 52.98 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.19 126.57 26.72 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 110.546 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.18 128.79 40.74 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.361 0.6 . . . . 0.0 110.577 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 47' ' ' CYS . 84.1 t -139.58 160.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.776 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.505 ' N ' HG12 ' A' ' 46' ' ' VAL . 11.4 t -158.75 33.84 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.702 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' H ' HG12 ' A' ' 46' ' ' VAL . . . -145.29 128.78 17.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.136 0.493 . . . . 0.0 110.533 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.26 131.68 44.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.01 144.05 10.08 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.739 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.464 ' HE1' ' H ' ' A' ' 88' ' ' TRP . 9.4 m95 -65.68 158.11 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.585 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.8 mtm -151.22 -177.69 6.19 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.229 0.538 . . . . 0.0 110.195 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.38 128.54 3.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.576 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 56' ' ' ARG . 72.4 tttt 66.11 37.56 5.12 Favored 'General case' 0 C--O 1.201 -1.481 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.047 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.89 5.87 0.1 Allowed Glycine 0 CA--C 1.54 1.614 0 O-C-N 121.764 -0.585 . . . . 0.0 112.39 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 67.7 ttt-85 -66.38 89.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.257 0.551 . . . . 0.0 110.445 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.1 134.48 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.76 0.79 . . . . 0.0 110.337 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.28 26.28 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.577 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.1 p90 -162.52 81.44 1.71 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.343 -0.429 . . . . 0.0 110.677 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 133.36 57.6 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.22 1.947 . . . . 0.0 112.57 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -118.3 109.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.369 0.604 . . . . 0.0 110.689 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.2 m -84.63 -15.32 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.167 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.87 142.6 2.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.133 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.32 149.75 2.48 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 121.067 1.178 . . . . 0.0 112.709 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -122.17 157.51 16.88 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.526 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.28 -43.21 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.351 1.367 . . . . 0.0 112.178 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.419 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -75.6 -21.3 57.92 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.347 0.594 . . . . 0.0 111.082 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.419 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.7 OUTLIER -124.86 144.0 50.54 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.062 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.44 -172.77 4.93 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.471 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.05 169.42 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.111 0.481 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.49 -25.14 0.07 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.24 -177.92 5.24 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 110.419 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 p -138.52 156.67 47.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.775 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 66.54 164.28 1.72 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' GLY . 76.6 mt -34.25 139.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 115.641 -0.28 . . . . 0.0 111.269 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.43 17.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.648 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 56' ' ' ARG . 2.4 p30 -61.34 126.83 28.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.967 0.413 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -68.73 -43.35 76.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.529 0.681 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.9 -128.4 3.58 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.21 108.46 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 122.243 1.021 . . . . 0.0 110.019 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.71 ' H ' ' NE ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.766 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 84' ' ' ARG . 69.2 mt -90.26 -2.78 58.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.842 0.354 . . . . 0.0 110.593 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -77.64 28.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.732 0.777 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.598 ' HE ' ' NH2' ' A' ' 81' ' ' ARG . 99.4 mtt180 -51.12 -1.22 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.733 -0.605 . . . . 0.0 111.73 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 83' ' ' ASN . 9.2 m -96.9 2.26 51.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -87.02 -158.84 0.46 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.936 0.398 . . . . 0.0 110.564 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 33.4 ptt-85 -155.83 134.19 11.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.608 0.718 . . . . 0.0 110.802 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.2 m0 -147.46 -172.99 4.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.274 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 20.5 t0 -57.89 -148.28 0.0 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.967 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.52 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.77 130.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.641 0.734 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -122.9 157.96 31.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.471 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 93' ' ' TYR . 6.9 t -140.86 -173.8 3.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.746 0.784 . . . . 0.0 110.296 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.402 ' N ' ' SG ' ' A' ' 92' ' ' CYS . 63.7 t80 -155.93 121.55 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.279 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -152.33 147.53 19.72 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.042 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 N--CA 1.5 1.906 0 C-N-CA 122.415 2.077 . . . . 0.0 111.886 179.327 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.25 154.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.128 0.49 . . . . 0.0 110.639 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 4' ' ' HIS . 75.1 t80 -118.98 139.16 52.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.477 ' O ' ' CE2' ' A' ' 3' ' ' TYR . 43.8 p-80 -74.77 130.63 39.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -141.23 136.43 31.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.078 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.13 177.49 6.19 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 126.61 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -70.28 -39.47 74.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -112.67 28.55 8.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.95 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.67 -139.05 2.61 Favored Glycine 0 C--O 1.216 -1.028 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.555 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -175.69 -66.98 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.272 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.5 47.61 0.87 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -132.29 31.05 4.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 120.937 0.399 . . . . 0.0 110.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp -118.32 126.09 51.42 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.54 0.686 . . . . 0.0 110.662 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 16' ' ' TYR . 45.4 m -99.5 160.4 14.31 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' N ' HG22 ' A' ' 15' ' ' THR . 41.2 p90 -53.38 -42.71 67.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' A' ' 16' ' ' TYR . . . -55.39 -42.91 74.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.868 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.18 -49.76 47.12 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.662 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.57 -37.84 58.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.037 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.9 tttm -71.34 -32.42 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 110.817 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.33 -54.39 17.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.569 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.21 -36.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.21 0.529 . . . . 0.0 111.029 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 25' ' ' PHE . 2.0 t -103.31 176.23 5.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 65.29 -15.83 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.035 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.3 t80 -61.57 -48.14 82.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 14.4 pt-20 -81.63 20.87 0.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.26 86.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.64 -155.16 1.09 Allowed Glycine 0 C--O 1.219 -0.796 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -170.54 145.26 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.449 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 mt -52.98 141.03 23.26 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.118 0.485 . . . . 0.0 110.564 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.28 106.55 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.9 m -69.92 146.99 50.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 5.4 p90 -53.55 -51.65 62.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.981 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.578 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 64.8 tttp -60.82 -45.47 94.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 110.558 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -68.46 -27.21 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -28.26 66.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -51.45 -31.06 21.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.1 73.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.18 -41.64 49.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.767 0.318 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.564 ' NH2' ' N ' ' A' ' 62' ' ' VAL . 37.2 mmm-85 -56.66 -31.86 64.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.83 -10.67 59.73 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.644 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 42' ' ' ILE . 94.6 mt -101.75 4.95 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.558 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.7 14.14 47.92 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.37 128.31 35.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.905 0.383 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -149.39 104.72 3.4 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.456 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.83 129.49 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.912 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -93.78 96.21 9.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.516 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.46 95.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.7 131.74 44.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.29 159.44 27.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.88 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -70.82 104.56 2.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 66.8 mtm -96.75 -175.56 3.33 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.219 0.533 . . . . 0.0 110.236 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.06 158.92 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.524 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 56' ' ' ARG . 63.0 mttp 50.63 38.02 17.89 Favored 'General case' 0 C--O 1.2 -1.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.72 0.46 0.03 OUTLIER Glycine 0 CA--C 1.54 1.603 0 O-C-N 121.878 -0.514 . . . . 0.0 112.062 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.5 mtt180 -69.55 149.06 48.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.141 0.496 . . . . 0.0 110.475 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.63 141.63 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.441 1.115 . . . . 0.0 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.73 166.66 30.34 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.415 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -128.7 107.19 18.65 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.46 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.51 119.47 4.51 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.544 1.496 . . . . 0.0 112.486 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.516 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 4.4 pt -148.83 93.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.722 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.564 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 56.3 t -49.28 -21.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.282 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -142.92 146.28 36.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.12 154.51 0.79 Allowed 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.579 1.519 . . . . 0.0 112.622 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.25 154.5 26.0 Favored Glycine 0 CA--C 1.543 1.834 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.735 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.79 -41.47 1.07 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.079 1.852 . . . . 0.0 112.353 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.62 -40.68 92.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.64 145.05 25.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.665 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.23 176.92 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.619 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -70.79 139.74 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.471 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.4 135.41 1.88 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.615 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.09 -47.36 84.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.851 0.358 . . . . 0.0 110.177 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.484 ' O ' HD11 ' A' ' 76' ' ' ILE . 62.6 p -132.66 165.17 25.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.284 0.564 . . . . 0.0 110.904 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . -84.28 -155.49 22.21 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 77' ' ' ASP . 40.5 mt 68.88 -7.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' O ' ' A' ' 73' ' ' THR . 38.6 mt -63.55 67.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.623 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' ILE . 2.4 p30 -85.71 151.2 24.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.446 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -89.48 -139.38 0.13 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.628 0.727 . . . . 0.0 110.184 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.68 95.56 0.18 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.8 mt 45.27 96.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.62 0.248 . . . . 0.0 110.674 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.433 ' O ' ' NH1' ' A' ' 84' ' ' ARG . 78.9 mtp180 -94.78 141.29 28.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.033 0.444 . . . . 0.0 110.081 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -79.58 3.98 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.604 0.716 . . . . 0.0 110.6 -179.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.466 ' N ' HD12 ' A' ' 82' ' ' LEU . 31.9 t30 -80.19 15.22 1.61 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.801 0.81 . . . . 0.0 110.304 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH1' ' O ' ' A' ' 81' ' ' ARG . 88.8 mtm-85 -58.72 -5.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.593 -0.692 . . . . 0.0 110.868 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -73.27 -35.58 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.646 0.26 . . . . 0.0 110.916 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -81.18 158.3 24.96 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.277 0.561 . . . . 0.0 110.617 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -86.84 149.11 25.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.734 0.778 . . . . 0.0 110.619 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -154.41 177.43 11.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.0 -172.56 2.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.647 0.737 . . . . 0.0 110.755 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -167.04 166.67 15.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.338 0.589 . . . . 0.0 111.053 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.88 156.86 46.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.953 0.882 . . . . 0.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.0 t -124.41 -167.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -159.21 145.96 16.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.999 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 26' ' ' GLU . 12.1 m120 -149.75 143.88 17.18 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.287 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 C--N 1.308 -1.593 0 C-N-CA 121.901 1.734 . . . . 0.0 111.93 179.217 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 t -84.49 136.52 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.656 0.265 . . . . 0.0 110.798 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.509 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 22.2 p90 -146.94 159.39 43.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.811 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -74.9 148.82 39.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.381 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.509 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 25.5 mmt180 -123.55 157.34 33.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.228 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -157.93 120.68 3.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.191 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 166.57 12.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.907 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.51 -36.62 81.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -64.81 -32.92 74.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.367 0.604 . . . . 0.0 110.632 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.71 177.73 23.19 Favored Glycine 0 C--O 1.216 -0.994 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.661 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.07 -105.14 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.328 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -68.8 69.92 0.18 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.665 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -144.41 29.08 1.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.787 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' TRP . 23.5 mt -123.36 143.36 50.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.8 p -95.69 168.51 10.62 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.753 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.579 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 26.5 p90 -46.9 -56.15 6.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -53.07 -42.29 65.69 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.969 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.54 -26.73 68.02 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.947 0.404 . . . . 0.0 110.555 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.95 -36.97 67.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -71.05 -30.63 66.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.222 0.534 . . . . 0.0 110.555 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.01 -49.3 75.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.614 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.56 -28.9 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.352 0.596 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.598 ' C ' ' H ' ' A' ' 25' ' ' PHE . 82.2 m -105.28 179.16 4.35 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.029 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 15.3 mp0 64.6 -28.29 0.1 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.887 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' H ' ' C ' ' A' ' 23' ' ' CYS . 59.4 t80 -62.18 -45.26 94.18 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.803 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -95.71 9.18 41.26 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.97 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.42 -4.06 66.55 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.32 -175.16 44.75 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -154.33 162.41 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.831 -0.185 . . . . 0.0 110.705 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 30' ' ' LEU . 9.4 mp -71.09 147.23 48.68 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.087 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.71 151.31 38.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.075 0.464 . . . . 0.0 110.806 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 m -125.02 156.66 37.79 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.155 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -54.05 -21.31 8.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.397 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -76.01 -57.24 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.117 0.484 . . . . 0.0 110.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.73 -33.13 73.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.47 -42.46 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.59 -34.76 77.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.555 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.4 -33.9 73.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 110.957 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -23.62 28.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.695 ' HE ' ' HB2' ' A' ' 60' ' ' PRO . 3.8 tpt85 -60.85 -42.55 98.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.567 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -60.87 -2.45 0.57 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 40' ' ' ARG . 18.5 mm -101.23 17.19 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.33 19.99 79.79 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.37 105.03 0.3 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.156 0.478 . . . . 0.0 110.39 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -95.48 133.65 39.22 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.389 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 47' ' ' CYS . 18.3 t -137.39 159.37 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 68' ' ' CYS . 2.9 t -156.11 42.03 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.752 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.68 125.18 3.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 110.723 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.38 138.74 45.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.38 152.79 24.81 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.924 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -68.07 101.96 1.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.062 0.458 . . . . 0.0 109.954 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 58' ' ' GLY . 1.4 mtp -91.38 166.29 12.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.649 0.738 . . . . 0.0 109.852 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' MET . . . -39.48 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.59 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt 58.68 7.52 0.76 Allowed 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.373 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.89 87.17 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.814 -0.554 . . . . 0.0 112.106 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -76.29 131.93 39.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.005 0.403 . . . . 0.0 110.632 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.81 112.5 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.855 0.836 . . . . 0.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -166.53 177.85 41.22 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.541 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 61' ' ' ILE . 7.1 p90 -167.84 142.28 2.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.745 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.695 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 72.8 Cg_endo -72.35 147.17 46.58 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.001 1.801 . . . . 0.0 112.651 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.447 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 17.7 mt -139.68 93.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.842 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.61 -41.85 86.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.346 0.593 . . . . 0.0 110.542 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -136.95 101.42 9.46 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.73 130.04 14.91 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.815 1.677 . . . . 0.0 112.474 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.91 22.04 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.397 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.99 -51.75 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.335 2.023 . . . . 0.0 112.241 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -67.54 -37.24 82.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 1.5 p -152.24 123.05 7.45 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.361 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 178.69 -26.63 0.05 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 90.1 t80 52.9 -85.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 110.763 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -172.98 -172.99 39.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 54.08 -171.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 0.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.58 HG22 ' N ' ' A' ' 74' ' ' GLY . 35.6 m -144.86 167.24 23.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.207 0.527 . . . . 0.0 110.63 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.58 ' N ' HG22 ' A' ' 73' ' ' THR . . . 93.64 -151.7 20.45 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.1 mt -100.97 128.61 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.392 . . . . 0.0 110.39 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.7 mt -132.03 71.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.415 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.23 135.03 34.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.842 0.353 . . . . 0.0 110.579 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.39 110.67 22.67 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.059 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.92 95.95 0.01 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.5 mt 49.39 100.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.756 0.312 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.835 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 70.6 mtp180 -68.81 148.07 50.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 84' ' ' ARG . 10.9 mp -74.95 -28.78 60.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.885 0.85 . . . . 0.0 110.555 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.835 HD21 ' CZ ' ' A' ' 81' ' ' ARG . 18.0 p30 -73.18 32.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.028 0.918 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' LEU . 66.0 mtp180 -48.65 -6.99 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.632 -0.667 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 83' ' ' ASN . 32.5 t -87.19 -8.2 57.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.987 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -91.39 147.57 22.94 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -83.31 152.36 25.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.266 0.555 . . . . 0.0 110.51 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.562 ' NE1' ' NH1' ' A' ' 81' ' ' ARG . 73.5 m95 -156.02 179.12 9.52 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.326 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 11.8 t70 -76.05 -161.54 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.826 0.822 . . . . 0.0 110.471 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.419 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.08 152.7 6.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.783 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.15 158.75 38.85 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.726 . . . . 0.0 110.408 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -133.11 -173.28 3.16 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.613 0.721 . . . . 0.0 110.138 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -155.29 113.4 3.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -117.41 85.81 20.95 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 N--CA 1.499 1.845 0 C-N-CA 122.48 2.12 . . . . 0.0 112.355 -179.885 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 t -84.89 145.87 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.63 0.252 . . . . 0.0 111.094 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -161.23 156.54 24.31 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.032 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.69 116.23 25.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.486 0.66 . . . . 0.0 110.752 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -103.85 121.5 43.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -103.85 130.7 51.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.545 0.528 . . . . 0.0 110.362 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.23 172.5 13.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -60.32 -34.7 74.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.967 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.548 ' O ' ' C ' ' A' ' 10' ' ' GLY . 73.9 m -82.14 -20.21 38.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.513 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 16.57 81.79 0.01 OUTLIER Glycine 0 N--CA 1.494 2.541 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.267 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -172.52 37.67 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 120.923 0.392 . . . . 0.0 110.398 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 52.25 62.01 2.91 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -132.08 31.83 4.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.698 0.285 . . . . 0.0 110.694 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -122.09 128.24 51.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -98.16 170.55 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.642 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 30.3 p90 -51.45 -60.14 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.584 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.39 -37.28 56.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.883 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -67.97 -49.61 60.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -34.92 58.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.645 0.26 . . . . 0.0 110.861 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 23' ' ' CYS . 71.0 mmtt -61.84 -41.88 98.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.551 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.55 -49.43 77.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.63 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -58.1 -37.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.498 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 25' ' ' PHE . 3.4 m -101.76 -179.27 3.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 94.4 mt-10 71.04 -18.79 0.26 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.5 t80 -60.39 -45.94 91.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.213 0.53 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -86.57 15.87 5.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.528 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 7.69 87.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -86.5 -158.55 31.77 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -162.96 156.51 19.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.735 -0.233 . . . . 0.0 110.409 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.6 mp -69.16 136.66 52.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.116 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.45 122.52 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 35' ' ' GLN . 9.0 t -103.83 178.72 4.48 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -52.49 -52.48 54.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -57.76 -44.94 86.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.568 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.405 ' H ' HG23 ' A' ' 32' ' ' THR . 69.2 tp60 -70.37 -37.7 74.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.88 -43.01 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.414 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -55.69 -47.43 76.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.82 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -32.23 71.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.077 0.465 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.24 -29.14 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.516 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.477 HH22 HG12 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -60.91 -40.52 93.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.502 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -60.49 -4.03 0.8 Allowed 'General case' 0 N--CA 1.458 -0.05 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 40' ' ' ARG . 16.8 mm -99.18 22.9 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.385 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.51 28.93 71.83 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -70.29 126.09 28.64 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.663 -0.316 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.465 ' CD2' ' CG2' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -149.98 103.69 3.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.175 0.512 . . . . 0.0 110.37 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -140.16 129.94 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 14.8 t -90.72 69.34 6.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.331 0.586 . . . . 0.0 110.279 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB1' ' OH ' ' A' ' 91' ' ' TYR . . . -148.63 95.26 2.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.653 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.97 153.2 36.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.75 171.76 36.94 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.889 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -85.37 105.0 15.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.528 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -93.27 176.52 6.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.145 0.497 . . . . 0.0 110.302 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -35.49 153.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 54.8 8.91 0.25 Allowed 'General case' 0 C--O 1.199 -1.562 0 CA-C-O 121.089 0.471 . . . . 0.0 110.12 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 53' ' ' ALA . . . 74.75 20.68 79.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.941 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.566 ' HE ' ' CG ' ' A' ' 77' ' ' ASP . 63.0 ttt180 -77.09 140.05 40.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.646 0.26 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.14 134.95 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.677 0.751 . . . . 0.0 110.972 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.36 113.95 0.7 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -109.27 156.27 39.64 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-O 120.415 0.15 . . . . 0.0 110.755 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.32 133.13 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.446 1.431 . . . . 0.0 112.044 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 73' ' ' THR . 3.4 mt -144.33 95.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.588 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.477 HG12 HH22 ' A' ' 40' ' ' ARG . 0.2 OUTLIER -47.11 -38.55 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.67 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -149.02 147.73 24.85 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.824 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -52.87 139.28 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.986 1.124 . . . . 0.0 112.456 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.46 177.9 22.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.862 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.63 -51.0 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.628 1.552 . . . . 0.0 112.153 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -66.92 -27.71 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.682 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.08 151.39 21.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.193 0.521 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 70' ' ' PHE . . . -164.37 -5.56 0.04 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.407 ' H ' ' H ' ' A' ' 69' ' ' GLY . 42.3 t80 -68.33 -1.88 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.3 0.571 . . . . 0.0 110.315 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.3 -165.82 26.34 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.576 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.15 79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.614 0.245 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER 176.81 173.79 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.459 0.647 . . . . 0.0 110.319 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -46.7 -95.39 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.5 mt -99.34 108.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.477 0.656 . . . . 0.0 110.208 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 pt -105.87 45.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.834 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 34.7 t0 -89.0 118.98 29.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.025 0.441 . . . . 0.0 110.721 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -67.15 -64.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.553 0.692 . . . . 0.0 110.33 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 130.04 95.12 0.73 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 111.844 -0.503 . . . . 0.0 111.844 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 79' ' ' GLY . 70.1 mt 56.76 129.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.762 0.792 . . . . 0.0 110.993 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -111.61 143.04 43.13 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.512 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.0 mm? -86.73 -8.5 57.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.377 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -108.55 23.79 14.0 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.49 0.716 . . . . 0.0 111.072 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 86' ' ' GLU . 80.4 mtm180 -44.37 -27.47 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.672 -0.643 . . . . 0.0 111.432 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -47.07 -17.09 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.004 0.19 . . . . 0.0 110.956 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -60.89 -176.64 0.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 179.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 68.5 mtp85 -125.19 136.63 53.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.026 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.2 m95 -153.01 -176.64 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.141 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -73.07 -167.58 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -153.23 146.97 25.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.141 0.496 . . . . 0.0 111.108 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.499 ' OH ' ' HB1' ' A' ' 48' ' ' ALA . 17.6 m-85 -140.61 160.74 39.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.775 0.798 . . . . 0.0 110.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.5 m -136.44 -165.8 1.78 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.108 0.956 . . . . 0.0 110.06 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -141.04 151.13 43.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.271 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.34 149.21 70.58 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.856 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 C--N 1.306 -1.693 0 C-N-CA 121.564 1.509 . . . . 0.0 111.644 179.771 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.38 132.75 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' OH ' ' CZ ' ' A' ' 5' ' ' ARG . 31.4 p90 -103.03 155.24 18.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -73.02 126.12 29.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.498 0.666 . . . . 0.0 110.548 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' CZ ' ' OH ' ' A' ' 3' ' ' TYR . 89.5 mtt-85 -101.91 167.29 10.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.384 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -163.56 120.42 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.24 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.89 169.53 17.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.33 -40.64 81.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.597 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 t -70.85 -24.36 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.402 0.62 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.62 -170.82 22.9 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 13' ' ' LYS . 26.1 pttm -108.37 -173.39 2.27 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 42.23 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' LYS . 64.9 mttm -133.28 28.86 4.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.66 0.384 . . . . 0.0 110.696 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 88' ' ' TRP . 33.1 mt -124.82 135.37 52.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.233 0.539 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 16' ' ' TYR . 85.6 m -89.84 161.1 16.15 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.589 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.518 ' N ' HG22 ' A' ' 15' ' ' THR . 32.6 t80 -49.89 -59.52 3.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.22 75.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.22 -49.15 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.584 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.37 32.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 16.2 tptp -58.62 -40.19 82.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.116 0.484 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -48.25 78.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.316 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.58 -22.09 17.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.426 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.505 ' C ' ' H ' ' A' ' 25' ' ' PHE . 53.3 m -103.94 179.48 4.26 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.567 0.698 . . . . 0.0 109.518 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 70.8 mt-10 70.6 -19.08 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.16 -46.29 91.13 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 110.837 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.2 5.46 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.9 51.42 2.64 Favored Glycine 0 N--CA 1.472 1.097 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.05 -152.87 5.73 Favored Glycine 0 N--CA 1.47 0.901 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.02 179.02 7.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.92 142.49 51.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.29 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.93 148.04 48.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.24 0.543 . . . . 0.0 110.811 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 34' ' ' LYS . 7.2 m -123.54 149.41 45.27 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CD1' ' NH2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -61.09 -20.89 63.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.215 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' H ' HG22 ' A' ' 32' ' ' THR . 37.0 ttmt -75.87 -57.12 4.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.095 0.474 . . . . 0.0 110.739 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -68.82 -31.86 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 111.015 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.5 -36.11 79.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.368 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -49.9 -29.41 8.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.002 0.429 . . . . 0.0 110.661 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.39 -25.57 33.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.413 0.625 . . . . 0.0 111.025 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.69 -42.53 17.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -56.04 -34.7 66.13 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.29 -23.57 56.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 mm -82.5 24.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.92 24.19 74.35 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.66 128.73 37.08 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.517 ' CE1' ' H ' ' A' ' 63' ' ' LYS . 58.4 t60 -135.74 110.25 8.54 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.445 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.21 112.3 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.738 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -93.72 73.75 4.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.09 118.99 8.7 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.228 0.537 . . . . 0.0 110.778 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.25 134.19 36.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.54 -143.7 4.21 Favored Glycine 0 N--CA 1.476 1.3 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -130.8 105.93 8.11 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 15.1 mmt -91.54 156.13 17.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.267 0.556 . . . . 0.0 109.647 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.03 169.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.53 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.64 38.53 30.28 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.84 6.36 0.32 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' NH2' ' CD1' ' A' ' 33' ' ' TYR . 25.3 mtp180 -84.31 162.99 19.88 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.424 0.631 . . . . 0.0 110.598 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 p -142.2 135.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.723 0.773 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.01 157.15 26.78 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 26.9 p90 -165.89 80.82 1.11 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.795 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.95 143.82 59.14 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.026 1.817 . . . . 0.0 112.677 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -132.02 91.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.414 0.626 . . . . 0.0 110.707 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.41 -20.23 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 60.0 mttp -140.94 86.33 11.72 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.95 136.8 52.65 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.02 1.813 . . . . 0.0 112.218 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.26 173.91 15.2 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.405 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.46 -47.15 3.26 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.06 1.84 . . . . 0.0 112.284 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 68' ' ' CYS . 39.2 p-10 -66.71 -36.62 82.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.704 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 23.0 p -153.55 119.39 5.33 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.049 0.452 . . . . 0.0 110.477 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 88.54 0.09 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -64.97 161.23 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.946 0.403 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.55 99.71 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -70.62 166.65 20.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.871 0.367 . . . . 0.0 110.563 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.4 p -139.64 159.83 41.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.17 -140.66 15.17 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.9 mt -89.24 119.17 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.925 0.393 . . . . 0.0 110.556 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.73 98.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.407 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 59.3 t0 -98.39 141.79 30.83 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 110.322 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 25.3 m-85 -129.99 147.51 51.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.669 0.747 . . . . 0.0 110.05 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.79 -78.73 0.46 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.8 mt -157.81 108.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.569 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 52.0 mtp180 -69.08 140.95 54.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.329 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.2 mt -85.49 -10.23 56.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.335 0.588 . . . . 0.0 110.777 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.569 HD21 ' CZ ' ' A' ' 81' ' ' ARG . 13.1 p30 -83.27 22.6 0.98 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.474 0.654 . . . . 0.0 110.379 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -52.0 -5.84 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.644 -0.66 . . . . 0.0 111.361 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 83' ' ' ASN . 62.8 m -91.89 -5.13 53.81 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.838 0.351 . . . . 0.0 110.856 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.29 -152.8 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.399 0.619 . . . . 0.0 110.422 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.419 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 83.3 mtt85 -142.94 151.2 40.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.817 0.818 . . . . 0.0 110.564 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 86.2 m95 -154.9 177.37 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.267 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 36.2 t0 -60.45 -156.06 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.816 0.698 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.541 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.68 141.95 2.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.168 0.509 . . . . 0.0 110.947 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.408 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 16.3 m-85 -140.34 142.25 35.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.52 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.437 ' SG ' ' NE ' ' A' ' 5' ' ' ARG . 49.8 m -115.56 -167.33 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.827 0.822 . . . . 0.0 110.077 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -156.42 143.68 19.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.455 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.11 148.95 22.18 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo . . . . . 0 N--CA 1.505 2.165 0 C-N-CA 122.345 2.03 . . . . 0.0 112.985 179.488 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.06 148.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 110.815 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.62 162.51 35.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -73.51 132.63 43.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.656 HH21 ' N ' ' A' ' 91' ' ' TYR . 73.5 mtm180 -117.99 149.22 41.31 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.502 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -154.78 125.02 6.78 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.594 0.559 . . . . 0.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.08 179.11 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.461 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -61.07 -48.62 80.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.504 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -87.39 -2.8 58.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.205 0.526 . . . . 0.0 110.513 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.23 66.59 0.68 Allowed Glycine 0 N--CA 1.472 1.068 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -143.99 41.82 1.42 Allowed 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.747 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 45.78 28.98 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.678 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.48 39.87 0.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.283 0.563 . . . . 0.0 110.825 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' TRP . 6.1 tp -120.31 127.74 52.64 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.781 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.8 p -90.94 167.75 12.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.529 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -61.23 -48.01 83.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.337 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.92 71.47 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.05 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.7 -50.16 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.736 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.55 -31.6 24.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' CYS . 26.1 mtpp -64.6 -34.92 79.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.428 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.16 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.65 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.04 -40.87 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.323 0.582 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.586 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.2 t -100.53 175.69 5.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.907 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 63.22 -15.84 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.7 t80 -61.87 -49.1 77.61 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.92 22.52 0.38 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.765 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.91 89.58 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.31 -148.8 4.7 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -164.66 152.97 12.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.666 0.27 . . . . 0.0 110.631 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.15 145.18 54.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.051 0.453 . . . . 0.0 110.224 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -64.03 107.33 1.23 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.903 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 p -88.01 167.14 13.95 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.552 ' HB2' ' HE ' ' A' ' 56' ' ' ARG . 69.6 t80 -54.66 -53.61 52.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.983 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -55.75 -43.86 77.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.993 0.425 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.26 -32.23 68.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -40.58 95.29 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -51.56 -49.38 62.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.25 64.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.431 . . . . 0.0 110.649 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.78 -37.02 31.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.2 -27.83 62.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -78.2 -4.55 48.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.67 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 42' ' ' ILE . 76.9 mt -96.0 8.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.478 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.52 21.45 44.08 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -69.38 131.78 45.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 122.741 -0.27 . . . . 0.0 110.354 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -149.89 105.28 3.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.076 0.465 . . . . 0.0 110.469 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.19 118.02 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.83 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.4 t -91.88 84.05 5.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.191 0.52 . . . . 0.0 110.293 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.25 94.73 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.635 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.2 46.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.82 -172.42 13.92 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.931 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.7 156.74 17.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.527 0.679 . . . . 0.0 110.47 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 56' ' ' ARG . 67.4 mtm -148.09 175.02 11.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.99 147.74 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.299 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 56' ' ' ARG . 9.0 mtmp? 57.69 40.43 26.49 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.659 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.2 7.72 0.58 Allowed Glycine 0 CA--C 1.532 1.13 0 O-C-N 121.794 -0.566 . . . . 0.0 111.8 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.552 ' HE ' ' HB2' ' A' ' 33' ' ' TYR . 32.2 ttt85 -68.14 146.42 53.45 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.321 0.581 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.15 162.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.668 0.747 . . . . 0.0 110.807 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.02 169.25 39.57 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.492 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 76' ' ' ILE . 3.8 p90 -154.95 79.89 4.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.386 -0.407 . . . . 0.0 110.322 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.44 128.97 32.67 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.21 1.94 . . . . 0.0 112.682 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.38 103.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.61 -24.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.304 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -161.76 143.81 8.72 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.567 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -41.23 166.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.717 1.612 . . . . 0.0 112.85 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.9 166.8 39.75 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.68 -41.89 13.53 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.403 2.068 . . . . 0.0 112.212 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -66.11 -36.06 82.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.43 . . . . 0.0 110.327 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.9 p -156.53 146.41 21.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.491 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -159.85 44.02 0.44 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -73.66 142.74 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.55 -104.69 0.89 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -162.95 -63.49 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.888 0.375 . . . . 0.0 110.469 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -145.72 171.1 15.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.387 0.613 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -153.33 20.46 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.6 mt -99.57 -60.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.755 0.312 . . . . 0.0 110.827 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.482 ' O ' ' CZ ' ' A' ' 59' ' ' TYR . 52.3 mt 56.88 105.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.317 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.467 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 4.8 p30 -136.37 148.98 48.11 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.03 0.443 . . . . 0.0 110.946 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -72.82 -72.4 0.25 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.619 0.723 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.05 -135.17 5.14 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -88.69 107.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.399 0.619 . . . . 0.0 110.151 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -94.16 129.79 40.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.44 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.17 0.14 54.35 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.424 0.631 . . . . 0.0 110.85 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.452 HD22 ' C ' ' A' ' 83' ' ' ASN . 0.4 OUTLIER -87.73 23.6 1.95 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.328 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -45.1 -24.32 0.23 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.617 -0.677 . . . . 0.0 111.662 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 m -50.54 -23.03 2.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.751 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.24 -168.26 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 0.0 110.813 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.25 139.22 44.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.391 0.615 . . . . 0.0 110.946 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' LEU . 86.8 m95 -154.18 176.2 12.54 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.451 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.0 t70 -71.23 -169.65 0.41 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.361 0.601 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.486 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.9 161.05 10.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.158 0.504 . . . . 0.0 111.002 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.656 ' N ' HH21 ' A' ' 5' ' ' ARG . 96.7 m-85 -138.57 152.81 48.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.636 0.732 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.2 t -129.99 144.48 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -119.48 122.0 40.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.359 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.467 ' N ' ' ND2' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -109.13 169.83 6.04 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.063 -179.049 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.503 2.037 0 C-N-CA 121.942 1.761 . . . . 0.0 112.146 179.062 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -83.8 151.92 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -126.75 126.94 44.29 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.559 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -76.02 148.48 38.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.48 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -133.18 143.19 49.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.07 146.64 30.05 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.263 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.93 132.4 46.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.95 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -81.04 -49.13 11.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.1 m -112.41 -33.85 6.06 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.61 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.57 177.75 53.98 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -134.69 95.82 3.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.453 0.644 . . . . 0.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 53.13 70.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.72 40.54 1.85 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.774 0.321 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 88' ' ' TRP . 46.3 mt -117.61 122.49 43.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -100.68 166.1 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.17 0.51 . . . . 0.0 110.723 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -49.11 -58.86 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -42.48 59.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.021 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.9 -26.56 66.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.526 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.46 76.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.038 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' CYS . 51.4 mtmt -67.17 -24.29 65.86 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.567 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.12 -55.46 9.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.634 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 23' ' ' CYS . 8.5 p -67.77 -44.7 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 0.0 111.199 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' LYS . 3.7 m -114.31 162.09 17.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.308 0.575 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 23' ' ' CYS . 48.8 tt0 84.33 -46.11 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.813 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -62.73 -46.37 88.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.048 0.451 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.23 16.8 0.71 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.946 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.6 60.72 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -153.18 0.02 OUTLIER Glycine 0 C--O 1.218 -0.883 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.6 ' CD2' HE22 ' A' ' 35' ' ' GLN . 66.8 t60 -173.25 143.5 1.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.473 ' O ' ' CD2' ' A' ' 29' ' ' HIS . 73.6 mt -78.18 136.23 37.78 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.158 0.286 . . . . 0.0 110.541 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.32 132.38 48.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.252 0.549 . . . . 0.0 111.082 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.38 167.1 14.85 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.121 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -50.49 -22.21 1.83 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.693 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -75.25 -57.96 3.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.172 0.51 . . . . 0.0 110.684 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.6 HE22 ' CD2' ' A' ' 29' ' ' HIS . 78.6 mt-30 -70.78 -34.87 72.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.7 mt -61.1 -39.76 91.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.441 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -57.78 -31.05 66.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.673 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 -24.33 48.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.338 0.589 . . . . 0.0 110.956 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.3 -45.31 33.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.45 HH21 HG12 ' A' ' 62' ' ' VAL . 20.2 mmm-85 -52.98 -31.55 41.41 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -69.46 -4.32 18.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.571 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.654 HG22 ' O ' ' A' ' 42' ' ' ILE . 74.3 mt -108.86 15.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.443 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.16 16.75 71.12 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.29 143.06 58.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.904 0.352 . . . . 0.0 110.343 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -155.35 107.91 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.356 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 46' ' ' VAL . 17.6 m -139.0 111.56 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.817 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.26 75.06 6.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.238 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.52 135.29 11.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.32 139.38 31.72 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.47 -174.26 21.41 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.804 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -94.12 143.27 26.52 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -145.3 173.41 12.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.142 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.78 142.86 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.685 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 62.17 14.95 7.05 Favored 'General case' 0 C--O 1.201 -1.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.48 16.98 68.15 Favored Glycine 0 CA--C 1.527 0.822 0 O-C-N 121.831 -0.543 . . . . 0.0 111.964 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.745 HH22 ' H ' ' A' ' 78' ' ' TYR . 51.6 ttt-85 -70.84 161.41 31.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.977 0.418 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.18 148.57 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 122.269 1.033 . . . . 0.0 110.458 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.77 168.28 40.57 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.405 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -154.64 76.79 5.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.334 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.77 133.1 49.02 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.474 2.116 . . . . 0.0 112.692 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -147.19 145.11 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.124 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.45 HG12 HH21 ' A' ' 40' ' ' ARG . 29.4 m -82.12 -30.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -152.68 152.15 28.11 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.427 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.3 151.32 2.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.026 1.818 . . . . 0.0 112.324 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.96 166.88 27.38 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.793 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.17 -48.44 19.45 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.833 1.689 . . . . 0.0 112.737 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -64.94 -27.34 68.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.5 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.43 144.93 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.94 -12.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -55.64 -36.42 66.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.408 . . . . 0.0 110.775 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.88 -166.39 6.64 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -73.43 -162.18 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.534 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 166.69 22.19 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.268 0.556 . . . . 0.0 110.819 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 67.76 67.03 2.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' O ' ' A' ' 74' ' ' GLY . 4.5 mt 53.23 125.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.572 -0.314 . . . . 0.0 111.071 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -119.91 91.03 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.569 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -66.89 143.39 56.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.924 0.392 . . . . 0.0 110.583 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.745 ' H ' HH22 ' A' ' 56' ' ' ARG . 59.2 m-85 -132.66 -96.59 0.31 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.523 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.42 -155.38 17.61 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.394 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.85 123.27 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.723 0.773 . . . . 0.0 110.079 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.48 141.92 34.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.186 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -82.65 -2.57 54.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -77.83 25.69 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.84 0.828 . . . . 0.0 110.649 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 82' ' ' LEU . 33.4 mtp-105 -49.4 -4.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.599 -0.688 . . . . 0.0 111.783 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 83' ' ' ASN . 72.2 p -83.1 -32.12 26.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -76.91 -163.65 0.37 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 110.692 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.432 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 60.9 mtt85 -139.27 154.24 47.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.52 0.676 . . . . 0.0 110.62 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' LEU . 81.1 m95 -154.13 174.99 13.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 23.9 t0 -61.06 -175.99 0.05 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.727 0.775 . . . . 0.0 110.972 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -157.23 150.85 24.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 111.069 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -118.94 159.58 23.55 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.525 0.679 . . . . 0.0 110.641 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -134.8 175.18 9.79 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.774 0.797 . . . . 0.0 110.216 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 4.6 t80 -159.9 134.48 7.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.825 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -145.35 148.59 38.11 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.101 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 C-N-CA 122.432 2.088 . . . . 0.0 111.753 179.234 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.467 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.6 m -154.19 137.73 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.779 0.324 . . . . 0.0 110.698 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -123.12 123.68 41.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.401 ' O ' ' ND1' ' A' ' 4' ' ' HIS . 5.1 p80 -86.86 149.32 24.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.527 HH22 HD21 ' A' ' 94' ' ' ASN . 75.4 mtt85 -143.77 147.62 34.43 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.228 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -146.43 158.33 43.88 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.26 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.41 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.06 -35.82 72.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.453 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 p -111.01 19.89 18.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.628 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.01 -137.6 2.92 Favored Glycine 0 C--O 1.216 -1.03 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.657 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -171.93 -42.67 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.301 -0.449 . . . . 0.0 110.468 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -143.3 67.34 1.3 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -137.02 37.59 2.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.254 0.221 . . . . 0.0 110.533 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -120.98 123.92 43.62 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.451 0.643 . . . . 0.0 110.384 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 16' ' ' TYR . 52.4 m -100.37 163.19 12.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.581 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.516 ' N ' HG22 ' A' ' 15' ' ' THR . 13.5 t80 -51.45 -52.33 47.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.8 -42.03 83.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.88 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.64 -51.5 59.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.775 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.82 -30.71 15.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.014 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -70.51 -33.22 70.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.46 21.5 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.849 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.29 -26.61 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.084 0.469 . . . . 0.0 110.365 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.491 ' C ' ' H ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -104.75 177.28 4.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.593 0.711 . . . . 0.0 109.385 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 28' ' ' GLY . 96.5 mt-10 67.67 -10.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.705 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.8 t80 -62.57 -47.75 82.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 0.0 110.789 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.9 pm0 -92.16 9.45 33.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.772 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.77 -17.16 56.84 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -82.69 127.28 7.89 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -100.1 173.17 6.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.639 0.257 . . . . 0.0 110.538 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.457 ' H ' HD12 ' A' ' 30' ' ' LEU . 2.0 mp -65.39 135.8 55.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.23 0.77 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.056 0.455 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 33' ' ' TYR . 1.5 t -72.43 179.85 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.778 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.471 ' N ' ' OG1' ' A' ' 32' ' ' THR . 64.4 t80 -56.0 -54.58 43.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.936 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -53.4 -50.47 65.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.845 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.556 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -66.18 -38.91 89.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.372 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 mt -61.67 -42.52 99.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.474 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.62 -50.46 73.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.717 0.294 . . . . 0.0 110.789 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.81 -33.13 55.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -84.33 -39.67 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.109 0.48 . . . . 0.0 111.226 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -30.16 21.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.286 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.16 -2.78 11.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.523 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.6 tp -92.45 9.46 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.112 0.258 . . . . 0.0 110.475 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.6 26.65 34.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -75.96 136.32 40.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.019 0.409 . . . . 0.0 110.449 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -154.02 103.04 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.55 129.05 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.757 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 t -93.96 83.46 4.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.494 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.54 95.79 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 134.91 54.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 0.0 110.779 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -140.85 170.64 24.43 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -81.51 156.75 25.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 4.8 mpp? -151.44 176.87 10.86 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 110.292 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.79 142.85 0.41 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.53 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 59.63 41.21 19.09 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.341 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.13 12.82 0.86 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.737 -0.602 . . . . 0.0 111.689 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' MET . 57.8 ttt180 -68.06 143.23 55.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 110.502 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.28 142.08 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.994 0.902 . . . . 0.0 110.928 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.01 -178.52 39.98 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.684 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 28.8 p90 -148.18 103.12 3.56 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.083 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.15 129.72 8.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.87 1.047 . . . . 0.0 112.308 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 pt -146.79 136.3 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.456 0.646 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.1 t -83.45 -26.49 7.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -156.03 150.5 20.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -42.24 130.64 4.75 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.508 1.472 . . . . 0.0 112.723 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.26 167.79 15.16 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.094 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.01 -34.54 16.85 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.937 1.758 . . . . 0.0 112.145 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -88.28 -10.16 50.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.435 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.2 p -170.54 141.35 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.612 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.18 9.36 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 54.5 p90 -62.63 -45.47 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 110.663 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . -60.58 -103.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -164.97 -151.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.78 0.324 . . . . 0.0 110.255 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.7 p -95.17 170.03 9.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.571 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.22 145.83 0.09 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.645 ' H ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -46.48 130.32 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -119.23 54.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 44.5 t0 -63.79 140.67 58.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 110.485 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.463 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 49.4 m-85 -92.31 4.51 53.19 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 58.66 84.48 0.04 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 79' ' ' GLY . 68.5 mt 50.32 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.079 0.466 . . . . 0.0 111.038 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -88.54 157.93 18.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.551 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -84.68 -6.67 59.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.216 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 85' ' ' SER . 49.8 p-10 -74.68 21.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.618 0.723 . . . . 0.0 110.606 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 82' ' ' LEU . 96.1 mtt180 -49.42 -10.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.6 -0.688 . . . . 0.0 111.052 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.42 -36.22 24.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.624 0.249 . . . . 0.0 110.591 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -75.24 152.58 38.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.291 0.567 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -86.97 153.81 21.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.786 0.803 . . . . 0.0 110.566 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -153.86 174.92 13.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.125 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.58 -161.96 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.536 0.684 . . . . 0.0 110.996 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.06 141.98 12.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.284 0.564 . . . . 0.0 111.039 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -114.79 150.53 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.899 0.856 . . . . 0.0 110.261 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . 0.444 ' HB2' HH11 ' A' ' 5' ' ' ARG . 1.5 m -142.26 -173.34 3.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.354 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 3.6 t80 -160.28 118.23 2.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.062 0.458 . . . . 0.0 109.993 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.527 HD21 HH22 ' A' ' 5' ' ' ARG . 3.0 m120 -103.61 150.69 38.36 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.992 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 N--CA 1.501 1.938 0 C-N-CA 121.285 1.323 . . . . 0.0 112.285 178.537 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.32 149.25 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.718 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -111.25 130.43 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -74.51 129.3 37.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.547 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.42 148.2 34.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.132 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.45 171.99 18.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.321 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.36 160.71 16.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.06 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.43 -27.73 46.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.301 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.6 p -72.6 -31.77 65.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.267 0.556 . . . . 0.0 110.966 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.09 160.19 12.21 Favored Glycine 0 C--O 1.216 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.633 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -68.06 -48.37 65.78 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.806 0.336 . . . . 0.0 110.673 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -98.52 49.35 0.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -136.44 24.23 3.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.944 0.402 . . . . 0.0 110.456 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 tp -120.68 129.96 53.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.807 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -85.14 161.33 19.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.66 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 50.0 p90 -60.16 -46.5 89.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.773 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -57.01 -40.71 77.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -66.08 -52.6 47.37 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.807 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.48 -31.62 56.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.231 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -68.15 -43.02 79.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 110.932 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.35 76.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.356 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 -26.27 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.396 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -105.35 174.79 5.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.401 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 39.2 mt-10 77.02 5.04 3.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.592 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -73.19 -37.74 66.37 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.157 0.503 . . . . 0.0 111.1 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -91.92 12.75 20.65 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.561 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 8.21 80.4 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.519 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -93.84 -157.25 33.0 Favored Glycine 0 C--O 1.218 -0.851 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -162.58 157.27 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.62 0.247 . . . . 0.0 110.721 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.69 147.76 3.41 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.498 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.65 91.9 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.029 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 35' ' ' GLN . 11.9 t -74.48 179.16 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.961 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -58.36 -53.41 58.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -56.17 -47.57 78.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' ' CG ' ' A' ' 93' ' ' TYR . 54.3 tt0 -69.38 -37.56 77.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.957 0.408 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.49 -42.56 99.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.411 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -41.74 99.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 110.653 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.12 -36.98 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.797 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.52 -24.44 34.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.46 -30.64 65.21 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -79.17 -6.6 56.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 42' ' ' ILE . 79.1 mt -94.04 1.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.41 9.52 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.31 135.29 47.32 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.662 0.268 . . . . 0.0 110.502 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.44 ' CE1' ' H ' ' A' ' 62' ' ' VAL . 79.0 t60 -155.87 102.67 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.88 117.89 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.927 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.86 94.88 9.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.75 115.15 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.559 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.05 142.2 52.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.457 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -157.28 170.81 34.51 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.803 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.417 ' C ' ' SD ' ' A' ' 52' ' ' MET . 79.5 m95 -83.71 157.82 22.03 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.307 0.575 . . . . 0.0 110.185 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -152.8 177.45 10.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.281 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.0 145.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.372 0.606 . . . . 0.0 111.194 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 56' ' ' ARG . 68.7 mttm 56.6 42.74 26.71 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.167 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.29 10.98 0.38 Allowed Glycine 0 C--N 1.314 -0.672 0 O-C-N 121.746 -0.596 . . . . 0.0 112.085 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.623 HH22 ' CB ' ' A' ' 77' ' ' ASP . 64.2 ttt-85 -65.05 143.56 57.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.333 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.8 148.44 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.447 1.118 . . . . 0.0 110.781 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.1 -172.98 39.82 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.313 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 40.7 p90 -155.36 102.72 2.22 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.8 132.16 11.72 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.759 1.639 . . . . 0.0 112.4 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt -145.92 147.33 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.826 . . . . 0.0 110.909 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.44 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 14.8 t -116.06 -12.34 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.3 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -144.21 157.22 57.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.063 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -37.84 147.08 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.258 1.972 . . . . 0.0 112.548 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.64 79.82 0.35 Allowed Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.412 -0.66 . . . . 0.0 111.545 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.76 -48.12 23.73 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.439 2.093 . . . . 0.0 112.325 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -81.84 30.19 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.131 0.491 . . . . 0.0 110.472 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 70' ' ' PHE . 7.1 p -178.45 -165.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.56 86.23 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 68' ' ' CYS . 51.6 p90 -83.29 23.64 0.88 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.134 0.492 . . . . 0.0 110.494 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -131.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -79.14 -143.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 0.0 110.36 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 p -128.35 171.71 11.77 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.582 0.706 . . . . 0.0 110.39 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.6 155.25 0.76 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.1 mt -41.53 145.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.617 0.245 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mt -141.7 51.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.623 ' CB ' HH22 ' A' ' 56' ' ' ARG . 7.1 p-10 -60.62 151.77 28.08 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.643 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.73 -80.35 0.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.23 71.01 0.02 OUTLIER Glycine 0 N--CA 1.474 1.196 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.124 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.6 mt 53.99 91.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.333 0.587 . . . . 0.0 110.905 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 -87.8 155.93 19.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.506 0.669 . . . . 0.0 110.664 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 84' ' ' ARG . 53.5 mt -84.17 3.06 36.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.294 0.568 . . . . 0.0 110.281 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -72.99 18.57 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.214 1.006 . . . . 0.0 110.476 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' LEU . 93.7 mtt-85 -49.74 -11.69 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.591 -0.693 . . . . 0.0 111.199 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' ASN . 64.7 m -87.09 -42.32 13.14 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -66.48 155.59 37.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.159 0.505 . . . . 0.0 110.403 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -90.72 148.96 22.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.215 0.531 . . . . 0.0 110.483 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -154.13 175.59 13.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.249 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 8.4 t70 -79.57 -169.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.713 . . . . 0.0 110.713 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.447 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.33 168.92 9.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.359 0.6 . . . . 0.0 110.928 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -135.68 141.57 44.98 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.536 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.57 143.53 45.49 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.737 0.78 . . . . 0.0 109.763 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CG ' ' NE2' ' A' ' 35' ' ' GLN . 74.4 t80 -115.63 150.63 36.39 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -139.36 153.02 70.5 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.502 2.02 0 C-N-CA 122.826 2.35 . . . . 0.0 112.253 179.426 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' TYR . 40.6 t -81.98 161.64 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.849 0.357 . . . . 0.0 110.617 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.479 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.1 p90 -154.81 154.23 32.44 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -96.99 149.03 22.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.646 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.505 HH12 HG21 ' A' ' 22' ' ' VAL . 14.6 ptp180 -136.66 149.02 47.73 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.427 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -144.61 159.18 43.23 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.197 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.86 140.43 36.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.392 0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -83.31 -43.27 16.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 t -96.43 25.96 4.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.76 -126.92 0.95 Allowed Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.697 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -150.24 -90.13 0.07 Allowed 'General case' 0 C--O 1.216 -0.689 0 CA-C-O 120.997 0.427 . . . . 0.0 110.334 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -100.75 80.64 2.2 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.16 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -130.31 32.57 4.44 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.8 mt -116.63 121.1 40.72 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.249 0.547 . . . . 0.0 110.657 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.7 p -100.28 169.11 9.35 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.384 0.611 . . . . 0.0 110.502 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -56.79 -49.86 74.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.415 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.88 -40.91 73.65 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.91 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -67.32 -49.98 61.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.422 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -33.54 52.52 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.689 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 7.0 tptm -71.48 -33.22 69.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.399 0.619 . . . . 0.0 110.748 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.74 -53.43 27.45 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.805 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.505 HG21 HH12 ' A' ' 5' ' ' ARG . 7.2 p -60.11 -36.63 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.485 ' C ' ' H ' ' A' ' 25' ' ' PHE . 1.3 m -103.34 178.06 4.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.4 -14.48 0.33 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.656 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 23' ' ' CYS . 92.5 t80 -61.42 -47.99 83.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.685 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -89.64 20.35 4.07 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.846 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.59 6.91 79.75 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -72.01 -168.77 10.87 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 79.9 m80 -155.49 144.58 20.78 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.605 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 1.6 mm? -67.01 135.91 54.46 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.368 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.467 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -60.72 140.85 57.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.248 0.547 . . . . 0.0 110.852 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 p -122.1 178.29 4.98 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.924 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -58.21 -53.34 59.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.684 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -54.13 -49.28 69.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.749 0.309 . . . . 0.0 110.472 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -66.88 -38.44 86.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.058 0.456 . . . . 0.0 110.942 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.22 -43.77 98.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.364 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -55.26 -49.36 72.26 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 110.765 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -50.26 -29.63 10.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 0.0 110.836 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -37.13 36.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.511 ' NH2' ' C ' ' A' ' 61' ' ' ILE . 46.7 mmm-85 -55.82 -32.36 63.49 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.326 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -71.07 -4.22 23.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.739 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 42' ' ' ILE . 84.1 mt -108.41 9.18 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.392 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.61 17.91 53.39 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -72.44 123.23 22.66 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.81 0.338 . . . . 0.0 110.173 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -139.86 113.05 8.27 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.526 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -140.32 114.25 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.735 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -92.89 87.26 5.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.935 0.397 . . . . 0.0 110.242 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.85 138.21 1.33 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.604 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.02 132.53 39.8 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.637 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -146.48 148.99 21.08 Favored Glycine 0 N--CA 1.475 1.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.903 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.69 152.24 39.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.961 0.41 . . . . 0.0 110.446 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.467 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 75.6 mtm -153.08 -179.13 7.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.156 0.503 . . . . 0.0 110.319 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.8 143.61 0.34 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.365 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp 55.25 39.41 31.34 Favored 'General case' 0 C--O 1.201 -1.484 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.327 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.04 10.37 1.75 Allowed Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.641 HH22 ' CG ' ' A' ' 77' ' ' ASP . 47.6 ttt-85 -65.98 142.23 57.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.424 0.63 . . . . 0.0 110.172 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 p -143.98 144.81 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.797 0.808 . . . . 0.0 110.818 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.82 167.59 40.64 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.911 -0.662 . . . . 0.0 111.523 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 25.2 p90 -133.3 78.47 63.71 Favored Pre-proline 0 N--CA 1.475 0.82 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.512 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.16 139.61 71.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.095 1.864 . . . . 0.0 112.76 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' ' NH2' ' A' ' 40' ' ' ARG . 20.0 pt -150.83 134.39 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.858 0.837 . . . . 0.0 110.959 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.429 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 61.2 t -62.8 -45.87 97.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.38 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 19.7 mtmt -158.41 -62.3 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 55.8 Cg_endo -63.49 143.17 87.4 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.866 1.711 . . . . 0.0 112.494 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.88 54.47 0.1 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -70.15 -49.59 0.49 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.645 2.23 . . . . 0.0 111.956 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -66.46 -39.09 88.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.645 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.1 m -92.81 132.68 36.77 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.246 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.14 50.52 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -159.88 103.85 1.52 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.708 0.289 . . . . 0.0 110.435 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.31 -140.61 35.93 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 tttm 55.77 169.77 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.845 0.355 . . . . 0.0 110.469 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -136.31 157.25 47.26 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.52 151.3 6.37 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -40.3 144.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 115.254 -0.473 . . . . 0.0 111.689 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 5.4 mt -138.16 45.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.535 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.641 ' CG ' HH22 ' A' ' 56' ' ' ARG . 1.9 p30 -68.71 145.77 53.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.041 0.448 . . . . 0.0 110.472 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -90.24 -3.77 57.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.313 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 66.13 94.14 0.03 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 79' ' ' GLY . 63.5 mt 50.77 104.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.47 . . . . 0.0 110.901 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -97.26 152.3 19.0 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.332 0.587 . . . . 0.0 110.173 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -85.45 -2.83 58.54 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.384 0.611 . . . . 0.0 110.277 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 85' ' ' SER . 97.7 m-20 -77.83 22.12 0.28 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.985 0.898 . . . . 0.0 110.561 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.405 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.2 mtt180 -51.68 -5.58 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.482 -0.761 . . . . 0.0 111.125 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.507 ' H ' ' C ' ' A' ' 83' ' ' ASN . 32.7 t -95.85 -25.62 15.95 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.773 -0.194 . . . . 0.0 110.638 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -72.04 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.458 0.646 . . . . 0.0 110.512 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 25.7 mtp180 -94.56 136.01 35.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.739 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.46 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 81.1 m95 -154.39 175.91 12.98 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.196 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -71.93 -164.44 0.13 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.511 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -162.41 149.74 13.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.465 0.65 . . . . 0.0 110.933 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -121.14 161.03 22.52 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.612 0.72 . . . . 0.0 110.451 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.91 -170.36 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.556 0.693 . . . . 0.0 110.182 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -161.23 151.48 17.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.368 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.457 ' O ' ' ND1' ' A' ' 96' ' ' HIS . 6.9 m120 -145.11 146.33 30.33 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.288 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.63 7.6 2.64 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.118 1.879 . . . . 0.0 112.084 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 94' ' ' ASN . 6.5 p-80 -53.96 -41.93 68.35 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.582 0.706 . . . . 0.0 110.914 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' N ' ' CG ' ' A' ' 96' ' ' HIS . . . -150.92 147.42 27.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.933 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 C--N 1.29 -1.982 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.97 177.01 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.39 144.01 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.276 0.56 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.89 161.3 26.88 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.72 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.61 140.19 37.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.75 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.52 HH21 ' ND2' ' A' ' 94' ' ' ASN . 38.3 mmt180 -103.59 161.9 13.5 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.454 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -142.37 134.2 27.03 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.379 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.69 166.74 15.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.716 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -68.38 -38.03 80.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.193 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.9 p -72.35 -18.3 61.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.34 0.591 . . . . 0.0 110.597 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.08 -154.7 16.78 Favored Glycine 0 N--CA 1.478 1.444 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' C ' ' N ' ' A' ' 13' ' ' LYS . 68.8 mttm -115.33 -177.47 3.15 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.416 0.627 . . . . 0.0 110.635 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 47.62 16.25 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.759 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' N ' ' C ' ' A' ' 11' ' ' LYS . 51.2 mtmt -128.52 26.35 5.65 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.777 0.322 . . . . 0.0 110.72 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 88' ' ' TRP . 48.4 mt -123.38 132.14 53.87 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.698 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.9 p -97.48 168.51 10.33 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.508 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 47.8 p90 -51.26 -54.21 28.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.973 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.78 -41.38 64.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.84 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.24 -51.45 37.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.755 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.27 13.51 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -68.07 -34.93 77.36 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.354 0.597 . . . . 0.0 110.663 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -53.03 59.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.886 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.2 m -60.4 -25.87 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.442 . . . . 0.0 110.506 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 25' ' ' PHE . 30.7 m -103.83 179.87 4.15 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.693 0.759 . . . . 0.0 109.247 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 67.17 -3.31 1.01 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.962 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.407 ' H ' ' C ' ' A' ' 23' ' ' CYS . 89.7 t80 -61.82 -45.39 94.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.981 0.419 . . . . 0.0 110.869 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.61 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.4 pm0 -94.68 5.87 50.58 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.005 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.7 -22.52 39.36 Favored Glycine 0 N--CA 1.469 0.889 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.5 143.1 38.25 Favored Glycine 0 C--O 1.22 -0.773 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -98.72 153.38 18.77 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.742 0.305 . . . . 0.0 110.238 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.5 mp -56.52 143.02 36.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.395 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -52.05 139.19 23.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.117 0.484 . . . . 0.0 110.735 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.614 HG22 ' N ' ' A' ' 33' ' ' TYR . 43.0 m -121.93 171.64 8.78 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.838 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.614 ' N ' HG22 ' A' ' 32' ' ' THR . 11.3 t80 -53.76 -53.42 52.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -58.76 -48.01 82.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 0.0 110.64 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.49 -36.62 81.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.243 0.544 . . . . 0.0 110.795 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 17.9 mt -62.12 -42.86 99.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.162 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.09 -31.15 40.38 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.863 0.363 . . . . 0.0 110.711 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -35.04 79.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.815 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.31 -25.34 42.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.186 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 7.5 mmm180 -58.8 -35.98 73.73 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -72.66 -10.59 59.98 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 mm -99.13 4.21 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.451 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.67 33.21 16.69 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -66.04 129.23 39.07 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.83 0.348 . . . . 0.0 110.508 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -147.9 102.42 3.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.39 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.61 107.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.891 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.2 t -90.08 92.62 9.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.153 0.502 . . . . 0.0 110.106 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -170.71 109.84 0.35 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.532 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.08 138.92 56.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.92 163.84 34.44 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.844 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -77.25 160.42 28.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.492 . . . . 0.0 110.277 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.473 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 77.3 mtm -156.12 -179.14 7.86 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.299 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -48.53 145.31 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.254 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' O ' ' N ' ' A' ' 56' ' ' ARG . 55.5 tttm 56.95 42.51 26.16 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.594 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.99 10.94 0.5 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.79 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 54' ' ' LYS . 10.4 tpt180 -64.97 140.23 58.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.259 0.552 . . . . 0.0 110.47 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -136.11 161.98 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.106 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 165.4 177.44 37.77 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.854 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -145.37 81.89 10.03 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.329 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.41 135.5 60.91 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.185 1.923 . . . . 0.0 112.307 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.7 pt -151.26 134.37 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.495 0.664 . . . . 0.0 110.833 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.21 -44.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.176 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.5 mtpt -167.5 -61.46 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.064 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.61 156.5 65.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 121.771 1.648 . . . . 0.0 112.051 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' CA ' ' SG ' ' A' ' 68' ' ' CYS . . . -172.44 65.5 0.13 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.902 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.88 -44.97 35.69 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.268 1.979 . . . . 0.0 112.403 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -78.47 -24.76 45.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.719 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.421 ' SG ' ' CA ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -95.72 166.85 11.62 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.448 0.642 . . . . 0.0 110.031 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' GLY . . . -61.8 150.39 45.61 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.384 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 71' ' ' GLY . 45.3 p90 -76.29 29.21 0.12 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.017 0.437 . . . . 0.0 110.581 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' GLY . . . -50.71 -105.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -141.9 -165.2 1.95 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.149 0.499 . . . . 0.0 110.322 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.9 p -94.67 160.84 14.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.467 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.55 168.69 0.44 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 54.0 mt -52.53 145.72 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.701 0.286 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.8 pt -149.85 -39.24 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -87.17 120.71 28.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.967 0.413 . . . . 0.0 110.613 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -145.05 -171.13 3.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.892 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.72 -179.69 48.99 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.3 mt -103.06 116.4 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.23 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.4 mtp85 -74.4 152.86 39.44 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.96 0.409 . . . . 0.0 110.051 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 84' ' ' ARG . 39.9 tp -84.45 -8.04 59.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.437 0.637 . . . . 0.0 110.609 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 85' ' ' SER . 45.6 p-10 -74.66 23.97 0.09 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.861 0.839 . . . . 0.0 110.64 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 82' ' ' LEU . 77.9 mtp180 -51.48 -5.59 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.594 -0.691 . . . . 0.0 111.448 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 83' ' ' ASN . 95.0 p -98.35 4.41 48.61 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.06 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -96.93 -140.0 0.28 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.531 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -158.23 147.04 19.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.494 0.664 . . . . 0.0 110.98 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.42 ' O ' ' O ' ' A' ' 14' ' ' LEU . 91.4 m95 -154.13 176.44 12.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.295 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.91 -165.21 0.2 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.889 0.852 . . . . 0.0 110.777 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -161.26 154.17 20.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.118 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 12.1 m-85 -148.24 156.21 42.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.467 0.651 . . . . 0.0 110.352 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 81.6 m -123.46 -166.69 1.5 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.778 0.799 . . . . 0.0 110.155 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -146.87 125.5 12.52 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.136 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' ND2' HH21 ' A' ' 5' ' ' ARG . 1.1 m-80 -103.31 154.03 38.03 Favored Pre-proline 0 CA--C 1.548 0.873 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.874 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -41.89 -47.31 6.52 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.75 1.633 . . . . 0.0 112.659 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.622 ' CG ' ' H ' ' A' ' 97' ' ' ALA . 0.4 OUTLIER -149.94 -105.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.48 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.622 ' H ' ' CG ' ' A' ' 96' ' ' HIS . . . -151.62 150.04 29.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.152 0.501 . . . . 0.0 110.096 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.5 mttt . . . . . 0 C--N 1.288 -2.075 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.215 176.842 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' H ' HG22 ' A' ' 2' ' ' VAL . 18.7 m -85.39 154.21 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.008 0.433 . . . . 0.0 110.806 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.486 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 34.2 p90 -138.58 169.2 18.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.873 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -73.64 132.85 43.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.227 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.486 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 61.8 ttm-85 -135.16 131.26 36.58 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.274 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -165.0 159.18 17.72 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.232 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.83 137.52 56.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.929 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -70.18 -39.65 75.13 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.03 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.0 m -113.08 -32.92 6.19 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.793 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.22 -134.29 0.51 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.626 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 12' ' ' TYR . 24.6 pttm -173.28 -35.7 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.676 0 CA-C-O 121.044 0.45 . . . . 0.0 110.821 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.441 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 82.7 m-85 -159.53 80.78 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.116 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -147.19 42.52 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 0.0 110.353 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -117.25 126.44 52.74 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.315 0.579 . . . . 0.0 110.788 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 16' ' ' TYR . 91.6 m -103.68 164.66 11.53 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.855 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.59 ' N ' HG22 ' A' ' 15' ' ' THR . 59.5 t80 -54.31 -48.17 71.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.486 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' HB2' HH21 ' A' ' 84' ' ' ARG . . . -55.2 -45.76 75.89 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.898 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.49 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 8.3 mp0 -64.49 -45.41 87.43 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.154 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.49 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.28 -31.16 69.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.174 0.512 . . . . 0.0 110.827 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.88 -51.32 41.48 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.598 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.0 m -59.72 -23.19 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 120.978 0.418 . . . . 0.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' C ' ' H ' ' A' ' 25' ' ' PHE . 57.4 m -104.89 176.59 5.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.488 0.661 . . . . 0.0 109.59 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 68.2 mm-40 73.99 -26.12 0.19 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.873 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.0 t80 -59.78 -49.05 79.23 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.947 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -93.96 17.47 12.23 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.115 0.483 . . . . 0.0 111.011 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.13 5.61 82.81 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -79.47 -175.53 47.67 Favored Glycine 0 C--O 1.219 -0.822 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 89.4 m-70 -154.96 158.52 39.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.752 -0.224 . . . . 0.0 110.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 136.93 57.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.044 0.449 . . . . 0.0 110.368 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 85.61 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.131 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 33' ' ' TYR . 40.9 m -71.05 170.36 13.02 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.611 ' N ' HG22 ' A' ' 32' ' ' THR . 26.1 t80 -55.37 -53.19 59.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.724 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.1 -49.14 77.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.681 0.277 . . . . 0.0 110.577 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -66.34 -36.25 82.42 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 110.682 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.4 mt -61.82 -43.75 98.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.541 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -49.72 -44.59 48.42 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.693 0.282 . . . . 0.0 110.543 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.56 -33.84 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.697 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.75 -46.65 44.54 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.046 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.587 HH22 ' H ' ' A' ' 46' ' ' VAL . 12.1 mmm180 -56.93 -30.82 64.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.558 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -79.61 -6.6 57.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.561 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 42' ' ' ILE . 5.6 mm -103.02 4.98 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.691 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.89 5.28 53.75 Favored Glycine 0 N--CA 1.466 0.644 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -68.79 119.41 13.12 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 117.44 0.62 . . . . 0.0 109.978 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.403 ' HA ' ' NH2' ' A' ' 40' ' ' ARG . 84.7 t60 -134.85 103.43 5.6 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.353 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.587 ' H ' HH22 ' A' ' 40' ' ' ARG . 39.7 t -141.27 132.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.728 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -114.36 92.69 4.05 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.69 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.39 127.29 4.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.43 . . . . 0.0 110.778 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.22 104.78 1.55 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.405 0.621 . . . . 0.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.499 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -122.66 157.24 17.25 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.024 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.458 ' CE3' HG22 ' A' ' 57' ' ' VAL . 88.9 m95 -78.68 145.7 34.43 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.313 0.578 . . . . 0.0 110.143 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 2.1 mpp? -142.99 171.84 13.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.324 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -38.71 149.78 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.665 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 57.27 34.81 25.3 Favored 'General case' 0 C--O 1.202 -1.425 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.194 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.83 6.85 1.36 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 121.796 -0.565 . . . . 0.0 111.888 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.407 ' O ' ' N ' ' A' ' 52' ' ' MET . 59.8 ttt85 -62.32 131.21 48.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.406 0.622 . . . . 0.0 110.065 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.458 HG22 ' CE3' ' A' ' 51' ' ' TRP . 2.3 t -127.88 126.59 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.985 0.898 . . . . 0.0 110.728 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.06 -172.31 25.06 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.289 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 78' ' ' TYR . 7.8 p90 -152.5 84.83 4.62 Favored Pre-proline 0 N--CA 1.467 0.402 0 CA-C-N 114.934 -0.633 . . . . 0.0 110.344 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.15 145.04 67.2 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.36 2.04 . . . . 0.0 112.49 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -136.78 103.51 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.629 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.45 -53.75 16.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.266 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -95.09 145.9 30.35 Favored Pre-proline 0 N--CA 1.469 0.498 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.327 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -39.89 140.54 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.067 1.844 . . . . 0.0 112.322 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -153.56 99.91 0.19 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-O 118.121 -1.377 . . . . 0.0 111.991 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.54 -16.09 19.23 Favored 'Trans proline' 0 N--CA 1.501 1.929 0 C-N-CA 122.19 1.927 . . . . 0.0 112.108 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -70.83 -34.73 71.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.109 0.48 . . . . 0.0 110.687 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -145.7 137.25 25.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.236 0.541 . . . . 0.0 110.384 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.46 79.31 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 49.54 79.57 0.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.719 0.295 . . . . 0.0 110.714 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.05 -123.14 32.05 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt 55.76 163.98 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.84 0.353 . . . . 0.0 110.552 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 74' ' ' GLY . 89.1 m -138.99 164.31 30.09 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.676 0.75 . . . . 0.0 110.666 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.584 ' N ' HG22 ' A' ' 73' ' ' THR . . . 73.96 153.71 3.02 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.241 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 37.4 mt -53.32 126.17 9.02 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-O 120.974 0.416 . . . . 0.0 110.367 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.472 ' O ' ' CE2' ' A' ' 78' ' ' TYR . 37.2 mm -107.84 118.37 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-O 121.191 0.52 . . . . 0.0 110.424 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -72.58 149.73 43.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.384 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.478 ' CZ ' ' CZ ' ' A' ' 59' ' ' TYR . 98.5 m-85 -131.36 -16.51 3.08 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.487 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -170.0 34.63 Favored Glycine 0 N--CA 1.473 1.112 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.1 mt -103.83 123.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 121.688 0.756 . . . . 0.0 110.504 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.51 HH11 ' HG2' ' A' ' 81' ' ' ARG . 0.5 OUTLIER -98.37 130.13 45.02 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.39 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 84' ' ' ARG . 27.6 mt -83.0 8.58 12.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.321 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 85' ' ' SER . 47.7 p-10 -71.86 22.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.672 1.225 . . . . 0.0 110.981 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 82' ' ' LEU . 72.0 ttt180 -48.06 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.597 -0.689 . . . . 0.0 110.986 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 83' ' ' ASN . 57.3 m -68.22 -37.66 81.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.656 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -80.18 -169.17 1.94 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 110.645 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.448 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 92.0 mtt-85 -134.03 144.93 48.98 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.552 0.691 . . . . 0.0 110.721 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.448 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 60.3 m95 -150.32 175.42 11.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.971 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 42.5 t0 -59.86 -179.7 0.1 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.418 0.628 . . . . 0.0 111.085 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.456 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -165.65 159.73 16.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.344 0.593 . . . . 0.0 110.884 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.11 160.54 38.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.637 0.732 . . . . 0.0 110.454 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.8 t -141.95 148.54 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.159 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -115.42 141.93 47.39 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.124 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -147.26 148.52 32.04 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.196 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.68 154.83 59.4 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.463 2.109 . . . . 0.0 111.897 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 m80 52.46 20.54 1.48 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.427 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.07 -68.98 0.26 Allowed 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 122.359 1.076 . . . . 0.0 108.594 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 C--N 1.291 -1.974 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 174.472 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 t -82.96 157.15 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.665 0.269 . . . . 0.0 110.718 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -162.68 155.52 19.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.769 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -75.61 135.1 40.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.616 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -141.97 139.74 32.53 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.224 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -140.8 152.38 45.13 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.332 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.13 159.12 1.96 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.079 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -49.14 9.99 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.871 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.0 m -114.0 19.0 16.86 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.606 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.12 -176.25 14.38 Favored Glycine 0 C--O 1.215 -1.082 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -147.0 106.23 3.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.193 -0.504 . . . . 0.0 110.49 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 56.53 17.25 2.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.537 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -80.48 38.64 0.44 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.892 0.377 . . . . 0.0 110.555 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.44 117.12 30.85 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 121.264 0.554 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.538 HG22 ' N ' ' A' ' 16' ' ' TYR . 61.9 m -101.58 163.62 12.17 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.546 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.538 ' N ' HG22 ' A' ' 15' ' ' THR . 62.4 t80 -53.85 -49.75 67.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.335 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -39.93 78.35 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.891 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -65.07 -49.28 70.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.713 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.6 -30.16 41.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' CYS . 44.1 tptt -60.93 -37.37 82.1 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.303 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.45 -54.2 13.3 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.449 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.49 -42.78 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.999 0.428 . . . . 0.0 110.788 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.525 ' C ' ' H ' ' A' ' 25' ' ' PHE . 62.1 m -100.51 173.42 6.57 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' OE1' ' NZ ' ' A' ' 20' ' ' LYS . 70.9 tt0 63.04 -7.98 0.14 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.025 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.93 -47.1 86.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.774 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -87.98 21.29 2.76 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.864 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.24 -1.2 84.33 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.599 -0.601 . . . . 0.0 111.599 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.81 -152.15 1.27 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.465 ' ND1' ' O ' ' A' ' 30' ' ' LEU . 53.4 t-80 -168.67 152.74 5.71 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.642 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.465 ' O ' ' ND1' ' A' ' 29' ' ' HIS . 44.0 mt -62.43 139.52 58.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.956 0.408 . . . . 0.0 110.438 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.49 103.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.998 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.8 t -77.45 179.02 6.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.045 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.461 ' N ' ' OG1' ' A' ' 32' ' ' THR . 50.7 t80 -54.81 -53.65 52.42 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.74 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.1 -44.75 91.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.734 0.302 . . . . 0.0 110.71 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.562 ' H ' HG23 ' A' ' 32' ' ' THR . 78.8 mt-30 -71.38 -30.85 66.63 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.062 0.458 . . . . 0.0 111.066 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.8 mt -63.48 -41.91 98.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -30.64 67.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.216 0.531 . . . . 0.0 110.674 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.24 -35.89 65.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.828 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.74 -42.18 42.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.102 0.477 . . . . 0.0 111.171 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.546 HH22 ' CA ' ' A' ' 61' ' ' ILE . 17.2 mmm180 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.161 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -75.36 -11.53 60.07 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.456 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 42' ' ' ILE . 99.1 mt -96.71 4.13 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 97.21 9.6 55.44 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -66.85 125.36 25.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.949 0.374 . . . . 0.0 110.392 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -143.64 103.06 4.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.246 0.546 . . . . 0.0 110.485 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -142.0 132.75 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.699 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 14.6 t -90.18 91.31 8.47 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.347 0.594 . . . . 0.0 109.988 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.3 149.73 17.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.652 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -126.99 136.91 52.9 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.466 0.65 . . . . 0.0 110.884 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.89 -178.58 21.47 Favored Glycine 0 N--CA 1.47 0.949 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.547 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -84.32 156.13 22.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.339 -0.431 . . . . 0.0 110.39 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 53' ' ' ALA . 1.5 ptt? -158.16 -175.28 5.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.551 0.691 . . . . 0.0 110.101 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -30.71 144.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.574 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? 55.35 15.46 1.39 Allowed 'General case' 0 C--O 1.2 -1.505 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.776 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 65.8 16.26 63.45 Favored Glycine 0 C--N 1.315 -0.623 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -66.59 154.5 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.98 0.419 . . . . 0.0 110.007 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 57' ' ' VAL . 11.5 p -129.9 118.12 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 121.862 0.839 . . . . 0.0 110.942 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 59' ' ' TYR . . . -113.73 -175.86 19.14 Favored Glycine 0 N--CA 1.47 0.917 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 6.1 m-85 -141.66 69.72 25.34 Favored Pre-proline 0 N--CA 1.473 0.718 0 CA-C-N 115.065 -0.568 . . . . 0.0 110.291 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -52.62 115.32 2.15 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 121.72 1.614 . . . . 0.0 112.559 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.546 ' CA ' HH22 ' A' ' 40' ' ' ARG . 97.8 mt -145.58 118.23 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.607 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 66.8 t -74.73 -22.33 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.932 0.396 . . . . 0.0 110.083 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -165.65 148.24 6.59 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.312 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -39.63 143.87 0.35 Allowed 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.878 1.719 . . . . 0.0 112.926 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.91 167.79 25.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.457 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.97 -43.29 0.8 Allowed 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.164 1.91 . . . . 0.0 112.317 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -64.88 -35.21 80.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.097 0.475 . . . . 0.0 110.46 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.17 113.47 25.74 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.216 0.531 . . . . 0.0 110.082 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.88 145.65 29.03 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 45.5 -97.32 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 0.0 110.848 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.46 104.5 0.01 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.81 -161.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 110.148 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.2 p -94.59 150.62 20.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.429 0.633 . . . . 0.0 110.423 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 167.48 8.97 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.91 131.7 28.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 110.17 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 77.6 mt -86.64 126.0 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.374 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -66.66 133.68 50.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.486 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -143.81 156.45 44.49 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.754 0.787 . . . . 0.0 110.227 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.38 -161.0 34.67 Favored Glycine 0 N--CA 1.47 0.935 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 85.6 mt -97.77 96.88 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.44 0.638 . . . . 0.0 110.193 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -71.52 141.94 50.12 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.262 0.553 . . . . 0.0 110.423 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 84' ' ' ARG . 24.1 tp -82.11 3.8 25.61 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.14 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 85' ' ' SER . 38.7 p-10 -76.06 20.44 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.916 0.865 . . . . 0.0 110.574 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 82' ' ' LEU . 80.9 mtp180 -54.94 -1.6 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 O-C-N 121.782 -0.574 . . . . 0.0 111.3 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 83' ' ' ASN . 96.7 p -94.94 -4.6 46.49 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.998 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.454 ' CD ' ' HE1' ' A' ' 88' ' ' TRP . 80.7 tt0 -94.98 154.08 17.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 83.4 mtm180 -86.17 136.81 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 0.0 110.651 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.454 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.1 m95 -153.2 176.84 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.328 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 30.9 t0 -73.55 -169.29 0.66 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.565 0.698 . . . . 0.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.47 153.88 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.499 0.666 . . . . 0.0 110.873 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.28 157.36 29.33 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.757 0.789 . . . . 0.0 110.371 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.53 -173.62 3.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.496 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -160.04 113.56 2.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.181 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -153.81 150.95 23.95 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.032 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.16 2.58 4.18 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 121.902 1.735 . . . . 0.0 111.581 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -86.95 -174.0 4.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.974 0.416 . . . . 0.0 110.377 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 58.3 -151.87 0.41 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.98 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 33.9 tttt . . . . . 0 C--N 1.29 -1.985 0 CA-C-O 117.531 -1.223 . . . . 0.0 109.559 176.765 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -147.47 130.14 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 120.89 0.376 . . . . 0.0 110.557 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -105.35 129.55 53.66 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.831 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -79.36 149.34 31.73 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.759 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -128.43 154.52 45.97 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -160.94 133.14 5.95 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.394 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.62 126.88 31.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -75.7 -42.35 51.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.532 0.682 . . . . 0.0 110.997 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 p -109.58 25.75 11.43 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.624 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.68 -142.95 3.54 Favored Glycine 0 C--O 1.217 -0.942 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.743 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -162.38 87.09 0.61 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.111 0.481 . . . . 0.0 110.526 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.471 ' CD1' ' OD2' ' A' ' 89' ' ' ASP . 2.3 m-85 72.39 21.71 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.645 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -74.1 48.04 0.3 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 122.408 -0.183 . . . . 0.0 110.758 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -123.99 130.12 52.05 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.543 0.687 . . . . 0.0 110.904 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 44.0 p -101.38 170.23 8.36 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -56.26 -50.19 72.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.56 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.91 86.81 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.041 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -68.56 -51.74 39.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.71 -30.34 13.58 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' O ' ' A' ' 23' ' ' CYS . 28.8 ttpt -67.92 -33.6 75.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.514 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -51.91 63.32 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 111.56 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.24 -38.72 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.207 0.527 . . . . 0.0 110.71 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.509 ' O ' ' O ' ' A' ' 20' ' ' LYS . 56.8 m -101.17 178.8 4.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.871 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 28' ' ' GLY . 36.1 tt0 72.68 -27.28 0.18 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.748 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.7 t80 -61.27 -46.62 89.58 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 110.799 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.1 pm0 -86.49 11.74 11.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -23.1 33.79 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -78.51 134.27 13.91 Favored Glycine 0 C--O 1.22 -0.738 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.44 173.34 6.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.1 mt -66.83 137.61 56.73 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.244 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.97 139.54 46.09 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.429 0.633 . . . . 0.0 110.819 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 p -122.27 174.35 7.04 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.921 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -59.71 -52.83 63.82 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.91 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -60.87 -45.25 95.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.927 0.394 . . . . 0.0 110.485 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.11 -34.73 75.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.82 0.343 . . . . 0.0 110.639 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 40' ' ' ARG . 10.7 mt -62.53 -41.14 98.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.467 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -53.89 -40.82 66.94 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.755 0.312 . . . . 0.0 110.884 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.83 97.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.081 0.467 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -85.56 -25.47 26.72 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 0.0 111.388 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.539 ' NH2' ' O ' ' A' ' 61' ' ' ILE . 1.1 tpt85 -56.41 -25.74 51.09 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.593 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -81.49 -1.35 45.67 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.508 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 39' ' ' ALA . 4.4 tt -91.65 6.31 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.506 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.13 26.24 34.62 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -70.55 131.23 43.67 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.83 0.315 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -157.65 101.77 1.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -143.43 133.07 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.14 78.74 6.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.862 0.363 . . . . 0.0 110.027 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.38 92.47 0.9 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.472 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.07 39.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.628 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.05 165.59 20.97 Favored Glycine 0 N--CA 1.478 1.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.814 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -72.14 104.97 3.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.385 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.459 ' O ' ' N ' ' A' ' 55' ' ' GLY . 71.4 mtm -97.31 -178.33 4.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.25 0.548 . . . . 0.0 110.418 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -32.07 144.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.769 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.7 mttp 54.4 9.27 0.24 Allowed 'General case' 0 C--O 1.2 -1.529 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.224 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 81.86 20.87 62.49 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.045 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 69.2 ttt180 -70.38 130.01 40.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.428 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.2 p -116.57 133.09 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-O 121.806 0.812 . . . . 0.0 110.745 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.46 157.18 28.81 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -113.11 106.07 55.14 Favored Pre-proline 0 N--CA 1.489 1.509 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.448 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 87.8 Cg_endo -79.05 126.93 7.36 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.101 1.201 . . . . 0.0 112.234 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 17.1 pt -145.97 137.95 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.831 0.824 . . . . 0.0 110.875 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.77 -45.36 98.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.285 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.636 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -168.5 -43.93 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.159 -179.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.636 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 31.8 Cg_exo -60.64 147.95 93.04 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.231 1.954 . . . . 0.0 112.164 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.461 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -156.73 50.53 0.44 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.371 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.3 Cg_endo -66.55 -53.41 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.321 2.014 . . . . 0.0 111.943 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.77 -23.19 31.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.56 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 12.1 p -151.03 124.94 9.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.715 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.56 110.5 0.25 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -144.09 -53.1 0.33 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.406 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.14 -72.7 0.58 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -172.36 -157.45 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 0.0 110.669 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 p -114.89 166.37 11.85 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.386 0.612 . . . . 0.0 110.626 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 68.41 68.32 1.69 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' GLY . 71.9 mt 56.44 128.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 115.587 -0.307 . . . . 0.0 110.899 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.46 118.15 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 120.992 0.425 . . . . 0.0 110.379 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 91.9 m-20 -92.54 108.1 19.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.496 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CE1' ' OH ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -95.93 -11.55 26.45 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.1 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.98 -174.51 44.16 Favored Glycine 0 N--CA 1.465 0.591 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.5 mp -96.61 116.87 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.212 0.53 . . . . 0.0 110.556 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.531 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 79.8 mtp180 -92.91 133.85 35.69 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.112 0.482 . . . . 0.0 110.162 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 30.8 tp -83.35 4.65 26.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.427 0.632 . . . . 0.0 110.308 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.531 HD21 ' CZ ' ' A' ' 81' ' ' ARG . 51.4 p30 -85.66 23.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.487 0.661 . . . . 0.0 110.537 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -44.31 -32.08 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.566 -0.709 . . . . 0.0 111.261 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 97.1 p -49.08 -21.96 0.83 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.009 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -70.51 -169.96 0.36 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.12 0.486 . . . . 0.0 110.743 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 84.1 mtt85 -130.2 129.81 43.87 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.373 0.606 . . . . 0.0 110.776 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.428 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.4 m95 -150.1 175.71 11.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.908 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.471 ' OD2' ' CD1' ' A' ' 12' ' ' TYR . 1.3 m-20 -55.69 -174.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.86 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.47 143.07 18.53 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.425 0.631 . . . . 0.0 110.935 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -115.43 160.08 20.33 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.008 0.909 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.88 179.71 6.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.264 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -133.36 116.7 16.4 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.183 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -149.41 88.47 5.0 Favored Pre-proline 0 N--CA 1.468 0.441 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.045 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -81.89 85.49 1.7 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.398 1.399 . . . . 0.0 111.559 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -133.75 -42.88 0.83 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.19 -73.02 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.83 0.824 . . . . 0.0 108.849 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt . . . . . 0 C--N 1.291 -1.95 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.007 176.186 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.9 t -83.98 136.64 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.669 0.271 . . . . 0.0 110.742 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.6 162.41 37.55 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.972 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -74.91 129.06 37.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.444 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -135.03 133.3 39.25 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.216 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -157.05 156.03 32.17 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.44 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.27 125.65 20.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -80.16 -37.02 34.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.094 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.3 m -84.71 -5.21 59.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.507 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.63 -118.65 0.81 Allowed Glycine 0 N--CA 1.473 1.104 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.159 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -167.53 -39.94 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.36 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -146.76 67.16 1.16 Allowed 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.978 0.418 . . . . 0.0 110.517 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.09 32.92 3.69 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.9 mt -119.3 118.72 32.0 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.649 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -90.32 168.31 11.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.656 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 38.5 p90 -51.64 -60.23 3.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -53.16 -40.24 64.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -66.24 -47.96 72.09 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.483 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.64 -35.87 61.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.795 0.331 . . . . 0.0 110.849 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 23' ' ' CYS . 56.6 mtpt -68.9 -31.31 70.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.185 0.517 . . . . 0.0 110.777 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -51.86 45.72 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.884 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 m -60.82 -33.87 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.364 0.602 . . . . 0.0 110.709 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -104.71 -178.45 3.66 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.326 0.584 . . . . 0.0 109.586 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 96.4 mt-10 69.77 -10.28 0.62 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.923 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.444 ' H ' ' C ' ' A' ' 23' ' ' CYS . 90.5 t80 -60.48 -47.25 86.95 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.867 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 18.0 pt-20 -87.39 21.37 2.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.42 14.46 76.26 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.11 -171.28 40.45 Favored Glycine 0 C--O 1.218 -0.847 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -163.45 121.07 1.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.679 0.276 . . . . 0.0 110.451 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.6 mt -42.15 136.98 2.04 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.701 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.495 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -66.12 144.66 56.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.97 0.414 . . . . 0.0 111.148 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.1 p -123.21 177.3 5.63 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.075 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -51.6 -26.74 9.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.474 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -70.66 -56.33 6.7 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.76 -35.29 74.82 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.859 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 32.7 mt -61.07 -40.85 95.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.419 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -58.72 -34.14 71.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 120.832 0.348 . . . . 0.0 110.541 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.2 54.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 110.785 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.86 -33.97 66.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -56.59 -43.47 80.13 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.402 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -63.77 -11.4 26.25 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.618 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 42' ' ' ILE . 79.2 mt -98.54 7.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.49 22.08 52.05 Favored Glycine 0 N--CA 1.466 0.637 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.47 132.78 46.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.751 0.31 . . . . 0.0 110.585 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -154.23 105.38 2.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.478 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 46' ' ' VAL . 14.9 p -141.71 127.05 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.879 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.9 t -104.38 82.56 1.94 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.586 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.82 118.21 2.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.63 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.721 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -137.99 151.04 21.19 Favored Glycine 0 N--CA 1.476 1.336 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.12 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -73.13 147.5 44.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.166 0.508 . . . . 0.0 110.258 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 31' ' ' ALA . 48.9 mtm -150.0 179.96 7.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.018 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.8 141.47 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.835 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 55.39 12.37 0.72 Allowed 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.179 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 75.62 21.59 76.75 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.808 -0.558 . . . . 0.0 112.158 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.0 ttt85 -74.36 135.89 42.47 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.209 0.528 . . . . 0.0 110.579 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.482 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 3.1 p -143.41 156.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 121.667 0.746 . . . . 0.0 110.783 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 57' ' ' VAL . . . -174.69 -178.47 44.6 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.271 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -116.46 67.04 3.51 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.879 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.29 118.78 5.68 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 121.762 1.642 . . . . 0.0 112.419 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.2 pt -145.02 147.98 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.682 0.753 . . . . 0.0 110.88 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -70.71 -66.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.338 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.767 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 17.7 mttt -144.76 -43.07 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.303 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.767 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 28.0 Cg_exo -63.32 150.14 89.36 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.211 1.941 . . . . 0.0 112.371 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.472 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -168.88 49.32 0.22 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.493 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 57.8 Cg_endo -66.73 -53.19 0.59 Allowed 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.428 2.085 . . . . 0.0 112.118 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -74.4 -17.05 60.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.591 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.24 132.1 1.02 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.228 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.95 41.4 0.03 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -61.64 -41.82 98.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.47 . . . . 0.0 110.32 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -67.47 -84.67 0.1 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -170.93 -156.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.546 0.213 . . . . 0.0 110.472 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 49.3 p -95.3 162.22 13.77 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.328 0.585 . . . . 0.0 110.597 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.57 -150.22 19.97 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.2 mt -102.67 123.34 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-O 121.097 0.475 . . . . 0.0 110.545 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.9 mt -93.88 131.21 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.351 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -85.51 97.33 9.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.373 0.606 . . . . 0.0 110.067 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -147.1 41.79 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.301 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.542 ' O ' ' C ' ' A' ' 80' ' ' ILE . . . -91.06 -147.34 19.26 Favored Glycine 0 C--O 1.225 -0.418 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.542 ' C ' ' O ' ' A' ' 79' ' ' GLY . 11.5 mt 15.72 58.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-O 121.435 0.636 . . . . 0.0 111.238 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.611 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 82.3 mtp180 -71.08 150.78 45.18 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.15 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 82' ' ' LEU . 10.2 mp -77.24 -16.6 58.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.14 0.495 . . . . 0.0 109.958 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.641 ' C ' ' H ' ' A' ' 85' ' ' SER . 9.1 p30 -91.52 25.18 2.73 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.381 0.61 . . . . 0.0 110.616 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -52.88 5.04 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 O-C-N 121.719 -0.613 . . . . 0.0 111.712 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.641 ' H ' ' C ' ' A' ' 83' ' ' ASN . 47.7 t -92.61 -8.47 44.12 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.413 178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -85.97 -165.27 1.2 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.005 0.431 . . . . 0.0 110.718 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.47 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -131.27 141.25 49.95 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.005 0.907 . . . . 0.0 110.849 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.47 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 61.7 m95 -153.07 177.26 10.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.862 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 12.4 t70 -60.71 -163.67 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.864 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -170.35 149.35 3.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.22 0.533 . . . . 0.0 110.759 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -118.21 135.32 54.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.458 0.647 . . . . 0.0 110.253 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.9 m -114.08 177.33 4.68 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 122.023 0.916 . . . . 0.0 109.637 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -150.43 151.41 32.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.303 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 96' ' ' HIS . 29.8 t-20 -143.11 132.77 11.87 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.362 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.8 11.66 1.62 Allowed 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 122.05 1.834 . . . . 0.0 112.275 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.479 ' N ' ' OD1' ' A' ' 94' ' ' ASN . 71.3 t60 -160.11 77.99 0.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.04 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.5 155.8 28.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.972 0.415 . . . . 0.0 110.25 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.945 0 CA-C-O 117.66 -1.162 . . . . 0.0 108.056 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 3' ' ' TYR . 97.2 t -85.1 155.51 3.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.209 0.528 . . . . 0.0 110.637 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.402 ' N ' HG12 ' A' ' 2' ' ' VAL . 89.9 t80 -117.79 129.24 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.576 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -74.09 127.53 33.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.137 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' O ' ' O ' ' A' ' 90' ' ' ALA . 24.0 ttm180 -146.06 128.78 16.22 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.037 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.9 pm0 -146.41 -176.82 5.32 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 123.468 0.48 . . . . 0.0 110.392 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.67 127.1 31.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -78.39 -33.96 48.48 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.846 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.9 m -76.82 -4.09 41.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.531 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.47 -95.16 0.1 Allowed Glycine 0 C--O 1.217 -0.952 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.873 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -171.34 -81.5 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 120.917 0.389 . . . . 0.0 110.311 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.02 80.15 3.28 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.001 0.429 . . . . 0.0 110.622 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -137.61 34.62 2.45 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.153 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -123.22 129.72 51.77 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.519 0.676 . . . . 0.0 110.258 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.6 p -99.03 168.27 10.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.245 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.543 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 31.9 p90 -53.68 -53.56 50.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.729 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.543 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -55.12 -45.97 75.56 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.798 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -50.67 69.24 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.746 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.47 69.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.531 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.5 mttt -71.87 -40.27 69.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 0.0 110.715 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.71 -46.64 84.53 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.717 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.33 -42.84 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 121.529 0.68 . . . . 0.0 110.94 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 20' ' ' LYS . 17.6 m -101.47 178.79 4.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.736 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 70.04 -45.78 0.59 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.619 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -62.71 -48.02 81.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.41 21.82 3.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.022 0.439 . . . . 0.0 110.871 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.15 1.48 84.33 Favored Glycine 0 N--CA 1.469 0.869 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -70.23 -171.38 9.54 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -168.41 137.03 2.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.557 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 30' ' ' LEU . 10.3 mp -72.94 141.27 47.82 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.973 0.416 . . . . 0.0 110.25 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.3 93.96 0.35 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.291 0.567 . . . . 0.0 110.726 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.616 HG22 ' N ' ' A' ' 33' ' ' TYR . 34.0 m -86.01 171.66 11.24 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.898 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.616 ' N ' HG22 ' A' ' 32' ' ' THR . 66.7 t80 -55.53 -53.98 49.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -57.22 -45.05 84.21 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.702 0.287 . . . . 0.0 110.542 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.1 mm100 -70.05 -34.93 73.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.136 0.493 . . . . 0.0 110.858 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -63.15 -40.87 98.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -61.15 -37.31 82.41 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.5 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.09 -39.77 93.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.934 0.397 . . . . 0.0 110.952 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.71 -27.62 31.07 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.365 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 tpt85 -56.96 -25.0 57.05 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.268 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.56 -6.24 59.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 42' ' ' ILE . 78.1 mt -94.36 4.52 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.521 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.29 25.09 24.86 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 111.616 -0.594 . . . . 0.0 111.616 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -66.31 128.66 37.02 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.701 0.251 . . . . 0.0 110.59 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.403 ' CG ' HG22 ' A' ' 62' ' ' VAL . 1.8 t60 -150.03 103.19 3.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.278 0.561 . . . . 0.0 110.468 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 46' ' ' VAL . 11.4 p -143.65 117.57 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.023 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.87 89.73 6.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.11 112.5 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.118 0.485 . . . . 0.0 110.618 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.45 137.21 52.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.905 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.98 -172.83 19.13 Favored Glycine 0 N--CA 1.468 0.8 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.689 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -94.73 150.81 19.82 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.099 0.476 . . . . 0.0 110.175 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 58.1 mtm -143.73 168.86 18.9 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.35 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.19 156.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.389 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.17 40.77 31.85 Favored 'General case' 0 C--O 1.2 -1.508 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.273 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.26 6.61 0.16 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.008 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 56.5 ttt180 -68.81 144.72 54.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.61 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.29 130.19 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-O 121.771 0.795 . . . . 0.0 110.786 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 177.76 175.59 45.08 Favored Glycine 0 C--N 1.317 -0.516 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.433 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.596 ' CE2' HD11 ' A' ' 61' ' ' ILE . 13.6 p90 -167.55 143.19 3.33 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.724 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.11 146.68 46.97 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.184 1.922 . . . . 0.0 112.474 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.596 HD11 ' CE2' ' A' ' 59' ' ' TYR . 16.2 mt -141.8 93.33 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.556 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG22 ' CG ' ' A' ' 45' ' ' HIS . 18.9 m -69.24 -36.76 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.031 0.443 . . . . 0.0 110.278 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -137.7 154.39 74.79 Favored Pre-proline 0 N--CA 1.477 0.898 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.678 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.33 144.77 59.2 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.362 2.041 . . . . 0.0 112.0 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.75 179.72 20.76 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.37 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.8 -47.63 26.14 Favored 'Trans proline' 0 N--CA 1.503 2.053 0 C-N-CA 122.174 1.916 . . . . 0.0 112.598 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -138.41 28.69 2.47 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.647 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.3 p -151.34 150.5 30.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.381 0.61 . . . . 0.0 110.273 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.0 93.77 0.76 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -61.43 -44.7 96.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.175 0.512 . . . . 0.0 110.597 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 169.21 -8.96 0.05 OUTLIER Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.16 155.78 38.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.708 0.289 . . . . 0.0 110.287 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -140.5 130.31 24.47 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.794 0.807 . . . . 0.0 110.598 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 75' ' ' ILE . . . 144.77 -47.02 0.78 Allowed Glycine 0 N--CA 1.465 0.625 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.195 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.438 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER 159.26 131.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 CA-C-O 120.868 0.366 . . . . 0.0 110.607 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.9 mm -111.24 62.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.58 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 44.5 p-10 -99.67 103.61 15.3 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.95 0.405 . . . . 0.0 110.296 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -71.17 -61.62 1.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.546 0.688 . . . . 0.0 110.556 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 163.45 -147.44 13.09 Favored Glycine 0 N--CA 1.467 0.707 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.515 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.0 mt -97.63 117.39 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 120.874 0.368 . . . . 0.0 110.074 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 50.8 mtp85 -94.24 133.5 37.7 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.7 mp -82.54 3.34 28.96 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.592 0.71 . . . . 0.0 109.831 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 52.2 p-10 -81.66 26.2 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.846 0.832 . . . . 0.0 110.479 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -45.38 -36.35 4.21 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.543 -0.723 . . . . 0.0 111.262 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.2 p -45.57 -26.99 0.67 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.563 0.221 . . . . 0.0 110.99 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 8.7 mp0 -74.13 -173.08 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.932 0.872 . . . . 0.0 109.988 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -128.49 145.7 51.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.917 0.865 . . . . 0.0 110.347 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -155.05 175.91 13.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.343 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 28.0 t0 -79.82 -168.36 1.57 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.72 0.771 . . . . 0.0 110.604 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.443 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -167.98 164.58 13.78 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.455 0.645 . . . . 0.0 110.87 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -128.93 151.52 49.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.534 0.683 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.53 142.45 45.42 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.227 0.537 . . . . 0.0 110.308 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 94' ' ' ASN . 10.9 t80 -134.34 149.91 50.89 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.274 0.559 . . . . 0.0 110.312 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.482 ' N ' ' CD1' ' A' ' 93' ' ' TYR . 11.8 m120 -117.71 89.97 34.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.505 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.54 132.02 34.35 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.272 1.982 . . . . 0.0 112.537 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 96' ' ' HIS . 16.3 t-80 39.63 42.7 0.98 Allowed 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 122.387 0.275 . . . . 0.0 110.287 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 56.27 -135.2 1.27 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 122.171 0.986 . . . . 0.0 109.047 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.0 tttm . . . . . 0 C--N 1.29 -1.98 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 176.024 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 3' ' ' TYR . 10.2 p -81.66 163.32 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 110.745 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.543 ' N ' HG22 ' A' ' 2' ' ' VAL . 24.6 p90 -146.71 127.89 14.74 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.804 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -73.79 138.44 44.53 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.456 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 92' ' ' CYS . 52.5 ptt85 -145.62 160.96 40.91 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.496 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.4 pm0 -160.92 -177.48 6.16 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.478 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.81 124.66 17.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.432 0.634 . . . . 0.0 110.71 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -66.24 -39.62 89.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.018 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.7 m -109.72 33.08 4.58 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.507 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.36 -134.1 1.63 Allowed Glycine 0 C--O 1.216 -1.002 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.798 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -154.87 -83.16 0.07 Allowed 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 115.325 -0.438 . . . . 0.0 110.424 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.61 28.78 6.23 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.316 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -94.81 33.74 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.903 0.382 . . . . 0.0 110.604 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.7 tp -117.47 124.54 49.03 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.534 0.683 . . . . 0.0 110.789 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 16' ' ' TYR . 32.3 m -87.97 161.3 17.5 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.472 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.472 ' N ' HG22 ' A' ' 15' ' ' THR . 31.8 t80 -60.5 -43.74 96.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.388 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.08 -36.24 62.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.957 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -65.46 -51.15 62.15 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.83 -31.77 18.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.924 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 23' ' ' CYS . 10.5 mtpm? -70.59 -33.8 71.46 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-O 120.576 0.227 . . . . 0.0 110.567 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -49.54 74.54 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.133 0.492 . . . . 0.0 111.765 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.68 -44.31 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.251 0.548 . . . . 0.0 111.173 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.578 ' O ' ' O ' ' A' ' 20' ' ' LYS . 7.4 m -102.26 178.25 4.65 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.085 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 67.45 -39.32 0.37 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.964 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.9 t80 -60.0 -47.03 87.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.658 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.67 19.76 5.18 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.676 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.31 8.95 77.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.476 -0.65 . . . . 0.0 111.476 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.57 -165.75 22.11 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -167.95 137.89 2.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.797 -0.201 . . . . 0.0 110.523 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 30' ' ' LEU . 10.7 mp -70.54 137.4 50.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.917 0.389 . . . . 0.0 110.144 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.42 138.64 55.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 36' ' ' LEU . 11.1 p -100.31 163.71 12.27 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.225 0.536 . . . . 0.0 110.68 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 22.9 p90 -54.4 -53.37 54.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.943 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.57 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 39.0 ttmt -62.28 -44.38 96.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.986 0.422 . . . . 0.0 110.334 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -67.06 -30.05 70.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.654 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 1.4 mt -62.41 -29.9 70.83 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.346 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.77 -39.36 58.46 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.407 . . . . 0.0 110.909 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.29 -38.03 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.83 28.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.845 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 42' ' ' ILE . 3.8 tpt85 -56.77 -37.47 71.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.686 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -63.48 -2.09 1.45 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.509 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 42' ' ' ILE . 24.5 mm -106.39 13.46 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.347 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.01 18.93 66.25 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -68.77 127.49 33.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.885 0.343 . . . . 0.0 110.181 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -140.93 104.43 4.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.506 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.53 125.4 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.023 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.4 t -93.84 91.51 6.98 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.887 0.375 . . . . 0.0 110.303 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.28 93.69 1.74 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.291 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.463 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . . . -72.11 121.37 19.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.479 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.59 162.6 25.82 Favored Glycine 0 N--CA 1.476 1.359 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.961 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -80.29 109.34 14.68 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.39 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 40.1 mtm -97.87 -172.61 2.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.248 0.547 . . . . 0.0 110.251 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.02 152.93 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.583 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 56' ' ' ARG . 68.6 mttm 47.19 41.03 11.13 Favored 'General case' 0 C--O 1.198 -1.607 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.562 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.96 5.68 0.1 Allowed Glycine 0 CA--C 1.538 1.497 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.892 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 54' ' ' LYS . 54.8 mtp180 -68.37 128.91 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.3 122.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.806 0.812 . . . . 0.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -173.81 150.74 12.16 Favored Glycine 0 C--N 1.316 -0.55 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.516 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 49' ' ' ALA . 11.2 p90 -160.53 140.36 8.26 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.607 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 143.37 31.59 Favored 'Trans proline' 0 N--CA 1.505 2.198 0 C-N-CA 121.632 1.555 . . . . 0.0 112.784 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.5 pt -149.49 96.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 121.435 0.636 . . . . 0.0 111.08 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 p -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.532 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -139.18 80.34 23.69 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.173 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.64 131.22 32.57 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 121.851 1.701 . . . . 0.0 111.977 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.41 169.13 28.71 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.048 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.79 -18.4 47.43 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.504 2.136 . . . . 0.0 112.056 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -102.84 30.77 4.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.019 0.438 . . . . 0.0 110.537 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.7 m -139.42 -174.02 3.76 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.2 0.524 . . . . 0.0 110.502 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.21 135.87 34.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -73.19 134.0 44.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.676 0.274 . . . . 0.0 110.442 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 72' ' ' LYS . . . 65.01 -154.93 49.37 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 71' ' ' GLY . 56.7 mtpt 54.15 109.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.805 -0.197 . . . . 0.0 110.875 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.0 p -139.12 170.75 15.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.285 0.564 . . . . 0.0 110.824 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.04 68.66 1.58 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.7 mt 59.98 145.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.776 0.322 . . . . 0.0 110.39 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.8 mm -116.43 136.28 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.11 0.481 . . . . 0.0 110.626 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -133.36 137.74 46.01 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.695 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.539 ' CZ ' ' NH2' ' A' ' 81' ' ' ARG . 9.2 t80 -143.21 -179.0 6.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.638 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.48 -69.06 1.17 Allowed Glycine 0 N--CA 1.469 0.838 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER 173.79 135.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.3 0.571 . . . . 0.0 109.98 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.539 ' NH2' ' CZ ' ' A' ' 78' ' ' TYR . 86.9 mtt-85 -111.4 133.49 53.67 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.232 0.539 . . . . 0.0 110.261 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 28.4 mt -82.39 2.35 32.87 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.481 0.658 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -83.42 21.66 1.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.837 0.827 . . . . 0.0 110.656 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -48.91 -36.07 16.38 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.572 -0.705 . . . . 0.0 111.182 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.7 m -47.56 -30.8 3.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.564 0.221 . . . . 0.0 110.869 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.93 147.62 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.777 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 81.8 mtt85 -92.61 133.15 36.26 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.261 0.553 . . . . 0.0 110.569 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.423 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 66.6 m95 -151.53 175.62 12.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.17 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -63.64 -169.0 0.03 OUTLIER 'General case' 0 C--O 1.234 0.28 0 O-C-N 123.726 0.641 . . . . 0.0 111.007 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -169.34 159.75 8.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.414 0.626 . . . . 0.0 111.106 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -126.55 156.95 40.01 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.592 0.711 . . . . 0.0 110.576 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.406 ' HB2' ' HE ' ' A' ' 5' ' ' ARG . 1.1 m -147.5 142.28 26.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.631 0.729 . . . . 0.0 110.002 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.32 114.67 13.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.833 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -102.96 105.96 48.14 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-O 118.079 -0.963 . . . . 0.0 111.163 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.32 -11.49 17.45 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.063 1.176 . . . . 0.0 112.081 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' A' ' 96' ' ' HIS . 84.8 t60 -94.79 42.46 1.09 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.516 0.674 . . . . 0.0 111.008 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -160.3 -61.18 0.06 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.2 mttm . . . . . 0 C--N 1.289 -2.041 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.518 176.402 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 p -84.01 150.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -158.84 154.19 25.69 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.754 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -83.17 142.3 31.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.589 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 71.9 ttp85 -145.87 134.57 22.26 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.94 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 79.2 tt0 -134.48 161.03 36.18 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.11 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.11 133.69 38.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.525 0.678 . . . . 0.0 110.977 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 6' ' ' GLU . 86.2 mmt-85 -75.66 -39.37 57.75 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.834 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -113.53 -30.34 6.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.86 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.59 -170.22 43.71 Favored Glycine 0 C--O 1.216 -0.975 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -167.23 99.45 0.52 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.127 -0.536 . . . . 0.0 110.282 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 55.12 60.76 3.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.936 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -142.48 42.97 1.63 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.719 0.295 . . . . 0.0 110.683 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 mt -126.15 137.91 53.62 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-O 121.405 0.622 . . . . 0.0 110.815 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 67.4 p -101.65 166.62 10.6 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.766 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.583 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 33.0 p90 -51.89 -60.52 3.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -56.29 -36.36 68.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.918 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.81 -48.85 65.09 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.83 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.22 -30.64 7.36 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.025 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.5 mtpt -65.03 -26.37 68.23 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.72 -53.69 30.79 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.555 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -63.98 -33.7 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.943 0.401 . . . . 0.0 110.994 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.595 ' C ' ' H ' ' A' ' 25' ' ' PHE . 56.1 m -102.88 176.11 5.26 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 64.7 -26.83 0.09 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.137 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 23' ' ' CYS . 87.6 t80 -61.14 -47.83 84.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.854 0.359 . . . . 0.0 110.728 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -93.21 23.67 4.26 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.6 -5.15 84.48 Favored Glycine 0 N--CA 1.467 0.765 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.56 -158.96 3.52 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -173.28 161.29 4.18 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.51 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.22 145.87 55.27 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.602 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . . . -64.03 81.21 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.433 0.635 . . . . 0.0 111.145 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 m -62.45 152.24 34.95 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -57.93 -52.62 64.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.757 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -50.72 -49.69 57.07 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.587 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -66.17 -40.44 90.48 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.714 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.21 -40.65 96.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.3 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -63.89 -33.38 75.56 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.485 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.16 -30.0 63.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 110.741 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -87.25 -32.32 19.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.262 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.7 mmm-85 -52.47 -19.91 2.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.428 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.52 -3.4 37.19 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.809 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.8 tt -101.84 13.56 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 116.643 -0.253 . . . . 0.0 110.625 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.47 18.84 70.11 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.84 145.23 20.31 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 117.239 0.519 . . . . 0.0 110.326 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -140.85 132.56 27.29 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.708 0.766 . . . . 0.0 110.352 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 47' ' ' CYS . 38.6 t -132.97 159.48 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.784 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.464 ' N ' HG12 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -156.24 41.48 0.37 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.523 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' H ' HG12 ' A' ' 46' ' ' VAL . . . -145.17 144.01 30.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.23 0.538 . . . . 0.0 110.595 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.97 118.46 34.6 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.618 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 57' ' ' VAL . . . -133.32 -171.34 12.66 Favored Glycine 0 N--CA 1.48 1.598 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.05 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -99.12 150.04 22.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 110.054 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 42.2 ttm -134.44 161.19 35.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.117 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.8 136.93 1.84 Allowed 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.581 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.2 mttp 56.77 38.03 29.21 Favored 'General case' 0 C--O 1.2 -1.542 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.598 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.84 15.47 2.29 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.836 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -75.12 50.94 0.5 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.69 0.281 . . . . 0.0 110.651 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 50' ' ' GLY . 2.2 p -54.81 132.76 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 122.086 0.946 . . . . 0.0 110.765 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.27 71.71 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -71.23 142.99 87.71 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 121.161 -0.215 . . . . 0.0 111.546 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 156.47 53.75 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.511 1.474 . . . . 0.0 112.501 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.6 mt -144.13 94.98 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.64 -72.92 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.422 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -71.82 155.37 92.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -61.76 145.56 97.22 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.381 2.054 . . . . 0.0 111.899 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.61 83.97 0.24 Allowed Glycine 0 N--CA 1.472 1.058 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.91 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.36 -42.14 56.02 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.237 1.958 . . . . 0.0 112.322 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -98.13 23.75 7.87 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.961 0.41 . . . . 0.0 110.701 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 4.2 p -177.7 111.98 0.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.393 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 72.21 16.61 77.04 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 50.85 -88.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.438 0.637 . . . . 0.0 110.803 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -158.74 18.99 0.29 Allowed Glycine 0 N--CA 1.468 0.797 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.46 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.74 126.77 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.881 0.372 . . . . 0.0 110.164 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.1 p -94.18 172.36 8.27 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.53 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.07 -170.9 54.2 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 73.3 mt -97.82 123.35 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-O 120.97 0.414 . . . . 0.0 110.714 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.9 mm -95.97 74.76 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.615 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -75.84 109.59 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.332 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -75.04 -4.3 37.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.435 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 50.22 69.53 1.05 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 79' ' ' GLY . 75.8 mt 56.04 120.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.071 0.462 . . . . 0.0 110.971 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -104.64 152.76 22.08 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.108 0.48 . . . . 0.0 110.388 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' C ' ' H ' ' A' ' 84' ' ' ARG . 48.5 tp -85.93 -11.03 54.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.389 0.614 . . . . 0.0 110.491 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 85' ' ' SER . 51.4 p30 -73.48 23.61 0.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.856 0.836 . . . . 0.0 110.508 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 82' ' ' LEU . 99.3 mtt180 -47.95 -13.61 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.587 -0.696 . . . . 0.0 111.114 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.469 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.24 -32.23 26.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.717 0.294 . . . . 0.0 110.669 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -72.61 149.06 44.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.609 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -85.79 158.25 20.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.431 0.634 . . . . 0.0 110.507 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -155.43 179.81 8.82 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.249 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 43.6 t0 -75.31 -177.08 3.36 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.645 0.736 . . . . 0.0 110.765 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -159.82 158.19 30.59 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.171 0.51 . . . . 0.0 111.123 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -151.32 159.0 44.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.672 0.749 . . . . 0.0 110.504 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 29.5 m -125.59 148.09 49.07 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.083 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -138.45 126.8 23.06 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.89 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' CD1' ' A' ' 93' ' ' TYR . 56.9 m-80 -68.41 148.83 98.18 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 119.184 -0.436 . . . . 0.0 110.709 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.49 -18.14 38.41 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.993 1.795 . . . . 0.0 111.466 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -52.84 -89.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 50.62 -168.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.165 0.507 . . . . 0.0 110.172 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--N 1.291 -1.952 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.225 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.0 m -83.14 155.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.802 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -146.99 148.67 31.95 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.547 0.689 . . . . 0.0 110.794 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.74 136.8 34.62 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.754 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -102.63 158.78 16.0 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.211 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -141.1 113.79 8.28 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.448 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.0 173.75 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.033 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -38.61 86.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.074 0.464 . . . . 0.0 111.157 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.0 p -75.92 -7.18 53.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.445 0.641 . . . . 0.0 110.759 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 40.44 45.21 3.32 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 111.644 -0.583 . . . . 0.0 111.644 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 12' ' ' TYR . 53.3 tttp -152.8 46.56 0.71 Allowed 'General case' 0 C--O 1.214 -0.771 0 CA-C-O 121.011 0.434 . . . . 0.0 110.735 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.405 ' O ' ' O ' ' A' ' 11' ' ' LYS . 0.5 OUTLIER 44.95 96.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.3 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -141.4 36.85 1.68 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.758 0.313 . . . . 0.0 110.486 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 88' ' ' TRP . 50.6 mt -123.88 137.94 54.56 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.884 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 16' ' ' TYR . 87.2 m -100.47 164.77 11.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.558 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.568 ' N ' HG22 ' A' ' 15' ' ' THR . 32.2 t80 -52.01 -58.5 6.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.62 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.5 -45.51 84.83 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.957 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.06 -46.54 89.21 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.989 0.423 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.77 -29.68 60.02 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.796 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 23' ' ' CYS . 5.1 ttpm? -70.31 -31.32 68.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.975 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.43 -49.19 70.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.111 0.482 . . . . 0.0 111.598 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 m -68.16 -33.84 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.462 0.648 . . . . 0.0 111.284 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 25' ' ' PHE . 12.3 t -103.85 176.89 5.0 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.012 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 62.59 -3.64 0.28 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.714 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.482 ' H ' ' C ' ' A' ' 23' ' ' CYS . 82.5 t80 -58.88 -46.2 88.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.067 0.46 . . . . 0.0 110.485 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 2.0 pm0 -83.38 -16.94 44.01 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.492 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.53 -16.37 5.65 Favored Glycine 0 N--CA 1.476 1.331 0 N-CA-C 111.732 -0.547 . . . . 0.0 111.732 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.477 ' O ' ' CG ' ' A' ' 29' ' ' HIS . . . -60.52 -162.5 0.13 Allowed Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 28' ' ' GLY . 99.5 m-70 -156.87 148.99 22.97 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.567 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 37.5 mt -51.29 137.04 23.74 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.471 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.14 103.63 0.07 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.201 0.524 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 35' ' ' GLN . 1.2 t -80.61 169.82 17.14 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.792 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -54.94 -52.2 63.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.076 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -57.64 -42.46 83.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.1 0.476 . . . . 0.0 110.597 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.541 ' H ' HG23 ' A' ' 32' ' ' THR . 7.1 tp-100 -69.48 -40.39 77.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.584 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -62.96 -44.91 94.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.803 0.335 . . . . 0.0 110.235 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.76 -38.35 69.75 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.803 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.21 74.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.109 0.48 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -43.77 36.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.155 0.502 . . . . 0.0 111.377 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.64 HH12 ' H ' ' A' ' 46' ' ' VAL . 18.3 mmm180 -55.48 -29.27 58.46 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.406 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -70.73 -10.2 58.93 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.432 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 42' ' ' ILE . 22.1 mm -104.98 13.3 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.36 11.1 78.76 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -59.12 104.22 0.23 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-N 117.023 0.412 . . . . 0.0 110.252 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -88.72 129.16 35.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.421 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.64 ' H ' HH12 ' A' ' 40' ' ' ARG . 39.2 t -136.65 157.36 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.953 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.427 ' N ' HG12 ' A' ' 46' ' ' VAL . 4.2 t -158.49 46.78 0.33 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.8 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.14 146.1 27.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.09 0.471 . . . . 0.0 110.65 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.87 115.16 29.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.602 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -126.35 160.02 20.71 Favored Glycine 0 N--CA 1.475 1.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.889 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -78.14 107.47 10.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.324 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.0 mtp -98.04 177.06 5.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.211 0.529 . . . . 0.0 110.134 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -35.79 144.54 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.721 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.6 tttt 59.88 12.47 3.08 Favored 'General case' 0 C--O 1.199 -1.575 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.202 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.21 78.65 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 121.914 -0.491 . . . . 0.0 111.929 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' CG ' ' A' ' 77' ' ' ASP . 58.8 ttt180 -73.33 135.94 44.4 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.713 0.292 . . . . 0.0 110.53 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.97 154.51 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.252 0.549 . . . . 0.0 110.672 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.05 139.5 5.81 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.664 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 24.4 p90 -148.03 70.44 11.08 Favored Pre-proline 0 N--CA 1.474 0.747 0 CA-C-N 115.635 -0.282 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.4 141.55 95.9 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.23 1.953 . . . . 0.0 112.449 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.0 mt -133.42 129.0 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.544 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 83.0 t -64.52 -43.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.239 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 64' ' ' PRO . 21.8 ttpt -177.37 -54.78 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.816 0 CA-C-O 118.847 -0.597 . . . . 0.0 110.118 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 63' ' ' LYS . 60.9 Cg_endo -65.38 145.28 82.77 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.505 1.47 . . . . 0.0 112.305 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.442 ' N ' ' CD ' ' A' ' 66' ' ' PRO . . . -165.14 51.98 0.28 Allowed Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.395 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 65' ' ' GLY . 59.6 Cg_endo -67.4 -49.63 1.2 Allowed 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.476 2.117 . . . . 0.0 112.032 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.435 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -87.95 -27.12 22.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.984 0.421 . . . . 0.0 110.812 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.435 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.9 OUTLIER -139.17 144.05 38.4 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.266 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 70' ' ' PHE . . . 79.01 156.46 10.01 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.431 ' CG ' ' O ' ' A' ' 69' ' ' GLY . 97.0 m-85 -157.1 105.4 2.14 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.858 -0.171 . . . . 0.0 110.673 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.52 -42.1 1.94 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -69.7 142.05 53.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.395 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.6 p -144.54 168.91 19.03 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.847 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 61.6 153.16 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 74' ' ' GLY . 82.7 mt -31.55 125.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 120.724 0.297 . . . . 0.0 111.26 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.8 mm -110.96 126.2 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-O 121.228 0.537 . . . . 0.0 110.601 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.401 ' CG ' ' NH2' ' A' ' 56' ' ' ARG . 56.1 t0 -94.82 107.02 19.03 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.77 -15.7 23.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.04 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.51 -91.07 1.64 Allowed Glycine 0 N--CA 1.466 0.676 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.7 mt -154.61 140.53 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 121.614 0.721 . . . . 0.0 110.046 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.614 ' HE ' HD21 ' A' ' 83' ' ' ASN . 18.5 mmm180 -102.85 117.74 35.28 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.765 0.793 . . . . 0.0 110.456 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.577 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -80.79 -6.76 58.95 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.845 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.614 HD21 ' HE ' ' A' ' 81' ' ' ARG . 51.2 p30 -75.61 22.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.429 0.633 . . . . 0.0 110.659 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 82' ' ' LEU . 8.1 ptm180 -48.08 -12.02 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.662 -0.649 . . . . 0.0 111.266 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 83' ' ' ASN . 99.7 p -80.92 -7.78 59.58 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.919 0.39 . . . . 0.0 110.863 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -98.82 -151.78 0.39 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.416 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.42 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 82.4 mtt85 -144.85 147.71 33.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.312 0.577 . . . . 0.0 110.803 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.468 ' O ' ' O ' ' A' ' 14' ' ' LEU . 82.3 m95 -153.88 178.96 9.34 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.427 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.5 t70 -59.81 -170.24 0.01 OUTLIER 'General case' 0 C--O 1.235 0.328 0 O-C-N 123.77 0.669 . . . . 0.0 110.851 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.0 151.07 5.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.05 0.452 . . . . 0.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -127.97 158.61 37.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.558 0.694 . . . . 0.0 110.594 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.9 t -152.75 149.43 28.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.871 0.843 . . . . 0.0 110.49 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -141.06 149.96 42.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.598 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -151.43 149.72 25.06 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.347 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -71.3 -10.14 26.6 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 122.388 2.059 . . . . 0.0 112.013 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -152.14 165.37 34.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.53 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 53.59 -175.5 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp . . . . . 0 C--N 1.291 -1.965 0 CA-C-O 117.806 -1.092 . . . . 0.0 110.012 177.339 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.4 t -82.62 148.01 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.917 0.389 . . . . 0.0 110.789 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -136.07 134.92 38.92 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.699 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -74.96 138.29 42.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.5 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 22.6 tpt85 -118.15 131.27 56.42 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.252 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -139.3 146.04 39.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.44 124.65 23.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.916 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -72.28 -33.87 67.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.881 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 77.3 p -110.03 32.57 5.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.554 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.3 -136.22 2.07 Favored Glycine 0 C--O 1.218 -0.882 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.641 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -171.75 -30.59 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.683 0 CA-C-O 120.949 0.404 . . . . 0.0 110.574 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -153.86 61.98 0.72 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.17 32.76 3.13 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.042 0.449 . . . . 0.0 110.578 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 88' ' ' TRP . 41.8 mt -115.64 111.62 20.9 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.681 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.432 ' OG1' ' OE1' ' A' ' 18' ' ' GLU . 54.2 p -100.03 174.33 6.22 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.566 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 11.5 p90 -51.02 -52.62 41.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.891 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.421 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -55.09 -49.28 72.08 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.128 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 21.0 mp0 -66.58 -33.13 74.99 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.65 83.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.664 0.269 . . . . 0.0 110.975 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' O ' ' A' ' 23' ' ' CYS . 97.9 mttt -71.48 -31.67 67.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.679 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.95 -48.7 77.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.512 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.4 p -77.84 -24.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 120.931 0.395 . . . . 0.0 110.943 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.534 ' C ' ' H ' ' A' ' 25' ' ' PHE . 64.6 m -104.41 177.11 4.94 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 109.809 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 28' ' ' GLY . 78.9 tt0 67.53 -29.15 0.15 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.216 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.8 t80 -60.79 -48.49 81.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 110.734 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 3.4 pm0 -78.68 11.69 2.44 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.111 0.482 . . . . 0.0 110.916 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.18 -24.67 23.93 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -86.29 133.79 12.06 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -98.31 176.78 5.59 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.4 148.59 48.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.34 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.92 141.06 40.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.019 0.438 . . . . 0.0 110.966 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.4 p -123.52 158.38 31.46 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.022 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -55.16 -28.78 55.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.439 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -68.66 -52.7 28.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.045 0.45 . . . . 0.0 110.85 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.5 -37.35 74.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.998 0.428 . . . . 0.0 110.606 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.6 mt -62.73 -39.77 95.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.32 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -55.92 -40.09 72.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.586 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.01 -23.96 48.09 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.7 -19.99 60.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.945 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.588 HH12 ' CB ' ' A' ' 60' ' ' PRO . 10.2 mmm180 -60.79 -41.86 96.44 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.663 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.36 -5.0 39.78 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.757 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 42' ' ' ILE . 46.6 mm -95.78 0.15 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.519 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.37 19.3 46.03 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.619 -0.593 . . . . 0.0 111.619 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -61.49 121.24 12.2 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.98 0.419 . . . . 0.0 110.558 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -155.79 103.3 2.25 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.302 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.95 126.32 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.745 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.86 76.21 2.43 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.895 0.378 . . . . 0.0 110.417 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.03 94.04 2.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.612 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 106.27 0.21 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.351 0.596 . . . . 0.0 110.645 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.36 151.98 20.28 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.943 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -64.01 153.46 37.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.535 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 55' ' ' GLY . 17.9 ptp -155.34 -173.8 4.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.488 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -34.57 125.1 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.542 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttp 57.35 31.86 20.84 Favored 'General case' 0 C--O 1.2 -1.51 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.529 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 55.43 21.42 27.14 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.713 -0.617 . . . . 0.0 111.708 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.44 ' O ' ' SD ' ' A' ' 52' ' ' MET . 29.9 ttp85 -73.31 59.59 0.58 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.115 0.458 . . . . 0.0 110.888 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.9 p -43.47 151.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 121.253 0.549 . . . . 0.0 111.312 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.59 169.69 41.81 Favored Glycine 0 C--N 1.318 -0.441 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.534 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.6 p90 -158.16 76.88 3.56 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.299 -0.45 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' CB ' HH12 ' A' ' 40' ' ' ARG . 50.3 Cg_exo -56.38 143.61 85.98 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.476 2.117 . . . . 0.0 112.541 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 99.6 mt -137.66 96.61 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.516 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 m -64.79 -28.54 45.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.103 0.478 . . . . 0.0 110.292 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -150.93 146.72 19.58 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -41.68 151.73 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.895 1.73 . . . . 0.0 112.656 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.06 159.05 27.94 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.552 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -72.27 -38.96 3.23 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 121.992 1.795 . . . . 0.0 112.323 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.43 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.5 p30 -66.7 -21.63 66.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.643 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.43 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 9.7 p -162.62 133.71 4.97 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.436 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.75 177.72 1.34 Allowed Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 40.1 p90 -58.5 -52.63 64.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.904 0.383 . . . . 0.0 110.817 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.569 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . 43.22 74.09 0.21 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt 53.23 -175.53 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.936 0.398 . . . . 0.0 110.668 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.2 p -148.83 172.93 13.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.764 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 73.99 77.08 0.66 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 74' ' ' GLY . 76.8 mt 50.34 103.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.755 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 31.3 mm -104.84 123.63 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.081 0.467 . . . . 0.0 110.619 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -136.38 142.97 43.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.679 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -82.6 9.66 8.99 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.924 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.71 -92.52 1.8 Allowed Glycine 0 C--O 1.224 -0.47 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.0 mt -156.95 124.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.377 0.608 . . . . 0.0 110.005 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -102.76 126.84 50.04 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.974 0.416 . . . . 0.0 110.382 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.4 mm? -87.57 2.65 50.22 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.445 0.641 . . . . 0.0 110.775 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.33 26.02 6.39 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.805 0.812 . . . . 0.0 110.708 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -43.9 -26.07 0.24 Allowed 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.656 -0.652 . . . . 0.0 111.142 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -56.2 -14.32 2.69 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.768 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -74.08 166.37 23.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 110.727 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 82.1 mtt85 -96.72 127.8 43.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.711 0.767 . . . . 0.0 110.413 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 82.8 m95 -155.09 178.61 10.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.07 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 22.6 t70 -75.54 -170.49 1.27 Allowed 'General case' 0 C--O 1.235 0.319 0 O-C-N 123.866 0.729 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.47 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -166.04 159.54 15.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.224 0.535 . . . . 0.0 111.002 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -111.98 160.78 17.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.547 0.689 . . . . 0.0 110.265 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 2.7 t -145.13 177.26 8.91 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.495 0.664 . . . . 0.0 110.212 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -146.59 130.43 17.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.149 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 96' ' ' HIS . 0.3 OUTLIER -148.62 157.55 41.16 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.336 -179.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.56 5.44 0.12 Allowed 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 121.929 1.752 . . . . 0.0 112.238 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.498 ' H ' ' C ' ' A' ' 94' ' ' ASN . 83.9 t60 -109.99 94.34 4.97 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.614 0.721 . . . . 0.0 110.463 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -163.14 -120.49 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.106 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt . . . . . 0 C--N 1.29 -2.009 0 CA-C-O 117.194 -1.384 . . . . 0.0 108.582 175.931 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 t -81.28 141.08 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.658 0.266 . . . . 0.0 110.749 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -148.94 154.97 40.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.755 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -79.03 133.98 36.79 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.504 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -120.29 124.54 45.87 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.509 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -113.24 135.44 53.82 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.459 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.74 145.45 55.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.403 0.62 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -81.43 -50.12 9.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.5 p -113.14 34.56 4.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.487 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.18 -146.1 4.59 Favored Glycine 0 C--O 1.217 -0.928 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.709 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -175.9 -54.59 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 115.346 -0.427 . . . . 0.0 110.3 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -134.35 12.97 3.84 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -94.15 38.11 1.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.093 0.473 . . . . 0.0 110.442 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.94 131.88 55.34 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.501 0.667 . . . . 0.0 110.584 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.1 p -95.29 168.22 10.87 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.691 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 48.3 p90 -60.34 -41.14 93.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.59 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.75 -40.37 66.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.073 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -60.1 -49.4 77.8 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.778 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.81 -30.29 63.58 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.018 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.3 tttp -69.85 -38.18 76.38 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 120.792 0.33 . . . . 0.0 110.675 179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.09 75.51 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.56 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.39 -41.67 93.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 121.631 0.729 . . . . 0.0 110.983 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.0 m -100.35 177.79 4.94 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.968 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 64.31 -15.08 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.974 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' H ' ' C ' ' A' ' 23' ' ' CYS . 67.7 t80 -62.92 -50.18 71.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.985 0.421 . . . . 0.0 110.8 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -83.52 26.29 0.69 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.755 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.07 3.92 90.6 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.9 -151.81 2.83 Favored Glycine 0 C--O 1.219 -0.824 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -168.93 147.07 3.89 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.424 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.11 149.72 27.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.386 0.612 . . . . 0.0 110.252 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.58 146.47 53.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.069 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 t -124.63 178.17 5.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -58.27 -52.27 66.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.638 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -49.02 -47.23 44.71 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.016 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.17 -43.86 73.38 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.293 0.568 . . . . 0.0 110.737 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.58 -42.32 99.49 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.666 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -60.33 -30.42 69.51 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.905 0.383 . . . . 0.0 110.558 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.01 -27.22 54.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.01 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.64 -29.19 56.33 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.819 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mmm-85 -55.37 -30.99 61.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.376 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -82.63 -3.26 55.93 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 42' ' ' ILE . 33.6 mm -105.81 6.2 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.519 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.67 17.99 52.98 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -56.19 126.57 26.72 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.0 0.429 . . . . 0.0 110.546 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -131.18 128.79 40.74 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.361 0.6 . . . . 0.0 110.577 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 47' ' ' CYS . 84.1 t -139.58 160.05 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.776 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.505 ' N ' HG12 ' A' ' 46' ' ' VAL . 11.4 t -158.75 33.84 0.22 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.702 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' H ' HG12 ' A' ' 46' ' ' VAL . . . -145.29 128.78 17.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.136 0.493 . . . . 0.0 110.533 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.26 131.68 44.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.78 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.01 144.05 10.08 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.739 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.464 ' HE1' ' H ' ' A' ' 88' ' ' TRP . 9.4 m95 -65.68 158.11 28.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.585 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 64.8 mtm -151.22 -177.69 6.19 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.229 0.538 . . . . 0.0 110.195 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -41.38 128.54 3.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.576 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 56' ' ' ARG . 72.4 tttt 66.11 37.56 5.12 Favored 'General case' 0 C--O 1.201 -1.481 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.047 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.89 5.87 0.1 Allowed Glycine 0 CA--C 1.54 1.614 0 O-C-N 121.764 -0.585 . . . . 0.0 112.39 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.505 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 67.7 ttt-85 -66.38 89.36 0.14 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.257 0.551 . . . . 0.0 110.445 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.1 134.48 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.76 0.79 . . . . 0.0 110.337 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.28 26.28 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.577 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 21.1 p90 -162.52 81.44 1.71 Allowed Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.343 -0.429 . . . . 0.0 110.677 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 133.36 57.6 Favored 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.22 1.947 . . . . 0.0 112.57 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -118.3 109.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.369 0.604 . . . . 0.0 110.689 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 62' ' ' VAL . 2.2 m -84.63 -15.32 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.167 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.87 142.6 2.42 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-O 118.776 -0.63 . . . . 0.0 111.133 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.32 149.75 2.48 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 121.067 1.178 . . . . 0.0 112.709 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -122.17 157.51 16.88 Favored Glycine 0 CA--C 1.542 1.743 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.526 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.28 -43.21 0.13 Allowed 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 121.351 1.367 . . . . 0.0 112.178 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.419 ' OD1' ' SG ' ' A' ' 68' ' ' CYS . 27.0 p-10 -75.6 -21.3 57.92 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.347 0.594 . . . . 0.0 111.082 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.419 ' SG ' ' OD1' ' A' ' 67' ' ' ASN . 0.7 OUTLIER -124.86 144.0 50.54 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.062 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.44 -172.77 4.93 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.471 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.05 169.42 23.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.111 0.481 . . . . 0.0 110.79 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 174.49 -25.14 0.07 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.24 -177.92 5.24 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 110.419 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.6 p -138.52 156.67 47.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.775 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' ILE . . . 66.54 164.28 1.72 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' GLY . 76.6 mt -34.25 139.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 115.641 -0.28 . . . . 0.0 111.269 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.43 17.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.648 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.505 ' OD1' ' NH2' ' A' ' 56' ' ' ARG . 2.4 p30 -61.34 126.83 28.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.967 0.413 . . . . 0.0 110.689 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -68.73 -43.35 76.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.529 0.681 . . . . 0.0 110.495 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.9 -128.4 3.58 Favored Glycine 0 N--CA 1.474 1.192 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.1 mt -96.21 108.46 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 122.243 1.021 . . . . 0.0 110.019 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.71 ' H ' ' NE ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.766 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 84' ' ' ARG . 69.2 mt -90.26 -2.78 58.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.842 0.354 . . . . 0.0 110.593 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.3 OUTLIER -77.64 28.19 0.16 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.732 0.777 . . . . 0.0 110.764 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.598 ' HE ' ' NH2' ' A' ' 81' ' ' ARG . 99.4 mtt180 -51.12 -1.22 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.925 0 O-C-N 121.733 -0.605 . . . . 0.0 111.73 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 83' ' ' ASN . 9.2 m -96.9 2.26 51.46 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.801 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -87.02 -158.84 0.46 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.936 0.398 . . . . 0.0 110.564 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 33.4 ptt-85 -155.83 134.19 11.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.608 0.718 . . . . 0.0 110.802 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 13.2 m0 -147.46 -172.99 4.15 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.274 -178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 20.5 t0 -57.89 -148.28 0.0 OUTLIER 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.967 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.52 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.77 130.67 1.04 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.641 0.734 . . . . 0.0 110.754 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -122.9 157.96 31.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.471 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 93' ' ' TYR . 6.9 t -140.86 -173.8 3.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.746 0.784 . . . . 0.0 110.296 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.402 ' N ' ' SG ' ' A' ' 92' ' ' CYS . 63.7 t80 -155.93 121.55 4.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.279 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -152.33 147.53 19.72 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.042 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.29 0.84 7.41 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.415 2.077 . . . . 0.0 111.886 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.589 ' CG ' ' H ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -160.96 -113.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.294 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.589 ' H ' ' CG ' ' A' ' 96' ' ' HIS . . . 48.6 -103.0 0.1 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 C--N 1.29 -1.987 0 CA-C-O 117.735 -1.126 . . . . 0.0 109.901 175.623 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.0 t -83.25 154.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.128 0.49 . . . . 0.0 110.639 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 4' ' ' HIS . 75.1 t80 -118.98 139.16 52.14 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.755 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.477 ' O ' ' CE2' ' A' ' 3' ' ' TYR . 43.8 p-80 -74.77 130.63 39.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.507 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.1 tpp85 -141.23 136.43 31.69 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.078 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -167.13 177.49 6.19 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.289 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 126.61 25.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.759 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -70.28 -39.47 74.9 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.244 0.545 . . . . 0.0 110.447 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -112.67 28.55 8.69 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.95 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.67 -139.05 2.61 Favored Glycine 0 C--O 1.216 -1.028 0 C-N-CA 120.539 -0.839 . . . . 0.0 111.555 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -175.69 -66.98 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.272 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -105.5 47.61 0.87 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.4 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -132.29 31.05 4.13 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 120.937 0.399 . . . . 0.0 110.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp -118.32 126.09 51.42 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.54 0.686 . . . . 0.0 110.662 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 16' ' ' TYR . 45.4 m -99.5 160.4 14.31 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.517 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' N ' HG22 ' A' ' 15' ' ' THR . 41.2 p90 -53.38 -42.71 67.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.478 ' N ' ' CD1' ' A' ' 16' ' ' TYR . . . -55.39 -42.91 74.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.868 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.18 -49.76 47.12 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.662 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.57 -37.84 58.73 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.037 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 23' ' ' CYS . 57.9 tttm -71.34 -32.42 68.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.946 0.403 . . . . 0.0 110.817 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.33 -54.39 17.73 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.569 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.9 m -60.21 -36.85 70.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.21 0.529 . . . . 0.0 111.029 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 25' ' ' PHE . 2.0 t -103.31 176.23 5.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 65.29 -15.83 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.035 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.3 t80 -61.57 -48.14 82.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' OE2' ' ND2' ' A' ' 94' ' ' ASN . 14.4 pt-20 -81.63 20.87 0.87 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.76 -4.26 86.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.64 -155.16 1.09 Allowed Glycine 0 C--O 1.219 -0.796 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -170.54 145.26 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.449 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.5 mt -52.98 141.03 23.26 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.118 0.485 . . . . 0.0 110.564 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.28 106.55 0.9 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.044 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.9 m -69.92 146.99 50.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CG ' ' N ' ' A' ' 34' ' ' LYS . 5.4 p90 -53.55 -51.65 62.22 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.981 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' N ' ' CG ' ' A' ' 33' ' ' TYR . 64.8 tttp -60.82 -45.47 94.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 110.558 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -68.46 -27.21 65.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.769 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -28.26 66.62 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -51.45 -31.06 21.87 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.976 0.417 . . . . 0.0 110.746 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.1 73.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.18 -41.64 49.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.767 0.318 . . . . 0.0 110.889 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.564 ' NH2' ' N ' ' A' ' 62' ' ' VAL . 37.2 mmm-85 -56.66 -31.86 64.82 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -74.83 -10.67 59.73 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.644 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 42' ' ' ILE . 94.6 mt -101.75 4.95 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.558 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.7 14.14 47.92 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.37 128.31 35.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.905 0.383 . . . . 0.0 110.469 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -149.39 104.72 3.4 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.456 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.83 129.49 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.912 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -93.78 96.21 9.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.516 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.46 95.01 0.54 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.56 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.7 131.74 44.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.29 159.44 27.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.88 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -70.82 104.56 2.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 66.8 mtm -96.75 -175.56 3.33 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.219 0.533 . . . . 0.0 110.236 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -44.06 158.92 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.524 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 56' ' ' ARG . 63.0 mttp 50.63 38.02 17.89 Favored 'General case' 0 C--O 1.2 -1.523 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.388 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.72 0.46 0.03 OUTLIER Glycine 0 CA--C 1.54 1.603 0 O-C-N 121.878 -0.514 . . . . 0.0 112.062 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.582 ' H ' ' C ' ' A' ' 54' ' ' LYS . 5.5 mtt180 -69.55 149.06 48.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.141 0.496 . . . . 0.0 110.475 -178.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.63 141.63 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.441 1.115 . . . . 0.0 110.531 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.73 166.66 30.34 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.415 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -128.7 107.19 18.65 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.46 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.51 119.47 4.51 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.544 1.496 . . . . 0.0 112.486 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.516 ' H ' ' HA3' ' A' ' 74' ' ' GLY . 4.4 pt -148.83 93.8 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.722 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.564 ' N ' ' NH2' ' A' ' 40' ' ' ARG . 56.3 t -49.28 -21.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.282 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -142.92 146.28 36.82 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.321 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -46.12 154.51 0.79 Allowed 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.579 1.519 . . . . 0.0 112.622 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.25 154.5 26.0 Favored Glycine 0 CA--C 1.543 1.834 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.735 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.79 -41.47 1.07 Allowed 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.079 1.852 . . . . 0.0 112.353 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -65.62 -40.68 92.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.696 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.64 145.05 25.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.665 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.23 176.92 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.619 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -70.79 139.74 51.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.716 0.293 . . . . 0.0 110.471 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.4 135.41 1.88 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.615 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -62.09 -47.36 84.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.851 0.358 . . . . 0.0 110.177 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.484 ' O ' HD11 ' A' ' 76' ' ' ILE . 62.6 p -132.66 165.17 25.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.284 0.564 . . . . 0.0 110.904 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' H ' ' A' ' 61' ' ' ILE . . . -84.28 -155.49 22.21 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 77' ' ' ASP . 40.5 mt 68.88 -7.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 ' O ' ' A' ' 73' ' ' THR . 38.6 mt -63.55 67.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.623 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 75' ' ' ILE . 2.4 p30 -85.71 151.2 24.05 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.846 0.355 . . . . 0.0 110.446 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -89.48 -139.38 0.13 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.628 0.727 . . . . 0.0 110.184 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -144.68 95.56 0.18 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.421 -0.671 . . . . 0.0 111.421 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.8 mt 45.27 96.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.62 0.248 . . . . 0.0 110.674 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.433 ' O ' ' NH1' ' A' ' 84' ' ' ARG . 78.9 mtp180 -94.78 141.29 28.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.033 0.444 . . . . 0.0 110.081 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 83' ' ' ASN . 0.3 OUTLIER -79.58 3.98 17.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.604 0.716 . . . . 0.0 110.6 -179.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.466 ' N ' HD12 ' A' ' 82' ' ' LEU . 31.9 t30 -80.19 15.22 1.61 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.801 0.81 . . . . 0.0 110.304 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.433 ' NH1' ' O ' ' A' ' 81' ' ' ARG . 88.8 mtm-85 -58.72 -5.86 0.65 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 121.593 -0.692 . . . . 0.0 110.868 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -73.27 -35.58 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.646 0.26 . . . . 0.0 110.916 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -81.18 158.3 24.96 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.277 0.561 . . . . 0.0 110.617 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -86.84 149.11 25.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.734 0.778 . . . . 0.0 110.619 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -154.41 177.43 11.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.0 -172.56 2.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.647 0.737 . . . . 0.0 110.755 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -167.04 166.67 15.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.338 0.589 . . . . 0.0 111.053 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.88 156.86 46.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.953 0.882 . . . . 0.0 110.376 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 9.0 t -124.41 -167.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.308 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -159.21 145.96 16.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.999 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' ND2' ' OE2' ' A' ' 26' ' ' GLU . 12.1 m120 -149.75 143.88 17.18 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.287 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.84 6.46 3.74 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.901 1.734 . . . . 0.0 111.93 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -56.93 -44.91 82.93 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.118 0.261 . . . . 0.0 110.67 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.69 -68.51 0.31 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 C--N 1.289 -2.057 0 CA-C-O 117.837 -1.078 . . . . 0.0 108.28 175.5 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 t -84.49 136.52 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.656 0.265 . . . . 0.0 110.798 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.509 ' OH ' ' NH2' ' A' ' 5' ' ' ARG . 22.2 p90 -146.94 159.39 43.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.811 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -74.9 148.82 39.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.381 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.509 ' NH2' ' OH ' ' A' ' 3' ' ' TYR . 25.5 mmt180 -123.55 157.34 33.87 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.228 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -157.93 120.68 3.84 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.191 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 166.57 12.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.907 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.51 -36.62 81.4 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.536 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -64.81 -32.92 74.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.367 0.604 . . . . 0.0 110.632 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.71 177.73 23.19 Favored Glycine 0 C--O 1.216 -0.994 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.661 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -69.07 -105.14 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.328 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -68.8 69.92 0.18 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.24 0.543 . . . . 0.0 110.665 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -144.41 29.08 1.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.787 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 88' ' ' TRP . 23.5 mt -123.36 143.36 50.15 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 80.8 p -95.69 168.51 10.62 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.753 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.579 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 26.5 p90 -46.9 -56.15 6.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.841 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -53.07 -42.29 65.69 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.969 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.54 -26.73 68.02 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.947 0.404 . . . . 0.0 110.555 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.95 -36.97 67.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 111.297 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -71.05 -30.63 66.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.222 0.534 . . . . 0.0 110.555 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.01 -49.3 75.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.614 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.56 -28.9 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.352 0.596 . . . . 0.0 110.839 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.598 ' C ' ' H ' ' A' ' 25' ' ' PHE . 82.2 m -105.28 179.16 4.35 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.029 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 24' ' ' GLU . 15.3 mp0 64.6 -28.29 0.1 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.887 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' H ' ' C ' ' A' ' 23' ' ' CYS . 59.4 t80 -62.18 -45.26 94.18 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 110.803 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -95.71 9.18 41.26 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.97 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.42 -4.06 66.55 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.32 -175.16 44.75 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -154.33 162.41 41.18 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.831 -0.185 . . . . 0.0 110.705 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 30' ' ' LEU . 9.4 mp -71.09 147.23 48.68 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.087 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.71 151.31 38.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.075 0.464 . . . . 0.0 110.806 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 m -125.02 156.66 37.79 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.155 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -54.05 -21.31 8.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.397 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -76.01 -57.24 3.99 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.117 0.484 . . . . 0.0 110.813 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -68.73 -33.13 73.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.756 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.4 mt -60.47 -42.46 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.507 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -67.59 -34.76 77.68 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.805 0.336 . . . . 0.0 110.555 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.4 -33.9 73.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.057 0.456 . . . . 0.0 110.957 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -23.62 28.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.695 ' HE ' ' HB2' ' A' ' 60' ' ' PRO . 3.8 tpt85 -60.85 -42.55 98.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.567 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -60.87 -2.45 0.57 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.782 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 40' ' ' ARG . 18.5 mm -101.23 17.19 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.259 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.33 19.99 79.79 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -59.37 105.03 0.3 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 117.156 0.478 . . . . 0.0 110.39 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -95.48 133.65 39.22 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.247 0.546 . . . . 0.0 110.389 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 47' ' ' CYS . 18.3 t -137.39 159.37 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.683 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 68' ' ' CYS . 2.9 t -156.11 42.03 0.39 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.752 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.68 125.18 3.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.039 0.447 . . . . 0.0 110.723 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.38 138.74 45.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.815 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.38 152.79 24.81 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.924 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -68.07 101.96 1.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.062 0.458 . . . . 0.0 109.954 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 58' ' ' GLY . 1.4 mtp -91.38 166.29 12.97 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.649 0.738 . . . . 0.0 109.852 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 52' ' ' MET . . . -39.48 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.59 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt 58.68 7.52 0.76 Allowed 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.373 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.89 87.17 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 121.814 -0.554 . . . . 0.0 112.106 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -76.29 131.93 39.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 117.005 0.403 . . . . 0.0 110.632 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.81 112.5 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 121.855 0.836 . . . . 0.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' N ' ' SD ' ' A' ' 52' ' ' MET . . . -166.53 177.85 41.22 Favored Glycine 0 C--N 1.318 -0.424 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.541 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CZ ' HD11 ' A' ' 61' ' ' ILE . 7.1 p90 -167.84 142.28 2.96 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.745 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.695 ' HB2' ' HE ' ' A' ' 40' ' ' ARG . 72.8 Cg_endo -72.35 147.17 46.58 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.001 1.801 . . . . 0.0 112.651 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.447 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 17.7 mt -139.68 93.86 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.842 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -67.61 -41.85 86.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.346 0.593 . . . . 0.0 110.542 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -136.95 101.42 9.46 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.955 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.73 130.04 14.91 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.815 1.677 . . . . 0.0 112.474 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.29 176.91 22.04 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.397 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.99 -51.75 0.27 Allowed 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 122.335 2.023 . . . . 0.0 112.241 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -67.54 -37.24 82.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 110.71 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 1.5 p -152.24 123.05 7.45 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.361 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 71' ' ' GLY . . . 178.69 -26.63 0.05 OUTLIER Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 90.1 t80 52.9 -85.56 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 110.763 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -172.98 -172.99 39.08 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 54.08 -171.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.398 . . . . 0.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.58 HG22 ' N ' ' A' ' 74' ' ' GLY . 35.6 m -144.86 167.24 23.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.207 0.527 . . . . 0.0 110.63 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.58 ' N ' HG22 ' A' ' 73' ' ' THR . . . 93.64 -151.7 20.45 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 65.1 mt -100.97 128.61 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.392 . . . . 0.0 110.39 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.7 mt -132.03 71.06 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.415 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -93.23 135.03 34.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.842 0.353 . . . . 0.0 110.579 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.39 110.67 22.67 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.059 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -49.92 95.95 0.01 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.5 mt 49.39 100.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.756 0.312 . . . . 0.0 110.805 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.835 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 70.6 mtp180 -68.81 148.07 50.83 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 84' ' ' ARG . 10.9 mp -74.95 -28.78 60.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.885 0.85 . . . . 0.0 110.555 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.835 HD21 ' CZ ' ' A' ' 81' ' ' ARG . 18.0 p30 -73.18 32.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 122.028 0.918 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' LEU . 66.0 mtp180 -48.65 -6.99 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.632 -0.667 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.54 ' N ' ' O ' ' A' ' 83' ' ' ASN . 32.5 t -87.19 -8.2 57.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.987 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -91.39 147.57 22.94 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.696 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 75.6 mtm180 -83.31 152.36 25.15 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.266 0.555 . . . . 0.0 110.51 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.562 ' NE1' ' NH1' ' A' ' 81' ' ' ARG . 73.5 m95 -156.02 179.12 9.52 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.326 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 11.8 t70 -76.05 -161.54 0.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.826 0.822 . . . . 0.0 110.471 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.08 152.7 6.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.783 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -130.15 158.75 38.85 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.726 . . . . 0.0 110.408 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -133.11 -173.28 3.16 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.613 0.721 . . . . 0.0 110.138 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -155.29 113.4 3.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -117.41 85.81 20.95 Favored Pre-proline 0 N--CA 1.475 0.808 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.703 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.85 10.29 3.57 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 122.48 2.12 . . . . 0.0 112.355 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.635 ' CG ' ' H ' ' A' ' 97' ' ' ALA . 2.0 p-80 -144.46 -62.92 0.37 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.275 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.635 ' H ' ' CG ' ' A' ' 96' ' ' HIS . . . -61.61 -33.39 73.84 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 54.2 tttp . . . . . 0 C--N 1.289 -2.035 0 CA-C-O 116.954 -1.498 . . . . 0.0 108.034 176.918 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.243 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 t -84.89 145.87 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.63 0.252 . . . . 0.0 111.094 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -161.23 156.54 24.31 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.032 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -87.69 116.23 25.68 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.486 0.66 . . . . 0.0 110.752 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -103.85 121.5 43.2 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.993 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -103.85 130.7 51.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.545 0.528 . . . . 0.0 110.362 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.23 172.5 13.72 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -60.32 -34.7 74.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.967 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.548 ' O ' ' C ' ' A' ' 10' ' ' GLY . 73.9 m -82.14 -20.21 38.44 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.302 0.573 . . . . 0.0 110.513 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.548 ' C ' ' O ' ' A' ' 9' ' ' SER . . . 16.57 81.79 0.01 OUTLIER Glycine 0 N--CA 1.494 2.541 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.267 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -172.52 37.67 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 120.923 0.392 . . . . 0.0 110.398 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 52.25 62.01 2.91 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -132.08 31.83 4.09 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 120.698 0.285 . . . . 0.0 110.694 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 32.2 mt -122.09 128.24 51.1 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.518 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.3 p -98.16 170.55 8.82 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.642 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 17' ' ' ALA . 30.3 p90 -51.45 -60.14 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.032 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.584 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -52.39 -37.28 56.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.883 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -67.97 -49.61 60.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.499 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.07 -34.92 58.69 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.645 0.26 . . . . 0.0 110.861 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 23' ' ' CYS . 71.0 mmtt -61.84 -41.88 98.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.551 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.55 -49.43 77.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.63 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.0 t -58.1 -37.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.498 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 25' ' ' PHE . 3.4 m -101.76 -179.27 3.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 94.4 mt-10 71.04 -18.79 0.26 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.879 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 23' ' ' CYS . 79.5 t80 -60.39 -45.94 91.77 Favored 'General case' 0 CA--C 1.528 0.096 0 CA-C-O 121.213 0.53 . . . . 0.0 110.75 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -86.57 15.87 5.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.528 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.7 7.69 87.78 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -86.5 -158.55 31.77 Favored Glycine 0 C--O 1.218 -0.882 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -162.96 156.51 19.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.735 -0.233 . . . . 0.0 110.409 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.6 mp -69.16 136.66 52.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.116 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.45 122.52 16.93 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.678 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 35' ' ' GLN . 9.0 t -103.83 178.72 4.48 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.031 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -52.49 -52.48 54.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -57.76 -44.94 86.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 0.0 110.568 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.405 ' H ' HG23 ' A' ' 32' ' ' THR . 69.2 tp60 -70.37 -37.7 74.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.263 0.554 . . . . 0.0 110.738 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.88 -43.01 94.3 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.414 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -55.69 -47.43 76.81 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.82 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -32.23 71.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.077 0.465 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.24 -29.14 24.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.185 0.516 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.477 HH22 HG12 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -60.91 -40.52 93.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.502 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -60.49 -4.03 0.8 Allowed 'General case' 0 N--CA 1.458 -0.05 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.64 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 40' ' ' ARG . 16.8 mm -99.18 22.9 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.385 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.51 28.93 71.83 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -70.29 126.09 28.64 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.663 -0.316 . . . . 0.0 110.427 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.465 ' CD2' ' CG2' ' A' ' 62' ' ' VAL . 0.4 OUTLIER -149.98 103.69 3.23 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.175 0.512 . . . . 0.0 110.37 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -140.16 129.94 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.685 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 14.8 t -90.72 69.34 6.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.331 0.586 . . . . 0.0 110.279 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB1' ' OH ' ' A' ' 91' ' ' TYR . . . -148.63 95.26 2.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.653 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.97 153.2 36.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.75 171.76 36.94 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.889 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -85.37 105.0 15.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.785 0.326 . . . . 0.0 110.528 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -93.27 176.52 6.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.145 0.497 . . . . 0.0 110.302 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -35.49 153.65 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.694 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt 54.8 8.91 0.25 Allowed 'General case' 0 C--O 1.199 -1.562 0 CA-C-O 121.089 0.471 . . . . 0.0 110.12 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 53' ' ' ALA . . . 74.75 20.68 79.41 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.941 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.566 ' HE ' ' CG ' ' A' ' 77' ' ' ASP . 63.0 ttt180 -77.09 140.05 40.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.646 0.26 . . . . 0.0 110.692 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.4 p -121.14 134.95 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-O 121.677 0.751 . . . . 0.0 110.972 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.36 113.95 0.7 Allowed Glycine 0 N--CA 1.468 0.772 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 91' ' ' TYR . 0.6 OUTLIER -109.27 156.27 39.64 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-O 120.415 0.15 . . . . 0.0 110.755 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.32 133.13 22.12 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.446 1.431 . . . . 0.0 112.044 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 73' ' ' THR . 3.4 mt -144.33 95.77 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.588 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.477 HG12 HH22 ' A' ' 40' ' ' ARG . 0.2 OUTLIER -47.11 -38.55 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.67 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -149.02 147.73 24.85 Favored Pre-proline 0 N--CA 1.479 0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.824 -179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -52.87 139.28 60.22 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 120.986 1.124 . . . . 0.0 112.456 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.46 177.9 22.31 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.862 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.63 -51.0 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.628 1.552 . . . . 0.0 112.153 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -66.92 -27.71 67.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.682 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.08 151.39 21.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.193 0.521 . . . . 0.0 110.031 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 70' ' ' PHE . . . -164.37 -5.56 0.04 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.407 ' H ' ' H ' ' A' ' 69' ' ' GLY . 42.3 t80 -68.33 -1.88 7.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.3 0.571 . . . . 0.0 110.315 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.3 -165.82 26.34 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.576 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.15 79.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.614 0.245 . . . . 0.0 110.791 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER 176.81 173.79 0.41 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.459 0.647 . . . . 0.0 110.319 179.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -46.7 -95.39 0.01 OUTLIER Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.5 mt -99.34 108.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.477 0.656 . . . . 0.0 110.208 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 pt -105.87 45.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.834 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.566 ' CG ' ' HE ' ' A' ' 56' ' ' ARG . 34.7 t0 -89.0 118.98 29.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.025 0.441 . . . . 0.0 110.721 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -67.15 -64.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.553 0.692 . . . . 0.0 110.33 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 130.04 95.12 0.73 Allowed Glycine 0 N--CA 1.477 1.427 0 N-CA-C 111.844 -0.503 . . . . 0.0 111.844 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' A' ' 79' ' ' GLY . 70.1 mt 56.76 129.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 121.762 0.792 . . . . 0.0 110.993 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.0 mmm-85 -111.61 143.04 43.13 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.512 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 82' ' ' LEU . 3.0 mm? -86.73 -8.5 57.34 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.377 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -108.55 23.79 14.0 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.49 0.716 . . . . 0.0 111.072 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 86' ' ' GLU . 80.4 mtm180 -44.37 -27.47 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.672 -0.643 . . . . 0.0 111.432 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.2 p -47.07 -17.09 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.004 0.19 . . . . 0.0 110.956 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -60.89 -176.64 0.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 179.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.459 ' O ' ' CD1' ' A' ' 88' ' ' TRP . 68.5 mtp85 -125.19 136.63 53.77 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.458 0.647 . . . . 0.0 111.026 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 71.2 m95 -153.01 -176.64 5.86 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.141 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -73.07 -167.58 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD1' ' A' ' 91' ' ' TYR . . . -153.23 146.97 25.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.141 0.496 . . . . 0.0 111.108 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.499 ' OH ' ' HB1' ' A' ' 48' ' ' ALA . 17.6 m-85 -140.61 160.74 39.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.775 0.798 . . . . 0.0 110.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 19.5 m -136.44 -165.8 1.78 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.108 0.956 . . . . 0.0 110.06 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -141.04 151.13 43.82 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.271 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 96' ' ' HIS . 4.2 m120 -134.34 149.21 70.58 Favored Pre-proline 0 N--CA 1.476 0.835 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.856 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.79 23.93 0.29 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 121.564 1.509 . . . . 0.0 111.644 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 94' ' ' ASN . 6.3 m-70 -80.21 -159.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.822 0.344 . . . . 0.0 110.329 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 52.74 77.43 0.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.185 0.517 . . . . 0.0 110.548 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--N 1.29 -2.015 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.828 177.197 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.145 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.8 m -125.38 132.75 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-O 120.876 0.37 . . . . 0.0 110.962 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' OH ' ' CZ ' ' A' ' 5' ' ' ARG . 31.4 p90 -103.03 155.24 18.52 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.034 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -73.02 126.12 29.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.498 0.666 . . . . 0.0 110.548 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' CZ ' ' OH ' ' A' ' 3' ' ' TYR . 89.5 mtt-85 -101.91 167.29 10.15 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.384 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -163.56 120.42 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.24 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.89 169.53 17.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.33 -40.64 81.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.597 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 t -70.85 -24.36 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.402 0.62 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.62 -170.82 22.9 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 13' ' ' LYS . 26.1 pttm -108.37 -173.39 2.27 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-O 121.17 0.509 . . . . 0.0 110.527 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 42.23 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 11' ' ' LYS . 64.9 mttm -133.28 28.86 4.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.66 0.384 . . . . 0.0 110.696 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 88' ' ' TRP . 33.1 mt -124.82 135.37 52.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.233 0.539 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 16' ' ' TYR . 85.6 m -89.84 161.1 16.15 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.589 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.518 ' N ' HG22 ' A' ' 15' ' ' THR . 32.6 t80 -49.89 -59.52 3.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.65 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.22 75.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -62.22 -49.15 76.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.584 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.57 -33.37 32.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 16.2 tptp -58.62 -40.19 82.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.116 0.484 . . . . 0.0 110.419 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.04 -48.25 78.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.316 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.58 -22.09 17.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.426 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.505 ' C ' ' H ' ' A' ' 25' ' ' PHE . 53.3 m -103.94 179.48 4.26 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.567 0.698 . . . . 0.0 109.518 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 70.8 mt-10 70.6 -19.08 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 23' ' ' CYS . 85.8 t80 -61.16 -46.29 91.13 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.977 0.418 . . . . 0.0 110.837 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.2 5.46 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.915 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.9 51.42 2.64 Favored Glycine 0 N--CA 1.472 1.097 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.05 -152.87 5.73 Favored Glycine 0 N--CA 1.47 0.901 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.02 179.02 7.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.1 mt -70.92 142.49 51.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.29 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.93 148.04 48.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.24 0.543 . . . . 0.0 110.811 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 34' ' ' LYS . 7.2 m -123.54 149.41 45.27 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.259 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CD1' ' NH2' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -61.09 -20.89 63.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.215 179.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' H ' HG22 ' A' ' 32' ' ' THR . 37.0 ttmt -75.87 -57.12 4.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.095 0.474 . . . . 0.0 110.739 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -68.82 -31.86 71.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.001 0.429 . . . . 0.0 111.015 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.4 mt -61.5 -36.11 79.58 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.368 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -49.9 -29.41 8.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.002 0.429 . . . . 0.0 110.661 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.39 -25.57 33.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.413 0.625 . . . . 0.0 111.025 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.69 -42.53 17.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -56.04 -34.7 66.13 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -58.29 -23.57 56.76 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.45 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.4 mm -82.5 24.16 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.92 24.19 74.35 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.66 128.73 37.08 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.517 ' CE1' ' H ' ' A' ' 63' ' ' LYS . 58.4 t60 -135.74 110.25 8.54 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.445 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.21 112.3 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.738 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.5 t -93.72 73.75 4.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.409 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.09 118.99 8.7 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.228 0.537 . . . . 0.0 110.778 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -80.25 134.19 36.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.54 -143.7 4.21 Favored Glycine 0 N--CA 1.476 1.3 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -130.8 105.93 8.11 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 15.1 mmt -91.54 156.13 17.89 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.267 0.556 . . . . 0.0 109.647 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.03 169.3 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.53 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' A' ' 56' ' ' ARG . 99.3 mttt 55.64 38.53 30.28 Favored 'General case' 0 C--O 1.199 -1.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.869 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.84 6.36 0.32 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' NH2' ' CD1' ' A' ' 33' ' ' TYR . 25.3 mtp180 -84.31 162.99 19.88 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.424 0.631 . . . . 0.0 110.598 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.8 p -142.2 135.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.723 0.773 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.01 157.15 26.78 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.445 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 26.9 p90 -165.89 80.82 1.11 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.298 -0.451 . . . . 0.0 110.795 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.95 143.82 59.14 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.026 1.817 . . . . 0.0 112.677 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.4 mt -132.02 91.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.414 0.626 . . . . 0.0 110.707 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.8 t -80.41 -20.23 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 60.0 mttp -140.94 86.33 11.72 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.907 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.95 136.8 52.65 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 122.02 1.813 . . . . 0.0 112.218 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -119.26 173.91 15.2 Favored Glycine 0 N--CA 1.474 1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.405 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.46 -47.15 3.26 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.06 1.84 . . . . 0.0 112.284 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 68' ' ' CYS . 39.2 p-10 -66.71 -36.62 82.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.704 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.465 ' N ' ' OD1' ' A' ' 67' ' ' ASN . 23.0 p -153.55 119.39 5.33 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.049 0.452 . . . . 0.0 110.477 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -169.3 88.54 0.09 OUTLIER Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -64.97 161.23 19.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.946 0.403 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -42.55 99.71 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -70.62 166.65 20.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.871 0.367 . . . . 0.0 110.563 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.4 p -139.64 159.83 41.26 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.17 -140.66 15.17 Favored Glycine 0 N--CA 1.466 0.697 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 82.9 mt -89.24 119.17 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.925 0.393 . . . . 0.0 110.556 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.5 mm -94.73 98.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.407 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 59.3 t0 -98.39 141.79 30.83 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 110.322 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 25.3 m-85 -129.99 147.51 51.75 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.669 0.747 . . . . 0.0 110.05 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -71.79 -78.73 0.46 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.8 mt -157.81 108.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.569 ' CZ ' HD21 ' A' ' 83' ' ' ASN . 52.0 mtp180 -69.08 140.95 54.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.329 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.2 mt -85.49 -10.23 56.35 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.335 0.588 . . . . 0.0 110.777 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.569 HD21 ' CZ ' ' A' ' 81' ' ' ARG . 13.1 p30 -83.27 22.6 0.98 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.474 0.654 . . . . 0.0 110.379 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 -52.0 -5.84 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.644 -0.66 . . . . 0.0 111.361 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 83' ' ' ASN . 62.8 m -91.89 -5.13 53.81 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.838 0.351 . . . . 0.0 110.856 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -85.29 -152.8 0.16 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.399 0.619 . . . . 0.0 110.422 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.419 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 83.3 mtt85 -142.94 151.2 40.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.817 0.818 . . . . 0.0 110.564 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CD1' ' C ' ' A' ' 87' ' ' ARG . 86.2 m95 -154.9 177.37 11.37 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.267 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 36.2 t0 -60.45 -156.06 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.816 0.698 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.541 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.68 141.95 2.97 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.168 0.509 . . . . 0.0 110.947 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.408 ' CD1' ' O ' ' A' ' 90' ' ' ALA . 16.3 m-85 -140.34 142.25 35.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.52 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.437 ' SG ' ' NE ' ' A' ' 5' ' ' ARG . 49.8 m -115.56 -167.33 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.827 0.822 . . . . 0.0 110.077 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -156.42 143.68 19.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.455 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -152.11 148.95 22.18 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -40.53 154.44 0.06 OUTLIER 'Trans proline' 0 N--CA 1.505 2.165 0 C-N-CA 122.345 2.03 . . . . 0.0 112.985 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -57.13 107.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.795 0.807 . . . . 0.0 110.66 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.19 -36.36 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.873 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt . . . . . 0 C--N 1.292 -1.91 0 CA-C-O 117.897 -1.049 . . . . 0.0 109.13 176.485 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.06 148.68 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.746 0.308 . . . . 0.0 110.815 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -143.62 162.51 35.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -73.51 132.63 43.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.345 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.656 HH21 ' N ' ' A' ' 91' ' ' TYR . 73.5 mtm180 -117.99 149.22 41.31 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.502 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -154.78 125.02 6.78 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.594 0.559 . . . . 0.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.08 179.11 0.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.461 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -61.07 -48.62 80.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.504 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 82.2 p -87.39 -2.8 58.87 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.205 0.526 . . . . 0.0 110.513 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 39.23 66.59 0.68 Allowed Glycine 0 N--CA 1.472 1.068 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -143.99 41.82 1.42 Allowed 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.747 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 45.78 28.98 0.63 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.678 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.48 39.87 0.86 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.283 0.563 . . . . 0.0 110.825 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' TRP . 6.1 tp -120.31 127.74 52.64 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.781 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.8 p -90.94 167.75 12.19 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.529 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -61.23 -48.01 83.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.337 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.13 -38.92 71.47 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.05 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.7 -50.16 63.76 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.736 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.55 -31.6 24.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.178 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.541 ' O ' ' O ' ' A' ' 23' ' ' CYS . 26.1 mtpp -64.6 -34.92 79.39 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.428 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.16 62.77 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.65 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.04 -40.87 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.323 0.582 . . . . 0.0 111.213 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.586 ' C ' ' H ' ' A' ' 25' ' ' PHE . 4.2 t -100.53 175.69 5.59 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.907 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 63.22 -15.84 0.06 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.144 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 23' ' ' CYS . 78.7 t80 -61.87 -49.1 77.61 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.98 0.419 . . . . 0.0 110.633 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.92 22.52 0.38 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.765 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.04 0.91 89.58 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.31 -148.8 4.7 Favored Glycine 0 C--O 1.219 -0.82 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -164.66 152.97 12.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.666 0.27 . . . . 0.0 110.631 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.15 145.18 54.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.051 0.453 . . . . 0.0 110.224 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -64.03 107.33 1.23 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.903 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 p -88.01 167.14 13.95 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.745 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.552 ' HB2' ' HE ' ' A' ' 56' ' ' ARG . 69.6 t80 -54.66 -53.61 52.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.983 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -55.75 -43.86 77.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.993 0.425 . . . . 0.0 110.32 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.26 -32.23 68.46 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -40.58 95.29 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.3 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -51.56 -49.38 62.16 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.25 64.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.004 0.431 . . . . 0.0 110.649 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.78 -37.02 31.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.2 -27.83 62.31 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -78.2 -4.55 48.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.67 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 42' ' ' ILE . 76.9 mt -96.0 8.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 121.137 -0.225 . . . . 0.0 110.478 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.52 21.45 44.08 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -69.38 131.78 45.33 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 122.741 -0.27 . . . . 0.0 110.354 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -149.89 105.28 3.39 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.076 0.465 . . . . 0.0 110.469 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.19 118.02 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.83 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 32.4 t -91.88 84.05 5.31 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.191 0.52 . . . . 0.0 110.293 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.25 94.73 0.46 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.635 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.43 138.2 46.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.82 -172.42 13.92 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.931 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.7 156.74 17.31 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.527 0.679 . . . . 0.0 110.47 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 56' ' ' ARG . 67.4 mtm -148.09 175.02 11.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.205 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -42.99 147.74 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.299 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 56' ' ' ARG . 9.0 mtmp? 57.69 40.43 26.49 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.659 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 53.2 7.72 0.58 Allowed Glycine 0 CA--C 1.532 1.13 0 O-C-N 121.794 -0.566 . . . . 0.0 111.8 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.552 ' HE ' ' HB2' ' A' ' 33' ' ' TYR . 32.2 ttt85 -68.14 146.42 53.45 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.321 0.581 . . . . 0.0 110.586 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 m -127.15 162.16 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-O 121.668 0.747 . . . . 0.0 110.807 -179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.02 169.25 39.57 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.492 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' CZ ' ' O ' ' A' ' 76' ' ' ILE . 3.8 p90 -154.95 79.89 4.54 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.386 -0.407 . . . . 0.0 110.322 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.44 128.97 32.67 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.21 1.94 . . . . 0.0 112.682 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.4 mt -138.38 103.33 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.476 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.5 p -70.61 -24.14 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.304 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -161.76 143.81 8.72 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.567 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -41.23 166.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.717 1.612 . . . . 0.0 112.85 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.9 166.8 39.75 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.535 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.68 -41.89 13.53 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.403 2.068 . . . . 0.0 112.212 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -66.11 -36.06 82.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.004 0.43 . . . . 0.0 110.327 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.9 p -156.53 146.41 21.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.181 0.515 . . . . 0.0 110.491 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -159.85 44.02 0.44 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -73.66 142.74 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.574 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.55 -104.69 0.89 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -162.95 -63.49 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.888 0.375 . . . . 0.0 110.469 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.8 p -145.72 171.1 15.24 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.387 0.613 . . . . 0.0 110.636 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.32 -153.33 20.46 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.6 mt -99.57 -60.35 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.755 0.312 . . . . 0.0 110.827 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.482 ' O ' ' CZ ' ' A' ' 59' ' ' TYR . 52.3 mt 56.88 105.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.317 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.467 ' OD2' ' NH2' ' A' ' 56' ' ' ARG . 4.8 p30 -136.37 148.98 48.11 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.03 0.443 . . . . 0.0 110.946 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -72.82 -72.4 0.25 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.619 0.723 . . . . 0.0 110.449 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 150.05 -135.17 5.14 Favored Glycine 0 N--CA 1.469 0.881 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -88.69 107.22 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.399 0.619 . . . . 0.0 110.151 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -94.16 129.79 40.62 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.44 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.6 pp -86.17 0.14 54.35 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.424 0.631 . . . . 0.0 110.85 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.452 HD22 ' C ' ' A' ' 83' ' ' ASN . 0.4 OUTLIER -87.73 23.6 1.95 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.83 0.824 . . . . 0.0 110.328 179.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -45.1 -24.32 0.23 Allowed 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.617 -0.677 . . . . 0.0 111.662 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 m -50.54 -23.03 2.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.751 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.24 -168.26 0.76 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 0.0 110.813 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.25 139.22 44.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.391 0.615 . . . . 0.0 110.946 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' LEU . 86.8 m95 -154.18 176.2 12.54 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.451 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 19.0 t70 -71.23 -169.65 0.41 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.361 0.601 . . . . 0.0 110.859 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.486 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -168.9 161.05 10.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.158 0.504 . . . . 0.0 111.002 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.656 ' N ' HH21 ' A' ' 5' ' ' ARG . 96.7 m-85 -138.57 152.81 48.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.636 0.732 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 43.2 t -129.99 144.48 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.285 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' OH ' ' CE1' ' A' ' 96' ' ' HIS . 85.0 t80 -119.48 122.0 40.71 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.359 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -109.13 169.83 6.04 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.063 -179.049 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.55 140.29 75.27 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 121.942 1.761 . . . . 0.0 112.146 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.435 ' CE1' ' OH ' ' A' ' 93' ' ' TYR . 97.0 m-70 -46.84 122.72 4.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.32 0.581 . . . . 0.0 110.785 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -168.61 32.72 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.742 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.554 ' HZ1' HG21 ' A' ' 42' ' ' ILE . 19.9 ptmt . . . . . 0 C--N 1.29 -1.997 0 CA-C-O 117.94 -1.029 . . . . 0.0 110.153 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -83.8 151.92 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.043 0.449 . . . . 0.0 110.716 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -126.75 126.94 44.29 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.559 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -76.02 148.48 38.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.48 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -133.18 143.19 49.04 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.366 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -147.07 146.64 30.05 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.263 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.93 132.4 46.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.95 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -81.04 -49.13 11.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.1 m -112.41 -33.85 6.06 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.61 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.57 177.75 53.98 Favored Glycine 0 C--O 1.215 -1.047 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -134.69 95.82 3.43 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.453 0.644 . . . . 0.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 53.13 70.73 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.467 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -140.72 40.54 1.85 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 120.774 0.321 . . . . 0.0 110.504 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 88' ' ' TRP . 46.3 mt -117.61 122.49 43.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.1 p -100.68 166.1 11.06 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.17 0.51 . . . . 0.0 110.723 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -49.11 -58.86 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -42.48 59.21 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.021 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.9 -26.56 66.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.526 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.46 76.9 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.038 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' CYS . 51.4 mtmt -67.17 -24.29 65.86 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.567 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.12 -55.46 9.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.634 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 23' ' ' CYS . 8.5 p -67.77 -44.7 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.026 0.441 . . . . 0.0 111.199 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.491 ' O ' ' O ' ' A' ' 20' ' ' LYS . 3.7 m -114.31 162.09 17.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.308 0.575 . . . . 0.0 109.583 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 23' ' ' CYS . 48.8 tt0 84.33 -46.11 0.09 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.813 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -62.73 -46.37 88.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.048 0.451 . . . . 0.0 110.942 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.23 16.8 0.71 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.946 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.71 -16.6 60.72 Favored Glycine 0 N--CA 1.47 0.94 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.21 -153.18 0.02 OUTLIER Glycine 0 C--O 1.218 -0.883 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.6 ' CD2' HE22 ' A' ' 35' ' ' GLN . 66.8 t60 -173.25 143.5 1.11 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.473 ' O ' ' CD2' ' A' ' 29' ' ' HIS . 73.6 mt -78.18 136.23 37.78 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.158 0.286 . . . . 0.0 110.541 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.32 132.38 48.24 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.252 0.549 . . . . 0.0 111.082 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.38 167.1 14.85 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.121 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -50.49 -22.21 1.83 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.693 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -75.25 -57.96 3.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.172 0.51 . . . . 0.0 110.684 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.6 HE22 ' CD2' ' A' ' 29' ' ' HIS . 78.6 mt-30 -70.78 -34.87 72.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.7 mt -61.1 -39.76 91.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.441 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -57.78 -31.05 66.15 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.775 0.322 . . . . 0.0 110.673 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.98 -24.33 48.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.338 0.589 . . . . 0.0 110.956 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.3 -45.31 33.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.201 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.45 HH21 HG12 ' A' ' 62' ' ' VAL . 20.2 mmm-85 -52.98 -31.55 41.41 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -69.46 -4.32 18.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.571 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.654 HG22 ' O ' ' A' ' 42' ' ' ILE . 74.3 mt -108.86 15.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.443 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.16 16.75 71.12 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.516 -0.633 . . . . 0.0 111.516 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -65.29 143.06 58.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.904 0.352 . . . . 0.0 110.343 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -155.35 107.91 2.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.356 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 46' ' ' VAL . 17.6 m -139.0 111.56 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.817 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.26 75.06 6.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 0.0 110.238 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.52 135.29 11.73 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.817 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.32 139.38 31.72 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.47 -174.26 21.41 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.804 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -94.12 143.27 26.52 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.415 ' O ' ' C ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -145.3 173.41 12.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.142 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 52' ' ' MET . . . -33.78 142.86 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.685 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 62.17 14.95 7.05 Favored 'General case' 0 C--O 1.201 -1.488 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.252 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.48 16.98 68.15 Favored Glycine 0 CA--C 1.527 0.822 0 O-C-N 121.831 -0.543 . . . . 0.0 111.964 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.745 HH22 ' H ' ' A' ' 78' ' ' TYR . 51.6 ttt-85 -70.84 161.41 31.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.977 0.418 . . . . 0.0 110.61 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.7 p -133.18 148.57 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 122.269 1.033 . . . . 0.0 110.458 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.77 168.28 40.57 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.405 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -154.64 76.79 5.39 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.128 -0.536 . . . . 0.0 110.334 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.77 133.1 49.02 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.474 2.116 . . . . 0.0 112.692 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -147.19 145.11 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.124 179.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.45 HG12 HH21 ' A' ' 40' ' ' ARG . 29.4 m -82.12 -30.93 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.123 0.487 . . . . 0.0 110.443 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -152.68 152.15 28.11 Favored Pre-proline 0 N--CA 1.475 0.776 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.427 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -47.3 151.32 2.83 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.026 1.818 . . . . 0.0 112.324 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.96 166.88 27.38 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.793 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.17 -48.44 19.45 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.833 1.689 . . . . 0.0 112.737 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -64.94 -27.34 68.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.5 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.43 144.93 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.08 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.94 -12.3 0.04 OUTLIER Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -55.64 -36.42 66.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.956 0.408 . . . . 0.0 110.775 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -70.88 -166.39 6.64 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -73.43 -162.18 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.227 . . . . 0.0 110.534 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 166.69 22.19 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.268 0.556 . . . . 0.0 110.819 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.527 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . 67.76 67.03 2.11 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' O ' ' A' ' 74' ' ' GLY . 4.5 mt 53.23 125.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.572 -0.314 . . . . 0.0 111.071 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mt -119.91 91.03 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.569 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -66.89 143.39 56.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.924 0.392 . . . . 0.0 110.583 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.745 ' H ' HH22 ' A' ' 56' ' ' ARG . 59.2 m-85 -132.66 -96.59 0.31 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.523 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.42 -155.38 17.61 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.554 -0.832 . . . . 0.0 111.394 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.9 mt -100.85 123.27 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.723 0.773 . . . . 0.0 110.079 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.48 141.92 34.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.186 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 82' ' ' LEU . 1.2 pt? -82.65 -2.57 54.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -77.83 25.69 0.2 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.84 0.828 . . . . 0.0 110.649 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' H ' ' C ' ' A' ' 82' ' ' LEU . 33.4 mtp-105 -49.4 -4.82 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.599 -0.688 . . . . 0.0 111.783 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 83' ' ' ASN . 72.2 p -83.1 -32.12 26.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.611 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -76.91 -163.65 0.37 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.092 0.472 . . . . 0.0 110.692 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.432 ' C ' ' CD1' ' A' ' 88' ' ' TRP . 60.9 mtt85 -139.27 154.24 47.92 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.52 0.676 . . . . 0.0 110.62 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.445 ' O ' ' O ' ' A' ' 14' ' ' LEU . 81.1 m95 -154.13 174.99 13.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.196 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 23.9 t0 -61.06 -175.99 0.05 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.727 0.775 . . . . 0.0 110.972 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -157.23 150.85 24.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.415 0.626 . . . . 0.0 111.069 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -118.94 159.58 23.55 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.525 0.679 . . . . 0.0 110.641 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.9 m -134.8 175.18 9.79 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.774 0.797 . . . . 0.0 110.216 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 93' ' ' TYR . 4.6 t80 -159.9 134.48 7.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.825 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -145.35 148.59 38.11 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.101 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -72.85 13.27 0.62 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.432 2.088 . . . . 0.0 111.753 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -140.8 21.7 2.31 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.678 0.275 . . . . 0.0 110.35 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.79 -68.71 0.3 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.056 0.931 . . . . 0.0 108.535 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? . . . . . 0 C--N 1.29 -2.004 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 176.219 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.467 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.6 m -154.19 137.73 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 120.779 0.324 . . . . 0.0 110.698 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -123.12 123.68 41.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.506 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.401 ' O ' ' ND1' ' A' ' 4' ' ' HIS . 5.1 p80 -86.86 149.32 24.9 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.527 HH22 HD21 ' A' ' 94' ' ' ASN . 75.4 mtt85 -143.77 147.62 34.43 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.228 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -146.43 158.33 43.88 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.26 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.86 126.41 27.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -71.06 -35.82 72.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.453 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.0 p -111.01 19.89 18.02 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.628 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.01 -137.6 2.92 Favored Glycine 0 C--O 1.216 -1.03 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.657 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -171.93 -42.67 0.02 OUTLIER 'General case' 0 C--O 1.216 -0.703 0 CA-C-N 115.301 -0.449 . . . . 0.0 110.468 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -143.3 67.34 1.3 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.451 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -137.02 37.59 2.56 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.254 0.221 . . . . 0.0 110.533 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -120.98 123.92 43.62 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.451 0.643 . . . . 0.0 110.384 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 16' ' ' TYR . 52.4 m -100.37 163.19 12.49 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.581 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.516 ' N ' HG22 ' A' ' 15' ' ' THR . 13.5 t80 -51.45 -52.33 47.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.8 -42.03 83.39 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.88 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.64 -51.5 59.04 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.775 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.82 -30.71 15.03 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.014 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -70.51 -33.22 70.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.196 0.522 . . . . 0.0 111.009 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.8 -53.46 21.5 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.849 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.29 -26.61 34.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.084 0.469 . . . . 0.0 110.365 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.491 ' C ' ' H ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -104.75 177.28 4.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.593 0.711 . . . . 0.0 109.385 179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 28' ' ' GLY . 96.5 mt-10 67.67 -10.92 0.35 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.705 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 23' ' ' CYS . 81.8 t80 -62.57 -47.75 82.47 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.926 0.393 . . . . 0.0 110.789 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 1.9 pm0 -92.16 9.45 33.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.772 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.77 -17.16 56.84 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 24' ' ' GLU . . . -82.69 127.28 7.89 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -100.1 173.17 6.76 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.639 0.257 . . . . 0.0 110.538 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' H ' HD12 ' A' ' 30' ' ' LEU . 2.0 mp -65.39 135.8 55.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.606 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.96 102.23 0.77 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.056 0.455 . . . . 0.0 110.629 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.471 ' OG1' ' N ' ' A' ' 33' ' ' TYR . 1.5 t -72.43 179.85 3.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.778 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.471 ' N ' ' OG1' ' A' ' 32' ' ' THR . 64.4 t80 -56.0 -54.58 43.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.936 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -53.4 -50.47 65.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.845 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.556 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -66.18 -38.91 89.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.372 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 18.1 mt -61.67 -42.52 99.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.474 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.62 -50.46 73.78 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.717 0.294 . . . . 0.0 110.789 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.81 -33.13 55.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.028 0.442 . . . . 0.0 110.858 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -84.33 -39.67 18.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.109 0.48 . . . . 0.0 111.226 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -30.16 21.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.286 -178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -69.16 -2.78 11.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.523 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 39' ' ' ALA . 5.6 tp -92.45 9.46 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 123.112 0.258 . . . . 0.0 110.475 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.6 26.65 34.86 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -75.96 136.32 40.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 117.019 0.409 . . . . 0.0 110.449 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -154.02 103.04 2.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.55 129.05 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.757 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 39.9 t -93.96 83.46 4.35 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.494 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.54 95.79 0.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -65.08 134.91 54.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 0.0 110.779 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.46 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -140.85 170.64 24.43 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -81.51 156.75 25.12 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.227 0.537 . . . . 0.0 110.358 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 4.8 mpp? -151.44 176.87 10.86 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 110.292 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -40.79 142.85 0.41 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.53 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 59.63 41.21 19.09 Favored 'General case' 0 C--O 1.201 -1.474 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.341 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.13 12.82 0.86 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 121.737 -0.602 . . . . 0.0 111.689 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 52' ' ' MET . 57.8 ttt180 -68.06 143.23 55.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.419 0.628 . . . . 0.0 110.502 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 p -139.28 142.08 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.994 0.902 . . . . 0.0 110.928 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.01 -178.52 39.98 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.684 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 28.8 p90 -148.18 103.12 3.56 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.083 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -79.15 129.72 8.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 120.87 1.047 . . . . 0.0 112.308 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.1 pt -146.79 136.3 16.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.456 0.646 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.1 t -83.45 -26.49 7.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.432 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -156.03 150.5 20.14 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.262 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -42.24 130.64 4.75 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.508 1.472 . . . . 0.0 112.723 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.26 167.79 15.16 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.094 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -69.01 -34.54 16.85 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.937 1.758 . . . . 0.0 112.145 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -88.28 -10.16 50.53 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.435 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.2 p -170.54 141.35 1.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.612 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 175.18 9.36 0.02 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' CD2' ' N ' ' A' ' 71' ' ' GLY . 54.5 p90 -62.63 -45.47 92.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 110.663 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' N ' ' CD2' ' A' ' 70' ' ' PHE . . . -60.58 -103.83 0.01 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -164.97 -151.98 0.16 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.78 0.324 . . . . 0.0 110.255 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.7 p -95.17 170.03 9.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.571 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.22 145.83 0.09 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.645 ' H ' HD12 ' A' ' 75' ' ' ILE . 2.4 mp -46.48 130.32 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.764 0.316 . . . . 0.0 110.952 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.8 mt -119.23 54.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.655 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 78' ' ' TYR . 44.5 t0 -63.79 140.67 58.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 110.485 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.463 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 49.4 m-85 -92.31 4.51 53.19 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.119 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 80' ' ' ILE . . . 58.66 84.48 0.04 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 79' ' ' GLY . 68.5 mt 50.32 104.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.079 0.466 . . . . 0.0 111.038 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -88.54 157.93 18.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.258 0.551 . . . . 0.0 110.313 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 82' ' ' LEU . 9.9 mp -84.68 -6.67 59.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.216 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 85' ' ' SER . 49.8 p-10 -74.68 21.2 0.11 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.618 0.723 . . . . 0.0 110.606 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 82' ' ' LEU . 96.1 mtt180 -49.42 -10.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.6 -0.688 . . . . 0.0 111.052 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.46 ' N ' ' O ' ' A' ' 83' ' ' ASN . 22.8 t -83.42 -36.22 24.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.624 0.249 . . . . 0.0 110.591 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -75.24 152.58 38.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.291 0.567 . . . . 0.0 110.709 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -86.97 153.81 21.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.786 0.803 . . . . 0.0 110.566 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -153.86 174.92 13.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.125 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.58 -161.96 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.536 0.684 . . . . 0.0 110.996 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.06 141.98 12.95 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.284 0.564 . . . . 0.0 111.039 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -114.79 150.53 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.899 0.856 . . . . 0.0 110.261 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . 0.444 ' HB2' HH11 ' A' ' 5' ' ' ARG . 1.5 m -142.26 -173.34 3.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.354 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 1' ' ' GLY . 3.6 t80 -160.28 118.23 2.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.062 0.458 . . . . 0.0 109.993 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.527 HD21 HH22 ' A' ' 5' ' ' ARG . 3.0 m120 -103.61 150.69 38.36 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.992 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 97' ' ' ALA . 76.1 Cg_exo -50.0 138.27 35.48 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 121.285 1.323 . . . . 0.0 112.285 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 95' ' ' PRO . 95.1 m-70 31.62 -88.83 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.53 0.681 . . . . 0.0 111.403 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 95' ' ' PRO . . . 54.89 58.42 4.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.827 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 C--N 1.29 -1.996 0 CA-C-O 118.755 -0.641 . . . . 0.0 110.223 176.498 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.6 t -82.32 149.25 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 121.063 0.459 . . . . 0.0 110.718 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -111.25 130.43 55.66 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.73 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -74.51 129.3 37.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.547 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 62.2 ttm-85 -144.42 148.2 34.32 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.132 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.45 171.99 18.99 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.321 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.36 160.71 16.71 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.06 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -78.43 -27.73 46.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.301 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.6 p -72.6 -31.77 65.44 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.267 0.556 . . . . 0.0 110.966 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.09 160.19 12.21 Favored Glycine 0 C--O 1.216 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.633 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -68.06 -48.37 65.78 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.806 0.336 . . . . 0.0 110.673 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -98.52 49.35 0.98 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.013 0.435 . . . . 0.0 110.215 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -136.44 24.23 3.19 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.944 0.402 . . . . 0.0 110.456 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.1 tp -120.68 129.96 53.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.807 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 63.9 p -85.14 161.33 19.69 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.66 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CG ' ' N ' ' A' ' 17' ' ' ALA . 50.0 p90 -60.16 -46.5 89.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.773 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.463 ' N ' ' CG ' ' A' ' 16' ' ' TYR . . . -57.01 -40.71 77.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -66.08 -52.6 47.37 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.807 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.48 -31.62 56.2 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.231 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -68.15 -43.02 79.19 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 121.417 0.627 . . . . 0.0 110.932 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.19 -49.35 76.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.356 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -59.92 -26.27 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.396 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -105.35 174.79 5.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.401 179.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' CYS . 39.2 mt-10 77.02 5.04 3.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.592 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -73.19 -37.74 66.37 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.157 0.503 . . . . 0.0 111.1 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -91.92 12.75 20.65 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.561 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.69 8.21 80.4 Favored Glycine 0 N--CA 1.468 0.807 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.519 ' H ' ' CD ' ' A' ' 26' ' ' GLU . . . -93.84 -157.25 33.0 Favored Glycine 0 C--O 1.218 -0.851 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -162.58 157.27 21.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.62 0.247 . . . . 0.0 110.721 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 58.2 mt -49.69 147.76 3.41 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.498 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.65 91.9 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.029 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 35' ' ' GLN . 11.9 t -74.48 179.16 4.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.961 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -58.36 -53.41 58.56 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.816 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -56.17 -47.57 78.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.582 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.51 ' NE2' ' CG ' ' A' ' 93' ' ' TYR . 54.3 tt0 -69.38 -37.56 77.62 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.957 0.408 . . . . 0.0 110.643 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 mt -62.49 -42.56 99.57 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.411 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.96 -41.74 99.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.793 0.33 . . . . 0.0 110.653 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.12 -36.98 68.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.797 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.52 -24.44 34.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.153 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -57.46 -30.64 65.21 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.428 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -79.17 -6.6 56.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 42' ' ' ILE . 79.1 mt -94.04 1.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.525 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.91 30.41 9.52 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -71.31 135.29 47.32 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.662 0.268 . . . . 0.0 110.502 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.44 ' CE1' ' H ' ' A' ' 62' ' ' VAL . 79.0 t60 -155.87 102.67 2.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.181 0.515 . . . . 0.0 110.284 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.9 t -142.88 117.89 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.927 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.7 t -91.86 94.88 9.53 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.844 0.354 . . . . 0.0 110.309 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -173.75 115.15 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.559 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.05 142.2 52.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.457 ' O ' ' SD ' ' A' ' 52' ' ' MET . . . -157.28 170.81 34.51 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.803 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.417 ' C ' ' SD ' ' A' ' 52' ' ' MET . 79.5 m95 -83.71 157.82 22.03 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.307 0.575 . . . . 0.0 110.185 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.457 ' SD ' ' O ' ' A' ' 50' ' ' GLY . 0.7 OUTLIER -152.8 177.45 10.71 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.281 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -45.0 145.3 1.0 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.372 0.606 . . . . 0.0 111.194 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' A' ' 56' ' ' ARG . 68.7 mttm 56.6 42.74 26.71 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.167 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.29 10.98 0.38 Allowed Glycine 0 C--N 1.314 -0.672 0 O-C-N 121.746 -0.596 . . . . 0.0 112.085 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.623 HH22 ' CB ' ' A' ' 77' ' ' ASP . 64.2 ttt-85 -65.05 143.56 57.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.333 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.8 148.44 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.447 1.118 . . . . 0.0 110.781 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.1 -172.98 39.82 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.313 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' O ' ' CD2' ' A' ' 59' ' ' TYR . 40.7 p90 -155.36 102.72 2.22 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.251 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.8 132.16 11.72 Favored 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 121.759 1.639 . . . . 0.0 112.4 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.8 pt -145.92 147.33 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.836 0.826 . . . . 0.0 110.909 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.44 ' H ' ' CE1' ' A' ' 45' ' ' HIS . 14.8 t -116.06 -12.34 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.3 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -144.21 157.22 57.2 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.063 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -37.84 147.08 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.258 1.972 . . . . 0.0 112.548 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.64 79.82 0.35 Allowed Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.412 -0.66 . . . . 0.0 111.545 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.76 -48.12 23.73 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.439 2.093 . . . . 0.0 112.325 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -81.84 30.19 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.131 0.491 . . . . 0.0 110.472 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 70' ' ' PHE . 7.1 p -178.45 -165.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.56 86.23 0.01 OUTLIER Glycine 0 CA--C 1.532 1.144 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 68' ' ' CYS . 51.6 p90 -83.29 23.64 0.88 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.134 0.492 . . . . 0.0 110.494 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -131.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -79.14 -143.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.974 0.416 . . . . 0.0 110.36 -179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.1 p -128.35 171.71 11.77 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.582 0.706 . . . . 0.0 110.39 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.6 155.25 0.76 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 80.1 mt -41.53 145.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 123.617 0.245 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.2 mt -141.7 51.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.644 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.623 ' CB ' HH22 ' A' ' 56' ' ' ARG . 7.1 p-10 -60.62 151.77 28.08 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.894 0.378 . . . . 0.0 110.643 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -88.73 -80.35 0.29 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.23 71.01 0.02 OUTLIER Glycine 0 N--CA 1.474 1.196 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.124 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.6 mt 53.99 91.15 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.333 0.587 . . . . 0.0 110.905 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 -87.8 155.93 19.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.506 0.669 . . . . 0.0 110.664 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 84' ' ' ARG . 53.5 mt -84.17 3.06 36.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.294 0.568 . . . . 0.0 110.281 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 85' ' ' SER . 0.9 OUTLIER -72.99 18.57 0.1 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 122.214 1.006 . . . . 0.0 110.476 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.474 ' H ' ' C ' ' A' ' 82' ' ' LEU . 93.7 mtt-85 -49.74 -11.69 0.06 Allowed 'General case' 0 C--N 1.321 -0.651 0 O-C-N 121.591 -0.693 . . . . 0.0 111.199 179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 83' ' ' ASN . 64.7 m -87.09 -42.32 13.14 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.631 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -66.48 155.59 37.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.159 0.505 . . . . 0.0 110.403 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -90.72 148.96 22.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.215 0.531 . . . . 0.0 110.483 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -154.13 175.59 13.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.249 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 90' ' ' ALA . 8.4 t70 -79.57 -169.45 1.94 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.598 0.713 . . . . 0.0 110.713 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.447 ' H ' ' CG ' ' A' ' 89' ' ' ASP . . . -169.33 168.92 9.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.359 0.6 . . . . 0.0 110.928 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -135.68 141.57 44.98 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.4 0.619 . . . . 0.0 110.536 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.57 143.53 45.49 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.737 0.78 . . . . 0.0 109.763 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.51 ' CG ' ' NE2' ' A' ' 35' ' ' GLN . 74.4 t80 -115.63 150.63 36.39 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.162 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -139.36 153.02 70.5 Favored Pre-proline 0 N--CA 1.476 0.866 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.11 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.09 160.57 48.14 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.826 2.35 . . . . 0.0 112.253 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -47.43 95.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.021 0.915 . . . . 0.0 110.932 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.16 -57.31 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.958 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 175.449 . . . . . . . . 1 1 . 1 stop_ save_